%PDF-1.6 % 129 0 obj <> endobj 156 0 obj <>/Filter/FlateDecode/ID[<2B793C921F46A241A42488A6F1E90108>]/Index[129 37]/Info 128 0 R/Length 112/Prev 496220/Root 130 0 R/Size 166/Type/XRef/W[1 2 1]>>stream hbbd``b` $"_ $mD, : $[@ @1ȼ $b=sAk% "@v q #?SOX endstream endobj startxref 0 %%EOF 165 0 obj <>stream hb```c``Jb`e`صA, 3)005r ضͶ:Ѐ"aU %Xd#;? ә9Y/p{toˌ\9<$\v760{pO‡þ d ͟/* cK* endstream endobj 130 0 obj <> endobj 131 0 obj <>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 132 0 obj <>stream hެ 0Ee~@aDҮ u  .=̅R@ (e#)0˗G (KRI S)w͸z_641dyƌzJ.~Tϥ(7:eM׹1P -Q endstream endobj 133 0 obj <>stream HWio6_!SZ4q6Y@XX^Y&M}gxV# sy3tB ')Ӯc%%NSJ /V'翬hs9ӉWY,E(Kҥ},c+Uq卄b # TBځ̕-@lHF)ED | @#H"q/Xc# F,J BMF:=fAW[  `-Ro2 ̰X xd 9qA=+\U_JO>O.R5Fj>3v1jxPy26[fhD35J|f:yk}ĝɈ fvsm\t .+TM>stream HWˎ6Wh bOˮ2Bc4$ӯ_evЍ1}9|Q%LbbxR.pm Z<=?;̸ k&k´JWNmLRwF[o:K.?YT ƶr .|V߲.A 뾪-ܟִK<@? 8}]>7lnfB@ { TMP B)^wֈ!B2ӊhH9 C<]Ϭvl]i5$%N cv|mvԕ0LuhBn/%QUM8F{u&,X e+e{ ec`e6pJ{_4ӧǯGc/}[??xAWv]ҲTDܞ6RQQ@Do.՛./肕0uױN͕/ўv#I4:}MV25q: $0 ]nf}4.Oр0WLjoiB8,0*`+(K#ӈݚ{ D%[! $ý’ ufkhsɕ!H< H=HIRT0+H3=6dBsD αn9Bj>kl8i&=8= m!8]a {> 7#)nAJ)l?vmp.$8ǡvU(D:rkj0WwiHSi׳úaȆb΂6U'(1wsbZJc3k\0]AU2,KOX40JLK v ޑ$4:FZk #**u Hۡ aԤc6ro8Lܙ Cϩ귅V<%uemnc4R0&86zY %F>}pΌi\BUxk437eZQ7zy`&{}4=$8aK:㨉E{#gt ₥(2sچ:[3vQ~< /UJ#X t*~~ LƪW*̲XА&ptcdCV$da(}Nj0W3u q&dj8U_5 EihȤB3Eܲ F=~ge@.,J?eݍrς68<%Qmm72#Vu?Y705!~Sv[ lKzVpe¹ ]6܊JmChh4&,ܭ=JRC3u$57L⛔2]8s,1f0U_<=6JOovqN%Q\ܦ+Z@{xm()86X'8k endstream endobj 135 0 obj <>stream HWmo6_|ɶ(&mÆatN YNERΆN{o:aeuZ_-0Bd/ɺd$[m8[F$I Bjx[7f0bDzޝz1x.)) W|W1IlcŜyÍdfR<*XBY.z2``ڞb0[4gܫ2|ݴ><)ʵviɃdةO%Irm0c!O`X?M_ܙCD(RbQ7E`%$lQj9Mad)̳%+-< rx8G|j{w&~ESUp2Yj_x4 h: XYs^^*wFUb2qL5WvاՀa\ 2>yP嗿;Sٛ7/fg޾}K%iĨ(AR/muOD"zz (+i]׮`I/PcK5y&8#R`gG|Ԉ i( x&jސqդ|YEuߚFE~sA?汓{'uJG cT"w/[Gv;StESãB4/f>QzjS(&c{?f:AbrӔOy؁U>-lKCUXٰ|/< IZr8p6 ҽ/.^y ˩[Q ֘& s1,^1"2Q4CCysdj jFA[HN$ =$gbbO``e4%N*.R?@v"K8kRm2N(7d+/qK@du;$d]PhɤKH `ʎCۮ3]ۀyut`lۆCToF3{]A1CeFbJ k/˩8p~4k A^,cUvmsP+BĈsOȚB å_$xcCa%D~0@C"砕'CP(2 sclё0] ?զ !ƌȐ@8`>=!` Y/6bx| 3+>7Vkۭi&:3<(WɸՃ+ƇMKþ4;{z(ɧ1Q~)#a85;зmPb "h7sۓ1e c5ꊾ8&3ͥ(S`H=` |6j=*e#vTaO b>lʯϡ% 9 &KAԒh%  KV EiSkg}, )6Xsr]2^ɄwzqCs訶."(/wÄN[`NIXv&\e()'VE9nuK" r9,m҇$N9}dܱibZKO>stream HWێ6}߯[R`E 4m(P(6VcK,QL!JÙ3g1œb.0DXm^V];5E|b_wK%RDYi a?H(7<J"J (VM6p21Z/lq`,KĤ6+}qlc#Z4'T#!ӫStgwX7_뀒IS< =T>5}Ftϧ+&`) D|Vd/%,ǜP>$أSP1qibJƫ1DnzWUw ~*cc*,4GSw_y8Y;pϤ iưpE)gug۪Oذh#TDz5϶5k! 9iXe״ߦ 1Z@5SL8cӷU|0@Xkӷ[Yz2' f}L\f/E܌`wN$TH%GS<䛉"y}*#u qN"v'ŒO&F]-C}NIڈ.ԓ8|[ ㉒m_x^?4IMZ8r2DO>uu:%hJO$weIGDɨBCbҳ:fBjCFѩrj(~2;R. hwR8昒0KNRޤYA'T±9{x5uޑC[5Gip.L .hc|eg*UjC4މ7?[իǷM]_yX +V[W; 0=Tc:9"svks|^-T09(uo4ܜ'l~(# oz.9CU/y_/. endstream endobj 137 0 obj <>stream HWM61v~MR9T(6V`K$gCѶM pfޛ77sOw0^ӯ.%Tb.JU? kᅠвX Wp B K3K(y֎RɽJ[6wo:unC7h*e46}q]l)SH#aWŘ4غvU] .c{`P 71^W*x:yoVauu~BiԌs.aW4aJ==kΜL?C3edqJ1(U®X?i3EkBoa_ፚ>C= 7!IK3U-TG??U3*~^5_Rd,d9~Ve"ʩfuص? \o5xB[j-'l¹[PFc'vj"OTuPiGgWM"Cw<-#1vη.j+sPvY\Μc4ii3^,p)¥soɃ9z6M}*-rFG%z>;Qs˩%6z#NlصЀ̨@tܦ=,o;4n㋱Y쐙Wd3`[3T䧮=,X:ݢvpp \۠ wR=D|Q&ڽlQ[S|m;Weʐ)Cux9y,y>u_2cʫ|vy_uOW<_z.Ҩ:HFI n,;kf cS+e9\E̙"3`+5e0͐@)oLk(!<_سzJM(T|읮m5KĎU}އim>fUXYxS%N4xR +4RD1uRć|oR' endstream endobj 138 0 obj <>stream HWIoFW = 4(*-6T)n},o/J`oRm 67o6ߐIY_ZG¨pO=Va4ZSfwRQRӊQ]Zk;0~[7J+8~mmo }@+RL [lƄ73738ṯ_c|^K%U$%HaUoR炀Ĕ+p.Z_XmoS<%Ś>þ6ynjvB1z6a.a|e6EG9a(ѵ7ptKWK0b\PBB$D 0%-FXC*#M<3osB,ը993qaY?Īз~k&j*|;;gT^.>w6zY+&]l/"OȀRa1-`&ێ+X4#JБJL' eh4U~Xϟy2N6*| vW8;} g| D:ZJsN.6C+vAW0Nub`BP ݾ&H`Vpa‡ w'@lDݾ\%2ekp2ѹO.YQ3 bYlaG6ik &K.0<"$y։^;F%NQ.L"eX|eΛ#Sˤ)qJ֫l%BSaL.?fl|DC؁g&>?uf6 ?#^R#+naD`.Ųh/6lk}#ɪ,Ls8]+*#r2,1H7 T @sקRGLAYRk\Fr4{ο3$E$gN aָuH!,7Om jE8I#D%u2)*Y:%,u+Ÿϙ -&a9q Go/CWS[w)p=xe=PĪз+[,pZ%N>stream HWۊH}2=}@Cf)fYHBP$VYYN@}|i' ˩SGT<[|{\ byEUHoS4/HÙ;k?QS?e10LXө?87[SX7‡ah?28 >u[O2Z&wknһ6)%20IzY_LIL~(F l˶eI'c:c)Y0엍nB>AJt#.Hh.VLjY(()BSJįbH;# (&EЉaȨԦ`쒯D 3P$% ,IR\Aup0j }PM. G]- +yʦcպV.;4.X o$)BMe6HX.+ 1!&nco ϙ9Oî7M6n'caMeLN:4t72ge3Np5A $Tժ-*>zJmҩ˲"&z f"oarnr'6 SsSʔoBHbv[ 寰 QיiB-$<' <?+,L3kB*|BI6T^_>l[Ŷ9jz Ycyq6 q?`M9bQ0NU9 mӭ*챂I.P~G1TD cS7eU?g%&H9uT9,pˆ,H'Q njaUvnٔacO*p$#ĸR*WnLd.Ui]S\RH`&*ƿ=s8 nیޝGǘϞ A)HB;V?Y3"/̠z)7p~yL}xlSx c`ھf"lw1u?Mi+z ć.F/{Cm !R8/1ڄ_Ī| MpY^>.G^#,e, j+'0 soeIj3aG#,ēY|iUn(ԐzlUt2& IK)vQ.MdrơUBIˆ”+x^~Ӌz>'^ƣ*¶;&|V|'L a  Ma4zElѲٟ~]KF˭in2LiU Gwwo/_| w9?`}ϐKd5X9+1*kzz2Jsb Wz=ݸc^}S0pa^v]>stream HW[F~?B'p @B>$ll9V%#ɹwV{J^7$|37l J\ 3V2HA,@g3+'BRZ;D> b#ܠO/H P+o~y]ܽܽ=?qg,9tlof[ JÃ_ _ 3)%R2ùm/Px7-$)Yz:Ӡn:T7 4j9\ؚH!(=.SN)ð,a4 'TC'&ApBCdb50U# [X2JPiMr` K:dcw:y(Pqsmk7%hpֶ&ݖU.6ҹl5:?HrҶqT .8M>\áWp(`){՛`UӘ"Å@Ad/nĸ(5?sBI)ն&( H) Y&Jav^;y8U۱x/_6&eH+s Qd每َhj|>%M+zIbGRb|o7 +1 +@)KĜP cm}=\xc2na[ gx'>'V4xMWߟO+]&O$ud,4 N<{3Z2i|/lErzSD^[4+ۓ\^q{T:evO;0$hX\u/ҩ" nu!V+CFZSu{̢V%/7(pdtʶ"{Xy>e6uie8yC!K&C~ZFDARn@OTNԃ w_#(|qT;ָ4bu4HZKmiC?  ~˜y9j/ANAI)X(S8$y-VaMKPd*` 7 endstream endobj 141 0 obj <>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 22921/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream 3͒Sv5(hVI~hxG<We.tT17Piȷw5*ZpZz3% &;n_z&g)!"gv>zL>)YG c1}o gR^k4jSNwQ!LeD)aˋP>HȺ,D3?lkV,:Ra3tK*a.4jJPyDԮ7l i%Vyz0,V %Y2Ȳұ`d BjJu:8Q{%Z=V/RZ x[Hׂm|;۟gJƑ?֬ @iI9RM1.J8U&nPƝͥ ɮ}Q+ְ-VҢki,{$׍A> 53By䥍oKrQ%ym݇[Ld,PylD){2 /jJ%w.ls3` z¢m}V5 S< :ΏUXe:,[gجabdj,B[m!k";[`qOB{̡]ps}xM'~F+14s i{;nG]*/voz5'}3ù*'jqNwg_3h4 ^;8wuѰ#'X.sVXPc* _R h](E*k(A߇F Fd4>ܗ? TΰyV1 &Ƽ+8C3cxpޜ3<31tfD|Q2hͶDj(BQV0 E"ٕ?ǔU)JV`Y:K?tF@N&yUmnF_-qп ,*qI~muf%d0\ˑz*W7vdá1PrOʧ+rh~7JOmٖn/ .~leY 05{!gdPբ9Ѻn7I r|T4xsOTnRAP_U1h˳ƶe |Tůޘ$ (}Ē83!ÆYqqS׭3Q+r<` zޏ>|75;ˏG0(x6;!o]#?oJ7;vWG^K y2 Os .dD"O慴b"2[O;7IB{:PG]o!7'7hqJEZJB(I }omę {5LMS4tM(uIYk3 2e\J:KxJ){u'1eSՅޘgq&[`V^)r c q=KKw5ˣ4<E\q+ƺTC^O,hwl+mtfQ̙Da+mL0Z\*AVã(G9AX#p/k(rD4v/&(̞ Kt?~W^]4hLUz[N IdDVDIe XqdvN|62 .F.%s@!_52C.e  2,FU0s$ ZeKIE;&+©?ѮFiIY~{:v,Kkg_h욎zm`?7Wrn$"p/ή]޴PבFH"ƊzTtV"i[=߫ v;ǣ7XAu&0wr1IV]vp5O%5dLd&D-Vă՜=xy̫=);bdNVm=zhqN.Rf-e%];a\Yk}'}+r0Xְl LgMXyQDyFtLS*D7j2̄e~M2]B K&on/^nTfX~ g\ŵ׌*͑aFJt#?R/z '*9(!~q]jϭ%cD_ti:eyiQlA8Y$_O}؇ '{\dSC*Lfy T#ЪW-W5 Tf֩9KЀhnwyJA4 ۘ7MJ0HD/Ud6{VT ,ډ%,)_uwd`*o`w=yҠc͍ꪡqH$;xxΈNxG_C9 x6?Sx|?1=n=ܽ$ O|D~AjdL֧q0EH۫DJİ߈8i>f61)G bk¢CAlmiݱ6 !N'^ $(\dn4h"P-] tbF Z x՗hgL?-n= ]?yѩtPmdHCDkj4J'*BRʛPOKZ =N.9xc0H`g獲(زt_e*Uc3¨/vXրH'4QO l GvteTR{p!̖ Y%4o&,}0',)'rb]-{Y[@~,DkAizٷ 8c1ޜny8DaNK&2D" tDj  d#qP8\҈7LJny tcshv}|b#S˜?^Y[E?LW,Jź~^-e͊焏Wщ>OfۻM%fe™~7 uK48׹O5Y&9hu؝&ul̗p:J Iꎩḵa4"J7?n>`8'KOG7ng&dtVs+WIem3o ݉*y[keg3X vlp.;"}FM Refq3Kނi6v*+pr|V<vDl& NvR|OIНlcF\V1[.Me~c\}N҅7;~9\u̘"IJMxRD_kgyHX SC:l `vFӆV[u#о{ɛ'"'Oygh5X(.6E@2(>3bw6mMN'śStV_&yYK"\ƕKq3bc?ӾOE0_GgOAߢ0IM׻`.X\|T3*Ț; lW%VNa3h_ Vuâꔮs'~Kf꠿K7Q]FDv1 CX?vJ˞ӛ(a b@LsǺYDfFک%}DCySm>oNX`' _F+$%xDH;{w Zx n80r2Nrؕ3eo#gX[> U{(K֔=8@rr eЛi4^[H =otif 3N@hR$} LCڰQ)!+7ټ}}=3Ȍ*TRY2OwʳuZorRI$s@Iu ԚÑ:)E>`W}]uLP+b$%j$_00C+|!Fi1)vQJ?nlfD\sz?cp=+y ܩjŇd;Tm<8v7^g9_EQRADQku68=!'iާvnSlu\[%Ta ԤLeҞWE. A:hz#iZ3+frO9*;ܵšGWj\M'Ţxi YznAxb}k;8Gu-5ww/ |q='CbjqO6:AْExFovMx4kPS @ifU+?O>ǩQBŨR`JZ`EVl!1<*3թFK #( &bɇUyzUfꧫOP"_y߷X欏 Z"->O㤖 Z;x>7)P&xs"4kWq^+U&2f"dzt\$rk.i8r$1+0lb?Xp~ ₐ2E> fTQNmlZw/`<%Y=[lĹ~A;P|dݙOTCW̅En| DiҊ)0e.c'b?hKc. =rPFϙwhž hY8| S|[*&r#AU,;KvE:K6YAȨYũ:Yin:2lduclzҞ:.a42i*KZw3NDԈJ= :̮U*^ =X)r^bH>1!m(u~R{`)LD.gjzz g.oDiN;*Ljsg@FSҾSϑħ[0yKaKh=_c Xu>3Y>HτQ3bfǭ /MGjH ô:sq7OH #KѬĂc5Ң.jʧQם82ʓeSd`Ӗ9ԧ{!c#5?bfR|!gW.d8Xu!  b2CA9}ڠ8fǙNn,2Sf nܠ!43U # |=ך}&Q0C8sr gS# |$+Vs c8cG9&f)=Qm|TIV: #5pIΩ(so%|>̝݀=YDAч•$&v^rg=Mw)bJBQ~]TwINnf#m^ w>D)G'KeG[Yw#]_66bGN[<B=ݱm_c"1&(q{\eVQӤkBDg2Yƿ1rBQ c%p A6MY}KEG Sk-AR$=B{EU68{t-kv3r;ؐAS^r2=O߫ Pkqf76U3gdx#djaOxC&cWa hLkϳMz (!9 diaO;^ &kbpg0J}^/sΪ%r nXİp0q+5$-ua/bS\6$?jea}yh%`TVCFw r v8Fx;8 J}J*e  t<V1M5CjńLNlOE::jlΥ݆}z _P=P(.͍LrڇzE |pԷXzHqŮd{3h|v:1XCmHku'Tew+d?7U*T1gIKwF1muOC㉼rߜ0p.Qf8z07^D 3 oaV9$3N\H>| {? -|͌)bPk~M)BkEr©euv`%=1R(9"Zš7"WQ0F;@_T䰶W>LoFT\F9G'\xIԿ948j8F2&maJcl%0}o7K+pM|x&?pHc->'UuY(4U%3d'l1*^iSZ*yO9^[r5:Cϵ?^ۡ9Ѕ02Up r`qJ\ߗ',Et`[/֐E++YdjZ3LS,c7'mT2#5#ߠJ*hrSDȓત}WUQqjAV@&YqV_S R@aRx.2{/: 970 :#m<ۇW2#gѳ,VtglS,Nӱ/(w +z1\F.9YmvTLv#$ta(Sz@1Jܑg_PΜ\t њ'\wDh5J>Ɖɺ\bBn1QTAj1n0&;v#v܇xDXcaE.60)1"߬nr1o45iH +Gs>DĢ`;Pe ۉ;5 3դ\*5īImr`sɄ#zuqtr!? @Yvbe Al:7gKj-Ems+0"sف鱆 K=ex[)᥹Pv!宿^0gy/<:1b q &vE[N;` OgX):j=|"c=hF}yN|SrhT( nr hl$ļJ (uW«q*lnFӖ:&fX3/lJ/Z;ZbBaS+g} FIX\`@(j1Ҟ|o*ø MO 8-.AI\C:͉0Uހ3D~W', qBP(Й LEp.גA4B 6P~>?Yb[^=C#nbʨ_WkKq%b,KTJH\f<_ + ` /nVxC`E^]f]0%qwW`W=LDA|Dp7-JC  N$+P?YvK'ɪcFԓ2>V۶s#p'Ndjb<<ڼ5LO],GMD >ȚQ͒Z [,ElbBE_]"H԰^Qp)6"H321;<阹n 'NIs\yڡuȶ] k+aPB썾H%|bk;>eF/叏Ŀ`t/FbhhA`b*dlRo Y~6F をѰ5Σ+b` dp$Yٌ-WMLJg״jpMsȻ4wIxy~?OD72_ݲoaf P0R!9z @ [i!Gk }V;w3"H&(ۦzIF+g2,eG".;! cuV:ӿ-7l03 fQ6QarU,ː,}Bd{`f,sΡ(\^Sw6\G #wʹî1Ǹ˕l_T飚Trp ˟49T8@l]n|CyoІU(ᦨPġ[p͒DڟK{s2&Kk24e' L􅅇>:%hU Տ -wB>@koeQgk]>:< ?_&rs&7.O )}._Pkz^'ƽP h E|Q.p7-[6.R拸tGF",aS܅3wB*CQzV@;ESFi,#@H' czuیs#RYneJ_Qb+濻[ QN󷔬zX^#G\}hݱ7զѻݵAЌd;\˳`pF.\s§qI{gBFD@A*O1UI<]Ѻe-k? (=I Mm ^+y*J?|3_?/|ʴٿ@;*o)aL& h㱲ZHfޫUxL;MNjIWm5l˦d{>%,0[}`s1ݑmzG |Fm\2 a T9=Gڲ:{'|~GT̹9Y-aߕU T`@!.ͣ沸hk_(@aх{:N3ʨ[~!2[tTh UXVi V*OxǽLbdui 4'g{EmM-n(NTmv&롣$|Qښi^A? TYxY--:CCP4w]87wߣjyc3seov E Q0w̑Xg -Nd1Pn? ]A,rh(1mn\a*ejP0@ %yDH]j]J/:m7@f&/mo nQيY o]EmdYZ6if `d5#gMˎVQRx1;>nXdlk_ՆX\%B[5ʰlnZ51-?U^)t:.E dːin71*e$9@Ӝo\hY$;֦-HU휁&(2ĄOi2~=t3 r$wi> =qCdB x^,B-ԙ^o"[@wFI36-G#oZ&9Dvo6~>#glCK$;Yx4]횥6ؚ~ըNط@E5Vzv*$?9vC/ZS;~Q.z/3ЁJ,ݖkJ:)mp{!@: ލ̄șQ})R#HƟy7R_N+]E78b*o6Ap/i P/)"ﶰP(pj8/>Ʌ(bB(}&?i V-}r>i۵DX8)5:S 'ItY%+4`B$>;g2tvHvE N+L\BZpY7Lj&Θ쳾 w5 &BwMݶu`vM2̷QWi2NX:YTvȺ2hss"R"n"tGZm U,C~IBLu:oqEy~58 Vr# n@pNfiٞ[ۈ#״]EK񵉃wJ]O3[,П*:W#9Nm{S0`GQ/6x$fqh1Xvp!a+P$&%"]ڤ6A]f/~g4:>=Ӣ^>8hA{2`A4c-.)4VE^(h.0VJhdePcGt3?!`]uz2ƦmIŢG״1 m_EKU {z2D{b@-jjZ¨*bqwihF*dlZN͡98 ]9Q|?B5}R3D}0uqT*(஻s`{Mv2;zԉgOVjnBލ2׏[\H IX ACLC[2Rl$tcJ&l@cY5;4i:YYm7x2?a ߪePB"`>`ޠq.[l@.MVL;aQnfrA'UWRmq)ž6.AUR6!+hcwpP3lѣ F.RKk!"f{o z?47 횘Ș4"sQ+]bagTN9l#ݒㅐdFUpw^>JmR Ƿr.O0+Y̮lM1Gdw(ˌܢ d,8V]f Jď&OV/C=W.؏ 0saG wh9sxmy,W widc}F>rQ>:ThR<ɴgZWrp$G?ХK~^$@ɤK,jb>9+{0K 9;huop (҅oR)o53T"O4%@qh>¤yXX$k9tĹ4P 9mIR<)'_@A5p#qD!)IM"-pal?0T"W42p[.95sوӓ? #W5C+P6f'$+!a!-=~KTx$[ܲ}{HO!w3:*3´)\DmB+-^^ ލ7N;Z!  h3KąBY Y!󸍰mb?v:FU/jMW]$I<˧a]҇>tg@RY EgVt`=1jg)(c A_9'/9D/A!- (̔q9:PK!UJxQ+$vMtKs30YVsZDjm~1wTU&)6-}o/,U}N;(xw޶ҿ`{ 6~Wk|t1iCI'u!QpmV?mu0:cu6@XIv~#V̖DFOqe# p-~Ywz~i=bT)KZ'Z{s HHl]>8eF't5jRP&PvB V{DQ ApnE~~'- 5hG"']"돑D0XhB;ׂYQE xWB%Bn bYZ*tB$2w.s!~EڢT4#`2@DQ1ա9@6wc/YD.?@Sg"@k\Nӵbxg_^LǒYtmEPT9#ǐ[2Tkl^~;{.2AS_858Ϣ./=%9c`zK$* O#ٲQy Ys[㩣3%'bVIqqFoa`\ݳNG{܏ڈ k*1%S8r˘#0)PeۖtZ굃r=M nl JBNޯʑN&-XsNonDN)fftðw5gt(ohB@1)R\!y^yR>*hi;a46ɶRWް@f$35e- uu=:٩6VcldBkT>`  >wW¹u\]A954y(ڿv&]u5N> ĦA{kˀ MlVA)-Y@¤SREВ Sqe.€m➠6[Ѯ:nI-$wf&c&5s_,[dJjm5YU_+# 3Tm(I> QVIux# ޽ Uݱin+yf4+T_3zDCpdo8`&>*n2n! >v9uW1|*{ق6b N x phf#xթwŬC 3?§I {M]C)-2[9{F_LEB4b^g Z+ELLY3>]9>k: LUTCg"xdka[Q6js r>u|065 s%(LRO]rQw#W+W'OPܧu r[t|VA:mwLIvWl2<3.+O2uy.Y]~U϶Dtnat:i@gY7hdby~p}ODrr/g!&Q ηNp{ V td&aj9 k~u #;!:lޯabEf8gC$n=[:-Aini8Zm''>NZ,t x.l9+HUMv+lNћJ- [2^ref8b>'&J+#,DL5Es2+kdX9瘡W2Me|T$GjΥ2:pF L38,c]0.>S_ύHu١ԯ)ւ:&K㨯Wx"[dWlejq'ԍ/%-0n}$ȶxW1v%L =@\>b:hIcݹ ls D" !Q%1wP1Y4Fliy>pHHnDˤl*"ld"N``?DžI2u'7T_',ub4aQ6qtڠ|&t]m@z\G"U, 7*r?8eт_ I! =+]z;_q>tL& yv1J$ (S(֗FKҼdOFF;'u-8WUj,M=tzz<=Ę̗"pTGLJUڋj_Z>d!s$6HjΑ^: z/f6]X F_Uω[PzHH ;H&+^Pz)/`]ey;<` 8HB?Dw;xG{a &eWoaVWf6(;ܒk65NEom(3ZI^Px-82۰=-<υ]Dnx":⥯8+#]FH 3j6G%%7|a_nlwI1/ԺW:@HOՠvff6Dwu8j5ӛU 4uJnhjfw݋}:o١ZVt -/g)RVG 4t֔A?Vt3PɎP#uU _?w1(MkCDN.[iPN[A^U^}[jٛ hb2P{b0@ RCsQNӽ;R -n*M䡉:iu&VAmqgTQesy'^ k7exKزS%UVP%+ i %r䫓?o|E!"&ovގg?τ.'K1jrӢu -dtY}6y phQJu)5O{9p&`<%j7KZ>tlP\,fؾRb[\3vFXZoG~Yd[V[҅*šB1c#"$)Aux3FtWk[9K7` K !zoڏ#&-Kμa"#{@skYp]>msA2;BzJ_8eK{ye4gϪ ~q6 DM}Y&wx|$~HzxU}!b5u)c_f3KCDXkcB[s+%|n|2Q#"&b6דc.GޔGH ETku1G>]C[ P)&̍K4ȗv,O'=,Bv`,Oo3 fs&oʍܢB[B>|jrSɺȓ.O½V2N}t ;0Cm|}եJ a\KT:q{fm圀uMe ;2e/Xm#5NEj ʮF&b8R1al7ErAL( uЗk~BqXBvfLЁRAdDZ"\zb}$SpPqmr(]ź~lG2u)S_ihl}9a \2D'5g-Nɣ4k4rͯY-_<%Q gB;}a]ۏV!d6oqSpZʝɜW?ckY=hpU[ԾA4$,g!-q2eE95>펑  m /溫۲$rO~bpV˹ᬱk܍BlÒeO:=0blP>~mH۞ǫrcLimaLsO6k4D73aUto|4[Ѷ )wΟӆkʆp1_ܻKih:<*+\7e˹[S>Y1NTO}HA_3Ju$V(Ȃ΋bb``Jyg.41]Ǧ/ZSzrwT\ӈ`8֛uu[hS7P[pQ+Y=C)Q.L:KZ7Ey*zn}+4m;y1I&.>5w.a^,`bx &xF`65rMVo=Gv@jaV3lW(bwYLM@A?[]ݾ !g(UzmMs;k@uR.QV0mGFԮ:풲Tv^x-q2F[dmΘZ\2sEc [K 97!L}]^YU@YpY+Mt(W ?Ih :}bUԼ#WXg^'Aɩ%9?eQ=56o*t4\P7#G#.PL7 @_)`*j?ӣ!MJ endstream endobj 142 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrZcolrjp2cOQ/ZZR \#B@HHPHHPHHPHHP880 Wϴp4~uB6I?x~$ilUJg+8۸m!]_gG ;6|͎F4`Wb4Y Oy FtI#6oy?*´h*lu;̉hR^W+ xWW0J B [ÏZ1O$x;LfBH)"M!IF?dfΜy4T(9v G2]MͯLa7VɌU&a endstream endobj 143 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr.&colrjp2cOQ/&.&.R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ2]C T" % |!@:@   : Blh p"Mp"ƀ  bqD",n  endstream endobj 144 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrJ&colrjp2cOQ/&J&JR \#B@HHPHHPHHPHHP880 #ϴ1E1D T1]t0 ,@:3|!: *7@ : 'p e e2Q 79ρY  endstream endobj 145 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrsFcolrjp2cOQ/FsFsR \#B@HHPHHPHHPHHP880 )ϴ$8JB׌EG؉t@Z ; !/) "f: %2ŷ @y =:D"bc&8]:Lz?haG;2Sn 'dH4ί7igL2_Ȁ /bl@CQ9zDyADzӀ 0u'd;1o0oY1b_( endstream endobj 146 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrojp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t  @:  @  >    endstream endobj 147 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr+colrwjp2cOQ/++R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ  t ! $@: " : HP    endstream endobj 148 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr6&colrjp2cOQ/&6&6R \#B@HHPHHPHHPHHP880 .ϴ,+8I G\n[9tP-iO R@:<- ; o:4T-'λ:iCD'9|Ě:,.W d #\&:¬>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr(6colrjp2cOQ/6(6(R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ[}CPL" )@ :@ à@  O:. $$,H=   endstream endobj 150 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrsjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ  t ! !:  ! e>zG    endstream endobj 151 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt  3@@ B:@ u{ @8  :ә   endstream endobj 152 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr*&colrjp2cOQ/&*&*R \#B@HHPHHPHHPHHP880 ϴPC t  &:@  :K2U    endstream endobj 153 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrijp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ  t ! :  :M|"р    endstream endobj 154 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrrjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t ! :  ɠ>ɕ,G #܀   endstream endobj 155 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrB&colrjp2cOQ/&B&BR \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ1HD X" ) |!:Ѐ 4 :$ ˪0 |&"Dl]2ɀ  "a>"%  endstream endobj 1 0 obj <>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 2 0 obj <>stream q 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q q 595.1999969 0 0 840.9600067 0 0 cm /Im1 Do Q BT 0.196 0.2 0.196 rg /T1_0 1 Tf -0.027 Tc 3 Tr 10.4 0 0 10.4 58.52 754.33 Tm (416 )Tj 0.05 Tc 9.4384 0 0 7.9001 232.76 754.33 Tm (B.I. )Tj 8.4957 0 0 7.9001 253.4 754.33 Tm (DAVIES)Tj 0.294 0.298 0.286 rg 0 Tc 7.9001 0 0 7.9001 287.4 754.33 Tm (, )Tj 0.196 0.2 0.196 rg 0.05 Tc 9.713 0 0 7.9001 294.68 754.33 Tm (F.P.V. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 8.1685 0 0 7.9001 327.32 754.33 Tm (MAESEN )Tj EMC /Suspect <>BDC 0.126 0.126 0.122 rg /T1_1 1 Tf 0.0104 Tc 8.6 0 0 8.6 88.14 686.17 Tm (BELGIUM )Tj EMC ET BT 0.196 0.2 0.196 rg /T1_0 1 Tf -0.0077 Tc 8.4 0 0 8.4 57.08 439.93 Tm (Fig. )Tj /T1_2 1 Tf 0.05 Tc 7.8667 0 0 7.8001 73.7 439.93 Tm (I. )Tj /T1_0 1 Tf 8.4936 0 0 8.4 86.84 439.93 Tm (Map )Tj 8.9033 0 0 8.4 107.44 439.93 Tm (of )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0118 Tc 8.4 0 0 8.4 118.89 439.93 Tm (Southern )Tj EMC ET BT /T1_0 1 Tf 0.006 Tc 8.4 0 0 8.4 154.5984 439.93 Tm (Netherlands. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0045 Tc 8.4 0 0 8.4 202.4784 439.93 Tm (Old )Tj EMC ET BT /T1_0 1 Tf 0.0078 Tc 8.4 0 0 8.4 219.7992 439.93 Tm (Mining )Tj -0.001 Tc 3.543 0 Td (District )Tj 0.0359 Tc 3.482 0 Td (is )Tj 0.0107 Tc -26.463 -1.03 Td (shown )Tj 0.0068 Tc 2.927 0 Td (hatched)Tj 0.294 0.298 0.286 rg 0 Tc 3.186 0 Td (, )Tj 0.196 0.2 0.196 rg 0.471 0 Td (with )Tj 0.0209 Tc 1.992 0 Td (Germany )Tj -0.0097 Tc 4.058 0 Td (lying )Tj 0.0253 Tc 2.235 0 Td (to )Tj 0.0197 Tc 1.086 0 Td (the )Tj 0.0218 Tc 1.482 0 Td (East )Tj -0.0017 Tc 2.054 0 Td (and )Tj -0.0174 Tc 1.776 0 Td (Belgium )Tj 0.0253 Tc 3.545 0 Td (to )Tj -0.0088 Tc 1.086 0 Td (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0254 Tc 8.4 0 0 8.4 56.4948 422.1556 Tm (South )Tj EMC ET BT /T1_0 1 Tf 0.0269 Tc 8.4 0 0 8.4 79.6032 422.1556 Tm (and )Tj 0.0197 Tc 1.836 0 Td (the )Tj -0.0024 Tc 1.542 0 Td (West. )Tj 0.0124 Tc 10.4 0 0 10.4 56.53 392.89 Tm (approximately )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0142 Tc 10.4 0 0 10.4 125.7212 392.89 Tm (40% )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 11.1292 0 0 10.4 153.01 392.89 Tm (of )Tj 0.0143 Tc 10.4 0 0 10.4 169.89 392.89 Tm (the )Tj -0.0035 Tc 1.973 0 Td (specimens )Tj -0.0007 Tc 4.85 0 Td (examined. )Tj 0.0079 Tc -17.714 -1.015 Td (Approximately )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0042 Tc 10.4 0 0 10.4 128.0508 382.334 Tm (70% )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 11.6856 0 0 10.4 154.45 382.33 Tm (of )Tj 0.0373 Tc 10.4 0 0 10.4 170.37 382.33 Tm (the )Tj 0.0302 Tc 1.985 0 Td (total )Tj 0.0187 Tc 2.589 0 Td (pathogen )Tj -0.0032 Tc 4.463 0 Td (flora )Tj 0.0051 Tc -20.029 -1.062 Td (consisted )Tj 0.05 Tc 11.1292 0 0 10.4 99.73 371.28 Tm (of )Tj -0.0148 Tc 10.4 0 0 10.4 112.68 371.28 Tm (\(in )Tj 0.0317 Tc 1.525 0 Td (order )Tj 0.05 Tc 11.1292 0 0 10.4 155.89 371.28 Tm (of )Tj 0.126 0.126 0.122 rg 0.0175 Tc 10.4 0 0 10.4 168.87 371.28 Tm (importance\) )Tj 0.196 0.2 0.196 rg /T1_3 1 Tf 0.0225 Tc 9.8 0 0 9.8 225.2 371.28 Tm (H. )Tj 0.0069 Tc 1.547 0 Td (influenzae, )Tj 0.0219 Tc -18.749 -1.126 Td (Streptococcus )Tj 0.0259 Tc 6.06 0 Td (pneumoniae )Tj /T1_0 1 Tf 0.0456 Tc 10.4 0 0 10.4 168.85 360.25 Tm (and )Tj /T1_3 1 Tf 0 Tc 9.8 0 0 9.8 188.23 360.25 Tm (B)Tj 0.369 0.372 0.361 rg 0.718 0 Td (. )Tj 0.196 0.2 0.196 rg 0.0128 Tc 0.491 0 Td (catarrhalis)Tj 0.294 0.298 0.286 rg 0 Tc 4.603 0 Td (. )Tj 0.196 0.2 0.196 rg 0.0251 Tc 0.556 0 Td (Haemo\255)Tj 0.0256 Tc -19.909 -1.127 Td (philus )Tj 0.0139 Tc 2.792 0 Td (parainjluenzae, )Tj /T1_0 1 Tf -0.0094 Tc 10.4 0 0 10.4 149.27 349.21 Tm (which )Tj -0.0102 Tc 2.71 0 Td (still )Tj 0.0255 Tc 1.758 0 Td (amounted )Tj 0.05 Tc 10.4772 0 0 10.4 241.89 349.21 Tm (to )Tj 10.7518 0 0 10.4 253.33 349.21 Tm (at )Tj 0.126 0.126 0.122 rg -0.0034 Tc 10.4 0 0 10.4 264.87 349.21 Tm (least )Tj 0.196 0.2 0.196 rg -0.027 Tc -19.964 -1.062 Td (13% )Tj 0.05 Tc 11.1292 0 0 10.4 79.57 338.16 Tm (of )Tj 0.0143 Tc 10.4 0 0 10.4 92.13 338.16 Tm (the )Tj 0.0166 Tc 1.574 0 Td (pathogenic )Tj 0.0083 Tc 4.833 0 Td (flora )Tj 0.0238 Tc 2.218 0 Td (in )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0254 Tc 10.4 0 0 10.4 194.518 338.16 Tm (1980, )Tj EMC ET BT /T1_0 1 Tf 0.042 Tc 10.4 0 0 10.4 219.8316 338.16 Tm (had )Tj 0.0042 Tc 1.895 0 Td (practically )Tj 0.013 Tc -17.642 -1.062 Td (disappeared )Tj 0.0075 Tc 5.398 0 Td (from )Tj 0.0143 Tc 2.501 0 Td (the )Tj -0.0059 Tc 1.696 0 Td (scene )Tj 0.0238 Tc 2.637 0 Td (in )Tj -0.035 Tc 10.1247 0 0 10.4 197.41 327.12 Tm (1983. )Tj /T1_3 1 Tf 0.0019 Tc 10 0 0 10 224.24 327.12 Tm (H. )Tj 0.0137 Tc 9.8 0 0 9.8 239.88 327.12 Tm (injluenzae)Tj 0.294 0.298 0.286 rg 0 Tc 4.229 0 Td (, )Tj 0.196 0.2 0.196 rg /T1_0 1 Tf -0.0094 Tc 10.4 0 0 10.4 56.15 316.56 Tm (which )Tj 0.0087 Tc 2.667 0 Td (accounted )Tj 0.0074 Tc 4.384 0 Td (for )Tj -0.0042 Tc 1.476 0 Td (65% )Tj 0.05 Tc 10.9648 0 0 10.4 167.41 316.56 Tm (ofthe )Tj 0.0186 Tc 10.4 0 0 10.4 194.85 316.56 Tm (total )Tj 0.003 Tc 2.117 0 Td (isolates )Tj -0.0224 Tc 3.231 0 Td (in )Tj -0.035 Tc 10.3601 0 0 10.4 262.2 316.56 Tm (1977, )Tj 10.0306 0 0 10.4 56.05 305.53 Tm (fell )Tj 0.05 Tc 10.4772 0 0 10.4 72.45 305.53 Tm (to )Tj 0.0124 Tc 10.4 0 0 10.4 84.37 305.53 Tm (approximately )Tj 0.002 Tc 6.276 0 Td (35% )Tj -0.0224 Tc 2.218 0 Td (in )Tj -0.035 Tc 10.0023 0 0 10.4 185.41 305.53 Tm (1980 )Tj 0.0225 Tc 10.4 0 0 10.4 207.73 305.53 Tm (and )Tj 0.0283 Tc 1.81 0 Td (has )Tj 0.0098 Tc 1.708 0 Td (remained )Tj -0.0095 Tc -18.1 -1.062 Td (impressively )Tj 0.035 Tc 5.214 0 Td (constant )Tj -0.0105 Tc 3.826 0 Td (since )Tj 0.0402 Tc 2.319 0 Td (that )Tj -0.0208 Tc 1.938 0 Td (time. )Tj 0.0125 Tc 2.304 0 Td (In )Tj 0.0202 Tc 1.151 0 Td (contrast, )Tj 0.0143 Tc 3.884 0 Td (the )Tj ET BT /Suspect <>BDC 0.126 0.126 0.122 rg /T1_2 1 Tf 0.0255 Tc 8.9 0 0 8.9 58.5 260.89 Tm (Table )Tj EMC ET BT 0.196 0.2 0.196 rg /T1_2 1 Tf 0.05 Tc 10.1837 0 0 8.9 84.63 260.89 Tm (1.-)Tj ET BT /Suspect <>BDC 0.126 0.126 0.122 rg /T1_2 1 Tf 0.0154 Tc 8.9 0 0 8.9 99.64 260.89 Tm (Results )Tj EMC ET BT 0.196 0.2 0.196 rg /T1_2 1 Tf 0.05 Tc 8.91 0 0 8.9 132.4 260.89 Tm (of )Tj ET BT /Suspect <>BDC /T1_2 1 Tf -0.0029 Tc 8.9 0 0 8.9 142.47 260.89 Tm (all )Tj EMC ET BT /T1_2 1 Tf 0.0065 Tc 8.9 0 0 8.9 154.0044 260.89 Tm (sputum )Tj 0.0106 Tc 3.611 0 Td (cultures )Tj 0.0066 Tc 3.97 0 Td (1977-1986 )Tj 0.126 0.126 0.122 rg /T1_0 1 Tf 0.0359 Tc 8.7 0 0 8.7 58.54 238.8 Tm (Year )Tj ET BT /Suspect <>BDC 0.196 0.2 0.196 rg /T1_0 1 Tf 0.0009 Tc 8.7 0 0 8.7 78.6022 238.8 Tm (srudied: )Tj EMC ET BT /T1_0 1 Tf 0.0192 Tc 8.7 0 0 8.7 168.1861 238.8 Tm (1977 )Tj 0.0008 Tc 4.193 0 Td (1978 )Tj 0.0192 Tc 4.138 0 Td (1979 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0376 Tc 8.7 0 0 8.7 276.6664 238.8 Tm (1980 )Tj EMC ET BT /T1_0 1 Tf 0.021 Tc 8.7 0 0 8.7 58.4443 217.2066 Tm (specimens )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0288 Tc 8.7 0 0 8.7 98.2816 217.2066 Tm (srudied )Tj EMC /Suspect <>BDC 0.0398 Tc 7.947 0.055 Td (3,240 )Tj EMC ET BT /T1_0 1 Tf 8.7 0 0 8.7 203.8996 217.2066 Tm (3,994 )Tj 0.026 Tc 4.138 0.055 Td (3,827 )Tj ET BT /Suspect <>BDC 0.126 0.126 0.122 rg /T1_0 1 Tf 0.0344 Tc 8.7 0 0 8.7 275.9617 217.6851 Tm (4,630 )Tj EMC ET BT 0.196 0.2 0.196 rg /T1_0 1 Tf 0.0223 Tc 8.7 0 0 8.7 58.5748 206.6448 Tm (positive )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0161 Tc 8.7 0 0 8.7 89.2075 206.6448 Tm (culrures )Tj EMC ET BT /T1_0 1 Tf 0.0209 Tc 8.7 0 0 8.7 167.7076 206.6448 Tm (1,315 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 8.7 0 0 8.7 204.1867 206.6448 Tm (1,380 )Tj EMC ET BT 0.126 0.126 0.122 rg /T1_0 1 Tf 8.7 0 0 8.7 240.6658 206.6448 Tm (1,422 )Tj 0.0071 Tc 4.138 0 Td (1,556 )Tj 0.196 0.2 0.196 rg 0.0293 Tc -25.123 -1.269 Td (percentage )Tj 0.0223 Tc 4.8 0 Td (positive )Tj 0.0471 Tc 7.718 0 Td (40.6 )Tj 0.0175 Tc 4.241 0 Td (34.6 )Tj 0.05 Tc 8.7596 0 0 8.7 239.9 195.61 Tm [(37.2 )-1860(33.6 )]TJ 0.126 0.126 0.122 rg 0.0306 Tc 8.7 0 0 8.7 58.38 173.52 Tm (*Bacteria )Tj 0.196 0.2 0.196 rg 0.0139 Tc 4.26 0 Td (cultured: )Tj /T1_3 1 Tf -0.0243 Tc 8.8 0 0 8.8 58.15 162.49 Tm (H. )Tj ET BT /Suspect <>BDC /T1_3 1 Tf 0.0123 Tc 8.8 0 0 8.8 69.4932 162.49 Tm (injluenzae )Tj EMC ET BT /T1_0 1 Tf 0.0177 Tc 8.7 0 0 8.7 167.41 162.49 Tm (65 )Tj -0.0279 Tc 4.192 0 Td (51 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 9.2781 0 0 8.7 239.48 162.97 Tm (40 )Tj EMC ET BT /T1_0 1 Tf 9.4759 0 0 8.7 275.89 162.49 Tm (32 )Tj /T1_3 1 Tf 0.0031 Tc 8.8 0 0 8.8 58.07 151.93 Tm (S. )Tj 0.0302 Tc 0.962 0 Td (pneumoniae )Tj 0.126 0.126 0.122 rg /T1_0 1 Tf 0.0093 Tc 8.7 0 0 8.7 167.7 151.93 Tm (17 )Tj ET BT /Suspect <>BDC 0.196 0.2 0.196 rg /T1_0 1 Tf 0.05 Tc 9.3105 0 0 8.7 203.46 151.93 Tm (20 )Tj EMC ET BT /T1_0 1 Tf 8.845 0 0 8.7 239.95 151.93 Tm (22 )Tj 0.0093 Tc 8.7 0 0 8.7 276.66 151.93 Tm (19 )Tj 0.126 0.126 0.122 rg /T1_3 1 Tf 0.05 Tc 8.9611 0 0 8.8 57.67 141.37 Tm (B. )Tj 0.196 0.2 0.196 rg 0.0209 Tc 8.8 0 0 8.8 68.09 141.37 Tm (catarrhalis )Tj 0 Tc 10 0 0 10 171.74 140.89 Tm (5 )Tj 0.126 0.126 0.122 rg /T1_0 1 Tf 0.0093 Tc 8.7 0 0 8.7 204.18 140.89 Tm (12 )Tj 0.196 0.2 0.196 rg 4.138 0 Td [(13 )-2915(16 )]TJ /T1_3 1 Tf 0 Tc 8.8 0 0 8.8 57.67 130.33 Tm (H)Tj 0.369 0.372 0.361 rg 0.856 0 Td (. )Tj ET BT /Suspect <>BDC 0.196 0.2 0.196 rg /T1_3 1 Tf 0.0236 Tc 8.8 0 0 8.8 68.4588 130.33 Tm (parainjluenzae )Tj EMC ET BT 0.126 0.126 0.122 rg /T1_0 1 Tf 0 Tc 8.7 0 0 8.7 171.75 130.33 Tm (7 )Tj 0.196 0.2 0.196 rg 9.4 0 0 9.4 208.21 129.85 Tm (9 )Tj 8.7 0 0 8.7 244.65 130.33 Tm (8 )Tj /T1_2 1 Tf 0.0293 Tc 8.2 0 0 8.2 276.22 130.33 Tm (13 )Tj 0.126 0.126 0.122 rg /T1_3 1 Tf 0.05 Tc 8.8669 0 0 8.8 57.67 119.28 Tm (P. )Tj 0.196 0.2 0.196 rg 0.0164 Tc 8.8 0 0 8.8 68.1 119.28 Tm (aeruginosa )Tj /T1_0 1 Tf 0 Tc 8.7 0 0 8.7 171.79 119.28 Tm [(2 )-3437(3 )-3442(6 )]TJ /T1_3 1 Tf 10 0 0 10 280.7 119.28 Tm (5 )Tj /T1_0 1 Tf 0.027 Tc 8.7 0 0 8.7 58.06 108.72 Tm (All )Tj 0.0298 Tc 1.593 0 Td (other )Tj 0.027 Tc 2.372 0 Td (organisms )Tj 0.05 Tc 8.829 0 0 8.7 167.69 108.72 Tm (14 )Tj 0.0093 Tc 8.7 0 0 8.7 204.18 108.25 Tm (15 )Tj 0.05 Tc 8.829 0 0 8.7 240.17 108.25 Tm (16 )Tj 0.0093 Tc 8.7 0 0 8.7 276.66 108.72 Tm (17 )Tj 0.0178 Tc 10.4 0 0 10.4 310.07 730.33 Tm (number )Tj 0.05 Tc 11.1292 0 0 10.4 348.37 730.33 Tm (of )Tj 0 Tc 10.4 0 0 10.4 362.69 730.33 Tm (S)Tj 0.294 0.298 0.286 rg 0.597 0 Td (. )Tj 0.196 0.2 0.196 rg /T1_3 1 Tf 0.0204 Tc 9.8 0 0 9.8 376.17 730.33 Tm (pneumoniae )Tj /T1_0 1 Tf 0.0157 Tc 10.4 0 0 10.4 430.89 730.33 Tm (strains )Tj 0.05 Tc 10.4195 0 0 10.4 464.63 730.33 Tm (has )Tj 0.0037 Tc 10.4 0 0 10.4 485.19 730.33 Tm (increased )Tj -0.035 Tc 9.9195 0 0 10.4 530.8 730.33 Tm (in )Tj 0.0015 Tc 10.4 0 0 10.4 310.07 719.76 Tm (recent )Tj 0.0046 Tc 2.677 0 Td (years )Tj 0.0225 Tc 2.39 0 Td (and )Tj -0.0033 Tc 1.808 0 Td (this )Tj 0.0057 Tc 1.701 0 Td (organism )Tj 0.0176 Tc 4.07 0 Td (now )Tj 0.0232 Tc 1.975 0 Td (accounts )Tj 0.0074 Tc 3.968 0 Td (for )Tj 0.016 Tc 1.483 0 Td (27% )Tj 0.05 Tc 11.1292 0 0 10.4 309.49 708.73 Tm (of )Tj 0.0143 Tc 10.4 0 0 10.4 324.93 708.73 Tm (the )Tj 0.0186 Tc 1.846 0 Td (total )Tj 0.0102 Tc 2.496 0 Td (bacterial )Tj 0.0193 Tc 4.109 0 Td (population. )Tj 0.0096 Tc 5.393 0 Td (However, )Tj -0.0047 Tc 4.663 0 Td (these )Tj -0.0195 Tc -19.993 -1.015 Td (figures )Tj 0.0422 Tc 3.093 0 Td (are )Tj 0.0153 Tc 1.67 0 Td (much )Tj -0.0327 Tc 2.67 0 Td (less )Tj -0.0073 Tc 1.8 0 Td (impressive )Tj 0.0428 Tc 4.713 0 Td (than )Tj 0.0143 Tc 2.308 0 Td (the )Tj 0.0199 Tc 1.654 0 Td (enormous )Tj 0.0032 Tc -17.906 -1.063 Td (increase )Tj 0.0238 Tc 3.6 0 Td (in )Tj 0.0143 Tc 1.16 0 Td (the )Tj -0.0114 Tc 1.653 0 Td (frequency )Tj 0.05 Tc 10.5727 0 0 10.4 421.34 687.12 Tm (of )Tj 0.0129 Tc 10.4 0 0 10.4 433.82 687.12 Tm (occurrence )Tj 0.05 Tc 11.1292 0 0 10.4 484.21 687.12 Tm (of )Tj /T1_3 1 Tf 0.0225 Tc 9.8 0 0 9.8 496.87 687.12 Tm (Branham\255)Tj 0.0116 Tc -19.118 -1.126 Td (ella )Tj 0.0335 Tc 1.96 0 Td (cat )Tj 0.0019 Tc 1.276 0 Td (arrha/is, )Tj /T1_0 1 Tf -0.0094 Tc 10.4 0 0 10.4 380.15 676.09 Tm (which )Tj -0.035 Tc 10.3816 0 0 10.4 409.43 676.09 Tm (was )Tj -0.0087 Tc 10.4 0 0 10.4 429.45 676.09 Tm (scarcely )Tj 0.05 Tc 10.6762 0 0 10.4 467.85 676.09 Tm (5% )Tj 0.0238 Tc 10.4 0 0 10.4 487.11 676.09 Tm (in )Tj -0.0275 Tc 1.266 0 Td (1977 )Tj 0.0125 Tc 2.343 0 Td (but )Tj -0.0055 Tc -20.679 -1.062 Td (now )Tj 0.01 Tc 2.437 0 Td (accounts )Tj -0.0157 Tc 4.338 0 Td (for )Tj -0.007 Tc 1.898 0 Td (26% )Tj 0.05 Tc 11.1292 0 0 10.4 426.61 665.05 Tm (of )Tj 0.0143 Tc 10.4 0 0 10.4 443.01 665.05 Tm (the )Tj 0.0242 Tc 1.94 0 Td (respiratory )Tj 0.0304 Tc 5.306 0 Td (tract )Tj 0.0139 Tc -20.072 -1.016 Td (pathogens )Tj 0.0064 Tc 4.419 0 Td (cultured. )Tj /T1_3 1 Tf 0.0118 Tc 9.8 0 0 9.8 397.04 654.48 Tm (Pseudomonas )Tj 0.0182 Tc 5.961 0 Td (aeruginosa )Tj /T1_0 1 Tf 0.0283 Tc 10.4 0 0 10.4 503.99 654.48 Tm (has )Tj 0.0058 Tc 1.652 0 Td (also )Tj 0.0037 Tc -20.352 -1.062 Td (increased )Tj -0.0209 Tc 4.114 0 Td (very )Tj 0.294 0.298 0.286 rg 0 Tc 2.111 0 Td (s)Tj 0.196 0.2 0.196 rg -0.009 Tc 0.375 0 Td (lightly )Tj 0.0355 Tc 2.917 0 Td (but )Tj -0.0102 Tc 1.692 0 Td (still )Tj 0.0077 Tc 1.805 0 Td (does )Tj 0.05 Tc 10.8321 0 0 10.4 468.47 643.44 Tm (not )Tj -0.0058 Tc 10.4 0 0 10.4 486.13 643.44 Tm (exceed )Tj 0.126 0.126 0.122 rg 0 Tc 3.233 0 Td (l )Tj ET BT /Suspect <>BDC 0.196 0.2 0.196 rg /T1_0 1 Tf 0.05 Tc 10.5774 0 0 10.4 523.09 643.44 Tm (0% )Tj EMC ET BT /T1_0 1 Tf 11.1292 0 0 10.4 309.49 632.89 Tm (of )Tj 0.0143 Tc 10.4 0 0 10.4 326.37 632.89 Tm (the )Tj 0.0186 Tc 2.031 0 Td (total )Tj 0.0178 Tc 2.679 0 Td (number )Tj 0.05 Tc 11.1292 0 0 10.4 416.05 632.89 Tm (of )Tj 0.0182 Tc 10.4 0 0 10.4 432.97 632.89 Tm (bacteria )Tj 0.0121 Tc 4.051 0 Td (cultured. )Tj 0.0163 Tc 4.478 0 Td (The )Tj 0.126 0.126 0.122 rg 0.0072 Tc -20.392 -1.062 Td (remaining )Tj 0.196 0.2 0.196 rg 0.016 Tc 4.334 0 Td (25% )Tj 0.05 Tc 11.1292 0 0 10.4 376.69 621.85 Tm (of )Tj 0.0143 Tc 10.4 0 0 10.4 388.29 621.85 Tm (the )Tj 0.0139 Tc 1.482 0 Td (pathogens )Tj 0.0232 Tc 4.373 0 Td (cultured )Tj 0.0051 Tc 3.692 0 Td (consisted )Tj 0.05 Tc 11.1292 0 0 10.4 529.33 621.85 Tm (of )Tj 0.0183 Tc 10.4 0 0 10.4 309.1 610.8 Tm (various )Tj 0.0342 Tc 3.777 0 Td (other )Tj 0.0083 Tc 2.908 0 Td (organisms )Tj 0.0131 Tc 4.887 0 Td (such )Tj -0.035 Tc 10.3825 0 0 10.4 456.85 610.8 Tm (as )Tj 0.126 0.126 0.122 rg /T1_3 1 Tf 0.026 Tc 9.8 0 0 9.8 473.74 610.8 Tm (Staphylococcus )Tj 0.196 0.2 0.196 rg 0.0043 Tc -16.804 -1.078 Td (aureus, )Tj 0.0114 Tc 3.393 0 Td (Escherichia )Tj 0.0279 Tc 5.226 0 Td (coli)Tj 0.294 0.298 0.286 rg 0 Tc 1.531 0 Td (, )Tj 0.196 0.2 0.196 rg 0.0043 Tc 0.641 0 Td (Klebsiella )Tj 0.0313 Tc 4.385 0 Td (pneumoniae)Tj 0.369 0.372 0.361 rg 0 Tc 5.211 0 Td (, )Tj 0.196 0.2 0.196 rg /T1_0 1 Tf -0.0183 Tc 10.4 0 0 10.4 514.45 600.24 Tm (etc. )Tj 0.0069 Tc -18.778 -1.061 Td (When )Tj 0.0143 Tc 3.047 0 Td (the )Tj -0.0123 Tc 1.894 0 Td (resul)Tj 0.294 0.298 0.286 rg 0 Tc 1.937 0 Td (t)Tj 0.196 0.2 0.196 rg 0.265 0 Td (s )Tj 0.05 Tc 11.6856 0 0 10.4 403.57 589.21 Tm (of )Tj 0.0143 Tc 10.4 0 0 10.4 419.01 589.21 Tm (the )Tj 0.0349 Tc 1.835 0 Td (sputum )Tj 0.0193 Tc 3.697 0 Td (cultures )Tj -0.0079 Tc 3.921 0 Td (from )Tj 0.0064 Tc -20.02 -1.062 Td (hospitalized )Tj 0.0191 Tc 5.218 0 Td (patients )Tj 0.0006 Tc 3.505 0 Td (were )Tj 0.0204 Tc 2.207 0 Td (compared )Tj 0.0249 Tc 4.393 0 Td (with )Tj 0.0041 Tc 2.213 0 Td (those )Tj 0.0075 Tc 2.438 0 Td (from )Tj 0.0125 Tc -19.971 -1.015 Td (patients )Tj 0.0214 Tc 3.634 0 Td (attending )Tj 0.0143 Tc 4.254 0 Td (the )Tj 0.0303 Tc 1.655 0 Td (outpatient )Tj 0.0037 Tc 4.615 0 Td (clinic )Tj 0.0107 Tc 2.629 0 Td (\(table )Tj -0.0295 Tc 2.729 0 Td (2\) )Tj -0.0088 Tc 1.249 0 Td (the )Tj -0.0136 Tc -20.776 -1.062 Td (differences )Tj 0.0238 Tc 4.893 0 Td (in )Tj 0.0143 Tc 1.39 0 Td (the )Tj 0.0102 Tc 1.804 0 Td (bacterial )Tj -0.0032 Tc 4.095 0 Td (flora )Tj 0.0006 Tc 2.503 0 Td (were )Tj -0.0009 Tc 2.53 0 Td (only )Tj -0.0068 Tc 2.349 0 Td (small. )Tj /T1_3 1 Tf 0.022 Tc 9.8 0 0 9.8 309.2 545.53 Tm (Haemophilus )Tj 0.0082 Tc 6.004 0 Td (influenzae )Tj /T1_0 1 Tf -0.0132 Tc 10.4 0 0 10.4 412.79 545.53 Tm (was )Tj -0.0026 Tc 1.971 0 Td (slightly )Tj -0.0019 Tc 3.375 0 Td (less )Tj 0.0246 Tc 1.845 0 Td (common )Tj -0.0224 Tc 4.062 0 Td (in )Tj 0.0165 Tc -21.231 -1.062 Td (inpatients )Tj 0.0274 Tc 4.621 0 Td (than )Tj 0.126 0.126 0.122 rg -0.0224 Tc 2.394 0 Td (in )Tj 0.196 0.2 0.196 rg 0.0207 Tc 1.384 0 Td (outpatients )Tj -0.0199 Tc 5.167 0 Td (\(37.3 )Tj 0.0227 Tc 2.632 0 Td (against )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0279 Tc 10.4 0 0 10.4 514.4084 534.4852 Tm (50%\) )Tj EMC ET BT /T1_0 1 Tf 0.0091 Tc 10.4 0 0 10.4 308.6132 523.9292 Tm (whereas )Tj /T1_3 1 Tf 0.0169 Tc 9.8 0 0 9.8 346.15 523.92 Tm (Branhamella )Tj 0.0128 Tc 5.715 0 Td (catarrhalis )Tj /T1_0 1 Tf 0.0179 Tc 10.4 0 0 10.4 449.66 523.92 Tm (occurred )Tj 0.0402 Tc 3.885 0 Td (more )Tj 0.0226 Tc 2.438 0 Td (often )Tj -0.0224 Tc -19.845 -1.061 Td (in )Tj 0.0143 Tc 1.113 0 Td (the )Tj -0.0035 Tc 1.558 0 Td (specimens )Tj 0.0075 Tc 4.434 0 Td (from )Tj 0.0373 Tc 2.362 0 Td (the )Tj 0.0064 Tc 1.617 0 Td (hospitalized )Tj 0.0257 Tc 5.264 0 Td (patients )Tj -0.0083 Tc 3.587 0 Td (\(29.7 )Tj 0.0204 Tc -19.983 -1.062 Td (compared )Tj 0.05 Tc 10.4772 0 0 10.4 353.73 501.84 Tm (to )Tj 0.0113 Tc 10.4 0 0 10.4 365.22 501.84 Tm (21.8%\))Tj 0.294 0.298 0.286 rg 0 Tc 2.985 0 Td (. )Tj 0.196 0.2 0.196 rg /T1_2 1 Tf 0.05 Tc 13.1112 0 0 10 400.92 501.84 Tm (It )Tj 0.126 0.126 0.122 rg /T1_0 1 Tf -0.035 Tc 10.1489 0 0 10.4 411.28 501.84 Tm (is )Tj 0.196 0.2 0.196 rg 0.0058 Tc 10.4 0 0 10.4 419.89 501.84 Tm (also )Tj 0.0139 Tc 1.894 0 Td (interesting )Tj 0.01 Tc 4.621 0 Td (to )Tj 0.0278 Tc 1.11 0 Td (note )Tj 0.0402 Tc 2.075 0 Td (that )Tj /T1_3 1 Tf 0.0216 Tc 9.8 0 0 9.8 308.72 491.28 Tm (Pseudomonas )Tj 0.0073 Tc 6.549 0 Td (aeruginosa )Tj /T1_0 1 Tf -0.0132 Tc 10.4 0 0 10.4 425.75 491.28 Tm (was )Tj 0.0145 Tc 2.299 0 Td (only )Tj -0.0026 Tc 2.58 0 Td (slightly )Tj 0.0248 Tc 3.751 0 Td (more )Tj 0.0154 Tc -19.9 -1.061 Td (common )Tj -0.0224 Tc 4.293 0 Td (in )Tj -0.0088 Tc 1.483 0 Td (the )Tj -0.0079 Tc 1.886 0 Td (clinical )Tj 0.0191 Tc 3.565 0 Td (patients )Tj -0.0295 Tc 3.91 0 Td (\(9)Tj 0.369 0.372 0.361 rg 0 Tc 0.821 0 Td (.)Tj 0.196 0.2 0.196 rg 0.0303 Tc 0.292 0 Td (2%\) )Tj 0.0428 Tc 2.449 0 Td (than )Tj -0.0224 Tc 2.533 0 Td (in )Tj 0.0125 Tc -21.22 -1.062 Td (patients )Tj 0.0214 Tc 3.588 0 Td (attending )Tj 0.0143 Tc 4.208 0 Td (the )Tj 0.0303 Tc 1.609 0 Td (outpatient )Tj 0.025 Tc 4.569 0 Td (departments )Tj 0.0123 Tc 5.49 0 Td (\(6.2% )Tj 0.05 Tc 11.1292 0 0 10.4 308.53 458.16 Tm (of )Tj 0.0044 Tc 10.4 0 0 10.4 319.7 458.16 Tm (positive )Tj 0.0165 Tc 3.445 0 Td (sputum )Tj 0.0099 Tc 3.282 0 Td (cultures\) )Tj 0.0456 Tc 3.784 0 Td (and )Tj 0.0121 Tc 1.808 0 Td (this )Tj 0.0098 Tc 1.71 0 Td (was )Tj 0.0058 Tc 1.79 0 Td (also )Tj 0.0373 Tc 1.9 0 Td (the )Tj -0.0121 Tc 1.516 0 Td (case )Tj -0.035 Tc 10.0047 0 0 10.4 308.63 447.61 Tm (wi)Tj 0.294 0.298 0.286 rg 0 Tc 10.4 0 0 10.4 318.69 447.61 Tm (t)Tj 0.196 0.2 0.196 rg 0.279 0 Td (h )Tj /T1_3 1 Tf 0.0298 Tc 9.8 0 0 9.8 329.74 447.61 Tm (Staphylococ)Tj 0.294 0.298 0.286 rg 0 Tc 5.186 0 Td (c)Tj 0.196 0.2 0.196 rg 0.0068 Tc 0.49 0 Td (us )Tj 0.0159 Tc 1.129 0 Td (aureus )Tj /T1_0 1 Tf 0.0107 Tc 10.4 0 0 10.4 426.12 447.61 Tm (\(table )Tj -0.0244 Tc 2.59 0 Td (2\). )Tj 0 Tc 1.342 0 Td (A )Tj -0.0001 Tc 0.969 0 Td (mixed )Tj 0.126 0.126 0.122 rg -0.0032 Tc 2.76 0 Td (flora )Tj 0.196 0.2 0.196 rg 0.05 Tc 11.1292 0 0 10.4 528.37 447.61 Tm (of )Tj 0.0139 Tc 10.4 0 0 10.4 308.66 436.56 Tm (pathogens )Tj -0.035 Tc 10.3816 0 0 10.4 357.11 436.56 Tm (was )Tj 0.0235 Tc 10.4 0 0 10.4 377.64 436.56 Tm (found )Tj 0.0238 Tc 2.911 0 Td (in )Tj 0.0162 Tc 1.244 0 Td (approximately )Tj -0.0039 Tc 6.53 0 Td (15% )Tj 0.05 Tc 11.1292 0 0 10.4 513.01 436.56 Tm (of )Tj -0.0084 Tc 10.4 0 0 10.4 526.93 436.56 Tm (all )Tj 0.0191 Tc -20.988 -1.061 Td (patients )Tj 0.0107 Tc 3.725 0 Td (\(table )Tj -0.0154 Tc 2.815 0 Td (3\). )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0124 Tc 10.4 0 0 10.4 392.5308 425.5256 Tm (Once )Tj EMC ET BT /T1_0 1 Tf 0.0088 Tc 10.4 0 0 10.4 419.8828 425.5256 Tm (again, )Tj 0.0208 Tc 3.008 0 Td (there )Tj -0.0132 Tc 2.587 0 Td (was )Tj 0.05 Tc 10.5475 0 0 10.4 499.19 425.53 Tm (no )Tj 0.0239 Tc 10.4 0 0 10.4 515.43 425.53 Tm (great )Tj -0.0078 Tc -19.939 -1.062 Td (difference )Tj 0.0008 Tc 4.811 0 Td (between )Tj 0.126 0.126 0.122 rg 0.0143 Tc 4.104 0 Td (the )Tj 0.196 0.2 0.196 rg 0.0354 Tc 2.024 0 Td (outpatient )Tj 0.0456 Tc 5.076 0 Td (and )Tj 0.126 0.126 0.122 rg 0.021 Tc 2.356 0 Td (inpatient )Tj 0.196 0.2 0.196 rg 0.0181 Tc -18.37 -1.062 Td (culture )Tj 0.0005 Tc 3.609 0 Td (results, )Tj 0.0229 Tc 3.544 0 Td (although )Tj 0.0143 Tc 4.392 0 Td (the )Tj 0.0241 Tc 1.932 0 Td (combination )Tj 0.05 Tc 11.1292 0 0 10.4 510.13 403.44 Tm (of )Tj /T1_4 1 Tf -0.035 Tc 9.987 0 0 10.1 526.44 403.44 Tm (H. )Tj /T1_3 1 Tf 0.0082 Tc 9.8 0 0 9.8 308.52 392.89 Tm (injluenzae)Tj 0.294 0.298 0.286 rg 0 Tc 4.229 0 Td (, )Tj 0.196 0.2 0.196 rg /T1_0 1 Tf 0.0132 Tc 10.4 0 0 10.4 355.49 392.89 Tm (S. )Tj /T1_3 1 Tf 0.0204 Tc 9.8 0 0 9.8 367.53 392.89 Tm (pneumoniae )Tj /T1_0 1 Tf 0.0456 Tc 10.4 0 0 10.4 420.37 392.89 Tm (and )Tj /T1_3 1 Tf 0.021 Tc 9.8 0 0 9.8 439.75 392.89 Tm (B. )Tj 0.0177 Tc 1.307 0 Td (catarrhalis )Tj /T1_0 1 Tf 0.0271 Tc 10.4 0 0 10.4 501 392.89 Tm (\(the )Tj 0.0301 Tc 1.938 0 Td ('big )Tj 0.013 Tc -20.438 -1.062 Td (three'\) )Tj -0.0132 Tc 2.817 0 Td (was )Tj 0.0112 Tc 1.8 0 Td (noted )Tj -0.0224 Tc 2.531 0 Td (in )Tj 0.0103 Tc 1.012 0 Td (3.9% )Tj 0.05 Tc 11.1292 0 0 10.4 418.45 381.84 Tm (of )Tj 0.0303 Tc 10.4 0 0 10.4 429.5 381.84 Tm (outpatient )Tj 0.014 Tc 4.426 0 Td (samples )Tj 0.05 Tc 10.531 0 0 10.4 512.17 381.84 Tm (but )Tj -0.0224 Tc 10.4 0 0 10.4 528.87 381.84 Tm (in )Tj 0.0145 Tc -21.232 -1.061 Td (only )Tj 0.126 0.126 0.122 rg 0.0064 Tc 2.19 0 Td (1.8% )Tj 0.196 0.2 0.196 rg 0.05 Tc 11.1292 0 0 10.4 356.53 370.81 Tm (of )Tj 0.126 0.126 0.122 rg 0.021 Tc 10.4 0 0 10.4 368.55 370.81 Tm (inpatient )Tj 0.196 0.2 0.196 rg -0.0053 Tc 3.963 0 Td (specimens. )Tj -0.035 Tc 10.316 0 0 10.4 318.7 359.76 Tm (As )Tj 0.0128 Tc 10.4 0 0 10.4 335.4 359.76 Tm (far )Tj 0.0098 Tc 1.663 0 Td (as )Tj 0.0143 Tc 1.392 0 Td (the )Tj 0.0005 Tc 1.788 0 Td (susceptibility )Tj 0.05 Tc 11.1292 0 0 10.4 446.77 359.76 Tm (of )Tj 0.0068 Tc 10.4 0 0 10.4 461.25 359.76 Tm (these )Tj 0.0116 Tc 2.635 0 Td (bacteria )Tj 0.01 Tc 3.827 0 Td (to )Tj 0.0111 Tc -21.192 -1.014 Td (antimicrobial )Tj 0.0087 Tc 5.954 0 Td (agents )Tj -0.035 Tc 9.3682 0 0 10.4 401.68 349.21 Tm (is )Tj 0.0106 Tc 10.4 0 0 10.4 412.22 349.21 Tm (concerned, )Tj -0.035 Tc 10.235 0 0 10.4 463.19 349.21 Tm (we )Tj 0.0324 Tc 10.4 0 0 10.4 478.94 349.21 Tm (can )Tj -0.0249 Tc 1.887 0 Td (see )Tj 0.0075 Tc 1.664 0 Td (from )Tj 0.0117 Tc -19.976 -1.062 Td (table )Tj 0 Tc 2.307 0 Td (4 )Tj -0.0066 Tc 0.777 0 Td (\(which )Tj -0.0051 Tc 3.095 0 Td (includes )Tj 0.0487 Tc 3.599 0 Td (data )Tj 0.0229 Tc 2.075 0 Td (from )Tj -0.0346 Tc 2.423 0 Td (1987\) )Tj 0.0402 Tc 2.524 0 Td (that )Tj 0.126 0.126 0.122 rg /T1_3 1 Tf 0.0349 Tc 9.8 0 0 9.8 503.12 338.16 Tm (Haemo\255)Tj 0.196 0.2 0.196 rg 0.0256 Tc -19.958 -1.127 Td (philus )Tj 0.0082 Tc 2.893 0 Td (influenzae )Tj /T1_0 1 Tf -0.0132 Tc 10.4 0 0 10.4 380.15 327.12 Tm (was )Tj -0.0035 Tc 1.892 0 Td (relatively )Tj -0.001 Tc 4.054 0 Td (insensitive )Tj 0.05 Tc 10.4772 0 0 10.4 489.57 327.12 Tm (to )Tj 0.0177 Tc 10.4 0 0 10.4 501.49 327.12 Tm (erythro\255)Tj -0.0131 Tc -18.591 -1.061 Td (mycin, )Tj 0.05 Tc 10.531 0 0 10.4 346.09 316.09 Tm (but )Tj -0.004 Tc 10.4 0 0 10.4 370.08 316.09 Tm (usually )Tj -0.0028 Tc 3.816 0 Td (susceptible )Tj 0.01 Tc 5.365 0 Td (to )Tj -0.0085 Tc 1.747 0 Td (doxycycline, )Tj -0.0024 Tc -16.893 -1.062 Td (ampicillin )Tj 0.0456 Tc 4.8 0 Td (and )Tj 0.0079 Tc 2.309 0 Td (cotrimoxazole. )Tj 0.126 0.126 0.122 rg 0.0139 Tc 6.882 0 Td (Paradoxically, )Tj 0.196 0.2 0.196 rg 0.0373 Tc 6.694 0 Td (the )Tj 0.0041 Tc -20.735 -1.062 Td (susceptibility )Tj 0.05 Tc 11.1292 0 0 10.4 369.97 294 Tm (of )Tj 0.0143 Tc 10.4 0 0 10.4 385.41 294 Tm (the )Tj 0.0116 Tc 1.896 0 Td (bacteria )Tj 0.0075 Tc 3.864 0 Td (from )Tj 0.294 0.298 0.286 rg 0 Tc 2.639 0 Td (t)Tj 0.196 0.2 0.196 rg -0.016 Tc 0.325 0 Td (he )Tj 0.0303 Tc 1.561 0 Td (outpatient )Tj 0.0008 Tc 8.7 0 0 8.7 313.14 238.8 Tm (1981 )Tj 0.0376 Tc 4.138 0 Td (1982 )Tj 0.0192 Tc 4.193 0 Td (1983 )Tj 0.0376 Tc 4.193 0.056 Td (1984 )Tj 0.0192 Tc 4.193 -0.056 Td [(1985 )-1792(1986 )]TJ 0.026 Tc -16.805 -2.482 Td (3,829 )Tj 0.0398 Tc 4.138 0.055 Td [(3,512 )-1454(3,914 )]TJ 0.0206 Tc 8.393 0 Td (4,179 )Tj 0.0254 Tc 4.184 0 Td (5,159 )Tj 0.0068 Tc 4.147 0 Td (4,881 )Tj 0.0209 Tc -20.83 -1.269 Td (1,785 )Tj -0.0205 Tc 4.248 0 Td (1,591 )Tj 0.0209 Tc 4.138 0 Td (1,717 )Tj 4.193 0.055 Td (1,876 )Tj 4.138 -0.055 Td (1,736 )Tj 0.126 0.126 0.122 rg 0.0071 Tc 4.193 0 Td (1,717 )Tj 0.196 0.2 0.196 rg 0.0471 Tc -20.991 -1.269 Td (46.6 )Tj 0.0287 Tc 4.193 0 Td (45.3 )Tj 0.0471 Tc 4.193 0.055 Td (43.9 )Tj 0.05 Tc 8.8142 0 0 8.7 421.4 195.61 Tm (44)Tj 0.294 0.298 0.286 rg 0 Tc 8.7 0 0 8.7 430.86 195.61 Tm (.)Tj 0.196 0.2 0.196 rg 0.23 0 Td (9 )Tj 0.0359 Tc 2.869 0.055 Td (33.7 )Tj 4.138 -0.055 Td (35.2 )Tj 0.03 Tc -20.855 -3.752 Td (35 )Tj 0.05 Tc 9.0021 0 0 8.7 348.38 162.49 Tm (36 )Tj 4.052 0.055 Td [(37 )-2652(37 )-2652(34 )]TJ 0.03 Tc 8.7 0 0 8.7 493.82 162.97 Tm (37 )Tj 0.0093 Tc -20.823 -1.214 Td (17 )Tj 0.05 Tc 8.845 0 0 8.7 348.43 152.41 Tm [(25 )-2724(26 )]TJ 0.012 Tc 8.7 0 0 8.7 421.39 152.41 Tm [(25 )-2907(21 )]TJ 0.05 Tc 8.845 0 0 8.7 493.87 152.41 Tm (27 )Tj 0.0093 Tc 8.7 0 0 8.7 312.66 141.37 Tm (17 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 9.3105 0 0 8.7 348.43 141.37 Tm (20 )Tj EMC ET BT /T1_0 1 Tf 9.3105 0 0 8.7 384.8992 141.37 Tm (22 )Tj 0.0093 Tc 8.7 0 0 8.7 422.1 141.37 Tm [(15 )-2860(18 )]TJ 0.05 Tc 8.845 0 0 8.7 493.87 141.37 Tm (26 )Tj 8.829 0 0 8.7 312.65 130.33 Tm (12 )Tj 0 Tc 8.7 0 0 8.7 353.13 130.33 Tm [(8 )-3481(1 )]TJ 0.126 0.126 0.122 rg 9.3 0 0 9.3 462.88 130.33 Tm (1 )Tj 0.196 0.2 0.196 rg 8.7 0 0 8.7 316.71 119.76 Tm (7 )Tj 0.0093 Tc 3.728 -0.055 Td (13 )Tj /T1_2 1 Tf -0.035 Tc 7.7627 0 0 8.4 385.67 119.76 Tm (11 )Tj ET BT /Suspect <>BDC 0.126 0.126 0.122 rg /T1_0 1 Tf 0.05 Tc 8.829 0 0 8.7 422.09 119.76 Tm (10 )Tj EMC ET BT 0.196 0.2 0.196 rg /T1_2 1 Tf -0.035 Tc 8.2478 0 0 9 458.14 119.76 Tm (11 )Tj /T1_0 1 Tf 0 Tc 8.7 0 0 8.7 498.61 119.28 Tm (6 )Tj 0.05 Tc 9.3105 0 0 8.7 311.95 108.72 Tm (24 )Tj 8.845 0 0 8.7 348.43 108.72 Tm (24 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 8.845 0 0 8.7 384.9068 108.72 Tm (20 )Tj EMC /Suspect <>BDC 9.3105 0 0 8.7 421.39 108.72 Tm (20 )Tj EMC ET BT /T1_0 1 Tf 8.845 0 0 8.7 457.87 108.72 Tm (26 )Tj 0.012 Tc 8.7 0 0 8.7 493.87 108.72 Tm (25 )Tj 0.0111 Tc -50.056 -2.483 Td (*Results )Tj 0.0272 Tc 3.762 0 Td (expressed )Tj 0.0066 Tc 4.414 0 Td (as )Tj 0.0261 Tc 1.06 0 Td (percentages )Tj 0.05 Tc 9.4598 0 0 8.7 184.23 87.12 Tm (of )Tj 0.0223 Tc 8.7 0 0 8.7 193.93 87.12 Tm (positive )Tj 0.0241 Tc 3.521 0 Td (cultures )Tj /T1_2 1 Tf 0.05 Tc 8.5307 0 0 8.5 255.68 87.12 Tm (in )Tj /T1_0 1 Tf 0.0406 Tc 8.7 0 0 8.7 264.39 87.12 Tm (each )Tj 0.0189 Tc 2.161 0 Td (year. )Tj 0.0284 Tc 2.314 0 Td (Because )Tj 0.05 Tc 9.4598 0 0 8.7 335.91 87.12 Tm (of )Tj 0.0251 Tc 8.7 0 0 8.7 345.58 87.12 Tm (mixed )Tj 0.05 Tc 8.8803 0 0 8.7 369.99 87.12 Tm (cu)Tj 0.294 0.298 0.286 rg 0 Tc 8.7 0 0 8.7 379.13 87.12 Tm (l)Tj 0.196 0.2 0.196 rg 0.0145 Tc 0.282 0 Td (tures, )Tj 0.0255 Tc 2.538 0 Td (these )Tj 0.0205 Tc 2.376 0 Td (percentages )Tj 0.0201 Tc 5.177 0 Td (generally )Tj 0.0233 Tc 4.08 0 Td (exceed )Tj 0.0106 Tc -51.335 -1.269 Td (100. )Tj ET endstream endobj 3 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrEjp2cOQ/R \#B@HHPHHPHHPHHP((( w@}肪:Ǫ)@2 ?l]jg,i!~\ /6bUTo..a!/ȵ/*}ws4TH $f0C) /z#(IV*u3Nװ=’yѽrǼ-<9I{z5^WR [!V=3[\ettKF'~Vde,FH ).[D] Uj%^!ZBL"nXLZߨ=*,䒲8vhN n-)Hdok{T*R` .L {j "*XGT(il*y%Rez $l6mmmV~,5Vk!Wvz0 %T& h-E&Ft(p[,K_8iGMf^p?[D,f#fGጂ7IJSZ9 g@ d k#ݪ ݨ5L{F13b}?/eDIy2źFSj$9*PI[rryyy+* f2`p> &l$E s؄Ô^gbG0+ A {-e4]RC4#da`bJ2@Ccq|N%D^S88u >zv%tÎA]|h^1KeZ1:i :߆΀8^3qiPQ)ۜYBB_V{ <9|cŸ+Dʜ؝)WKG|w^+=l|ԺFVY /F;[᫷K-X)c8ufy%&AM>%i}GHGy>>jM9zp X#RowP]| kɗ2t=RxG(g\qˏż. 6Vkq*6C^W^µ"yg?JqW{ "Ѣ_^;{, 8G%t0M֊*pɌɥ ]$B@HHPHHPHHPHHP(((]$B@HHPHHPHHPHHP(((]$B@HHPHHPHHPHHPHHPq-SxfVU8QFŘdM\_&ܼǣw7u]}@-`( &eZUC ϯSc>^eTp@e7ՙ"ug7=c}] M1T/dNbf͡=_7/َۭi5?c ǟ\Ẇ:t"UCG"ɩez ~,$`ROShMq~hl1&7㥕N67. Ek̜FyI ?y0 ¤[H lHKX@/3K<꣯k)Y'5!JυQrp>Z*JRAq`!\BBv(F+e/1F.P84\nC 93GY&kԕp d@O*AL4.Edn ,r xWs`V?R\/:iγ LB.UtgD;k(=(AѕR/osXH-8Mudeeǭ[P-s~<t-'ucS;աfI]~)YʚE@2\BCUa.Yėe?{z淩a /qo^X [QΞ @6^ \/S puZ1{1 Yv&[IꑞkYGw3>Dfm|a(HOٮ$׸#mn (.ڂ}VҳT51Q>sW4@m;ӤGtc:8? . +Xh]A;TyZZGV}2͹kf DzD8 K)BFuqsBB,j~bXtk*,|EυCB&Y v`jT}(uh:?:;E0ؠ8 "` |^-SOGeR)+}lU˻!1xh 1ݞӦHWy J12szˋ`p^7D̤*fܪ\f9h .mu&E3-чڼMA^\λOqLYcIt,n Z~E"_8NYl1;jK/Om8#fQvӪ+-t"x"o_%f*|I#=V0rFfu#׈Q&1ߵ};&  K>#Vř&:jJWH^ʥ1<9X=-pP* Vh;{!9Cj&2plf_TJ;!~У]_]-Cr87!f?sg~IP>D:>m78o ɟѴ/;tyCMnkf#QuijDŽ; a=`sdN>yz'R,In 5=JS= Zj靱X=oUvDf^[XIܟ=-Թm<h2 m2i 8/] Vb1b&5naA_cߗ;I0Ӷj_E\n?EOPi +qh8Z"G:>l)ǶƓ+6}n_z#gHb:xq+ESmNE k~JO`5|zpJZ l/'5a e I{*j J!nJCKu˿ .mɈc*$+iB,J{(N!j0 `fSidYk EM=l`9>*IXiӾ# *^,؍!vh4T]kI@/Ų`U4'|^77yFӢ` .'fRjpO'0Y]lYы}Dmbr<CooxqSri>M|<(9b~O>>b5c!m- 򊀀 {Ԝ|-']zE5$'L~w%2ƈW0 P؉r-ǟ_1shoB4") utx. 絴 Q6ZowfH.hY)ʥ?/7.Wyَ2rtvN4ڷxP;tANIʙɎzfy0V[yFƱX LnwW!`gqOXt-zK3`䢓N1u9ʔUX3Fnx& ,!jo I`j\dQ|Ej N}T6n'^k&G^N `Sv}qWja-E [=G没bBtӮBdgyAmxGOq.Al B8QɏJK=ub5~lh~0+ IiI}KeGx4~19 dfEʇiq bLſ?e:w p{mfGG7O;řSJpvH T4\2H+ţQK}{x~t f("X#dpgPzƘCBtlǑs hO!-J}vz-}fmKg6o??(\DFwUg(:RX:g.,1s9P=!N[I١C =ataCWlmS nĢ{,!jE9SW]VgoGC>S) ,SP^#U}&oןgk`w?,c86tjgV~#1% $_LI3ʐ,"83޸ĬF:X 3~'<(&{Vx!w䔍U{ϛz x=./.l#,H;d#J旅ETjʻ"h֪p{1U.~خ]  &Gt8珏)ZT 6EE:0> ʲEo˾#Ň^IRXy-j$wYܢP:jS#]:ÆRJ1\ܾsp'b`=Nz:@fajKRpg =llEX7i?_r&)ZbW -CFW"<zsGB]*Y;}BN >ԙY>A/Y|#WI_MuA#i~YaE8ik"A9^TsYye{ W L"1& vF~ʀԋ^C)Xt'9]g1~#S쮺dLXiy^ i3πt_y%,z0jVJ`?[8 M0i}+u9Y^"҂cZ#1 Q HM;)} -|>_|=C{oўWoZN;l?_7-m>Fg&kOm vC?aa_~kUgݑWH>!=Jz?I+r ;Qy(YRS8' qV˝ep* bXs- 08#tݯ d65⣞Q*i9VA;OLM6a/kj8~]r-6"t/5iE ;\LaWmR7{lp|f2H'جeђ핪"O"塋@ᰋd :oY9θ@H!.>z86t3xnH>gf|=\5WBCA2Z%ZQ\7,{>[g1c&PQ(VnC k :"x`e^1i6bd H9R0%dH4``k 65c"7>b\ST_|X 5뇯J ^~OԢD Q!<Ҋr[<ÌpAsL<D6\TV?p.X٧SŠeAHeKP7e+ ctYc7q{/~MaAzUʳ+ EiYK+b8|˫.ɫ2==aK ~ x%DhwROz0F5&Z0EDϩR R'RH,hr A,O9)Z9= 󁮙|v > v 4WML_NWs~_@ۅHK!e̞N{_v~%ѯxMwq0 Uw$/TAɘsnUF."%\!NkO3,O'um|P%oH6*C bIjełNn8MZzDapA# SCK21:EhԐr4 S%ΒfOQC]}N6ve][ʪuK Js%L+LUh̤́'z]v}HV-H &50,s;4-)%,A5quȘIȦzGz- dgʓq_zV`cq͒4jHsNO]e qgb@ukI M|̄翴J.)ުng=qYe ]yX@NтѻmG&AnJG`sN *)_$f6+~_qDQ5XIuk3~)XL@,6w/ŏ+HuL'%%)wx3jR׾݈fqjɁ?Z82"$5]tFbTҨ A:CGNiR?c@B]BDX{2k XVn4;:R\DJ4IA?ոߩ~1iSQ&VMf)n6RRs,%7if?h=~"0 YG 9ULai'&Nh#8^g^8?IҞ€;daglRkjEg͎8B`fٓ?$Aav#[lw$3Vtx&"ny-o>I%+BK=ү2MVySo%ҭd/7/(p.ȴor|wsO|MW.;j' dVgiǸv=˻RjGeP}bZw~Rh2mᾨ}d&!)PKpqzI}j{{7յbkG^"݉zgɻ#wy`)WT(Zl~iuBR]\^JQn+YRӣ8sli?^~ߣF/&튻\E< B)SyQ( UѲЂ `AVc67/}.-^PDYl2Z#5V0";`D.q#w8YLZN:5-D82b;~펵nY1:LGRy3 _JDsmжMuY]ֲٓyjt-f_V1x)wI ؒ~4f;sphBi[UI\qClRC^X󚂅)yCƅx۰dQ x û*t2rS*6H36)xB#8d)On@kLJ!N{NEwIwof3w$?/8ep&bAp#KKXq}Ҍ |ssD#(гoDpodZw+b8^<^N`Gx%)Sr T~j;o|K:hWN %EU<2k(`9ΡWES<q7Lf'www01ڙm&n5 eԓ6_WES.LE/nd xwZ$$pӍΏ?sCz4~ꙋUl(c| nw?h3VMt>9̧\sZ`ݺJ`: [Lq|P]#_wG = /$cBʵ%(|;/^jz!2apM.3ti9Q(RV/^c9ČS]-/ gXjn߅\$AH)ʋ1?+iXEFAα.]y5OE웣`S-/SjXbƙ a@FM,N!?s8)/F߽O<~KW!Y[;{W@T#M/e잘J3,%^9@7٠nQY;RR#K_ڠ +bP;}jl(wr fs"wku>ͧ?E rz@nyeyIyZtUGTtzgg2U ?hzz0*os# j4A9rtSJLx܃Td²?~IM])]*>|Pq1?kbp},Op{>Y8=Fpx ?bj9YQ?J0^ w{tFx[]E:u٧|Q=_*kժ"=Y>}BrҤTi-.E7tJ[퓄IFg'm:ѷ? ǭuRfn*u$yWĞ!IQw+!jVAbV!{g߈H.]C}>l`A:67Z+!W4BB> ͡LJqsjN'Ez*,Ʊi1.˃|^N_6n .ZPe̡0C ,s fM76P+aypt$@n̡V`Mzb~@ن»[0ڹ%%E7b8G(x V!nJI"Mr$w]R>%m#zT,ֻZ|q_#RaC't0mIBGj_>#{ sגaI9:E*\h9 i/F; K$XcԝJ{ke,Do4p+L7K,%_HPBM "Gb܍GhBmvS-!ީ/3v!="JMjBQ:6g-VN@i{OÍ *!FXǢbDn~gg?v4}pBymζnY,s[̼p&apD,MG j(ronO4(([P Ҧ=\&YW]}LqF*Cpة\q:kS6I\NIcE W?UF(xPAw, >@0<GKZv[J/Y-t<(;и/_L'>n0_4{ X~+0'm;'5C֌-6ܾq~5sykG%9g_ XKI >=It@֕q$R(@RX^ Ͼ$aFW 9RV`| F_wUjz]Wwn6 g l;} T.ȅW\] ЬKPya .97RYN7}1Q,zz/WCkB*L> -E ?* LG՛Dk4##Ax-;%W«֜CAN#5U7c3=iT_{{sQ;ifQgv⬃);w:. "ܡOj{ʹBc^$ӟLNL]o }pxnu5@ٌAIA41?2Na,>˜l˴ 9j[A/rc5m+ '7 >.Qf0(BBW-sdb1m;1$ג.?@hOv m3b'`Ip|}5{f{U.m^EϮCO(Vh}DL ᏁZ~CJ![sGWᢧ!A2H'Zr*nν6C؂ԣwD5 €+n@؏Od,R 42;Lԫ\l1ԙes.Cf1Y[ ge )m A&}o26r_kbL8XEUAmhVyЊGv3Lcv#vӓ`{Tt4C>?z~`ך=N]HhB3K5Ɍ hs YٸiTW]a}}5;*PIGl:6<iJPCJ@PfJVJl4ʣIZ6Q: L%JEu$,G.^^!¬8O9b8ͭh9%dpU!$/#dd^@8mXٷ`dO rtTfrg27:Yh:µ SL\6US`=6II&Nק-uH*N e䫪S# W,<ʟк&9hh/H!nim C@>]iaqӢ=Edo!\S9cKMҠjUΟBNIO/R> }tD98FO䧵 mT0. (%'uNF+Hthg IfГխJMClZ"B:b   T럇cp7zOW+MϺCc;\] |N5n[Zwm蝜9] jV)W+Om?Lۚ"r0*cL6&-*$t鋖svԎFlNlcH)`Qv]٭<-Q>$aq-26gUEgEO)ͤS|߮_m4G$';A>gmGT7Ya#{`zCbSL#o {G!q1+MjvJ.:չ%\1`V'Z* ZL8G>E#렢b Huݍ'G_dm+)om[l DZ-u`-DM, PqdArZ<1oQuK5 4AHjYa$lqDIm~E^)8X| ;W ( >rie\ aqٌyEFΐs[aǒAFVaS*54#VV2k;6X~FJաjS])S5(wuq8gctd $Cl7iZ^PTY#qiSvdO֓-_קGjU?Bږ+MKh"4G[L>!pzv H"וy<ߕ ;aeu`de]5` 6_#A9$wp#֯5nKvKA+at#b57ҿT@4xmȤÄV]aF-v9! i=>3g?3Z]6mv;":iWhNNñz$|/ˡM)d BMzK~mb<CAӟjn30x:5lܣ3}E+Ƣ<#:;]T'U1V9:'}HvY\nH,5`pd"?7ʳd'vAe34\ ȫݤGL(ke8y'# *QUL+Zk>!>J=2H˵C8^3C,SPJ #sS$ܵ}>ЯqG0/g-?D L5H6[U#N5+*Xv/RIlwUL`PPȲN>{Xb-wDz^^8U.QcByBOrQ*=?bit׈έp|Z!]07Ba0>##E΃5<^#YWK"L8i䑬{V͎Q.?ֲXi Hc5p($ GPJm=-mj^t#vaˡ S< GSy}:1Tfccu$vԿƇéqg_ i[,w|-s7FUI;Ok7> Gw[ZtxQ[0%[!Ȭ7S8c'#8GV0[E'c#N 5Po_3fch^~D͘J$:{ev0*b*" vw}AaݍnK*n+5YM\ pdR{y|?3HKPF50}nDl`</fʜK ?5)1 L'`rcyѧkJJ@ `|^ F.)^<7 "Þ? /4#0C4qe&ۮ}QOKe^?jHY? w5?`{X`2pb :\݁')Mƻy:z[':Ґuׁx d}#ӽ7 8J0ʣ"nxݸņ +cCGw^{.=3EC-fͫ~`Ddax]wqd>{!Dѻ׼00c60o2Mt!OeDHzQC:2>.@ƹ8Ajdm~~Ηq9U a#wvv4a~W5Tƽ_0W k.jQ{9PgQ 0$ˇ+Sum#OGl+N"_\Yڑ!lCHZn=j`H&2ԚZ0]_Wq2#8VF:)v\F=0VDn'?U}!ZҨ3ʆe_OhLz:tXWYΝ.2|[;?F3xl3rgYJ7YܟD\}g;AEH mZvmdoҿpFqypHNmtҠ_]nĒH0yȼ;]ɥshQ*'W_.M,' 1"ƍV7=o-I5!djE ?[5qņz9~uט)qK r)]s>2+|R`i@cu+`G~ jW]ujN5R.’% ;u7]ŔݕwN;q*zLft_#VٱԨ<= bɀMcܝ7q̋% g2ql dAt|ΫDв[i,j+:-4Dqt9Ԓv%B Dлx^Ga/ >#U˩3jOIp'r.`ZoDğ{:3&HᲮ1Z|+ ׯZcJů3%Un@'ɯx_BOLhL|f13Z;2S:RnLRU1ʾB oTeW2ʭ>4t2;2Ia`ku&dS\mîa+.7WL@7my~.: :U"_Cڗ 2dJ;kh_}]]w/~kzc5?z z=_+\W|z/N_~T+mi4/J~ҟzL _wSW=B~j@ޕ F=9z5h~*}?[|=#wn;ֿH~;"74Vlmͷ,t'OC]__\wzn= {=) 4O( VF}Iw˝?Em߃c\8qEtq,?c ҜVAm~e^[kj6)z)&N9 .q(x7ӭ\zQTE*hQ^8r&"2)+xX\_mU4:DA-J͆8(~ܥ. m&&?P.GŲO^P[Lx7,ꡉw=@2IoEuݑ9y"Oř CǸ=]tkEM`i҃x(4]c_4 `j]H,, 8!/adhgiDP}y J1gIb4e'ċ>;oUpɋ H%OCD̞ ɑ\eqr l~BA'\>DwUKueHPOA'C]gBvVc"r8bLkxt7>\QPu Wf޳:͋4Mly*3T6Ei|VK IhT?nT2vU^6bgrƐ I}OMʧ@AX.j )4,2ȹg ?58@G[/(PM΅́&+مY+x^ޱB"y3JD+Z%Do/X("cp/\gs׈Ĭ?@-/Te7sQe(#nF#^oʓ (Fwap%,9c6cyOMtkW_镴/S%HEjEpo@}Gkht}cw`&k"}7 }{KbC K vp hb]y Qe7Mn 37]0P'V > [،lN5fc&:#_66*e G]Io#7ֿػ ɒC~ K2hRFbcPM^^9k Xc7>'~"MgQCbcKV8L`2O[mH7]/ylaGG]Ѿ}  ?gGY"j1fdS@:^Hz QՎWv!gҙnSh\8Ψw7j~_mr~ y_QNt3V{bnj~Z*l>"*i}2B ah+%dgEiЍ=UFhlQhHb F.̩W 5R^i+ ](E5K$.IujȎ~N*S)b4vߛz C'Ŵ0.\\xmAS]e -lT[Yf-db![_WB28bl*֖Ѳ͖%2X%Ow?!bǵR+(̦|bF9@[I9AQ}pr ~ CSNc\ R_+i%*؏To}>ZGeN@HAI)H1xcFڴ#%cԯjf ؂uJQowZ} ;(TV[5$*tƺ@3LS'ekAHǮH&ɯ:]z.)4[Lp!QApG=fѷJ1#P8\u#&$$JJ)\ZEx4$]d9oB};hO{,'xԯ;EcW@~ 4.#s|c#ׅj]_Lqjt]p@2iAeSn 7ETf3" Rbqjf,A0L)PHHS*O!YU\% Pbd^}#P nnzM5йt8QiIm˸ -J}5}wA6ŏڈПdw%:Cy$tsbsK3+iy%|0D`P j;xSS$EZݭgp|˩tt2`ړ#ps&. 9H&thNV}}I6L{kJ(RӺ!<-yv)M9n@9X=UsDp~lO΍{.ج:ɆA# _ 0h|-H]mNp$_bW-o:si:f&Nn Lqhl"sظt&nѼ*;jx]; WD0\ݏ&FĐ;T_s$(1/CB5gu/N!D0HPM=]8 y /=$E3ܢԊB`\Vhzx.= <{M\jK\% tUMpXHvtK7mqe'Q.].MENޱ \KcWs*zR71]q":>N_{iنz]y$ nDXwBMd6 r!R"ϒoǴɞz>XQj޽u^pgh9j2|+C6WPz0BscW K Wn~_ܾ"\3j Pv'`oLe΅&NhtwUԷ5=-q:sO (@?`d>8J%I<֑2r $/̚^YlXB5رxL5y!&*qMފgW9=NF 5 J;o-O՝6B$)bYmpŴX\g lUor-?{=ӹĖgOY^fhufM9ysnz,p`uuHQ3]e Q`Zܶ6h)H\ aڣLJX^8{_>C^ \6ȋWo/ٸ H-Ё{SEY]_CNed;Y83ꛋZT a& u1aw s:\[M=aE{%k`=PaZ/a0fb95 .بoN1CoPao:.Y_p.#]VBJh#v(QȌ3@d<;)[!0Ő}J'ĭQM8L{07Er:0|m0asgheY`$ Pm;'hRTͭ eɇf:D!hT` ;jI:iıg^K9&jȭDA1]%Y\+QÒpA J$s P8?{71Pe[0襱h4WW<;s#A n`ݍ˞`A>5 QXAzoJ4CK\ 9a'DopђgU,ߨ+pOþkIȘh5\&T7rzc eQqj7wŌ.m:S}t[!T炛T6L4NcT|ρX~u?a3;0㎑en J6DňDSX&O0!VBϗǺZfζb.)q1S/+cYv8UL,,?찥40 ӏNbvhȎjb>f<{6ԨyW0ݗgc{ $h֞6hcP @0崦fWf3 ^34'~m=8/alf"Te(RWj#-1<$_uk9oUe"`Un.a$rUE&4g+44zF`eԹɧWHnOseظK\飼wnw;d{?~J)=M1sW>0>L I۪O뽵aӏ7eA26!QaHhK|fqC%5-H>u]h2u-T"aޛ^ *o+?lpr]E=IscXhe6W`` S]_\UϘ{ شhu&;f\19NBrysBƊb_3Q_/2P㷧_?[5V~ Z͓lT0n)Q[,{1MtTٸT{>=ps~/}CCY֝=Io@[-j \:V-߅pc5LO,*)PUsIڬvue@!J8@u3pBVЊPxLM' ElfA2̭)Pm:3IdxRqxh׭FC@1Ƶ2kҬݴrU2{ȧdd :O-? Z3ydluon\RX;[oP =e.$C؅7tL/r|%hleW5IPOB'å U v. *|Q 2ST¬G0Tk#oE})>s(M.)xA*8y7(nҟ"UuMwi^'yx5ˉp Hs9-R}S:?jnIA\OѲmpŕ Ix2'\ {,u3P-KBI'q ˀ\ܡZ+4:iLakͻڙyhVk^?GQm:uW-՘ ߦTS)xvH_t, {(^E@v1(`J{u<8Vs+{煘ڷt(4vϟ;qY"ىެ8<\[-5ޕK-L̠&*iy! 6ESgrJX'NOi+k4E''îo{)i#Ɋ[͵ۮ9x{ä a;VyeJ_{f’es-9⫃P5UoT i} >\0_ L4aRS7_={sCQ?̮4$}s@.op*j<F|;ʺO)P2+*sU#quwgܙr洊Th{$)0$GΣ4%G=IfO),[ 5mm¦KВ =?oؘd_<Hm遲)w/TrQSv mi[;6#㿖J9IéG A<ۀ3$DQ+]fteΡ>f%3 ڂr+ZEyﴸ},?ݿQ`{DEivIT90(fمW6[:Zd{zS@ tk\='ؓ$lgUC9 mKJq3/ۺEyZb[ח;A> /G "2SPSoj8ybN=g.+#;}Vr\O͞#g3~T7}#QK*a V<'u\u2'd~ u]cc _S8PO7.-YӸƠjEWp V\(-[&magSb[A_04r ٕ`\K #we5Jգ*8.7go'm\,Nb&FN3@ W㌜^7)a5?6\6lE6,{ֳ̮(8remm1ͳ9{zݶ'S- Dej";K/Ǵ!LdVEwb`6}Gw"oBadt\UPy?(ϗܓNb1~m{gfd=3^>hcqV%׃Hᐥ'AyHӡ/V?.âI|*g2e ψ܂ws+y,Q_ }r H'OR.E;] {:%orsp.|JMXNI'E;LU>NNj#vN3ow箿'dLO`PcoOpseeq|] حUj9j hY;X&a|0JKU`sKf֢zKvMj6)ݥx7HgU2]t?=ip4L83lmH@:՗} %45 4=JkQn2OŒйVf"Gup*Ovikno-L \}T::^AG$ 7!cyfXT4oA!= ׏o}TK I5AxqFHV`t 7u|)33QtYك滈\KMC1a}y%蛘/xda:2i?P;BQKNfas3A UU;c'w1?Ct; ؝ >:^ }lxҳP)ik jև,u ea&NS0$1jF:`|V)Wp͢pj}4hqn"~4RiF@qfc6r6W1]&fuP@3?2:F䀏(ggMTmBWҟTP;@( \q௯<;~䋺ga 屹k` .Jѻ_e'HL;E .AĹIPg|1Cs 5żeg7hJ~/Ibu {l#:#ڧa~y|zZVّ_Ȕ2^ r\]+r<bqim'2Bh1:E:KѰ~(_EC~T?<67B[Y5rLf鲣:c\s1Uz+y.Z ,A U dדnqG;&U%_cmCC|TS`m7hMW1ȺUu\y]?ͼC}oR?yz +Xt xćZN ww)g1p<>e1Dr8S}B~qӅϵ{睠n+O2da Ӎ9,LHb;cxv1TEǚsN{g\#܁*SW (L@kX~2M>=5Lc A طyQi iwȄ OS|_ۻ}v_L,֝ 94^vI:@+ItR]#BR"Gd¬OsTfWr Q_=։&.Ka,:@ 5UO+i (?xwnP*ybeXw"*OzH4Amef:+2|uqnM9褎QW5aiVi'(Y%S5o*,]&x6*?#Z[[G4"!%[*S_f8] X!;yj&:"|<8,S<:R\ "Um0;IMQ d<-lO}5i(x FO#q8owyNu I3k3dgR@Ӹ6c{Ԇ\^ <[x<컅DřgLA׼R[؈RFK4,JznO`hUV3&i~ԁk҉-KZ{;ac"!I{ASb٢l}8/d"anC3x8eUBohw nܽV2|4DUFMA "7ڮ;fOav9yb@8j8,E\~k[rX1 ]]IN {Fz6:cM<vRvPv4g)*u2HXZvG EPTRV>1a /ea:F.&A˱gKJrgYA:|8w%ixc3unC}KPU}?/#!\_)wnl6s;!hEp+ 6aR Iw ASBɀ * iLTI:Øc|Q>ԗ$!En3_~-ajNU%(%ZA Z[eʱFݿs!pԑzZQ]K4,Lͷ;erPގbW'{Mvp@v$3 `cߍ!^1s5V? HrYgկ{$P_t OfmO:@pLM>jlo+ pNE;(_uQ9 ֵWet )v*:;ݗfOu/S+2k,NVb 8d)ZTEO^gL>A1p\Ng?ŏL<]jH^|wk_rljJGga )E.fo~xMֱQsz idfUآw _%0F3Ga# <6*1m} M ˕ v)w}7/^+@5ߗI qzvA$:@RR]a04Q =]KRɊ3wH mLzk Skcjxvsydm5HϬW,RyׅOjZ]S\s:mGDxHMPz݃iRv- % K~Ӛǝ"U! LĒccɾu{({cl"#iudV'տ1\2Wf7kLzV=u<6yvX6X_L=^}7J%L{ D=KmYK1K|ћYU;@[|2Ӊ8b Kq+N%Ys؈fٲ"K^P<.'3γsH"jVm͍?_OT%7|S[,p԰n@ayKb0NQh'1R~/^.=g7~?'c^j&vXߦEIqy,WMw{[VIHrSph!Я0@-^D̕!i?{q(P-Ў:}Xq0Cjt/,I\8ӫu1pg;Zkno{Jj? P?g=P\uy(=@ùp{dzpӁl#OlT@־~q*|N(biTqDW X󏰾|+ds'3 E`LoXMxzQ><,UX ؉mX["s͕8'a;=CpLD[gtW]/2%5)WmƾJH/q,.d_P$}{%8$e { Im43zҷ}mM#H^cxFͫlIIOmJ$!O͹. [;*H ,^=7*p%4gky AƋ !ovR 8ቇE֖-aF+奴Eg^0I"ykzً(p43~6xUX^tK ,T,Μ{c& k Q|,D'#@0A. #jpgxΠwN,5 B XLWuTC"`SNtQsLtݱiΨLU6gZeW#$*T_:axysm:ፕ xpl鞁r2?P&G'[ ARZa8=Djp x aPFЛA( kc0+hQKL'bF 3z/JP]Nq-,䃹(vA!zU?&vuO3˯+7ZuP&\*ܔ sju.!WaEդ M=a3S!Pp|?N@@=4R"ZXS5`g}o4>rtm6I$YeHͼNy6lq¢dFr8jX%G=`}B\dLag `vt m4mbټL'qqB545+Y->G(A0XuV&_73ShjE@Ieqz@HX՚feOx ŔW,(zѐ0eI`] lmʆ=8^;?-Ñ%B%O4ytoQyӦv+5͈^m%lg%67EqMSp쭃ƥNo\dQuߝR)sxfJ==,Qd}%>b3E-#Ƨos/lds;>wk`z'AQ%p̗"-dz(b7~(F\Kom>g RL D{3VX3P+= 20!7\'|};Y2kE bǚUpXM_Js _bb OO5]h3@>ol02 ձ,6Hb{vŜ ’!TX]6v ՚5U D$¾ =m:zepA6U clTA;8Y+^scERcEXKҾZ]-dmnFn04;մ_t1?*v;5=̛s{yC_+(9[`aZ^{:>g rvNz]Iܩx#kVP[Ȧ12LG9GyP%i NXO2 Jlm*ǡ8@#$eJKZg6 Ҋ,\E&.[\gOY5!-:; {[!9tc̨`@\1q\=[)ɋꇸ#{CiF T!}xzgur1G􌡤]B`8/,>d)sM𫐢~,9_`zEX1CMMIǀw 1P,*Gۯ[Z^ 7GcR3ёLVlM1m1XESO8T* sPO{7a^R¤x 5-oFo;_!]b%=KT[zq^@O=)(${;ҞesuLK2yb X0Fc1C aTΛ]#B힒@}kՑ)[ьDq/[ޗɒ +ue']nN-WqP`_d[" Q7b'6۟-`gmtUV (Ǘܚ?Vƽx w6`߈y c̟ y3=עq3 Ueg()gkgyۧ/?ˑLAD{ݛ/SkÏ%hO{KD T.5rq&f5b[ͫC%ZV~5#F}3bsP!؝uco}/$ d8-ս\Љ]PKDC3\= 7(/dyGw}"犟1r!!-i3B԰0[*:lKFkݾχ7F1C<^Өoe܀ z]g*Y m6,uJbde] d*!d =zn),M6A ev}g3_7Zڄ"N #}6Ry m ԟ5l& 㙗Sp@M^ 0Y%_NRp#'/%Hcq-Ϝ$]o~vP%8~8څ+N1:}^'̋ZG G<0py[z𓘁W}OWU߯$;疪=~Ud׸y r1Ҟy\Eèy Dj^wIzs2w;Vn\05Qd6\1].[n8;㨜ԊV߆]/x[+~gl\U0KsMï8/D1l`QDc :`Jfp`77]$/(8C&3fխ9E̳|u1 {Sid4T! EP!I& GDd. R4LKZ*|f<Ŭ%B+rdXӅn&o|DZkf?e(R%.8#c㱗W#(mSi&"&=u6K3Dǀ s|u7?ǟ'_KHh%HWyhΓ 91P5X1G5)mcfdy +ϰ0,8 67mS7V*bou&2(4=Y/ vU=7͐:%h DsB,@)X&;[Da=GS ~ruI;%u6@ޞҞ߃r<66x<y { ̔wږ+Zrafig7"1LS3BdUa5j4F9"`C1-ɹ3Ӧ{ѡ{@* aDu1L6유[ zv s=JDoA7ro9:A_&#>T$8$ v*EUBX5YR?oBO2[-+RXòZV`~ i+d{[B@z/w7mǿQ}sa{IS~kC U߂m7tkvt׋nmW76ڿ۴[_n~<ѭu݊^ݷto}߅=/ֶO&A?o`_v۞isYzCky§A~ k6AD֭Rx:oA~ ࿶_,wؿ6{ֳ';xj1:OzW: l;CjQ}hgZs}Α/?lvsҟ?F6ysuG黝y~.w:~ tC$VUՒ;/w>S-oޯWֳ?]j{s^_[SnVmηۏ߷ΛW/7-ۛwt[bWvswLy}+uDvn[_^ۦmͼg]~t5[?V5~n>ۛ%Owg|)y[?uoTv݋m_}VϮVo[pB{RjKu5O\n~Q^ طENF=2"$^iӻcuߕhsGJ']z͡ vڝSzߵڻGk_ջ|{g}ӻwPnvzc{wNmljy};[66UQ?zSΌv}:M[_5mMLU[.Si:V=ڝ6Y}Q3UISnvtoWc8BEAV-#ք<) ڠ7 LorTq8_}1F!`q@(Gݔ{ytvYgG5bjγk9ba^1' jU^LKv߉\b5F'V{۶a7Cα@3}@!9Z '3Pjo0wB=ymt֚H~C٘͢܁e*K Y RH|DB]uC)%rT/k͖mjVWz!|ɇW= g,l{AAAu^tڣuOH;\ҶDvKHuz7w'̈ɱٺlG(X!ɇB]E[N5lǎ#aCѭ͞0Nq; QD wl4P BQz "%)33dpSˌ_Qz7DQm"+]JDHP+{p$}$A`g-R3.ϫ.EC#/O@pPFJ!.˛6VgӴ vǰ.vڐjz}FPn.րlN9 og_pPk33vЩkts[v+|s-Ԣx DqKf+#ЈA 1_"[JǤPf [+чJ \wvg_)"I-;)#Uý>5S4GLHWh2%j~6ń1iҎt?LQqQ7F547r죰,(4PJ'uTM9xi;r7{%0͝؁GD+T`<+Bi}#E/&T?"3~(Em^_귦Q\H[Oıs #Mg| QS%)%p/kgQqx452ƈ(-]='5)gjUt_'+sC8L[S9Ey:\g.F?Bf+ps&+G\3](SPKj{_U UEoLb=ۇ,4vs3,$>T! A%3ZƜW|},m0/V ^HKn{Nj=`mfnDpj { M4䐚x-vi*(jWt(CJ0uvx۰uq߯/V $CUO8[0زȈ^tRun@)҉[(X8]ҹ&P jKݲ} Q:Tc1!Ƈ譖&emYڕl[ 1 -눍p3eLmMQ(2$JN5aP;T"Q,I1 ݱttB6ϢԖrq2"+WiU\^0In dKJ7/_qςsXp71O(dB;d0?e;icj*,Su# n}Cv:zl,z7S EH|*Cpk&C;%|4 Wט3:D]Ȋ#]?{A:1{4;'S{ob8𑬎PbEL=)!{P+= bZSEU8g4$L[ꊴFԞԅ.5a9 *OS( hHW| VB=@A& iPD6vn:X`>뇿!㎺]rF{1Q\Ų'jT@b){)w-=NMWk@ikhwaǘs)WcZ%f*x.RMN^z Uk䒜`a0 &mjWu fӠy<QVz[f_/ŀ>? 2$P}}. ɔ|Avp>z73EQdbQj@SE_@`/ 3KIGydF '<4FBi'/]@" C,M}2eͮ,.qw;׺4HYnBsw+PZ Y(+׆ i~&bPq#}\PXVp !LZy*E }WLgw QFW \` /!Sr =ϐQ<%-vŘcAiRoDa:Ds-KSAW˧:Q㠾|t7ssŬaE<&4}Mږfkb?e54 a}ƦqAT@|u:𝾑Dmя*f~8m, D\o&N X/Ӌ~Քm(q% ͧ@!퉢{1  Kow{++(sA0nvW^€3׿V E]*7jX*v2+jǓBu(gU_-ck %#SHw}X# v<S>7C:RqU_K䮃6Cexnq|K&3L#10O-C\ߓxig9Hz<\ ȜMCoPPk~ lQe̳\ܬ'3W$[<% <[NUE^M(7k"gGGs^M]5A4ҹit[l`z,W l%꼔I̎nT!O oΛx~<wa`_V K-En0Q."z k+_ͫgS@ r>Ϟ1z#-o~6r 9m$dѡ?wwUX]l.!1QRU-Mh(ʖ5V9Ӣ'0~;RJrvHTQoT`p{̈́;:Zݎe1%-xd߄U67%aDj&(Y6r%%U sT..۩U`SlMdA?V1o)#-@suc3MGn`t!"8lrMe+ADN%a*7z4z;-vV~AAX0'6.|1S9YaLw~`~KmthՅ:4{@M9y e'8V:TT LR Yǝ7{Eih!DuL15iSC'opΒ./R5X#:"2A8)F|%V&tL/݉ Ԧ1(rڎm%.:&ޛP|qѭꍬ<E [J7pe+F6p{N0'1:r\ItBE Cn ͰyV83=;+U:d^ka<0 a{2qڤU+Gߓ|9)$},VRcjԄCQAd\_! ystfLA8K?*ՒSz!XcesƹT\5ԗ'5cÍjCMU n5W4B! P Q$t2િ@ՂTLRi4lz:DQ'nO+W u /Z`vxh#Ѐ]TI=[cLjR, lXxv q*ObM,:6;P9ww9tS^AdvR8"f[0h >A̾5 }rٓX|ٻ|碥ا5Np;/ٷ N0}rRi׌3?_AШaoM5K_g93}ٳNVnf: DZUCWN :VĜĕKͩib-x!<&~ @nր%DJKe[v,Q/)#/ _|t|.:vlnlg) 2]5A?r 9Ǻ}8k{,mS`&]qjbCBz:I#xQ. ԋ&Yhإc7k:.ʦVΉ3x?.`hgp) wmVv]?k/ގF<. ;9]Jti~r+hœKrxf&JvԿُ88l_C(Cǃaѣ1|؝.2S[ C/܌y-bNUl$JQUv)9.[E{jGUdmqvR"n2 p=A"!~v|Oxm/ԭ&#Xx>Ϟ>@TjA2E*'1ӡ\GҢR\du5rSx=hՕPqGX3Lyㆩ_VYJؓC$X`5G!W3u)hǖCXNE{Z!6B1[N]ݩkZv4$L{]ŋ1&tsd׹@0 .Q^ًL?0\e f]  Bn=8nEBػy,GS#"KlHpH`|q~X褄ꅜ%x;*:{iG-"Pƶ4[AV_x`v|0]6 دL> OTxˤ &a0%ũ(qYT>sJu p gᲑrf6gߩn(3j+- 3 ~Aޮ c9f t#/G a~Pl?Z`a Æӝa'Ȩ8_|*$x2WA[qZ3߁f^& 2uWG;T>I\%YRfIViKmt(v y5=}v䭵`|mƔLXjC.""h8jX?Q]w0k꯭"₪zf" d"Fߓ.{':ltP<>S{@VcKmDQZ;lGhq>a0\T؎n#Yav;Ɯv5 oE?js1Yأ5u ymapiÐ'D_RBҐ{S~Um*ƒ6tW8Aw,N (-h*Rp tA\i ìdCJ" `4t<6~Ct#-O5mr~y}A {Ͻ$H]rm.㙯͒C,T6穼hسOâMot-~W W?Z\pKAE6nݫdաky7m 15WDr'y G#и?e5g.LY6NJ&.R5Z"@%u~:ϲsOZ[`$șGXڼgD):iB( d_Z ͸_^@5a!%$]54o 'B# *P+=B}WU2jhRVvaFgzzޞf`sGrVtmIfy*ω`qT]<-Qs(,(Gn}dӄ^KiG ٿ2 PnL}1~fo5\ٝZ$F4uS4~= @ E%sz?OyN#]gNcR%7J/ѤHJ>Lo'ʊue A>o⹛&4g͎(`cJО2D1c/{^ dTRrmג=̆1_;\\hOlq2U vF3s $w{g Eog~}R29 xDŽyV !tgu% 遙H񃆸z 3ZeN왊=h !p9yZT)E7\FKGl3(hLvж_թ3BĻqrK/ :~ʍѡbha+% Mg7N]l~G~f HDPЙR> ^i$%-70yu.y&^|aWNϹˆW:PC>GiT~ M`Gl#A~'v-0]ԁT:nd6E q})97=tZs*YzOu:2l^1K JPePmȬI˄<z)0 /8*8F%!"hT {߉XlGӵ"n hJQ ylh lL1:~ wX*ۜh|1?%0 7Sap6Jʸ9_* bqtvg Ry_M%3+?(ހ=Nݐ'i TIė"yCQ"n*W4rwj1iw2|G% G LXkT+RQޮ6x% 2P\kdΔ!^vC/fN_"UU!}/(no}ӗZpi׆лQ?/xP;܌7v-ey-w=e06DwJt~|D?MSRnxWp€uu~jyex{K  2T y^8eⷐŔ|="t*|%jtR2yͭ2zg=솴{85؇Uil<>q8+#ǘgѱ[wdTߢ~*THW6Xc$虭"AQAG :Q:VOs+͏=Ԓ]fpH~/[u0DN\xAe7+PI+/Ãqvzggݻ_$t9Nq{*蚊ԁ;v7) qy6z/kO㑤)^dK'棻U-k=@C^lծr0lo %!Eq7w(" keކHPʠ2[xU9 дyƥjpyD:UH_&$QD {|1nXEӎp2@[+P%O Pu7[=nPQΕ͉2Jg?&e`>/cۀ](>|Va2lCa\bQ2r e=!2c ÝlȍT=-CbJ#kZ6*uU U@w\3@3psmBu߱F䤄C馢8S p7T:`(򄿆!pQ y ys#R'~m)/*Kiu&4ZiUΤ9`gFFd$m[~o~\HHHI\G$F&+Oprw0F{e0,'C fMjΪ؅=;IeSzXo*By3[O}v] 9\襎ˤxFqPn-/xw\X0P'Ws,ta#P`iEy0@QGkF8C[G.FM743i345a&"oH+uMO>ANp g+?(A^k~^o; gKW2A흡kUkLN6,`)7=V/:QG'P54tað|zL̤eVDԷMZ2ΫS GxT ? Ğ/cwV<< ٶ|az՘Vkp-d>Fq~Llφ80lZrV`vcKZ2*nKhb76ھ;+(giܤD,}CQPd3(Jnồ;FW+ 23n9R XDrך6ԝ/pK4 _5{=g5Bdؘ>_h%DB_,D|KA",Ϡ*]y@Mk)-z,/`*CnŋrCjSa ͖If_o_d&ɔIhDo"j<׸alm>piT@_R1ʳaֽ͉^k ~w1(C;_?/Wd1X{^Nn|mWXcX^Ɏ[biz^֔X1J}AELd H9sF % 0~KBُݪ!x:*8"|pBЁaHx ~K=.KmE&f$֎W5t^ Mhc3T'5FyCp^N0b$O1Z؅PjDރmfp ~m O񠢂 gOa]ݷfouf49bYj:oT*J_H zs0PLZ4'd8W-4Bl'jJXKl S)?qqVI-!1/v=Ռ!'edrɮG wX>p&} ^ZYL4E!b'n9rNNM( 355kfw t ܲ+uӕ%f\li[ǕɄk-?/*wmL {dZΨb=z8:B@?̒a5F+; .w8㞶+EXHͯ@ɁD2[6̸/ !SZ#ʡ- 囼Cu~\mIŃ5YSo;6K7[_"ʰvhL:fȉb(k #4]W88zN?I~9>\/dmDQ\3Uf!|pò= SDRH5f{蕴4.(ZbP֧*AEX _kul^,xH燍/q:(-%Mj*cIp4?#9~Zf ?R!蛿H:qCBb7&AxR"gKȕtիz:h9 n!vp'<7}\٬}r>Fw!?DX426UBwq#ҷ)&tȠ*jMy.2oP4I.@_˗|#eTaOi%Q҃Z#̳oqMu3>Ň6PCU#BWDe@'N]Mg koߧ߳&>vjJQUP K9u=5Kd%.dT-\[C=^O%-RL5 Ze=Ԃo SIDĝrzQCIO:75_l5+2 a1GxO/7hѣM AuЊ7:;?]x\9 OPJڝ#L]ŐhUU$@j@[^&!@mVP\"{gѥʤc %]W.TfL]%?-K2ֆ ;`bNf1nOfQ:.넁J#ꗆv\;8'З6¾h${oN0Hy8. *`ÉekCC2AI g+L:$Iة?" xs ӒZ#/? g9Va>;D_ky)l9E{Jkl鋩dyK?u,zit u3뫓^4{X٣W d÷lv VG,t- L$UaĩI1 N0>qEd􏏇ϪzNe&YZj"jL1U#_%QUTC.կMg]6"4Omڤ-ԺC$#pUNjƬC-^7DUl a>5UEbjfʮ~R*5t+һC a93p O UPUS6>:M3c2^Ys6̸~in]pDo+4!Z#0$l(e |otM"I[;&hcr P PXŁIn_j`L!_ !@Tq W7U&UQfnТQ{i3jyR=eQ#]MR$T0֖h֝ d!/lA!}T0T%%*؂])0 dgrWhM*zǽ, -cy'(q-N?& Nj?r_G@OFcԩpBR62VTO b w}iEyGOڑtL 9r!gZVV >yĸ ~(`r8Q6tp!h5Y̐ jkM2uET%HOI:&*F"o¸V\Г\[|8XڭS =q&܄r+H! [f`:veGD%aeZ싆O zxR.=N_P| Kd>ζ z0) u9Zޝ ǚc6"QG{W(jce '=7%Xn{B^aF]Qic-H'vBZk* S(ު,wOKu7-R!XqVt! fVf!Abb,n}VIxBánARXLKgx!͇xNAz%'YQ}8/E^Į$iǏ DuWK眊_-лixEw!k_gő<{A ǿ$4@ ̹U͖-4B (\-$LrH`YL`Qj(CXBSqu:'vطlG5TظZ= ~Bs2^,֑ oYZAF(>0RyB)V@nH r*V[aLBsi(' #qsWZP-Z(:5\L=X\Cv)IZ †dHmPu. DD ػ^[t.F/b^PrW_.661bR>& :y7ΖތNOwCD&+AVﻩo77^[JЗմژP\ezS \:0y6՜6r)' I0֗(zaA^x`uvJOYx, IducY_`Xk "6m8ǯqz +&4/ً#i)+WUjKKV1$렒JpQKG[xE/ߖBGyvud/ G V7r ` ";k6/P Db~U\m{j[HHI!-{ I]Wգ\∘3{κN ipOc(V(Uܕթ[464ixȱn8Z0Жs$AEWz 8c coe#rjQ7)ܾ~d7BaZG9qOg"ڔ $=p.HKجʍs k^Z]~Q }/3njb QWT?u_UFM|)v1aʀ5pA2r= Zv@CcrE4FMוjD-h~`qe4'}65r>z?&zCp=~9 !rE #:>>Kw ȡ3~iNjAX*"o+7pݿ~ l3e3C. z'۾a8["wT9d[quoŭV,M΄[ieM.WHHwpxU S wɠyCn6w$Y ǪUZ\A;GN3QgDk?1dK %~D[e3[}LȆQ{bl5Z:>q?m]U-Bp_rz =O$_U!P u(FlV3[5i"l AX2E %:I @jkzᎯ+Ddn?RhxN64%R^LgCs!ý4wa6 J?!\nk'2pĔ/dǫ KeR"XPEkv{~kJI1+hH Nx @{o| h 6["  A_De.>1Y̾,;6?x(9__>{R[t*izJ|{&4#b=V*>m3~AC*pl(N23 ){~`!Qф9) GetfUƣe Btwe{Cqf5!6iǬbwvyȸ"I e/&pdoj\%UsVdCY6ȫa i*|T%^OM FbSkP2F͢mۀarP-o}[v̔&<.upu^Pއ&b~/ %;Lc279ɇ=WTOrw)Av*Kܩm 檇-՛h~ۘ!m1!QK6q(V-՞Ns\_/K;,dQUz,?d<#D0tϼMd=q߱,x & m!9!twݥ M񎅅銼tH1eۣzx2~W2P]#a*/\C'ɻUD"v i1ٙgŎ+N7#.}%HM2#R.0 ~ 8͌|:m೗P\y-olnA~L7Y6gy  犥\DR嵡Pww,H,z5WB{QxXe WC %dYlaսDP6)SAeѻ }"[N0WsIVMBf2o$jx'"}+,EZ/dFO}a+4f2:KE< 1O:ЛӁ٣ fL؀E][RS,՟'d\^4A-[2!S1-YՈr;ReF 1M$=DrCӅo!W:&z(alAhrk\uru P)=8OX=zn4S^9xȅhʬ_aHЊO G y=3[_%zWoxebs$++ƏT& Yf$#qUy-Ka7ti1lSpZ< E)xʟ @/:ƧJJTEd~6~Rt ir_Y}zR(KI43Znʄ?Tж+EN[Ocإ7ZR.eupFG{IX9AD0LXs2V S^3"MpsiȀ x:xF\6JTOuB "Y{F ŝ. ̯pE 02W~!%{kH·sBnO6;7UtSZ"TڥgS̸hJeڧ1 mW(b$g4^أϐk+F@x½N|WYV)8]HpGhIt8h­kkNzkΗ3c/ pBdeýZW12ZcҴ o33[k5+.yࢤh,n%&(1iBa!`#dr6?#cW;V~(8% \U4̾"7LBɚ`~]w몄4@QD, ;~ 夸_m{⯑"]J&I@tLF?F %QOsfJ] kW?Gj'6aq)5,RO>n%2+G I+!$kubU{+a^LNi<)-|ץt&"騳j>tg_(@୶GzifpAfHym3aᣔ7/鸔3{ dE$Nzǟ ?9mCQnLp dIyJ~CuGTTA78fzsh"IԗJt:yI*VAoyaUon1HӴ[BLxlCC^pq c^Ns<'}=d\ Hy$}3kX]S?v~Q)meC id\:o=dѭUJ qovYdQHK7Z2~N8'&K_ձ2 ,MѴ2:Z ~qM[[9]';&c>B9b'~Pz9*d-3-ߘxp^!]Y Yhv_4 #^֩%WD__e^fI/H^ZB: HQmz4fch@ȓc=pm]*,MupHz,&TtCI6X\#y-񍕙e,V@*p2{3LI%wfmvEr U⠎-ڳ5ʣbC+Ÿm5gX(? -T{J*:F8b{0.^q+1=pkPYȸ{L؄r!/Cm|rMd@>Zm%<}¹PBT_,CJ6lA'K) .vV?R ~L,%= !s`WzI+e5e3t)|TB?mYw|䐔'1絘?Y~F_.F¸(1LT$-jaꦶϓ8ڭ+|ɋ)TktMߵk4W>JG(unJ`삄tezؔ9+ly ?es},K߮Kb1T ֦;5gQ K*hv:X`n؉Baȼ99/ LRޚێ/V?-F&aD!ïbd< #׸pjy(!uy Ӄo$sX"hb 5lJP_=Fffm 6c~6Rɢ[Rn(ySyWrz.)cƍ9tTH iYll_6v b۔C9-ѷ DTDJ9tlm[FgMw1p,Zͽr|WJ~d*`AΘA/a9JgDk4]/;ZPA';҅EDJ`mJߗ'ubIOBU{SbjI#7$߃IEU^fWywxEWKD(oˈ:c@ fK;f#U^0h!9iD -aɻƏ[ߤy5:M(܍]hvܙzU2D0TvB-{aG0`\{-GvT5򜊁5~xoONijNjAE6|V!SV5E4(O?o?g^!U3 EgmBV*iM'|v0gI%ߘ^I,%wz>*3C-$eleePk *Q˹&'m.z{uݸO7?*]>u~S7#Gw-*^./0ɥz!P* Z om7dWrUY05ބ<+N6Kp[sg+$.K%M*aBَ]u>h=OOҞM,ZFbbP|S5l`ٹJqNйOipD zcv K{E E<_{(W+8Y7'ȏcCڒn}t*c+"#ؾleq @QuplxP;:3e5/,Ua'oڌ]w"fLۣP;$KZ™HIJkG*9Lzy1dƚr`(J鷀ԛ^ {lU~݁!b$?iK}&m= dTMY,Z_ME|XːA( }qw?QS_Af3MNM#+5yOL[űvToA$r{ORc/+0Ub6>`,028 O™!L7} Gceܭ$ 1td0RzAX@Py5}3jOllv7d:_Gи]5i>DώpkI04moԚwz"+Ȩ7|SBM_GiBmFnG%[*d,foee9s-QvN1/d}'ס 1˳_ˢe_4&D/_r8)J 4 n h,)jʴ_c?؎ @IVFגnrx/衇ylS~^RB>v͊$վ+DJcR(lpz$LRT.p2 'K笍k%Cmv?Z7}{޵e(LKt Emi7YeZ7fX`@+? >w@tS0`.W8|~BWF{&OیMlx$(">e,(nbpٛ8֛ !\V*d68A43^Z~R@; aOsީ-KCC J筦#E:h(eQ%X*1DY!9ZXCwr$[4L/j+≳I!!=l獅y\2:6Q& ?i Bmj ӑr2f#XѢi-fp]zMJ+lEl]f쬬)1V9{- [ lQ+ sUsĘ+SՋp4?u3Y9fV+,qy;łz+^/ 0XhEs+!7$ c.\/ɄEgm@!jAȫ "7VZ{ʩߎKT .+_^"twr8'Ծk< ZGK&/~}%giE2;6)O׼ Ea>+e[ӼA)BP&4r)t!(>Tw%0nx;=w8w#lMS̄k";a'MчZ 7OrSPAFDxȬKw_V$W!6tXVNVat^ 3.&sP|p1hWUHA:=޼΋juph <("-85N NK(@c:w/s` Q$7U"= Q*@ +!}蟧ПNM48^[ 8/0S^ n4Tl>W:&` i IFueEeL7J@mrP:FC|4F* vc)eRvVÕ|@0s8:(jeek0;w)fd |;sw厱1T.(rwF~45<ud|5KXKmENvBWofU`4$ {S-U| ۈ|N`q% % 8T4j5%JE`,:\EaӤ3; |zgYջ}G JZ1Ո ~`#) 5u~=·z|r(Mţ-3/wm4:K&lJ[~_~AH_)4ILBi;vxW9#: E3P涛$_Ssu-+} y)xw,L پRF;cPxا/mJzi{ ={t_>Z1=QhSs~;Տ:׶~@$O*f08gi57pS؈~yS1R%sreh% ȍPqpB­ۮɍ̆13V()F `iH+\"FViJl[xpat> c'4@?fCW>Є>|n (vҚxzP: & = 9 `X:u]a0]VQ)_F)`tJ[>NN '_7?s{ H~nw7ΚsyAvnt `#ϚND[]bM]o^vMۛWJzͯΫZ+Kmsi9?iv۝|ҷC:m{Gv6m=m-HζWtk5PFV E.l~A`#-(,8 AĴL 6ڙLIUƛnT_Ou&.NoG!7ѣe= 65^(Ig\ Mw.#(]%GrbHúu%L^ |y҄ԘO 'fc(FN&6iSvPjxX>.1I |a"p_?pcdHD\m& ny`%'2tjCg &U0^ @B>YEc:ѣlI,mN >m I!|mU۰O%ij4^`9c~ Ymhb bc\< e5]ܩ DzD,?k<'G0+/Z`R'BCּYKE~,bW3sMw^D&mrn|LrivP,ż .|L9QBƊÉqCR}Ŕu`$[ >@#7hIw!?`_twvWdGa%# SJtmlp(#|-PgL\ Nb߿&MZ$ JG^ +*{STtkxӛ)(ONs=WjkAc# O1/Zz\5>vCMnɭ4ke)BΌ %s0{ާNA1#fW[ RKEfu?sj7W#xU/5_zv[+VZFw:MPv+#ԏYɆtCv$nqP%L/ A(`?tn"%*aqg}Cְ[r>V rS_Q `q5Y5}R] Xsi\_2)·w` N,YQmN eMv0bLL[ Hݯ 1 m$|jYyyaO;[~3o͇*;̞Ğ'\gtK s{jz}?>˭QW1Ui4.kWĊc(\ .5w:,iGKux)  9Q蝞p.;C PbgKMtd*?it*_8g%Q ׻ۏ _ ;N4 \81tME=]"7md#gT1-!z3٦ >Ha?_:@~P14k^nzb٤0fƣƭ^wYtml \Cz/zD 5-g3⻄=Ǫ^9C!,PlD]U2X}_9oYԸ[jZ]k*O SLIN~+`2_/$O}}V jvB*~En'LMɳ'йW=j mFFsj`?zJfq$ɧCBw !VxK,~ T~_sXlVSEySGX)i=ɰСp`2A"X/ Ofnrr^uWQG=I*%XE_ύ1j#]'In[v7mS`8\)Exn0/awGbW;i3$x&5)Ԓ űMRD5nUi?'P4WH^*>ϒi*#5dҦK,PWqg汀O߻Tid5{ E #;m&?FRMd:ۇx_]u>%f"": A8eA0T &+iʔ,ot pHjdfI\|ӜjR UZ| Jz~e–GB3\OTdUg{N~Pa~H)O| &s0helP2"G^]2DoBk4aIJh]P.(/FZ#ޓ:p (tIJ\"rܜ`~)TXkEӢ2- H*$d qxWODʁKgʙhn@!i!'3- Ir B,T&2 hWYEr^a%bg ތ3)u eko \^*0I)|rF- 6us^Zv`"HrRjl^L-:ʠ󈰡$Jw<&&T2oAXNxgn!1;"vw!S t(akx͗:=ߔgKJ h"}=I<@wRtya Jװ%G9 Bcp y]3l2ڪzmŨ^N n}R_gBL~&_mIZ!5zj[o2PY ppN`hdv@8)z psDBѲTn=);p|+l'Ϟ3(bfv{N溝5Jog"72;Ex(HADlGkPYZ. 04~zed91)F RUJl"䢉G7c`b%:-߷ZgLM؁_-1X'6d c+-- GrI!ިNl-9a`,fb鄫R266 IJ+Ug9+JQ"ŏ(o+J%Jm{=&^A=l+8/Zvm(OA^ mgƎD6d# I)3ʠ;f;-|(]U#7p.O"OܴXZɹ2 蜉DǥMQڻw}_r||(u0Q,+\#^pT u4)銊m~'"$aȋ{BruYæ9ڞI0NkWuTm F~">&+k ,wG띫_A75x:tݝcn߃vڿn7˝T~ ldxMͦo{Eny757O{uux=ΏNͿ|/Q[~o{E}aϵ=^)DN~[oc`+Gmݫ5{4֭Z *mUz[ijigiv$^X5^{a{UNᲿqk~+m.4>{A꾼k~/}O՝jz ޭêu4_ߺ緾<}V}nI_]{{Sj;}vڛ_t]ۚwL[OX>zjGO]ͩGn}~յ@km[J/i&ڡkz7ֵ[ eԑy7N z6ln&E"6gZ $KPVqb1A-,VW ']jhǣA(c SNcԏnGuvcUrU2R&9.~z *CJR z?+5i"-`yV?w&E׶4 ak w\T]tㄅ%8s6PvWcWf&_ۅyt67ˌ !Xܠc?Hp>Tyɰޠ=IfQC-xvPruq˼2rJ^IrTp}VL,/q~Uz÷9M3=޴FSyl qW:%`h$PU-111g d [N6J,~񺗁{a^P9nn:0|;dăM4kbb\vZKu#HAgxJ*/94l? /J,F Olx8{i"bI"}-[ lwe)8#Qlpx!b5fqsз5[VcrFϲ;d* o,UfUP|'`/8 yB@ ϴs@qɴHvغ,49CQ3žs%lS5D%) yXs= 4/g48Hd/iLhdb!yr> WWv3g1ƃL$(RO0v2a8\|Ephc)a>֨Ff+4;\yC|iz@Cg<  k[2#r<֋8lJk"+02ܠ$DX+wx1bӹ \= h?OXy:ߠޚDJ{ &QQds Ƅ"|dh)kzFZ-8x[ZM5CiT&QA-L<?Dg%*P?"И=ᕯwX71;ǰ*r 1CzZ҅XVr$t mA<\sj]} șz pľm-!CS`ej \~čӉ-BB|!dc<0*26Q%`$ӓ[̧Хc@Tb2ľ1E.xjA\E=Xi-@n^"؃G.-}?S5(,ß gT81&@y7쳠Uo#ftXo7l*qM7qBEMjEX}(J\1iGTԨ{x~chr,'`&oIN:X@ΈbӻCx=@HIX[0/N1W33%*->Pw,rúF u!ջKɨxIz!06wz,VWx{ מ؅Y06PYxCraZJȁUB℞}J+ |GiI8WExSx1о43f?ɆG AKWSKa;5߶7E?PÎA;G<C\\9Ef7j>nԽ=f$ Ɣ|}Iw%Q7ķo`1N4U YbV'j6TU%AxEvGMU &2!^l..x$??TysQޢ9ܐ$?Sɡ&I̐ciT5^Oё5c s?!=&p),f { 0r a*=;[:c"葾=.D<<j-(+' kˑ1dtvOf0 oh1pь@'D!Ѓ9 JDt- I(Uǿ1쩁_{?Pz)κYTgF G[&o20ЮKa?9*U\H }=mʹ]l #1cwVkMR~BXWSc F?Ҹcv$a . Ei^]L}]h:d-=lcjσnZޚw27n?kO ҳug|8W2;3ŦڴX@xȏ1$3eϷ]/hnq>&{`pgeY_.qei#ֿBQy˃lCVr8ǃ>;/?Q!Bi3>I{JVcSdD;T^e"# K􀘂LI~4~.Ƅ)pJJc2 WnssLt ]M@/+ E}+݁ЋQ"=4/ln-)2l`0) h佋\"Pͽ~,8ze^sXoͩے鷚# ـ{۵Kuqg/:`K?O8;]E1d%<ô\@32"SD4#mSWRJgėfouL|Ԫ՘  Ȣx ([V|=` 8ʈB0όmȴ X /늴4tD7SբQ l|åwFi7N3QioùP-t/;uQ}ڐ~BBWҏZ vh0g" Ե;<`f 5oOޯ{* -7ˬ%X\f7w'0v2~XdT߂ |T*g]%"EjUn?m+rUTތ, 7/9~1[CsyDzV3Ȋ6x̱4ӹßrr5ŽC}YXӥ~7@~f:!W>'Ѭ[PV%P9,2RUǷXet^ ]39?m] .zX"hK/Qׇ@!/}Hds5sAg}_e~MQgRsxŮD߱_/ysLHȱfϮ19E=Ǔ7rѮ8wwb"N\P,Y.VӇY8YhB/ gn>AW m.C8=]?(k8vwAMޏc~r"Ɂg*7iD.I*\O%s s}Pl8 0aJMaDL=3}q#珀vX}C,yRP|5kEn؀)S x[ `AɱDuR67лy\x]Tɜ$摔% B$4%ֵ24<눜Abt6ywՕ_/#D Wě LJz5[<,y@kxeڨ)q)Vуy}eht[ &_wQv,A#]$QMwcƌ;\zyd}~M )R9GJYEEyzJ ,esx] Gdkv׬p?a `9¸bsT =7S8pǾE0>jk\xbzݭUQc$.*uKZ!qcI&}3lVE }D.>,$@d"ofĩo;\XY#'3L,i`kLP$Ё8;FՐ |\Ta[E޼ޞ`5]=3qҡ3N}%d|唱@MS[/pl'*ZIn[]PEt=ubu=?ۋ'wA KE3GĔ/-'7INxяlKM4EOfm³bə2tpH#Q`'yu3#*4Yy(1!s/^_/nXgjxŒ0iNK | ᡇ$y,)qMU$f Yޟp!'a|:90$⠥pn<+'Q . uNsŝiaX{ 8:'Sw̖ y^O. T <[C,op~Ͷ~t]07N% OBN3fe"uYd $Swvxv_pdx² Sl=BC:6udVgɢD+LZRঁPk%特( inWg7'X. VF@KZ Z,*?8?8T2Tɞ?lDd+;ޟ ~Tx"/G5#'dWhk?9ZE*D/t 7 U yaZ3/ ZqCUTqؔ`ԯ<1{ƿx(yqepW^Aڍ|C䌐Ee*+Pgn-Pa{/~ Bv~OsHP6ʃg6-&Pʯ_6 pHvhqx]CHrOx2F_ΥFCd[Y&L4,ش\!~#cnVø\Ν':!W&+&q-Em]bd_v A[ԋ9]wAaf5M ݑ \mpŅ]m8nnV:ڇ{W+L8e g/Nb$eOEkuZ,1Ĝ8/iEt_"jdKp#yHв7]:wn8a#"!I|ZlN^ _}m@˦C-'i28w9@>Hb0HlHLe4K4|. z/Ȯ]Jݽ@U]KUeOyiQ Y>MBI(H9$̙dqh#g42חcle[;iH-Z˕(茪PAz@i}QRP[㈮>ȼ6ŵ _6RԨws|$"XTa ZL¤i_/$7H1jvi={TpWwm5h֖G>{`ە_֖>$ 8*(MEVN0)"׳`v o>E:āG,-_ f c52QH֖,,CMqjB+5覎ͯ0/@EĚC4_; rk8Mz*C'm=i>Ν49mA5Ow\(U24V 8M@nK#i#zg k8@6:"|,[- PoFbb=mSu)991$H7:vKBXXpjВW{*K ޣl"PqT̸\P\W㑤Tvxg$ij@qf| 4#;kÍSע5 J+E[@l?6g` P$y@ nY@>#q~t>:0jRLBĹ!PcP0a.ʑ&}ġ>&0qZgπx @źfN`t2nx"Dŵ̲6~X#YnU&('KP0n- X!YYiYyl%~j\?ѨwWjWC߲[[`?5pTWb$w{- yhvSVUibڣdnV4-[f {\ >!ڇJ2Z8'~ sՇΉ-r-I- q 2ݫcX Y X;Ŗ-m/i;N.:OI5"PF z/}j? L2Aր +w5/W:t{ݧ5Պ~A iGWOfJ|}[qXX6S-ϋߗ$Ua)90EO+$#hrv vJBkxl; rײ,O;1F'ff;^JG% .(6+`U/jjw;:\d{V ǣ@ q]g9 GC3^"1iaV? +_*_?0&iUl1υƗu 81d`E)=OC47x ;TBy[0~ݞb+K&~$f <1 OdX%q757}.*6y)v&DT /vg^Ec_wqGG|}.<^_3[f x*X`:ky~J.N:8@_7!䑌zBg? Ц6jl3AgdT54{[&0oL@2wafThdp7Oj `l*ۓL ZF Al# 2{|(gAp3@lmNliE\#°a}mc+!>϶l.N!T#,/gd< FqT\rQ&:׮< S-9 l>w $(-< 9$b^DhȓPhcz#alHHYqXQ-3k1 R w%H7]`wi6JnE8!e^g櫰2f+rmT1DڟdC߶b.܀ؼSvd3be#h0 jLRMxguc%M9e'w jYG 9tS/CBKR  endstream endobj 4 0 obj <>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 21205/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream 3aJpfbdqۯ-)T4B }\[j/٫(1/"?ޣEN 9*(>g2K,qc29XbBxWzTj,&X[.cFr,%uf#|~AD @; u}t؞; oetB#:V޴l@lcg?3[A0㏷ 0wMU89% CL;Ԩ?VZčD #6W&UTM)f;A3y,YvڏAgztCսU6L'ɘc}}((bXΧ 4Z)l]ޛJ~WK[/Zإ(b3fyx ӣDs ŊZamuT;ŮҗaS#a-8@ nqFq@O ާ7t"M笐aeuݡϘɈhū~R0]M((1NI`N(ЁW;C\uY. `bf"V>' ͌$! ljedžܕ#瀻D{(+j-\b6@k=w$f>^jK3r7BmJij-Nݱ{,"leKۓ[DYN};Q}~Fp(v|8y@O OzYhQjeΝLuɈ\y39$Kg*U7;ζ'JɔE!˝qXA:L)9ɏc JSŒT,*N?+O*b [G74i!fΈWAD7|mO2Jc*J||J?X6xo'h[JJ Z0w8K-Cy G4'Rؓ[Q XFİ;U9Db ezz+`%Mo4)%Z~ aq4F[1Zj[Ii5sXTl-]ރ;Uj#b^V=P ~r}Z7'?'۝ZD>I猄AUU_#Ycj~n4娬MnBh La5omrr<{4DG+hPΗ<ϓ%k/a?eEݳ|! [W/^%wq6"k{QLtPE͟!qSuSۍqفIx?tK gϩL)Q]H0VZîqGVKhEl3#xfi b oW90 (PZs-u 'z ^v2ыXה\L;^⌎}h&18($xFFqdTib ᗑ-M AZ@4itQ(:GH"lv Z?oߟn%@>[ J ƫ4@?Eq-fudy OSuo;E2|fY.8Ӭ;H$ $H(Q2ɠ8G[DEu\)l1P1'ĜDU)kdԨ.^)90"GW8MV27~\ԛ]Jiif8u9/?e(t7b u-MknlP抧dC5*7>8s@wGԼ nkCLV,CUٿ~#_,Oe&* Uر\Tvi4"1%$\<)&сpg&X j+Gk?t|y뱕bi UG,ޒq 2MpC ]X ,V?x_*l|Q[xw(2;'zQ_uNc>P >yMu@/K;7a_`f 71Zbw B z0 m]cb=+LLg/+/|7ίBmL_aRpQF2B:uB+Ɂ.ts?HrWL`46L=ݛ;f8ތRf=*/ECY{BDķ"+Z)jQR3[HdHDm*t{!޺~B jNw62c.gz`z}>Խ)ڱݠ'1,>#%"r &C빊KƔ;pfM0dTV{IܱƢgL&M^!I!ז9rj,/U|_?1PC}n^%A;*@mJ[t"4/&NKx(bE&>sr໌Ngי7ElS&'%¤i\4Dc jd^vOLpwzla99ѥ2=7r k>I8 kʃ%>n#\ Y,$SЃR%Kyc1֧>AuksJغhGS/Hpۭo1zw#OZMhurNny OgSvz}k'hm1zqN避K [fg?of]1[k(G7C~Qc-h0fT[zʟs^-o_y? bPcx3e{{=B_o磂=t^'tE*z)rF_UET &Ԇ4JV?Q!\78qwI^z@ץ%;f9ihe /h+yHӶfo NrW:yDc<'RS䴄׸Ų;Kc Jprb@N#DFӃHqhTZ\]רfwQ;4>ߙG-f|.+[x`}gWDkc8W9q!M V~Q ΂Iq)G}GaҦ? j+Ncʭ0U2׀ Dcb _ܱ]]엸}wޝ$#B-;e4+r5]ivDi0Ÿ.0:8*wǴEjTi҅\9];S *.׆ 6ʱt:pR5cR=z8Zh.Z4(,>vPQ}~C"7k ~Zc<[Q@ 6ܺ?,+NQF8ʋ}'iGf}#={ A9 G 󩬏8"ͣ7j/rWE }U Fl\B \)UaS!=R ֶG. γG a\R:U߽cP-$!ބJh*@#;Go#r( htw`mcsٌy٩ԶtԵ 7 &$|͎ŏc#`cY0aPKQ#/F1 9( 0RK6 rх[+t^Z㿚H,!ݝͻ̷6s* ".h\]@9⺱5D HCL#,"yUm]<]'YP?yBJvE^zT?'w)Wɴ6*V I3`F}qt3 +bk4nФy4BhTo͠6ͧ7g9Jk&z6,eB3ʌwpT^S׻]R ]C1?su"٭Twس0EARjc%9eB{tP!%MNO9)PG{/*݇'qroc3W2ܔzYkfwLJKtr^6UA%z:bl4|3;w # `>;Fy/MW:\?DsOW,[TE3^b^^y6Wר_0sԊX:ZmqGOdj%mW1ў{A~9su;h]KHҒ*iA?mجFm]MwmE,|=/"?W%r |tGQ ߪDQ\æsU6@,LmPtQ>=&޵M#UyK6̬rCGOzjś12*–qҶw̉CTD$_m G591@ oeYޢq ijD[BIG Ԏ_=zoXŮǴ|=nysiB˓~>T琖tDߺcòj ,AGs]dCm~ 3rB}/PfҀНOq;UrJy7buDˠrʤcM18MEˏYR2-2GΡ8^BZ*ah=7@#S(GK}9uo#󥉬b.XFZ%:*sۯUYg8rw_qoqCVڼ f=>r#IcDK+,w@Nϣb CZ]`x'3¶SpGP^J9j2>vn}8:dtZՒErN[b{Ջ|ă5zvb_\0  ƆtQb_dn`d[\cvMZ=pU r/W1dkE}uU>fa: ᱆ pHx|?eѩNt,U;Zbo<*`wXx nlv6֪(>+Nb=vI/3(r> z}c&6A9$jl{Y ͺlx[H/v*Tq5{ /b p#ƂVazIf ZH:j1ty{؉Qp3#V }:[˅a m~}FHn,nMai7鬞אsjWF),s!b27v6r3]~.jY /!ӅIrx *,O!BY͹=aӿA(Y[6^s,Qb6sX,[ƌt\C)P`suvukYK:0VO9)R2Ϋ054mZth<j(z-/5 >%CLmxnijSYֿdu:E`Q xI|Z$*SFGu%5'-*u[H۝m$W}'a lB`Y+Sq8&;Tv^ZͲKʍ'|VkC"&'U$X %PEfTa@D GpU/Ȕ> yw%<'< $TƿPK{`$ 4857 4#5ONwxU<UbM#y5{^C-Mh#2E bRrRc4GUyŤ|An@/YʕqԂ &EGU@ 'T7QISh ߼1GHjevQSqw o!Dy8DF2JXb#w 6{U{"""w9M2XFR#kt!u(!:FXC4\@2",,Н|Q^["^רPk~N;(!t;ztW[WB8(+FGRIyq<3aKkz6;Y2\I~(w?a74=,1 M*˜U1XT߬VwVDutRa1l"cy ˒iM =4̙|C12@)B^N{+5 htuvѺh%,f7U-YjuM;Ч\ヶM=|90L: 0o.Hׇ9I.Eqmp{sUS1'|Ss6TՇ1ڟ~jm#+v#d[T!`HH<YF θ8u=r ]9A)Er{ eجsU]zhӬiWjW"M25:#ʞѢۙ=z)XZ0Nܕ*ސcdfyfzא ~nhs_}cnv90 %"kKךgF0^̻$K O׀BbK-RQلPz޿g~b/8_qXu:Rm8DG!bP3%=-Ӿ &tT_ 4ѕZn5, &Pgp+ܳ£q\u6}/gV( C:`$r~߀X^%fR7q`?/Tp?S"v3 l3P2JH RR~1kN,XC ȷ \KWһ>^Hz]s䙘"5yD)hy+5Tm93_%*[l >_ݸGef ,){i fkf8V/^Q\3_fKĴeeFGy+[+1+q$TiQo3k C}m33rŤ BP7ijIB҉!/-8['ir"NY>tVAGP W|Z,js0;n oIzD `Uѵ 59:njF$$yjF >H?3g(NJ`% XT,oZG!V@rDۯc$A?> *'$U씉bl-Єl P\.[HHMIس%ft]gmEV/($яH-sѸE O~$ EfW/퍢iZVܕS8k#WXY|ě+R)Wu#UDR7x^/1а>(Qm%#V]YuF`^ρP|XHп~{6:x' #8/W$t}K^=mkf)(~^\Vaꌌn܅-3pTDanb+f* LqNf/PkӵelNg+ru?O/g?GKj+rVa6<3w&q'Ag㶥`ꕠ74` ToBA~/л8Jox ̀pZ4Ӱ_H7Խ0DӍ:5yy(-MF" Al0k{Ԣۇ?Y jr?oD;.f*onbl|2y-C 秕{C-ZUTWPt '{<% T拂>.tZGheaVAB9QJlA{G Dz곙?窉]AC}z#xXvPip3)sx?/缯{ͼ"M1n!B4[ W%N :/A*UW8|t1p uWL(.>H؄E)7ummu{ I z- &p0Q7cƼ 9o-jU7-t#0MR;a8 >>TB)~X[1~7,M 8y~Z ]kF}((?_D$}R?\i3rarV}7B\~ձ}e~D٬Rx "_ BV%7Pl/FzQPZWB 7wۈ)rҹٛ Rۄ~o5ar_FP,^ 1UqHoշͷ#BVz3of_1/Iz&`dS ȴ% K[UC~ (X?`7Er((ovg%?Qb9zYI AC^<.:> WK9<詨c~,s&-(ѥbA7LIjܠsv:~93fF$Hԥ2h/d/FmKHs(jz2_n8 ߤʐvC]>~5Q * fK;cMXM|[lx+3HCLOo"R]|GXUHDv]1Ѹ~ZM&8s0oH*;T~~t|Ҋ i<,\yxhl/q} (gV\$? .s-~hF+0\na(,YϟQHk rNI&F|fuP+24 i.69|AMV=K)eW 80L21'ļi pLֹ^;HYQg {'8Oyo[qI\da8O"ު j)%`;A)|Ca}II"j O/+~/ B7M ymqSf㗌p[9f(OOgyIHKAtO\%p\?x}uwjO49 CAyH)ɺ pBY\%3)y3iƂOI^Ϫl>|Mj8?g.`M& ~9 8VƼ+#?eR${yWq4kfLq=֣Qabt*w:[È T[3Dd9a*HFtsٍv䤵LXvT۞\J/cP.GJ"jibxD`+509B1QJc7s+쎹.7t)YڑP$mX ГbrߪzJgfd0`NFwRX0RvԨ`_)  0/ ٴU4cHZ+D1YSYt[Qf2Y;xw㞴@?c;|"{nF/L,?0@  *8~5\ #/vftY"O;U=l, z)7GLMc{C}o \{:J"!KRY?g}߽ʉGEdO4i(=]a8*~+Z26*",wil0E{2?pk8`Y3AX^QumI"(vU2}ɇsmv5)fbW)fL-,\ffQVA/"۠gi{6".eXOSJ\ė](^(Ta}.q%\8UIYi3}2Uc;qR3VWQ7e)"g; f*BABBapoT%({՘+GS}{Y:a k>{{>XpnX谶Jf1&ey;_<S?w97}cM+1!^]QjPM9m-Gh$8Z|CH/q*'h1Y]_V,DѦq,]5}G=k/Pc!͍v]r:dpSt؊g!緕h REY 5+.LF@n\- u !#ǨB_=P m$|V-!Rs\:ە RUD!lJTATXC:.6LcPZV mf[[u| W(*=Ys/% B`i%h=-F c J*CVmts,[-|._oi#9zCYQ-Vm b5m 6 @J; Y ~F~ѓ0}F>^TB:I Daz[ P%#ޭ8 W{Ca+> ϼ3xiSB_QKL8:8i A08%2WNRV lYc%;}w LFQQNp>ό@Kj|'li2h90nڠA6si@3 bP6WUǦYz[)6OS0+Uސ!Jd㝬,2qsX\5b[G\=^}-vˆ,X!zȼ!}8QΛU `Ifƿ_^Se! >iSETyX'63 z 2חHO34ʈsx`mRc!acۅ qS C^4ҷTDvRn9 lߪ\T~!gdvdpTrCТ?+iiǐ|NgӇ?1jezFH;_\I$W,yVyQl |͑{K22+2I0I߱-ƣޖCojdET+";Y.@utlpE.i1bܭ6}\/;&_ i[ 6}j5Bˆద$'%դӥOrǨTȂ!;k G2uvXxw3jeq:3^1;8ިfU༕?HKkLemhܮ 7Mk1>Зma~sIGp'}w6ҢUpv𪯩{n[Egie _>>V (3DL&U n4㷘Vӝ-{nh,::O>cI+Y_!4L%6{`' aD)` ;Y/=\u4`@ s q 0EX<*up*&% .e->J2f}.ςh,OLZ\XJNmܭr"uZ t(e:BÃ܏P5&?ZLmD1ˋ%SH?v&Lnx?Zhq*b~~ǤAzTtA-BmYllc_&gh+aUgמʑe%IhK|]ƤKхYDm6G}6\Bއtxg2OEccʢX(NDpMX|vh,Q*wW]o]CdkQn%~v9h"<$mVi $ruZvHtQG jqC#t}#鼻ŷj F8B&qܚbwB < ̽ɴcB~y&#!ҵNmCX]pѶSAª@`hSjƳ1 9(D}TA5ثDBFU`JՋo:F$^q 3 G A@]E?Yx>IWA 9 qBlC!TA4(GY;tx\qX3@\ZVK;ɹ!LWJ1aH&uY B9{\7>+gOQlis VUr6)u֋ `$oןRnϸHkyդbsh0Қ!5cpW a,AR/ed\5~Q!1;sDB k1W䂵Ya*d^U۠9ſKPqe$noId{JvSG!5iQpq9]IR C䰵2U0ڨh >dw"xNa&K-(nHic&#p&~TYkR74{$\0`L.}О~#v]8-4qsyyWͼZdz2 s ?O}11sӤ7 ʹboWx WPFoWXntbp)„+Gp%9l=Q %ᤣ ߌxNk6Y_3Xz (B"|0^x˨d6$[ip~HNK3J>{0VKX 2Vxg6^@$Ԝ)ޔ"1$G,6/]n2>^Clo A,pHs%FU\>IA9?DZDC]ƇfRR_UiqOwUKZ,g_8MRSSgqDz-DDtZYTw뺍ЕLjŔ@r}J0Mj?򧚫wݗR5|bb3z ݻWWNPS> ݖ^]2[E͊-aH9jH Ahuc@OΨ:qHTB8SMG_nc,]tig)\iJ GȲ5L^8>>ѣam2! *4"quƉ$0ԐJF-5fm,(UR sҽU%,5% CykvT46/%i(P@f<,ܽXL NܟoWܪ/.el0BT Ky"DQߪ}?h\P8W"0aӴUq]HCUaG-9 M 2K ϔ  uDݶNv<Ѕ]>V?N X4hxZW w4#C&_#do$W :D>8zcªf 9́ '=SjF `7dȑ~ )d2x߲!AOjh1g P ;Idh"迆Uomj `Y̶]]7A>P(f.U|@k# fMͶȖ,Q,,g+)L[ *zcÎFiG0AQo;A\[ }nL;1fi-X$ϥhH,}:(鑴ݠ|#Xf{@Xs xIb7NX=UN_E"6_ ><VleQ:8UOLA9jfoY݁h3Ia/C bXT|Tm[RKHLϹFJ d DgChՒ5D6 ObqY>g2nCS#`g(ЗK.Ƣ R)¡_p].?ntc?VF KviZғmF  Y Mq-򥬚sq(SZ@Rd՟d8ee)rsL:30""05.1`sȈ=ep"zob7U1l}/1\ T̒~$>D)ēgSRq˫X{-ؓ J^AdhDTlJ^ gTڳKKkAgPܶVJ0Q^م isD 0Ͱ_F}tjw*Z&NT0pQ!fnyVm:e;3d"JEޥ٧_]_+JxW[oG +L:ݳBzj JĞjG΀y ),sc'@ +"-4{:TH͡xZ Prh AmlZظ #/λ~vi;@6:"mY>,RO'}^T: ܽ^zכIypE㸢jFZۉw2W+UoH!h@ (8$1?siꌗ%}gFa $ ӯO=j{ 'ւN=D [#$}&w6SDOu2;0ɚH)@B 'u|t>mGL5`0&N{S Lޡ+xF=J&2T+[L .YƫUD~CmmLhy霹}v!#a0-f|EzyQ]-O" ËnEKWuxCXia~%VO1XL~{:Ӏ9$'ZX<%5)!rmwYqMpWll9D2J;yuۼXON6}2؊ 'a%E8Z}!WmKqлL*J<>V>rŃtNcY!okFwzKYpUW@1qoR)CмGhx _9+ ~]IC( `=!tp$mˊ[)v Ԛ\ٮʔ\T9)bЧGDzlX#OZ[`i.IaȔJ'\єpH.|g}d?l=ܰ+%*o,/x!9$&jXR;QË9,{a_ϡq`'Lc4 -5F_Ti,J  iIf) _|I$S&.Ou{PH!52Ւ3X0"9klU!7CjV2&.$ 떉$%*vlxqh;Q\no`j!SBHFһnӬw~Ρa t VkD䟦i%)dsI2VC%98iaϗ~㚓L=0ReZh:Gۛ]`#Shz:. 6Osa#I.IFwQ,mO΍4 loZ2/46 QD endstream endobj 5 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrllcolr*jp2cOQ/llllR \#B@HHPHHPHHPHHP((( ]$B@HHPHHPHHPHHP(((]$B@HHPHHPHHPHHP(((]$B@HHPHHPHHPHHPHHPϷKPT p~^VT5(iQdifw5wpfjB2i7-V(WpN9xnkGUͷY gK1E=yb N*l6G k/EG OLtUĶ:1:u-9FU;`})#+[B́M}vJl=쫸9u|$vp/DLX,ys*"P\ VΈ;M>F.Ѭy+A*Eac.6 z>T@v۹`9J %+U젪~#Uos.9zȔ̂2>:S?x".7 I٦GhF]BD_L|, GChPrNd~uԀfp+)!Y@PzՉZ:GTMۊQmSC͡˟or ˱wA8Ԧ@jggʅ)F:V}V5ܠ#F|3TIv F]&o6-<֤L[ƹkpR, 7U>t^uSBŌCi?kb&s3! B1ΙZ 1=2fumdnDQcj[_҇J{nSY!9x><_X0˄ݍ =muۻ]q>Î~}_`{О燎cCS /=pϕvpfE n\eXդXiPpq  wΰg\M?6)$g'ى!`&|-XGiЊtnrݑ67|b{' Q,ԻB! $Yx. 7I}#p[v5ZV=[i'ҴM;ӕ}>jA 4זK?L+"2៧4,ZDu7ͤiok9Hp>*9&U.q <8teT*StDC utn)CL1N \?t - M &\i$k?u`+v%T%k6Qfw]u.W~#:@)fד2">u'Z<;=9vz8 q0}ՉӢ> ɕwM/+2Jh̊*ejE/Jr[C !,$-$ZՐ/4 c>6M|pr4FK` mtC{𕶟)aguO1_e7hLG٢伥F-Ihvv4T[KaT`zfbl]#O@bt>h/sy?i: =th)7+0p.|ArȔkff_26sY;GMjc #}B;'~x^'u&}_X}ǵ?ڟiH_[5m]] @AK77\SDO YS|9~:*#Y14D܈VUdM+sd+yAxh+twkQI0ʙy8Rt_M9f0{ $EcJs"Hp}((ay֝BPe[lsBxf6*J☸$iwUX-ƅN; hiwAh-Ux+729&<[ ۠8{vȊCwqժĀ".6?!gZa0{AKcTK2C`?=Ьnq¿Ʉ>#ԌIZ(=-.ARccX1̞]Z H1N갰N9fRFk9``}:/Rx38cY;QE>05ÑތIoć;YXtGk+㇒Mvۭ;IOb?g6+js,g䙡D:Fn7~x'2+]%`DKu-W!0  C(1\x^xR3"_FoY;puR= "L,.<⬒KxөGuk~`yg_}ؓ#^,!-R(NUͽB'/EU{Ot-Xh\lv"On"pgz5't!BaQaH%`5x,iZ=4~pYUW >g\0EŅ匰>6j?@DKZP6Z^KL8m2,t8ڏ.,lr\鄌Nur ڻ3 \q̊gt8mF: SۍzFjyd[˒#&\ $|. oΨy\(.KZm ӄ1>)q>Dk$ {DYoDyuzX-,8 4UD$q&`\V"9|w&+@w1)?DO{XуhuPKS߾P <13h)`+=٦>mA[N^-HiG լ WpЇG:<')x_T\#ScM?1'Y}o[*#vaP޻@7`rJWpAeQ I!0$w3p_qVǶ<`ծ`thVN/ck,Ѐ@pF':mj=RU.M ,&d$Vxwq+2e:e.?LP& ҩ]b5ӍíIgEIoD{`N|:.iX#!O<ty_ Xwvc;2م#+F`6_Ҳ8 _! w~QH 6!6r%gJm+Lŧ-Q(iά`{~TYDxG ?/ѿo~3w;'IU7+Xt/hߋ헶Z_u7;g['{}zߺ݃zGt=kڏh^=c\y2HOhm}tvmk&J_!]]wyع7sjwWB ֻ\.sY{N}oEO]TlOt _ivh5vnݺo @+v-tlmV?Uq`h _9U={,ڐŚ+ϐo!ĔN-_=nZO\\jQ %d̍7J-UbQqI@)0<z4E~¦&^O !{ -ynOgJcaf &XpIKь/LϬA#w um\=TN~GډӇ l)<3ݩLk>:yŻ"u|z)CFL_ٝ$( sֹњ4ʧzV㷕xn93-*U=1Q(AR`' Y!aƬ#&6s u'D✘QS^H"ffkN4 !>S+ gob䢐\7lKFK$w=aӘA\UEP(z 2,RY<;hq$S!d(&Hx1Ğ88"U@O'_כvM E7TAͶy>}UETsx^ymKpo윫$:GH ꄏBƒNE)Ec͓(º8OEd.! Tx%.i/n8)&1r?1yN` ~}BxϿeBP9"V T$۝UY(#yYH{DV Jk7"5.{Ng=]rZvZF玪mtijxEܿ9dX=ڠ#Zg3lE|>t+I=V-i謴`H5P]r Dp VCPze ;f)1do'asvn̿QZqo2Dȳ[@'W/OZ'BBSL|XTs&x ^!>d ='jy^8?Q|>7_YƢqX&ADFG>6Q{h}~cߖf7&i M7Ss9758Z-hy䵮(RC|R,{NY@c]9][-UB;7;lyr$=mڂAm1mh8o5JZlfO#=Q Mf~p 1kdk>dHQOZO^1,<>म@^h1͙quCx`e%};W3ЪMbbѤ-<֞dZݩAmȈÇ>̣KJ&$< _'TZ/1hWP5ytES\]:P|xw>Eh9"` ίpFqFYw^G[bAA^T˃v,h SmL'26. b85&i)g(zn5HhڛhnԑDN`W(ݴ*l,)1v i&|4*eʘhDٱ+{ãQ'zҖů#6X{!`bK2 t =j8v ES,ǃ--r"K^6WFI`љ3\_G@R6.GwM'oGʥYov9wFЩF#gpjF[wuoMOD5&y)p<(sp_@0JymUZԖx,_ &!>np*D"'{h⹱O.-N\iB~_5CfJ?S*z5NL\^W|va}aOTTmTQker =c,s gHBbT}m64ׂ:~[ ~E>"o(Rmb |xwcɁ1: m U&IHWY!(c8sabxZ/(۝wy -n\GwЇwy|T=Q(o}ˡt&dFX+o^(mpE%Lc!O$(9X$DYW39֋9yWAp0k,y2&xۊ i)AkRǰnm RE3vpTNVQZ@}QBVn)GIkt38tG"5Sܢd!Ã5r='2>D}(RMMcQԏ\nʗ9ɜ1N@+BU#ʼՇC&ί#r$ߘki=#d} `Nx`օJ+#I뷟Pm,f(mV2ә=ŜV m.V0%3P9k z(l ư쥁mģN'ῂcpt<D,8Ԗ~?d+(Xgٙ:JzXo_M\&i–<$Qscns+}=T _kx='Sj4Pru&`"W%zF#` ΊQq[YwS^Hr8Ki].cD( \5GdfzDܴL e~j+:0PlyztD`<:vbxS?| X,KhFi>g3wAH9|+; PŻKT"*3~o@Jwn 9\QK}|ރ訯>caC?8/z +1S_CKGYbmh9: c%g[=cPG %h)bIڞnu.'JgdBG*AFԊgn};xꬉIe.\-"PJH쵹@*]nle2I,Sκ2PRyBxۢ:w(9:Dq|kI Z[&ԣpzC"fR&6Ś6r=CA7is>Co0r{)D$_ɴ'k8흖=f)urA 7b~$m$b=Hkׅ,N+xumQy@ߠdPPLŖ_rgeőc^Pow`4=d6 !jNN/zZiKηmϮj#V=X]K;]@j޷W/q˻`|l^fr YI330X [yZ~1_ӧb=J-y/G >|[[Z}ՌB Ǘ)xaufM ^[r8@7F@e6LQENF3y Oz~˖s}i֎vDڎW1(.fL.b .ϗ-:_D"0mDm"0:^`ykbXi%,6'>dΉa\l-X/6vr^U֐U6dpRׇ9wA>,[=Is*GL=5([D$C;PWM$[ialDhin8 Q!ܫ$A}LAFFoQq@#?EBHZ7"/ j>($BSќ9*J_[>l3J :r/ ː yd,{MF~L'0uVm}=:cw>\+zFa_\d15^:Q=y[ͳl--)Z.)Q;YIuvdݖ,v;SuĔ<1Ë MHQW2wiT]v蘉A]`A@ :OV(V endstream endobj 6 0 obj <>stream h޲0T0P0R0U0V0W0475R0Q04210>= endstream endobj 7 0 obj <>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 8 0 obj <>stream q 0.2 0.2 0.2 rg 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q q 220.8000031 0 0 32.6399994 363.3600006 770.3999939 cm /Im1 Do Q q 358.5599976 0 0 37.4400024 0 762.7200012 cm /Im2 Do Q q 14.3999939 0 0 15.3600006 564.9600067 646.5599976 cm /Im3 Do Q q 12.4799957 0 0 18.2400055 570.7200012 397.9199982 cm /Im4 Do Q q 13.9199982 0 0 25.9199982 567.3600006 328.8000031 cm /Im5 Do Q q 15.3600006 0 0 14.3999939 565.9199982 286.5599976 cm /Im6 Do Q q 14.3999939 0 0 12.4799957 566.8800049 106.0800018 cm /Im7 Do Q q 18.2400055 0 0 25.9199982 563.0399933 29.2799988 cm /Im8 Do Q q 25.9199982 0 0 18.7200012 555.3600006 0 cm /Im9 Do Q BT 0.239 0.239 0.235 rg /T1_0 1 Tf 0.05 Tc 3 Tr 9.1355 0 0 7.9001 202.52 750.97 Tm (DUTCH )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 8.7134 0 0 7.9001 239.96 750.97 Tm (RESPIRATORY )Tj EMC /Suspect <>BDC 8.725 0 0 7.9001 308.12 750.97 Tm (PATHOGENS )Tj EMC ET BT /T1_0 1 Tf -0.027 Tc 10.4 0 0 10.4 507.32 750.48 Tm (417 )Tj ET BT /Suspect <>BDC 0.165 0.165 0.161 rg /T1_1 1 Tf 0.0341 Tc 8.6 0 0 8.6 104.58 727.44 Tm (Table )Tj EMC ET BT /T1_1 1 Tf -0.027 Tc 8.6 0 0 8.6 130.0102 727.44 Tm (2. )Tj ET BT /Suspect <>BDC 0.239 0.239 0.235 rg /T1_1 1 Tf 0 Tc 8.6 0 0 8.6 140.0808 727.44 Tm (-)Tj EMC /Suspect <>BDC -0.0051 Tc 0.615 0 Td (2,091 )Tj EMC ET BT /T1_1 1 Tf 0.0201 Tc 8.6 0 0 8.6 170.7226 727.44 Tm (bacterial )Tj 0.0244 Tc 4.197 0 Td (strains )Tj 0.165 0.165 0.161 rg 0.0381 Tc 3.355 0 Td (from )Tj 0.239 0.239 0.235 rg 0.0246 Tc 2.481 0 Td (1,623 )Tj 0.0183 Tc 2.871 0 Td (sputum )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0204 Tc 8.6 0 0 8.6 313.345 727.44 Tm (cultures )Tj EMC ET BT /T1_1 1 Tf -0.0122 Tc 8.6 0 0 8.6 347.831 727.44 Tm (in )Tj 0.165 0.165 0.161 rg 0.0321 Tc 1.103 0 Td (1986 )Tj 0.239 0.239 0.235 rg /T1_0 1 Tf 0.0034 Tc 8.9 0 0 8.9 213.08 705.36 Tm (Hospital )Tj -0.0043 Tc 10.139 0.055 Td (Hospital )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.018 Tc 8.9 0 0 8.9 104.5445 693.8523 Tm (Organism )Tj EMC /Suspect <>BDC 0.0109 Tc 12.135 0.054 Td (Outpatients )Tj EMC ET BT /T1_0 1 Tf 0.0074 Tc 8.9 0 0 8.9 302.8187 694.8046 Tm (Inpatients )Tj 0.0437 Tc 10.083 0.055 Td (Total )Tj 0 Tc -19.947 -1.348 Td (n )Tj /T1_1 1 Tf 8.6 0 0 8.6 262.42 683.76 Tm (% )Tj /T1_0 1 Tf 8.9 0 0 8.9 302.87 683.76 Tm (n )Tj /T1_1 1 Tf 8.6 0 0 8.6 352.66 684.24 Tm (% )Tj /T1_0 1 Tf 9.6 0 0 9.6 392.63 684.24 Tm (n )Tj /T1_1 1 Tf 8.6 0 0 8.6 443.38 684.73 Tm (% )Tj /T1_2 1 Tf 9.5 0 0 9.5 104.24 661.68 Tm (H)Tj 0.369 0.369 0.361 rg 0.74 0 Td (. )Tj 0.239 0.239 0.235 rg -0.0277 Tc 0.502 0 Td (injluenzae )Tj /T1_0 1 Tf -0.0132 Tc 8.9 0 0 8.9 213.29 661.68 Tm (193 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.006 Tc 8.9 0 0 8.9 257.6565 662.1695 Tm (\(50.0\) )Tj EMC ET BT /T1_0 1 Tf -0.0143 Tc 8.9 0 0 8.9 302.8329 662.1695 Tm (461 )Tj 0.006 Tc 5.063 0.054 Td (\(37.3\) )Tj 0.0443 Tc 5.069 0 Td (654 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0168 Tc 8.9 0 0 8.9 438.6202 663.1218 Tm (\(40.3\) )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 9.1249 0 0 9.3 103.99 650.65 Tm (S. )Tj /T1_2 1 Tf -0.0178 Tc 9.5 0 0 9.5 113.12 650.65 Tm (pneumoniae )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0286 Tc 9.8 0 0 9.8 212.78 650.65 Tm (104 )Tj EMC ET BT /T1_0 1 Tf 0.006 Tc 8.9 0 0 8.9 257.66 651.12 Tm (\(26.9\) )Tj 0.0235 Tc 5.07 0 Td (382 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.006 Tc 8.9 0 0 8.9 347.906 651.6095 Tm (\(30.9\) )Tj EMC ET BT /T1_0 1 Tf 0.0127 Tc 8.9 0 0 8.9 393.0824 652.0901 Tm (486 )Tj 0.0168 Tc 5.117 0 Td (\(29.9\) )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf -0.035 Tc 9.3023 0 0 9.5 104.23 639.61 Tm (B. )Tj 0.239 0.239 0.235 rg -0.0133 Tc 9.5 0 0 9.5 114.17 639.61 Tm (catarrhalis )Tj /T1_0 1 Tf -0.035 Tc 8.7752 0 0 9.8 217.77 639.61 Tm (84 )Tj -0.0048 Tc 8.9 0 0 8.9 258.14 640.09 Tm (\(21.8\) )Tj 0.0235 Tc 5.016 0 Td (367 )Tj -0.0048 Tc 5.124 0.053 Td (\(29.7\) )Tj -0.0143 Tc 5.022 0.055 Td (451 )Tj 0.0168 Tc 5.117 0.054 Td (\(27.8\) )Tj ET BT /Suspect <>BDC /T1_2 1 Tf -0.035 Tc 9.1945 0 0 9.5 104.23 628.56 Tm (P. )Tj EMC ET BT /T1_2 1 Tf -0.0216 Tc 9.5 0 0 9.5 114.18 628.56 Tm (aeruginosa )Tj /T1_1 1 Tf -0.035 Tc 8.6661 0 0 9.1 217.37 628.56 Tm (24 )Tj /T1_0 1 Tf 0 Tc 8.9 0 0 8.9 257.66 629.53 Tm (\( )Tj 0.0019 Tc 0.862 0 Td (6.2\) )Tj -0.0132 Tc 4.292 0 Td (114 )Tj 0 Tc 4.985 0 Td (\( )Tj 0.002 Tc 0.863 0 Td (9.2\) )Tj -0.0132 Tc 4.291 0.053 Td (138 )Tj 0 Tc 5.039 0.054 Td (\( )Tj 0.0054 Tc 0.91 0 Td (8.5\) )Tj /T1_2 1 Tf -0.0326 Tc 9.5 0 0 9.5 104.15 617.53 Tm (Staph. )Tj -0.0271 Tc 2.673 0 Td (aureus )Tj /T1_0 1 Tf -0.0117 Tc 8.9 0 0 8.9 217.61 617.53 Tm (16 )Tj 0 Tc 4.554 0.107 Td (\( )Tj -0.0012 Tc 0.816 0 Td (4.1\) )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0132 Tc 8.9 0 0 8.9 303.5306 618.4823 Tm (107 )Tj EMC ET BT /T1_0 1 Tf 0 Tc 8.9 0 0 8.9 347.8971 618.9718 Tm (\( )Tj -0.0126 Tc 0.91 0 Td (8.6\) )Tj -0.0132 Tc 4.244 0 Td (123 )Tj 0 Tc 5.039 0.053 Td (\( )Tj 0.0199 Tc 0.864 0 Td (7.6\) )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0041 Tc 8.9 0 0 8.9 104.6156 606.9746 Tm (Various )Tj EMC ET BT /T1_0 1 Tf 0.0124 Tc 8.9 0 0 8.9 135.3651 606.9746 Tm (bacteria )Tj -0.0046 Tc 9.209 0 Td (68 )Tj 0.006 Tc 4.585 0.053 Td (\(17.6\) )Tj -0.035 Tc 8.8327 0 0 8.9 303.53 607.44 Tm (171 )Tj 0.006 Tc 8.9 0 0 8.9 347.9 607.92 Tm (\(13.8\) )Tj 0.0145 Tc 5.075 0 Td (239 )Tj 0.0168 Tc 5.118 0.055 Td (\(14.7\) )Tj 0.165 0.165 0.161 rg 0.0167 Tc -37.589 -2.59 Td (Total )Tj 0.239 0.239 0.235 rg 0.0117 Tc 2.383 0 Td (positive )Tj 0.0041 Tc 3.494 0 Td (cultures: )Tj 0.0235 Tc 6.309 0 Td (386 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0026 Tc 8.9 0 0 8.9 258.1346 585.848 Tm (\(100\) )Tj EMC ET BT /T1_0 1 Tf -0.0053 Tc 8.9 0 0 8.9 295.8439 585.848 Tm (1,237 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.016 Tc 8.9 0 0 8.9 347.8911 586.3286 Tm (\(100\) )Tj EMC ET BT /T1_0 1 Tf -0.0053 Tc 8.9 0 0 8.9 386.081 586.3286 Tm (1,623 )Tj 0.0295 Tc 5.902 0.053 Td (\(100\) )Tj 0.165 0.165 0.161 rg 0.0167 Tc -37.589 -1.401 Td (Total )Tj 0.239 0.239 0.235 rg 0.0043 Tc 2.374 0 Td (isolates: )Tj 0.0397 Tc 9.765 0 Td (489 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0216 Tc 8.9 0 0 8.9 296.3156 574.8031 Tm (1,602 )Tj EMC /Suspect <>BDC -0.005 Tc 10.115 0.055 Td (2,091 )Tj EMC ET BT /T1_0 1 Tf 0.0178 Tc 8.9 0 0 8.9 103.7107 552.7311 Tm (N.B. )Tj 0.0051 Tc 2.262 0 Td (because )Tj 0.05 Tc 9.4598 0 0 8.9 156.39 552.73 Tm (of )Tj 0.0106 Tc 8.9 0 0 8.9 166.54 552.73 Tm (mixed )Tj 0.0075 Tc 2.743 0 Td (cultures, )Tj -0.0001 Tc 3.783 0 Td (these )Tj 0.0095 Tc 2.538 0 Td (percentages )Tj 0.0121 Tc 5.328 0 Td (add )Tj -0.0286 Tc 1.736 0 Td (up )Tj -0.035 Tc 8.4365 0 0 8.9 321.58 552.73 Tm (to )Tj 0.0183 Tc 8.9 0 0 8.9 330.22 552.73 Tm (more )Tj 0.165 0.165 0.161 rg 0.0027 Tc 2.373 0 Td (than )Tj ET BT /Suspect <>BDC 0.239 0.239 0.235 rg /T1_0 1 Tf 0.0067 Tc 8.9 0 0 8.9 369.291 552.73 Tm (100; )Tj EMC ET BT /T1_0 1 Tf 0.0353 Tc 8.9 0 0 8.9 389.2715 552.73 Tm (n: )Tj 0.0265 Tc 1.079 0 Td (number )Tj 0.05 Tc 10.0163 0 0 8.9 428.54 552.73 Tm (of )Tj 0.0205 Tc 8.9 0 0 8.9 439.07 552.73 Tm (sputum )Tj 0.0057 Tc -37.64 -1.294 Td (cultures )Tj -0.0069 Tc 3.505 0 Td (from )Tj 0.0108 Tc 2.221 0 Td (which )Tj -0.0156 Tc 2.749 0 Td (the )Tj 0.0264 Tc 1.396 0 Td (organism )Tj 0.0072 Tc 4.107 0 Td (was )Tj 0.0005 Tc 1.827 0 Td (isolated. )Tj ET BT /Suspect <>BDC 0.165 0.165 0.161 rg /T1_1 1 Tf 0.0341 Tc 8.6 0 0 8.6 102.66 503.76 Tm (Table )Tj EMC ET BT 0.239 0.239 0.235 rg /T1_1 1 Tf 0.0304 Tc 8.6 0 0 8.6 127.5828 503.76 Tm (3. )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.05 Tc 8.8699 0 0 8.6 138.16 503.76 Tm (-Sputum )Tj EMC /Suspect <>BDC 0.0141 Tc 8.6 0 0 8.6 177.5 503.76 Tm (culture )Tj EMC /Suspect <>BDC 0.0142 Tc 3.453 0 Td (results )Tj EMC ET BT /T1_1 1 Tf -0.0122 Tc 8.6 0 0 8.6 236.4616 503.76 Tm (in )Tj 0.165 0.165 0.161 rg 0.0321 Tc 1.103 0 Td (1986 )Tj /T1_0 1 Tf 0.0188 Tc 8.9 0 0 8.9 242.84 484.09 Tm (Hospital )Tj 0.0111 Tc 9.169 0 Td (Hospital )Tj 0.239 0.239 0.235 rg 0.0055 Tc -9.12 -1.134 Td (Outpatients )Tj 0.0074 Tc 9.064 0 Td (Inpatients )Tj 0.165 0.165 0.161 rg 0.0302 Tc 8.303 0.055 Td (Total )Tj 0.239 0.239 0.235 rg 0 Tc -17.412 -1.187 Td (n )Tj /T1_1 1 Tf 8.6 0 0 8.6 279.22 464.41 Tm (% )Tj 0.165 0.165 0.161 rg /T1_0 1 Tf 8.9 0 0 8.9 324.47 463.93 Tm (n )Tj ET BT /Suspect <>BDC 0.239 0.239 0.235 rg /T1_0 1 Tf 9 0 0 9 360.39 464.89 Tm (% )Tj EMC ET BT /T1_0 1 Tf 8.9 0 0 8.9 406.07 464.41 Tm (n )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 9 0 0 9 442.47 465.37 Tm (% )Tj EMC ET BT /T1_2 1 Tf -0.035 Tc 8.8973 0 0 9.5 102.8 443.76 Tm (H. )Tj ET BT /Suspect <>BDC /T1_2 1 Tf -0.0164 Tc 9.5 0 0 9.5 114.12 443.76 Tm (influenzae)Tj 0.459 0.459 0.451 rg 0 Tc 3.878 0 Td (\225 )Tj EMC ET BT 0.165 0.165 0.161 rg /T1_0 1 Tf 0.0138 Tc 8.9 0 0 8.9 238.73 443.76 Tm (133 )Tj 0.239 0.239 0.235 rg 0.006 Tc 4.069 0.055 Td (\(34.5\) )Tj 0.0145 Tc 5.021 0 Td (288 )Tj 0.006 Tc 4.093 0.053 Td (\(23.3\) )Tj -0.0143 Tc 5.076 0 Td (421 )Tj 0.0168 Tc 4.146 0 Td (\(25.9\) )Tj -0.0248 Tc 9 0 0 9 102.56 434.16 Tm (S. )Tj ET BT /Suspect <>BDC /T1_2 1 Tf -0.0134 Tc 9.5 0 0 9.5 111.68 434.16 Tm (pneumoniaet )Tj EMC ET BT /T1_0 1 Tf 0.005 Tc 8.9 0 0 8.9 243.24 434.16 Tm (53 )Tj 0.006 Tc 3.562 0.055 Td (\(13.7\) )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0145 Tc 8.9 0 0 8.9 319.6287 434.16 Tm (208 )Tj EMC ET BT /T1_0 1 Tf 0.006 Tc 8.9 0 0 8.9 356.0564 434.6495 Tm (\(16.8\) )Tj -0.0125 Tc 5.075 0 Td (261 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0168 Tc 8.9 0 0 8.9 438.1322 435.1212 Tm (\(16.0\) )Tj EMC ET BT /T1_2 1 Tf -0.035 Tc 9.3023 0 0 9.5 102.79 424.09 Tm (B. )Tj ET BT /Suspect <>BDC /T1_2 1 Tf 9.2611 0 0 9.5 112.73 424.09 Tm (catarrhalis+ )Tj EMC ET BT 0.165 0.165 0.161 rg /T1_0 1 Tf 0.0476 Tc 9.3 0 0 9.3 242.84 424.09 Tm (44 )Tj 0.239 0.239 0.235 rg 0.006 Tc 8.9 0 0 8.9 274.94 424.56 Tm (\(11.4\) )Tj -0.0125 Tc 5.075 0 Td (225 )Tj 0.006 Tc 4.039 0.055 Td (\(18.2\) )Tj 0.0145 Tc 5.075 -0.055 Td (269 )Tj 0.0168 Tc 4.147 0.055 Td (\(16.6\) )Tj /T1_2 1 Tf -0.035 Tc 9.3916 0 0 9.5 102.32 414 Tm (H. )Tj -0.0247 Tc 9.5 0 0 9.5 114.12 414 Tm (injl. )Tj /T1_1 1 Tf 0 Tc 9.8 0 0 9.8 130.88 414 Tm (+ )Tj /T1_0 1 Tf -0.0248 Tc 9 0 0 9 138.56 414 Tm (S. )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 3.9601 0 0 6.72 147.37 414 Tm <0070006E00650075006D006F006E00690061007E002100270020>Tj EMC ET BT /T1_0 1 Tf -0.0117 Tc 8.9 0 0 8.9 243.53 414 Tm (19 )Tj 0.369 0.369 0.361 rg /T1_2 1 Tf 0 Tc 3.52 0 Td (\( )Tj 0.239 0.239 0.235 rg /T1_0 1 Tf 0.0168 Tc 0.825 0 Td (4.9\) )Tj -0.0046 Tc 4.792 0.055 Td (69 )Tj 0 Tc 3.507 0 Td (\( )Tj 0.0051 Tc 0.861 0 Td (5.5\) )Tj 0.0059 Tc 4.742 0 Td (88 )Tj 0 Tc 3.62 0.054 Td (\( )Tj 0.041 Tc 0.807 0 Td (5.4\) )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf -0.035 Tc 8.8973 0 0 9.5 102.8 403.93 Tm (H. )Tj 0.239 0.239 0.235 rg -0.0247 Tc 9.5 0 0 9.5 114.12 403.93 Tm (injl. )Tj 0.05 Tc 9.6625 0 0 9.5 130.78 403.93 Tm (+B. )Tj -0.0218 Tc 9.5 0 0 9.5 149.21 403.93 Tm (catarrhal )Tj ET BT /Suspect <>BDC /T1_2 1 Tf -0.035 Tc 6.5122 0 0 9.5 183.76 403.93 Tm (is+ )Tj EMC ET BT /T1_0 1 Tf 8.5945 0 0 8.9 243.54 403.93 Tm (11 )Tj 0.369 0.369 0.361 rg 0 Tc 8.9 0 0 8.9 274.94 404.41 Tm (\( )Tj 0.239 0.239 0.235 rg 0.018 Tc 0.815 0 Td (2.8\) )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.04 Tc 8.9 0 0 8.9 324.4418 404.41 Tm (40 )Tj EMC ET BT /T1_0 1 Tf 0 Tc 8.9 0 0 8.9 356.0635 404.8906 Tm (\( )Tj 0.024 Tc 0.809 0 Td (3.2\) )Tj -0.035 Tc 8.7667 0 0 8.9 405.96 404.89 Tm (51 )Tj 0 Tc 8.9 0 0 8.9 438.14 405.37 Tm (\( )Tj 0.0419 Tc 0.809 0 Td (3.1\) )Tj 0.165 0.165 0.161 rg -0.0248 Tc 9 0 0 9 102.56 393.84 Tm (S. )Tj 0.239 0.239 0.235 rg /T1_2 1 Tf -0.0221 Tc 9.5 0 0 9.5 111.68 393.84 Tm (pneum. )Tj 0.05 Tc 9.6625 0 0 9.5 140.86 393.84 Tm (+B. )Tj ET BT /Suspect <>BDC /T1_2 1 Tf -0.035 Tc 9.1593 0 0 9.5 158.81 393.84 Tm (catarrhalis+ )Tj EMC ET BT /T1_0 1 Tf 0 Tc 9.6 0 0 9.6 247.51 393.84 Tm (8 )Tj 0.369 0.369 0.361 rg 8.9 0 0 8.9 274.94 394.33 Tm (\( )Tj 0.239 0.239 0.235 rg 0.018 Tc 0.815 0 Td (2.1\) )Tj 0.005 Tc 4.738 0 Td (53 )Tj 0 Tc 3.616 0.054 Td (\( )Tj 0.0168 Tc 0.762 0 Td (4.3\) )Tj -0.035 Tc 8.6772 0 0 8.9 406.45 394.81 Tm (61 )Tj 0 Tc 8.9 0 0 8.9 438.14 395.28 Tm (\( )Tj 0.0419 Tc 0.809 0 Td (3.8\) )Tj -0.0248 Tc 9 0 0 9 102.56 383.76 Tm (S. )Tj /T1_2 1 Tf -0.0221 Tc 9.5 0 0 9.5 111.68 383.76 Tm (pneum. )Tj 0.05 Tc 9.5907 0 0 9.5 140.86 383.76 Tm (+H. )Tj 0.165 0.165 0.161 rg -0.0247 Tc 9.5 0 0 9.5 160.2 383.76 Tm (infl. )Tj 0.239 0.239 0.235 rg 0.0383 Tc 1.804 0 Td (+B. )Tj ET BT /Suspect <>BDC /T1_2 1 Tf 0.0283 Tc 9.5 0 0 9.5 194.8085 383.76 Tm (cat)Tj 0.369 0.369 0.361 rg -0.035 Tc 5.1204 0 0 9.5 206.83 383.76 Tm (.+ )Tj EMC ET BT 0.239 0.239 0.235 rg /T1_0 1 Tf 8.5945 0 0 8.9 243.54 384.25 Tm (15 )Tj 0.369 0.369 0.361 rg 0 Tc 8.9 0 0 8.9 274.94 384.25 Tm (\( )Tj 0.239 0.239 0.235 rg 0.024 Tc 0.809 0 Td (3.9\) )Tj 0.0436 Tc 4.752 0 Td (22 )Tj 0 Tc 3.554 0.053 Td (\( )Tj 0.165 0.165 0.161 rg -0.0005 Tc 0.893 0 Td (1.8\) )Tj 0.239 0.239 0.235 rg 0.0077 Tc 4.716 0 Td (37 )Tj 0 Tc 3.613 0.055 Td (\( )Tj 0.0359 Tc 0.815 0 Td (2.3\) )Tj ET BT /Suspect <>BDC 0.165 0.165 0.161 rg /T1_2 1 Tf -0.035 Tc 9.1945 0 0 9.5 102.79 374.16 Tm (P. )Tj EMC /Suspect <>BDC 0.239 0.239 0.235 rg 9.0751 0 0 9.5 112.74 374.16 Tm (aeruginosa+ )Tj EMC /Suspect <>BDC /T1_0 1 Tf -0.0103 Tc 8.9 0 0 8.9 243.31 374.16 Tm (20 )Tj EMC ET BT 0.459 0.459 0.451 rg /T1_0 1 Tf 0 Tc 8.9 0 0 8.9 274.9406 374.6495 Tm (\( )Tj 0.239 0.239 0.235 rg 0.041 Tc 0.807 0 Td (5.2\) )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.9862 0 0 8.9 324.8 374.65 Tm (80 )Tj EMC ET BT /T1_0 1 Tf 0 Tc 8.9 0 0 8.9 356.06 375.12 Tm (\( )Tj 0.165 0.165 0.161 rg 0.0019 Tc 0.862 0 Td (6.5\) )Tj ET BT /Suspect <>BDC 0.239 0.239 0.235 rg /T1_0 1 Tf 0.0138 Tc 8.9 0 0 8.9 401.9306 375.12 Tm (100 )Tj EMC ET BT /T1_0 1 Tf 0 Tc 8.9 0 0 8.9 438.1447 375.12 Tm (\( )Tj 0.0199 Tc 0.862 0 Td (6.2\) )Tj 0.005 Tc -38.552 -1.239 Td (various )Tj 0.0312 Tc 3.229 0 Td (other )Tj 0.0124 Tc 2.383 0 Td (bacteria )Tj 0.0059 Tc 10.174 0 Td (83 )Tj 0.006 Tc 3.566 0.053 Td (\(21.5\) )Tj 0.0145 Tc 5.075 0 Td (252 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.006 Tc 8.9 0 0 8.9 356.0511 365.0541 Tm (\(20.4\) )Tj EMC ET BT /T1_0 1 Tf -0.0035 Tc 8.9 0 0 8.9 401.6547 365.0541 Tm (335 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0168 Tc 8.9 0 0 8.9 438.1358 365.5347 Tm (\(20.7\) )Tj EMC ET BT 0.165 0.165 0.161 rg /T1_0 1 Tf 0.0302 Tc 8.9 0 0 8.9 102.1519 344.415 Tm (Total )Tj 0.239 0.239 0.235 rg 0.0194 Tc 2.437 0 Td (positive )Tj 0.0134 Tc 3.494 0 Td (cultures )Tj 0.0235 Tc 9.383 0 Td (386 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0026 Tc 8.9 0 0 8.9 274.9276 344.8956 Tm (\(100\) )Tj EMC ET BT /T1_0 1 Tf -0.0053 Tc 8.9 0 0 8.9 313.1175 344.8956 Tm (1,237 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.016 Tc 8.9 0 0 8.9 356.0511 345.3762 Tm (\(100\) )Tj EMC ET BT 0.165 0.165 0.161 rg /T1_0 1 Tf -0.0053 Tc 8.9 0 0 8.9 394.241 345.3762 Tm (1,623 )Tj ET BT /Suspect <>BDC 0.239 0.239 0.235 rg /T1_0 1 Tf 0.0026 Tc 8.9 0 0 8.9 438.1269 345.3762 Tm (\(100\) )Tj EMC /Suspect <>BDC -0.035 Tc 8.8804 0 0 8.9 102.2 324.72 Tm (+The )Tj EMC ET BT 0.165 0.165 0.161 rg /T1_0 1 Tf 0.0155 Tc 8.9 0 0 8.9 121.9 324.72 Tm (total )Tj 0.239 0.239 0.235 rg 0.0118 Tc 2.322 0 Td (percentage )Tj 0.0007 Tc 4.68 0 Td (for )Tj -0.0001 Tc 1.735 0 Td (these )Tj 0.0087 Tc 2.26 0 Td (groups )Tj -0.0185 Tc 3.344 0 Td (is, )Tj 0.0033 Tc 1.409 0 Td (hospital )Tj 0.0459 Tc 3.444 0 Td (out )Tj 0.0199 Tc 1.52 0 Td (patients )Tj 0.0185 Tc 3.44 0 Td (73.3, )Tj 0.011 Tc 2.328 0 Td (hospital )Tj /T1_1 1 Tf 0.05 Tc 9.14 0 0 8.8 390.54 324.72 Tm (in )Tj /T1_0 1 Tf 0.0121 Tc 8.9 0 0 8.9 402.25 324.72 Tm (patients )Tj 0.0001 Tc 3.44 0 Td (73.1 )Tj 0.0391 Tc 2.319 0.055 Td (and )Tj 0.165 0.165 0.161 rg 0.0182 Tc -39.417 -1.242 Td (together )Tj 0.239 0.239 0.235 rg 0.0493 Tc 3.552 0 Td (73 )Tj -0.0203 Tc 1.122 0 Td (.1. )Tj -0.0035 Tc 10.4 0 0 10.4 42.09 291.12 Tm (specimens )Tj -0.0132 Tc 4.629 0 Td (was )Tj -0.0026 Tc 2.017 0 Td (slightly )Tj -0.0327 Tc 3.513 0 Td (less )Tj 0.0121 Tc 1.944 0 Td (than )Tj 0.0402 Tc 2.354 0 Td (that )Tj 0.05 Tc 11.1292 0 0 10.4 214.45 291.12 Tm (of )Tj 0.0143 Tc 10.4 0 0 10.4 228.93 291.12 Tm (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0202 Tc 10.4 0 0 10.4 247.0988 291.12 Tm (orga\255)Tj EMC ET BT /T1_0 1 Tf -0.0053 Tc 10.4 0 0 10.4 42.2292 280.0856 Tm (nisms )Tj -0.0079 Tc 2.805 0 Td (from )Tj 0.0143 Tc 2.455 0 Td (the )Tj 0.0022 Tc 1.756 0 Td (hospitalized )Tj 0.0085 Tc 5.357 0 Td (patients. )Tj /T1_2 1 Tf 0.017 Tc 9.9 0 0 9.9 212.14 280.09 Tm (Streptococcus )Tj 0.0147 Tc -17.225 -1.115 Td (pneumoniae )Tj 0.165 0.165 0.161 rg /T1_0 1 Tf -0.0179 Tc 10.4 0 0 10.4 96.47 269.05 Tm (has )Tj 0.239 0.239 0.235 rg -0.008 Tc 1.79 0 Td (always )Tj -0.0255 Tc 3.288 0 Td (been )Tj -0.001 Tc 2.292 0 Td (sensitive )Tj 0.01 Tc 3.935 0 Td (to )Tj -0.0024 Tc 1.285 0 Td (ampicillin )Tj 0.0225 Tc -17.815 -1.062 Td (and )Tj 0.0075 Tc 1.892 0 Td (erythromycin )Tj 0.0225 Tc 5.908 0 Td (and )Tj -0.0033 Tc 1.946 0 Td (this )Tj 0.0174 Tc 1.835 0 Td (situation )Tj -0.0109 Tc 3.974 0 Td (did )Tj 0.165 0.165 0.161 rg 0.0324 Tc 1.716 0 Td (not )Tj 0.239 0.239 0.235 rg 0.0105 Tc 1.745 0 Td (change )Tj -0.0006 Tc -19.015 -1.015 Td (over )Tj 0.0143 Tc 2.13 0 Td (the )Tj 0.0086 Tc 1.562 0 Td (course )Tj 0.05 Tc 11.1292 0 0 10.4 111.73 247.44 Tm (of )Tj -0.0088 Tc 10.4 0 0 10.4 124.29 247.44 Tm (the )Tj -0.0094 Tc 1.571 0 Td (years. )Tj 0.165 0.165 0.161 rg -0.0036 Tc 2.719 0 Td (However, )Tj 0.239 0.239 0.235 rg 0.0143 Tc 4.294 0 Td (the )Tj -0.0044 Tc 1.562 0 Td (degree )Tj 0.05 Tc 11.1292 0 0 10.4 261.01 247.44 Tm (of )Tj 0.0005 Tc 10.4 0 0 10.4 41.61 236.41 Tm (susceptibility )Tj 0.01 Tc 5.827 0 Td (to )Tj 0.0102 Tc 1.239 0 Td (cotrimoxazole )Tj 0.0225 Tc 6.276 0 Td (and )Tj -0.0028 Tc 1.939 0 Td (doxycycline )Tj 0.0052 Tc 5.27 0 Td (has )Tj 0.0113 Tc -20.552 -1.062 Td (shown )Tj -0.0023 Tc 2.954 0 Td (some )Tj 0.0194 Tc 2.366 0 Td (variations )Tj 0.0173 Tc 4.434 0 Td (but, )Tj -0.0224 Tc 1.883 0 Td (in )Tj 0.0015 Tc 1.062 0 Td (general, )Tj 0.0145 Tc 3.507 0 Td (only )Tj 0.05 Tc 10.893 0 0 10.5 232.18 225.37 Tm (6-7% )Tj 11.1292 0 0 10.4 261.01 225.37 Tm (of )Tj 0.0157 Tc 10.4 0 0 10.4 41.61 214.33 Tm (strains )Tj 0.0034 Tc 3.06 0 Td (have )Tj -0.0101 Tc 2.263 0 Td (been )Tj 0.011 Tc 2.213 0 Td (resistant )Tj 0.01 Tc 3.783 0 Td (to )Tj -0.0047 Tc 1.154 0 Td (these )Tj -0.0036 Tc 2.392 0 Td (agents. )Tj ET BT /Suspect <>BDC 0.165 0.165 0.161 rg /T1_0 1 Tf -0.0055 Tc 10.4 0 0 10.4 229.3404 214.33 Tm (Owing )Tj EMC ET BT 0.239 0.239 0.235 rg /T1_0 1 Tf 0.01 Tc 10.4 0 0 10.4 261.0916 214.33 Tm (to )Tj 0 Tc -21.1 -1.062 Td (a )Tj 0.0224 Tc 0.879 0 Td (laboratory )Tj 0.0387 Tc 4.706 0 Td (error )Tj 0.0238 Tc 2.448 0 Td (in )Tj 0.165 0.165 0.161 rg -0.035 Tc 10.3601 0 0 10.4 138.36 203.29 Tm (1983, )Tj 0.239 0.239 0.235 rg 0.0373 Tc 10.4 0 0 10.4 164.53 203.29 Tm (an )Tj 0.0168 Tc 1.395 0 Td (unauthorized )Tj 0.0105 Tc 5.806 0 Td (change )Tj 0.0098 Tc -19.053 -1.015 Td (was )Tj 0.0189 Tc 1.891 0 Td (made )Tj -0.0224 Tc 2.486 0 Td (in )Tj 0.0143 Tc 1.113 0 Td (the )Tj 0.0107 Tc 1.524 0 Td (medium )Tj -0.0105 Tc 3.694 0 Td (used )Tj 0.0074 Tc 2.112 0 Td (for )Tj 0.0104 Tc 1.532 0 Td (testing )Tj -0.001 Tc 2.988 0 Td (susceptibil\255)Tj -0.0112 Tc -17.302 -1.062 Td (ity )Tj 0.01 Tc 1.39 0 Td (to )Tj 0.0044 Tc 1.101 0 Td (cotrimoxazole, )Tj 0.0225 Tc 6.414 0 Td (and )Tj -0.0033 Tc 1.854 0 Td (this )Tj -0.0132 Tc 1.756 0 Td (was )Tj 0.0145 Tc 1.837 0 Td (only )Tj 0.0022 Tc 2.077 0 Td (discovered )Tj 0.165 0.165 0.161 rg 0.0238 Tc 4.662 0 Td (in )Tj 0.239 0.239 0.235 rg -0.035 Tc 10.1247 0 0 10.4 42.37 170.65 Tm (1986. )Tj 0.0081 Tc 10.4 0 0 10.4 67.63 170.65 Tm (False )Tj 0.165 0.165 0.161 rg -0.0015 Tc 2.404 0 Td (resistance )Tj 0.239 0.239 0.235 rg -0.035 Tc 10.3816 0 0 10.4 136.79 170.65 Tm (was )Tj 0.012 Tc 10.4 0 0 10.4 155.4 170.65 Tm (found )Tj 0.0143 Tc 2.723 0 Td (\(due )Tj 0.05 Tc 10.4772 0 0 10.4 205.41 170.65 Tm (to )Tj 0.0143 Tc 10.4 0 0 10.4 217.41 170.65 Tm (the )Tj -0.0034 Tc 1.528 0 Td (presence )Tj 0.05 Tc 11.1292 0 0 10.4 41.65 159.61 Tm (of )Tj 0.165 0.165 0.161 rg 0.0178 Tc 10.4 0 0 10.4 54.61 159.61 Tm (antagonists )Tj 0.239 0.239 0.235 rg -0.0224 Tc 5.125 0 Td (in )Tj -0.0088 Tc 1.252 0 Td (the )Tj 0.165 0.165 0.161 rg -0.0004 Tc 1.663 0 Td (medium\))Tj 0.369 0.369 0.361 rg 0 Tc 3.679 0 Td (, )Tj 0.239 0.239 0.235 rg 0.0355 Tc 0.662 0 Td (but )Tj -0.0088 Tc 1.842 0 Td (the )Tj -0.0009 Tc 1.655 0 Td (only )Tj -0.0171 Tc 2.214 0 Td (effects )Tj -0.0147 Tc -19.375 -1.015 Td (were )Tj 0.0105 Tc 2.77 0 Td (upon )Tj -0.0088 Tc 2.905 0 Td (the )Tj -0.0038 Tc 2.079 0 Td (results )Tj -0.0059 Tc 3.415 0 Td (with )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf 0 Tc 9.9 0 0 9.9 184.88 149.05 Tm (H)Tj 0.369 0.369 0.361 rg 0.855 0 Td (. )Tj 0.239 0.239 0.235 rg 0.0036 Tc 1.065 0 Td (inf/uenzae )Tj /T1_0 1 Tf -0.035 Tc 10.3498 0 0 10.4 253.8 149.05 Tm (\(see )Tj 0.0117 Tc 10.4 0 0 10.4 41.73 138.01 Tm (table )Tj 0.165 0.165 0.161 rg -0.035 Tc 10.1033 0 0 10.4 65.72 138.01 Tm (4\). )Tj /T1_2 1 Tf 0.0121 Tc 9.9 0 0 9.9 58.63 126.96 Tm (B. )Tj 0.239 0.239 0.235 rg 0.0082 Tc 1.633 0 Td (catarrhalis )Tj /T1_0 1 Tf -0.035 Tc 10.1489 0 0 10.4 126.16 126.96 Tm (is )Tj -0.0005 Tc 10.4 0 0 10.4 140.06 126.96 Tm (often )Tj 0.05 Tc 10.4827 0 0 10.4 168.95 126.96 Tm (not )Tj 0.0019 Tc 10.4 0 0 10.4 190.53 126.96 Tm (truly )Tj -0.0068 Tc 2.619 0 Td (sensitive )Tj 0.01 Tc 4.119 0 Td (to )Tj -0.0024 Tc -21.1 -1.061 Td (ampicillin )Tj -0.0022 Tc 4.535 0 Td (because )Tj 0.165 0.165 0.161 rg 0.05 Tc 11.1292 0 0 10.4 126.13 115.93 Tm (of )Tj 0.239 0.239 0.235 rg 0.0143 Tc 10.4 0 0 10.4 139.65 115.93 Tm (the )Tj -0.0086 Tc 1.756 0 Td (relatively )Tj 0.0096 Tc 4.236 0 Td (frequent )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0014 Tc 10.4 0 0 10.4 242.3084 115.93 Tm (occur\255)Tj EMC ET BT 0.165 0.165 0.161 rg /T1_0 1 Tf -0.0097 Tc 10.4 0 0 10.4 41.2764 104.8852 Tm (rence )Tj 0.239 0.239 0.235 rg 0.05 Tc 11.1292 0 0 10.4 69.49 104.89 Tm (of )Tj -0.0254 Tc 10.4 0 0 10.4 84.39 104.89 Tm (low-level )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 4.5382 0 0 7.68 128.17 104.89 Tm <007E002D006C0061006300740061006D0061007300650020>Tj EMC ET BT /T1_0 1 Tf 0.0173 Tc 10.4 0 0 10.4 184.34 104.89 Tm (production )Tj 0.165 0.165 0.161 rg -0.035 Tc 9.5041 0 0 10.4 236.89 104.89 Tm ([7] )Tj 0.239 0.239 0.235 rg 0.0225 Tc 10.4 0 0 10.4 253.33 104.89 Tm (and )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 4.5382 0 0 7.2 41.76 94.32 Tm <007E002D006C0061006300740061006D0061007300650020>Tj EMC ET BT /T1_0 1 Tf 0.0195 Tc 10.4 0 0 10.4 95.54 94.32 Tm (producing )Tj 0.0157 Tc 4.507 0 Td (strains )Tj 0.0034 Tc 3.06 0 Td (have )Tj 0.165 0.165 0.161 rg -0.0123 Tc 2.262 0 Td (risen )Tj 0.239 0.239 0.235 rg -0.0033 Tc 2.297 0 Td (\(with )Tj 0.0131 Tc 2.443 0 Td (some )Tj 0.0046 Tc -19.797 -1.062 Td (fluctuations\) )Tj -0.0079 Tc 5.631 0 Td (from )Tj 0.0152 Tc 2.452 0 Td (zero )Tj -0.0148 Tc 2.256 0 Td (\(in )Tj 0.165 0.165 0.161 rg -0.035 Tc 10.1811 0 0 10.4 166.21 83.28 Tm (1979\) )Tj 0.239 0.239 0.235 rg 0.01 Tc 10.4 0 0 10.4 193.89 83.28 Tm (to )Tj 0.0124 Tc 1.285 0 Td (approximately )Tj 0.0189 Tc -15.971 -1.061 Td (63% )Tj 0.05 Tc 11.1292 0 0 10.4 63.73 72.25 Tm (of )Tj 0.0143 Tc 10.4 0 0 10.4 75.33 72.25 Tm (the )Tj 0.0302 Tc 1.523 0 Td (total )Tj 0.165 0.165 0.161 rg -0.0224 Tc 2.163 0 Td (in )Tj 0.239 0.239 0.235 rg 0.0015 Tc 1.069 0 Td (recent )Tj -0.0002 Tc 2.677 0 Td (years. )Tj -0.0046 Tc 2.683 0 Td (Nevertheless, )Tj 0.0069 Tc 5.662 0 Td (despite )Tj 0 Tc 5.261 21.045 Td (a )Tj 0.0284 Tc 0.97 0 Td (constant )Tj 0.0066 Tc 4.057 0 Td (search, )Tj 0.0143 Tc 3.381 0 Td (the )Tj -0.0147 Tc 1.791 0 Td (first )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 4.5819 0 0 7.68 422.89 291.12 Tm <007E002D006C0061006300740061006D0061007300650020>Tj EMC ET BT /T1_0 1 Tf 0.0137 Tc 10.4 0 0 10.4 479.06 291.12 Tm (producing )Tj 0.0228 Tc -17.786 -1.061 Td (strain )Tj 0.05 Tc 11.6856 0 0 10.4 321.01 280.09 Tm (of )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf 0.0121 Tc 9.9 0 0 9.9 333.19 280.09 Tm (B. )Tj 0.239 0.239 0.235 rg 0.0033 Tc 1.245 0 Td (catarrhalis )Tj /T1_0 1 Tf -0.0132 Tc 10.4 0 0 10.4 392.63 280.09 Tm (was )Tj -0.0009 Tc 1.837 0 Td (only )Tj 0.165 0.165 0.161 rg 0.0141 Tc 2.031 0 Td (detected )Tj 0.239 0.239 0.235 rg -0.0224 Tc 3.739 0 Td (in )Tj 0.0277 Tc 1.065 0 Td (February )Tj 0.165 0.165 0.161 rg -0.035 Tc 9.8892 0 0 10.4 295.34 269.05 Tm (1980. )Tj 0.239 0.239 0.235 rg 0.0163 Tc 10.4 0 0 10.4 319.59 269.05 Tm (The )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf 0.0121 Tc 9.9 0 0 9.9 339.43 269.05 Tm (B. )Tj 0.239 0.239 0.235 rg 0.0033 Tc 1.245 0 Td (catarrhalis )Tj /T1_0 1 Tf 0.0157 Tc 10.4 0 0 10.4 399.21 269.05 Tm (strains )Tj 0.0188 Tc 2.967 0 Td (have )Tj 0.0098 Tc 2.215 0 Td (remained )Tj -0.0023 Tc 4.108 0 Td (highly )Tj -0.0068 Tc -19.398 -1.062 Td (sensitive )Tj 0.165 0.165 0.161 rg 0.01 Tc 3.75 0 Td (to )Tj -0.0043 Tc 1.101 0 Td (doxycycline, )Tj 0.239 0.239 0.235 rg 0.0117 Tc 5.399 0 Td (erythromycin )Tj 0.0225 Tc 5.815 0 Td (and )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0062 Tc 10.4 0 0 10.4 480.3716 258.0052 Tm (cotrimox\255)Tj EMC ET BT /T1_0 1 Tf -0.0075 Tc 10.4 0 0 10.4 294.118 247.4492 Tm (azole, )Tj 0.165 0.165 0.161 rg -0.0059 Tc 2.825 0 Td (with )Tj 0.239 0.239 0.235 rg 0.0145 Tc 2.207 0 Td (only )Tj -0.035 Tc 9.9503 0 0 10.4 369.97 247.44 Tm (few )Tj -0.0025 Tc 10.4 0 0 10.4 389.17 247.44 Tm (exceptions. )Tj 0.165 0.165 0.161 rg 0.0394 Tc 4.987 0 Td (The )Tj 0.239 0.239 0.235 rg 0.0078 Tc 2.076 0 Td (occurrence )Tj 0.05 Tc 11.1292 0 0 10.4 513.49 247.44 Tm (of )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 4.5382 0 0 7.68 294.73 236.41 Tm <007E002D006C0061006300740061006D0061007300650020>Tj EMC ET BT /T1_0 1 Tf 0.0137 Tc 10.4 0 0 10.4 348.98 236.41 Tm (producing )Tj 0.0157 Tc 4.553 0 Td (strains )Tj 0.05 Tc 10.5727 0 0 10.4 429.02 236.41 Tm (of )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf 0.0115 Tc 9.9 0 0 9.9 442.16 236.41 Tm (Haemophilus )Tj -0.0027 Tc 5.943 0 Td (inf/u\255)Tj 0.239 0.239 0.235 rg 0.0164 Tc -20.942 -1.115 Td (enzae )Tj 0.165 0.165 0.161 rg /T1_0 1 Tf 0.0283 Tc 10.4 0 0 10.4 322.55 225.37 Tm (has )Tj 0.239 0.239 0.235 rg -0.0255 Tc 1.94 0 Td (been )Tj 0.165 0.165 0.161 rg -0.0035 Tc 2.398 0 Td (relatively )Tj 0.239 0.239 0.235 rg 0.0284 Tc 4.238 0 Td (constant )Tj -0.0105 Tc 4.103 0 Td (since )Tj ET BT /Suspect <>BDC 0.165 0.165 0.161 rg /T1_0 1 Tf -0.035 Tc 10.2655 0 0 10.4 481.56 225.37 Tm (1980 )Tj EMC ET BT 0.239 0.239 0.235 rg /T1_0 1 Tf 0.0225 Tc 10.4 0 0 10.4 506.29 225.37 Tm (and )Tj 0.0075 Tc -20.446 -1.062 Td (averaged )Tj 0 Tc 10.5 0 0 10.5 336.9 214.33 Tm (2)Tj 0.533 0.533 0.525 rg 0.451 0 Td (-)Tj 0.239 0.239 0.235 rg 0.0173 Tc 0.548 0 Td (6% )Tj 0.0107 Tc 10.4 0 0 10.4 366.6 214.33 Tm (\(table )Tj -0.035 Tc 10.2984 0 0 10.4 395.86 214.33 Tm (5\). )Tj 0.0096 Tc 10.4 0 0 10.4 410.83 214.33 Tm (However, )Tj 0.0148 Tc 4.434 0 Td (monthly )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0061 Tc 10.4 0 0 10.4 497.2644 214.33 Tm (varia\255)Tj EMC ET BT /T1_0 1 Tf 0.011 Tc 10.4 0 0 10.4 294.2148 203.2852 Tm (tions )Tj 0.165 0.165 0.161 rg 0.0034 Tc 2.356 0 Td (have )Tj -0.0101 Tc 2.263 0 Td (been )Tj 0.239 0.239 0.235 rg 0.0049 Tc 2.205 0 Td (observed, )Tj 0.165 0.165 0.161 rg 0.0075 Tc 4.244 0 Td (from )Tj 0.0187 Tc 2.411 0 Td (no )Tj 0.0225 Tc 1.387 0 Td (production )Tj 0.239 0.239 0.235 rg 0.05 Tc 11.3843 0 0 10.4 499.56 203.29 Tm (at )Tj -0.0084 Tc 10.4 0 0 10.4 511.57 203.29 Tm (all )Tj 0.05 Tc 10.5203 0 0 10.4 293.76 192.73 Tm (up )Tj 10.4772 0 0 10.4 308.61 192.73 Tm (to )Tj -0.0039 Tc 10.4 0 0 10.4 321.72 192.73 Tm (10% )Tj 0.165 0.165 0.161 rg 0.05 Tc 11.1292 0 0 10.4 344.53 192.73 Tm (of )Tj 0.239 0.239 0.235 rg 0.0143 Tc 10.4 0 0 10.4 357.09 192.73 Tm (the )Tj 0.0157 Tc 1.604 0 Td (strains )Tj 0.0179 Tc 3.005 0 Td (cultured, )Tj 0.0456 Tc 4.061 0 Td (and )Tj 0.0112 Tc 1.9 0 Td (therefore )Tj -0.0088 Tc 4.062 0 Td (the )Tj 0.0028 Tc -20.73 -1.062 Td (overall )Tj 0.0049 Tc 3.242 0 Td (percentages )Tj 0.0427 Tc 5.098 0 Td (just )Tj 0.0211 Tc 1.998 0 Td (quoted )Tj 0.0191 Tc 3.322 0 Td (are )Tj 0.0152 Tc 1.663 0 Td (indeed )Tj 0.0145 Tc 3.138 0 Td (only )Tj -0.0088 Tc 2.268 0 Td (the )Tj -0.0093 Tc -20.721 -1.062 Td (yearly )Tj -0.0051 Tc 2.852 0 Td (averages. )Tj 0.165 0.165 0.161 rg 0.0084 Tc 4.206 0 Td (Beta-lactamase )Tj 0.239 0.239 0.235 rg 0.0276 Tc 6.561 0 Td (production )Tj -0.0212 Tc 4.937 0 Td (by )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf 0.0176 Tc 9.9 0 0 9.9 501.2 170.65 Tm (Hae\255)Tj 0.239 0.239 0.235 rg 0.0122 Tc -20.959 -1.115 Td (mophilus )Tj 0.0106 Tc 4.063 0 Td (parainf/uenzae )Tj 0.165 0.165 0.161 rg /T1_0 1 Tf -0.0132 Tc 10.4 0 0 10.4 398.39 159.61 Tm (was )Tj 0.0112 Tc 1.892 0 Td (noted )Tj 0.239 0.239 0.235 rg -0.0224 Tc 2.669 0 Td (in )Tj 0.0192 Tc 1.174 0 Td (13% )Tj 0.05 Tc 11.1292 0 0 10.4 481.33 159.61 Tm (of )Tj 0.0157 Tc 10.4 0 0 10.4 493.77 159.61 Tm (strains )Tj 0.165 0.165 0.161 rg -0.0224 Tc -19.24 -1.015 Td (in )Tj 0.239 0.239 0.235 rg -0.035 Tc 9.739 0 0 10.4 306.86 149.05 Tm (1981 )Tj 0.05 Tc 10.531 0 0 10.4 330.25 149.05 Tm (but )Tj 0.0373 Tc 10.4 0 0 10.4 348.93 149.05 Tm (the )Tj 0.0178 Tc 1.655 0 Td (disappearance )Tj 0.05 Tc 11.1292 0 0 10.4 430.93 149.05 Tm (of )Tj 0.0121 Tc 10.4 0 0 10.4 443.97 149.05 Tm (this )Tj 0.0057 Tc 1.932 0 Td (organism )Tj 0.165 0.165 0.161 rg 0.0052 Tc 4.209 0 Td (has )Tj 0.239 0.239 0.235 rg 0.01 Tc -20.593 -1.062 Td (changed )Tj 0.0143 Tc 3.745 0 Td (the )Tj 0.165 0.165 0.161 rg 0.0009 Tc 1.62 0 Td (picture )Tj 0.239 0.239 0.235 rg 0.0078 Tc 3.122 0 Td (somewhat. )Tj 0.165 0.165 0.161 rg -7.467 -1.062 Td (Figure )Tj 0.239 0.239 0.235 rg 0 Tc 3.045 0 Td (2 )Tj -0.0274 Tc 0.92 0 Td (gives )Tj -0.0089 Tc 2.444 0 Td (an )Tj -0.0073 Tc 1.386 0 Td (overview )Tj 0.05 Tc 11.1292 0 0 10.4 428.05 126.96 Tm (of )Tj 0.0143 Tc 10.4 0 0 10.4 441.09 126.96 Tm (the )Tj 0.0036 Tc 1.709 0 Td (mean )Tj 0.0148 Tc 2.631 0 Td (monthly )Tj 0.165 0.165 0.161 rg 0.0202 Tc -18.509 -1.061 Td (totals )Tj 0.239 0.239 0.235 rg 0.05 Tc 11.1292 0 0 10.4 322.45 115.93 Tm (of )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf 9.9992 0 0 9.9 336.08 115.93 Tm (H. )Tj 0.239 0.239 0.235 rg 0.0036 Tc 9.9 0 0 9.9 352.2 115.93 Tm (influenzae )Tj /T1_0 1 Tf 0.0225 Tc 10.4 0 0 10.4 398.29 115.93 Tm (and )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf 0.0163 Tc 9.9 0 0 9.9 419.11 115.93 Tm (Branhamella )Tj 0.239 0.239 0.235 rg 0.0033 Tc 5.9 0 Td (catarrhalis )Tj /T1_0 1 Tf 0.0148 Tc 10.4 0 0 10.4 293.66 104.89 Tm (over )Tj 0.0143 Tc 2.314 0 Td (the )Tj -0.0146 Tc 1.745 0 Td (five-year )Tj 0.165 0.165 0.161 rg 0.0081 Tc 4.075 0 Td (period )Tj 0.239 0.239 0.235 rg -0.035 Tc 10.0023 0 0 10.4 411.97 104.89 Tm (1982)Tj 0.369 0.369 0.361 rg 0 Tc 10.4 0 0 10.4 430.92 104.89 Tm (-)Tj 0.239 0.239 0.235 rg -0.035 Tc 10.3601 0 0 10.4 437.4 104.89 Tm (1986. )Tj 0.165 0.165 0.161 rg 0.0218 Tc 10.4 0 0 10.4 464.62 104.89 Tm (Although )Tj /T1_3 1 Tf 0.0018 Tc 10.1 0 0 10.1 511.08 104.89 Tm (H. )Tj 0.239 0.239 0.235 rg /T1_2 1 Tf 0.009 Tc 9.9 0 0 9.9 293.64 94.32 Tm (inf/uenzae )Tj /T1_0 1 Tf -0.035 Tc 10.1489 0 0 10.4 340.72 94.32 Tm (is )Tj 0.01 Tc 10.4 0 0 10.4 353.18 94.32 Tm (cultured )Tj 0.0238 Tc 3.924 0 Td (in )Tj 0.0142 Tc 1.383 0 Td (almost )Tj 0.0284 Tc 3.278 0 Td (constant )Tj 0.0115 Tc 4.116 0 Td (numbers )Tj 0.0308 Tc -18.417 -1.062 Td (throughout )Tj 0.0143 Tc 4.938 0 Td (the )Tj 0.0022 Tc 1.525 0 Td (whole )Tj 0.0047 Tc 2.677 0 Td (year, )Tj 0.165 0.165 0.161 rg 0.0143 Tc 2.306 0 Td (the )Tj 0.239 0.239 0.235 rg 0.0295 Tc 1.528 0 Td (proportion )Tj 0.05 Tc 11.1292 0 0 10.4 478.45 83.28 Tm (of )Tj 0.0165 Tc 10.4 0 0 10.4 489.93 83.28 Tm (sputum )Tj 0.0023 Tc -18.923 -1.061 Td (specimens )Tj -0.0057 Tc 4.583 0 Td (yielding )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf 0.0163 Tc 9.9 0 0 9.9 379.27 72.25 Tm (Branhamel/a )Tj 0.239 0.239 0.235 rg 0.0082 Tc 5.852 0 Td (catarrhalis )Tj /T1_0 1 Tf 0.0044 Tc 10.4 0 0 10.4 486.09 72.25 Tm (shows )Tj 0 Tc 2.958 0 Td (a )Tj ET endstream endobj 9 0 obj <>stream Hd͊zy8 >sRhF^#y QG#Oç==o/ϧ;c_mӷKv|~_oo~y>}~W=|z>{O݇q~?>Ï?o+~ߒ~;%zΏx߽w;>lp?(O?{wٸ^ PZUuTGu^5P5FjFDMԤU PjVjUmFmک]uPuNNE]E5|| _#_k55|| _#_k55|| _#_k55|| _#_k5Z||-_+_kZ||-_+_kZ||-_+_kZ||-_+_ku:||_'_uu:||_'_uu:||_'_uu:||_'_uz||=_/_z||=_/_z||=_/_z||=_/_ || ߀o77 || ߀o77 || ߀o77 || ߀o77 KG#(~? ?G#(~? ?G#(~? ?G#(~? ?z $߄o77MM&|| $߄o77MM&|| $߄o77MM&|| $߄o77MM&||3,ߌo77f||3,ߌo77f||3,ߌo77f||3,ߌo77f|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|ۯ\t;]~~߅ww;]~~߅ww;]~~߅ww;]~~߅w߁w;;|C߁w;;|C߁w;;|C߁w;;|C߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S ߅w]..|K ߅w]..|K ߅w]..|K ߅w]..|?|x>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 17883/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream *'Ҿ%T >n X!(hB0 ƾҎӛ\d@Z#m+ !qGص~[rRJ!_.MvMAZNMJn!Ϸ U){$&WDhU#(`r;Ŧ:(~6AZ9Б@wDP\ƤlA[p'7=A2A*FQ\jHiϿ (s,[F|MxQO~tU(]Д3dq ?+sށ u\SW䞟WN Vr^`ݵ=)M^duË^:޿AZSJ;,R- qiƃbUBQ֬ɇ4Ipc>ʣ87A9'Œ2˒ZjJrˡPONw/v )BB0}!Cw[-w-d5KR:)"s.ޔm@ZR=-I~\&.B-@&$xֱR<<0r!z8J`>17Kg w3uY\j!,xIq1 |<„TCDdHO!^m[w;s>f2W=qb:`'g_G=y}~Z<`" Ѿhp]Gg0R?yHA.˗kbLxI 3\-c[m# INݭܛp{rx;bNCcRp᥾:vq:Kj. 8ebuoBX66^kgW;V?Һ)8_r7!l)3苏$NGӼx!d@P׹GeGEmUӏ%vA_Eaœ Gru#]{!(xlNKxGa*> mBxw>Tv jA-L{fp}G_jU{;}Y&ϰ"/h<)0gZ><5OM:0/Y'(@(+=TIܥmYj{+?oG !j6{=h9(q̷! <#8{$Ar8;Oyl)m:a{D.0w +1h>@Mm@t[&u=T; %_hxWR7Ϭl5shj; S$i ٖ1!V6& ~ a"%`x~BML7s1y.ӹJO]ot^ ~$ݝlr~/ȥ2G-RE;/$/tlqo`U]PY^IrdUwа 1$jz,2-+ /n@N?_ҏ!Es=kJkym O \[kSyEpI,`m$FA ;4P\HbGy BC٨ ?uH=,^`p |[ݘe(Zu&E!5 [7؍3]]J5JFή k^zU}ASV-ZVR[|g\MEu %f4"w]UX N+`OQV4ro DAn1StB(LkX KqʻNǖHYv1L=>'i{^rf@(}.n{G#oK+qRQO.;̳`틢?DAAS<d=2NEmaB`CZO-N%9Й#hCwͮdrnBm˪-@]ܴS.oP-WrEh<;iT#m(QVJƼ:FF1F!Ps#pk jݕİlжP,4ThfV#\c"M͸b44 }HOW\-xO9∏.@S[L ˧I5NP=]^]r׎D1+7(ۂZ,IwY*Щ"(IJ|:}i}\I ]?imwX. rK=) 50Y^ :PR.s7X]}Aj>uO/v]ANFEO xbwѢ'~GVͷ& F+0BYqs*z@[S;rS HmdP*Qx9(09@CY*򘧒FVsx{Q*nбv)ȡ&n!I8f_,̘(g(&cZ1Ռc}{|t0RE><Πh#̞~1Fsjh$e].82Y#_O37ML\>[*A  nyclQpp?5Սbkk5e2L]+hW5WZVȰYBa-wlM:LBeN]SmR|p~#̬ Ҧ"40gyj O>'đ~8l:nRulmDm-D)JvGxb5a8r]bQôIz0?~W/rVN[K䨰z07 ʬ҃u# /hDgv/lt$!SwR2jP]GykgHZh=ibK5n@Zjl`%QKm⭦@;lfMY8旡i7Q<&ɪOQ:#}392YB!\#϶P?J%p8i-bV..U{[}b+*QXv|o9-Oe``얳r_9KA6@7:5 NcyZ»yy#B_]9:-X:ER̸W]?6+ aC*:d*hN]ƚ(UxNrȣCQ;RKG6yToj~PO8@[\!n` >Z; `S^LP\wZ9dJG`8} ;j#N~{ $T"S^ E"YAk|N3%VDFKo!0v%q-0|v |? /N5_7NqqEwRl\NjnRM X[շ۬KCϳ,xR )ZiH8} B;ugC$ 5)ӾS,f>{ #T i)xoN) X.Ѿhk4^0ഇI*Te jnJxpXxܝR{_t؎Q ߁[4&-u *%B%a Uf31q9;3/5r:9gEC{N{a,1f@T ~o6h 6#Gt=fFx;5kyc@(Z!=ŝOm` "53#>clT}Ej^kIJfinרJRq(=q+> T᝛IxAL}IQ!Rjx'݊+3l)/.1f}*uC‘r9]`۟D2T1!A)Ojxbj5+i.c;0DvRj>qbz)1^Ðjr K$!̗$7W/.t^zZgJOoMx Y9p{̚P %1~E*Yڣ+4YM⭓/3hvo ̬ﱯ_ఒ΄H.Q-_O?+ ӄt~,/Cдs*$%JjhP! p6hOsn>2`HxRIJ’ Z61[R͔.7;Nב`̺Vh s)/l qF؇2{ͩmeċLcSwk=~g-{A$) /6=)i`1S e\f*F,e5g($@b]5hv~IJ pOpbHƑ`j܈A҂"7, غ3|/"ٸIt)T&2%dzF:K_'J.<2\:"զ LBͲNm Xa/A[wX YwSm{v}sU% Q1tawf TKlEMo4U^ցkl,jL4Jy$<'DIo>O#BC\)a@ :Ǒ3UE1+=i W+lNe῝@ƗZ+ K\%6 k<[5.RK%/g$ƝjTD(J-ҳ ޤO=t R믚߮|gnpM}yT4OM aQ#r {3g 4SRߏw}@|'&L@\d=nsksuFammèv# :e11|2 m kQe nvmE\_O{:]4C6Hs{x+t׊dP k?졈W(!O9b1ԌJTgh}1h ^ ]fL*X쳙?9^}] 419 ` )"S25RZ:5(#]8Q rxտA ruC ݊VG% E;raZn-tBf"vmväo 9A0w3K%,FjLLٷ@{l{ `bQ{_ Xp8/ M)qz @4Ղ ī K+K3vyxj(O4γʦ01>t{_%A쫲} ,Ӈr0nիn9˳lbQ,q d3c=tuوR%& Y}iz0ܾ}~{/C=K: Ht9y4'"$[ 3,z@8/'WaR(F1vDV,N!oDj3䅒vU%.F/Hg[׬FY~u],#wj21džzH %l[ËT%V^HpOK?~$/:E=@!(VfzVh Q4jP}ډxI|Eb>#{Tp[e0{a@wJdrmJ_w밵#h 9=t*a7!lQ1y]1h!tR&&$XhBWJMHM5~ĶmXX6gZZ @z~UM 5BFXt! W~֖q瞱3l+˵ -3_򟇫}^@C_#}VP}*JYΫ=tIvAUM{/Oe$]6|:4;Gq c8 ~u1 `4:+(>AϾTnx4i Og{ŭ) @[ ͡R@Yr\(+Scn;VҼ 9rrardp& coW`%/yji0NϏ)N/V݉j4G?&a0״αT*SnC-WB8 ~9Y4X$ZɈGl)ؠE)h4L;- Ƒ#dqnʥN>2Xy9co%R"7Ҍ2P#̒ SX)PbG*&,$s:/b3l& &ʶƛaK_)S*qwKx C/LPF=4;Zw 8\n-"2P&A €*%7ݠ)C:`/+YTyIs<S|tz;iv.M@ wh?RT<9wWٗ<@AwFwkf(&౓_ dI,C;iЧ``89m.CV?ֻⷁa ?̤!g#6${n3.wFyfN a^C$3د@)S LBu3"I}E,"8DӋvTRҏ)Qh;V7ݑ[$ k 5xy쫻)c2g0*%tD)7U0f\̳kJ s@:2D/E]ZQ,iچ]M+.8/Ϯ{Tlh;1LPnv{y"T\]NǓ9:cΖcv)v@m?|G"uCI k-:p^3@*F& =Kc,  zKTu`O]=Nuƽ/ Ѽ >nY-xb|eS{BZA*-/=On!/vcd r,^ i!}%rי@!bW`e)L۞B@Ofc:텫%<;b\v./% %wiS}S1ܾ!ڷ  P=3bCu?Q" e(ڡt~$Lr )r8ƣ@>OYu?DGm I$&8fHN:+Ъ~9ns`HADn4~J\DlM#o.&|ۀt!gF>r!c:o\ݜ=OgOu)50g!qp},J1fi$l)v6WJ>)SXv5n$q=8s@tHN&2~vdtOZD16 RN}K:΁!(&Mri:nj a^i"!fG - '8u➓ `%^87o2n&ǴTޤ7Ii?)*>GLYu+:"MRu= y猛-ls+*j/qoԭP=~/?Bof?$ 4x%!GqtU4Eu wזQpi9kpc'U7fr\P^2 "? Zc`9 Z¾7CNVtI-`"ri~knTO IN5VV?8 T`.muD&kI.y!m0M oR?T=,s }GL B;:.`Ǭ.YGՄdyx8oHȕ3LEBvVWa m:GrϢ;Gcf~-2se?RbY5ۘNeVK;~vm󍇿|urB B.[(-o_YS7ɁNCۍm J=23p#)DblJ @ㇿ50qTb_8'yt칟44MI(4kM]sũ&'|Ě PYWμ5`8+Xpr*a нZA+ Yf8#WylYATI)*!c 0"w#]}:bS#:ye 8Z={JXGUAjV`ǩagV@Ȼ\h;b1b]`*qUASvF2睍x" ioOSawGbli n^%)i'%@%zΒ,KƑJBAOʴ oBKFrm#.DEJxtBXiЇvZ%MC=c)1g;y rpSpOh|EJeB~峈.6._: i.muB"1,F({@!zb);/kZ*rP35M(B7}*RJ*l3KVJc_ްML3܅Da2ƴY]Mb#^KW/|YTTaY:rf:Dz|b t*N]-e(lX5;%rl.f/ŔI{=#n1ºU=/K, @G/\,$kp*Gk6 P 1j&>!V e9k;zMni+M{C01Q<' {Pm ic/6Eg_Qq–K? 3̥Lʈ,L *DeQ,r 'I'%)ڻ1C[h7Mr",' oiGZ"5aooǦ_v 1ޘVO d8x451슋72s~-+ұ"ffdE(Nbr(g p(_wCt0y]C;-hw[cQdYQpmlW`G o%m!ᴾsZx}OqR=Bى̮*rΤ ęLP,T4,=bdżG [nS* \X.ByLlv&=`;O 6/aY4)B@u1.nɼ0-Cb\c)I}2OQ Q9⹱8ED, V'n&З|!M%>F5jeN-9I| .+x}nhHiXGyd1|f%8Y|cnGRM//'KަI~^Wg(Wrw:LH} rᩜ?"Lq^iH,_E9Yu̘K'4 uṮ0$NZF{MFܟfJKJV'j].z0rI4tn(F3*(Of X|$ͧ9t/rrkv^`)!X^TY vvL/=Il!}h:!S@{7N$2~OMa9&Q&oTL0S-PK\҆'bXc5 U,u w c`qX Վ05Kd**(/ё_)˵AĽ\NO][Ŕjȼhjp 7 cz ~ :V*$eVc2)^>CP~RU7>->dcq.- U_@fd͘yK$W6زhS~Dn}-ҹ(.jT c. ~_ag+efxcO˧^U℠~~@\;.L$f"_?d85|+$)3b.0BM7jm[m7 7xk-"%juUˏ؛L4t̑! ~*39'5u!ˆ1+Dvgv{ $AP oyÖ_V ?}y~IDF_нW+>R^$\trbSVEYfDߠM)Nmǚ[HK.Fɔ⎗!@k05[ךGWg=dRͪN-ڷ a3ת]w|)W^~Ap<8^9 uNҘ`W"T//eف׻9tG >Bk%K9:NflsZCvKPv6UL`|hPV7\KO f򒍆'5%M9XQ 2ؚocr1 aR}|. }DUN"NA^dHQT7MBݞmOr7XhOeO @i8A|_:t* T4s'2u!l&Smz\Ys uH[>秝lȱorS昉[d^SΗ{M~KIO14!Y%n7qTYo8Y8IPǵ5M529^b.~i5e4CXWB2İT0)5Bjo/ I tj2XZƺQY㻎Ƙ{^7EъzO(~a 6װ:X@aN0"=B#y0?G >~& V3 ;4\cNs? KQs۹`@ p UZŖ?[ VX(V4]3e4qI$q E*3@+k-w$8=w/j+8XEc{mċNhU _^C_)GΣ&*鸎!t?MBb)& \gbjZn87K_u9cwW:d1Rs8`s]|kxF?M2ˌ"Slܳ G(14EdzmW _U9mVQfzsF8Vժ1 9̝K"'5l.D0;8"CPϮGLJ v{܌pra\ œwF}fK/X Ƭv=p nbꦢM{UEջfc!Ml фܳ|8L#:y7[#Jg&[h>1M+:\Q}<Ѽ+̹]gc"C( ȊBdǁ#!]:;<]^,>1G03T'`E9Tz>Gc^ vI:JHU%=MNP~b#!͟^_Gx&טV F]4n[8㮬ik q|ZS+f(|1cfVݘm͒0.1~Rl,|LJѦT.(?`:9֌8GaMD؛1 &?/^{d>*A2tZKUq qջwbOO*#( ҴƬ҃PYkAh"fcSwZV^hq\Fe'U/hª3&|ڦQ`f٥whVt}vAUq2una^ {Ъn2ivEfA }Az"ҵJ"36HҧS֤ i*mAW?QP2]-1@HNyuFhE*?˚LdGC&%W^,7hK#c\ܷ];VW_P?A[mk2yџ{$fYJt>P~RF.Fﶜ>%(6zMf6\VwmA: -(ᗼUteA"N!yr}NTS9#'T9ͰGt^O E՟NlvAl57# ):D/ "6`0Bײo08~)spo+F԰%2G` ɂBFm#ADx"UsQFe~YP8D!̧/Y?58JWZ$BZn*cG%M/ٗjٖٸVp``3j t7._hd7t&a,L~&Po>?zvVNrXZ%wAHn86-äCs095`D׉<|kdǝt:Ug*emu(zKXDP0K;RDu)>b;zj\c}ms>>eW|Tc_9&nI4v̓H BVz'2v^C!5zr׏ry$mbQC=)w-IDޱ+e]LYPnlxy~- @, x|%|;&Lo{;_Js/QΜxf|Q$ZBx~>L<K}PPAՊPDrԟ;qv`hh#֍u@Uhap_Iy#Ki՛gb|ջ؞y Pzo7qy-;ټ_0yk_)i[kpƥ9GEb:]dᝓb/#ddV!@ۤLw44m̔^(mz1\p ˀfKr@a57k19e%`b6:QrȺ,Ng|S|UY9q$ U3No 5෨r# ւb z{*kIBswOaa8٤EQS,dSXΙ9T @ ]91. ʇեAx{<&4/suZV -l } lKaK\ce-cY.qKX(42#.ĵ7 497sUqk@2X,(| Д,NuvvWjDxmϙ?NR-ReH͢r|BY(>EYZ!I: MU."whhB;`+K׽+VM1  Vy?_aŤ-L+gp;9ʱoڢU<֯\氠dU\ 9 oE@L`Un|,$u"ED(Cȉ,Nc .#&~)S;~Ϫ٦豊2`KHثۺ\53~勞.BĢ z1!^elNr}CSY4*-Z7 POv ;~V{, !h_sRx*p#:3{2K!\MZ"B|׳bv1'9[[ ~I 7IPbzmu!ƒlqFna endstream endobj 11 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrDcolrjp2cOQ/DDR \#B@HHPHHPHHPHHP880 @ϴH4r2/ʜ{$'T/#OҨnczyst fg- a@@ VJ[+~:\@( :u( [Sx*s4 n"ݢh]᫝  pJnK ʺĕ6%c>tLl|.@|4*:ʽ=V Oy(xh;h[!M;nJ9&Th2H<d-q ^8*7MB ĩ\lzj~ Ѓ-YDCA/[=f͎a$QK0:#\ݥICeIMyKčn XບoaF[";ptzA>FȟBݐ%`l;+ ED %X)+&qwP^~@X$}8{Y3`ʢs$ {ր $eFA[tim  endstream endobj 12 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrNcolrjp2cOQ/NNR \#B@HHPHHPHHPHHP880 Wϴh41 h-%e&W V1٤;P73cy0^Һt n\+<˨Q  K '3:F\:w$*!d:|œ@ e(b#sX=$x#:? P~`hLAXwCRS幐:["`g /kq= f\)1hKP[j&"!VQ#zcT:j5$>Y(c S}q{dm"m1ZR!vxc3$cŗ*A B$,&m7 '*H2(GHIGҼtt-"a|@c XS}Ɨto~Pp,Dbd[ t_A/ C9xrdfl57L.lakELsR2}Sou4%yIbRiz)J,>9/N L׺%Qsm! M.h(F -?9񝾘/@U PL>he%xj=B̿NH7 9ZM^}~?Ҹr))43>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr colryjp2cOQ/  R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt !:  @ + |!|!>_u B    endstream endobj 14 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrsjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ [t  : @ |"M8|"]  "iH!  endstream endobj 15 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr6colr{jp2cOQ/66R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ [t ! ": :@ |"b, %zz L*[V  endstream endobj 16 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr colrjp2cOQ/  R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt! $:  @ $ :` |" &   endstream endobj 17 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt!  &:> U 4 |" pg .b᠀  endstream endobj 18 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr6&colrjp2cOQ/&6&6R \#B@HHPHHPHHPHHP880 ϴ2]C $t  . |!@:Ѐ U   :T c%9Y 9ew π  endstream endobj 19 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr'6colrjp2cOQ/6'6'R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴPC$" +@: |!|!@@ + B@ :$32Ud )th2+D+ z궝 Kg!z  endstream endobj 20 0 obj <>stream h޲0Q0P0U0U0S0W0475R0Q04210> endstream endobj 21 0 obj <>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 22 0 obj <>stream q 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q q 595.1999969 0 0 840.9600067 0 0 cm /Im1 Do Q q 242.8800049 0 0 28.8000031 340.3200073 772.3200073 cm /Im2 Do Q q 228 0 0 121.9199982 0 678.2400055 cm /Im3 Do Q q 87.3600006 0 0 22.0800018 240.4799957 778.0800018 cm /Im4 Do Q q 20.6399994 0 0 32.6399994 0 640.8000031 cm /Im5 Do Q q 12.9600067 0 0 31.6799927 0 601.4400024 cm /Im6 Do Q q 12.9600067 0 0 16.3200073 0 578.3999939 cm /Im7 Do Q q 12.9600067 0 0 16.3200073 0 478.5599976 cm /Im8 Do Q q 20.6399994 0 0 16.3200073 0 447.8399963 cm /Im9 Do Q q 12.9600067 0 0 106.5599976 0 317.2799988 cm /Im10 Do Q q 12.9600067 0 0 16.3200073 0 286.5599976 cm /Im11 Do Q q 12.9600067 0 0 18.2400055 0 213.6000061 cm /Im12 Do Q q 12.9600067 0 0 16.3200073 0 140.6399994 cm /Im13 Do Q q 12.9600067 0 0 16.3200073 0 117.6000061 cm /Im14 Do Q q 18.2400055 0 0 12.4799957 2.3999939 81.1199951 cm /Im15 Do Q q 28.3200073 0 0 72.4799957 0 0 cm /Im16 Do Q BT 0.223 g /T1_0 1 Tf 0.0026 Tc 3 Tr 8.7 0 0 8.7 60.45 751.92 Tm (418 )Tj /T1_1 1 Tf 0.05 Tc 9.5737 0 0 8 234.2 751.92 Tm (B.L )Tj ET BT /Suspect <>BDC 0.165 0.165 0.161 rg /T1_1 1 Tf 8.8033 0 0 8 254.36 751.92 Tm (DAVIES, )Tj EMC /Suspect <>BDC 0.223 g 9.713 0 0 8 295.64 751.92 Tm (F.P.V. )Tj EMC /Suspect <>BDC 0.165 0.165 0.161 rg 8.0581 0 0 8 328.76 751.92 Tm (MAESEN )Tj EMC ET BT /T1_0 1 Tf 0.0266 Tc 8.7 0 0 8.7 65.22 727.92 Tm (Table )Tj 0.05 Tc 10.385 0 0 8.7 90.69 727.92 Tm (4.-)Tj 0.0217 Tc 8.7 0 0 8.7 106.36 727.92 Tm (Percentages )Tj 0.223 g 0.05 Tc 8.91 0 0 8.7 159.28 727.92 Tm (of )Tj 0.0246 Tc 8.7 0 0 8.7 169.75 727.92 Tm (bacteria )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.009 Tc 8.7 0 0 8.7 204.463 727.92 Tm (fully )Tj EMC ET BT /T1_0 1 Tf 0.0199 Tc 8.7 0 0 8.7 223.1245 727.92 Tm (sensitive )Tj 0.002 Tc 4.308 0 Td (to )Tj 0.165 0.165 0.161 rg 0.0157 Tc 1.16 0 Td (various )Tj 0.223 g 0.0171 Tc 3.634 0 Td (antimicrobial )Tj 0.0114 Tc 6.124 0 Td (agents )Tj /T1_1 1 Tf -0.0009 Tc 9 0 0 9 101.72 705.85 Tm (Results )Tj -0.035 Tc 8.9271 0 0 9 130.97 705.85 Tm (in: )Tj -0.0029 Tc 9 0 0 9 210.89 705.85 Tm [(1982 )-3738(1983 )]TJ 0.0149 Tc 12 0.053 Td (1984 )Tj -0.0029 Tc 6.027 -0.053 Td [(1985 )-3844(1986 )-3898(1987 )]TJ /T1_2 1 Tf -0.0243 Tc 8.8 0 0 8.8 65.35 684.24 Tm (H. )Tj 0.0123 Tc 1.289 0 Td (influenzae )Tj /T1_1 1 Tf 0.0077 Tc 9 0 0 9 101.67 673.68 Tm (ampicillin )Tj 0.0382 Tc 12.586 -0.052 Td (96 )Tj -0.0151 Tc 6.027 0.052 Td (95 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.05 Tc 9.365 0 0 9 322.93 673.68 Tm (90 )Tj EMC ET BT /T1_1 1 Tf 0.0382 Tc 9 0 0 9 377.18 673.68 Tm (96 )Tj 6.08 0.054 Td (97 )Tj 0.05 Tc 9.365 0 0 9 487.09 673.68 Tm (92 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0056 Tc 9 0 0 9 101.67 662.65 Tm (cotrimoxazole )Tj EMC ET BT /T1_1 1 Tf 0.0382 Tc 9 0 0 9 214.944 662.173 Tm (99 )Tj 0.009 Tc 6.026 0.106 Td (64* )Tj -0.0124 Tc 6.021 -0.052 Td [(83* )-4326(83* )]TJ 0.0043 Tc 12.067 0.052 Td (41* )Tj -0.0151 Tc 6.127 -0.052 Td (95 )Tj 0.0033 Tc -42.824 -1.173 Td (doxycycline )Tj -0.0151 Tc 12.584 -0.053 Td (98 )Tj 0.0382 Tc 6.027 0.053 Td (94 )Tj -0.0151 Tc 6.027 -0.053 Td (96 )Tj 6.027 0.053 Td (93 )Tj -0.0049 Tc 6.073 0 Td (89 )Tj 6.133 -0.053 Td (88 )Tj 0.007 Tc -42.873 -1.173 Td (erythromycin )Tj -0.0151 Tc 12.587 0 Td (97 )Tj 0.0382 Tc 6.027 0 Td (92 )Tj 9 0 0 9 101.67 662.65 Tm 24.642 -2.398 Td (96 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0484 Tc 9 0 0 9 377.628 641.068 Tm (80 )Tj EMC /Suspect <>BDC 0.0025 Tc 6.084 0 Td (50** )Tj EMC ET BT /T1_1 1 Tf 0.014 Tc 9 0 0 9 487.185 641.068 Tm (47** )Tj 0.0179 Tc -42.832 -1.174 Td (otloxacin )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0057 Tc 9 0 0 9 373.641 630.502 Tm (100 )Tj EMC /Suspect <>BDC 0.0324 Tc 6.027 0 Td (100 )Tj EMC /Suspect <>BDC 0.0057 Tc 6.187 0 Td (100 )Tj EMC ET BT /T1_1 1 Tf -0.035 Tc 9.1249 0 0 9.3 65.11 619.44 Tm (S. )Tj /T1_2 1 Tf 0.0241 Tc 8.8 0 0 8.8 74.22 619.44 Tm (pneumoniae )Tj /T1_1 1 Tf 0.0077 Tc 9 0 0 9 102.15 608.41 Tm (ampicillin )Tj 0.0382 Tc 12.532 0 Td (98 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0057 Tc 9 0 0 9 265.131 608.41 Tm (100 )Tj EMC /Suspect <>BDC 0.165 0.165 0.161 rg 6.027 0 Td (100 )Tj EMC /Suspect <>BDC 6.027 0 Td (100 )Tj EMC /Suspect <>BDC 0.223 g 0.0324 Tc 6.027 0 Td (100 )Tj EMC /Suspect <>BDC 0.165 0.165 0.161 rg 0.0057 Tc 6.187 0 Td (100 )Tj EMC /Suspect <>BDC 0.223 g 0.0056 Tc -42.429 -1.228 Td (cotrimoxazole )Tj EMC ET BT /T1_1 1 Tf 0.0382 Tc 9 0 0 9 214.956 597.358 Tm (93 )Tj -0.0049 Tc 6.073 0.054 Td (84 )Tj 0.0382 Tc 5.98 -0.054 Td (92 )Tj -0.0151 Tc 6.027 0.054 Td (97 )Tj 6.08 -0.054 Td [(93 )-4929(98 )]TJ 0.0033 Tc -36.744 -1.173 Td (doxycycline )Tj -0.0151 Tc 12.584 -0.052 Td (95 )Tj 0.0382 Tc 6.027 0 Td (98 )Tj -0.0151 Tc 6.027 0.052 Td (93 )Tj 0.0382 Tc 6.027 0 Td (97 )Tj 9 0 0 9 102.15 608.41 Tm 36.695 -2.401 Td (94 )Tj -0.0151 Tc 6.133 0 Td (97 )Tj 0.007 Tc -42.88 -1.227 Td (erythromycin )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0057 Tc 9 0 0 9 210.915 575.758 Tm (100 )Tj EMC /Suspect <>BDC 0.0324 Tc 6.027 0 Td (100 )Tj EMC /Suspect <>BDC 0.0057 Tc 6.027 0 Td (100 )Tj EMC /Suspect <>BDC 0.0324 Tc 6.027 0 Td (100 )Tj EMC /Suspect <>BDC 6.027 0 Td (100 )Tj EMC /Suspect <>BDC 0.165 0.165 0.161 rg 0.0057 Tc 6.187 0 Td (100 )Tj EMC ET BT 0.223 g /T1_1 1 Tf 0.0043 Tc 9 0 0 9 101.709 565.21 Tm (ofloxacin )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0324 Tc 9 0 0 9 373.653 565.21 Tm (100 )Tj EMC /Suspect <>BDC 0.0057 Tc 6.08 0 Td (100 )Tj EMC ET BT /T1_1 1 Tf 0.0382 Tc 9 0 0 9 487.62 564.733 Tm (99 )Tj /T1_2 1 Tf 0 Tc 8.8 0 0 8.8 64.87 554.17 Tm (B)Tj 0.392 0.392 0.384 rg 0.747 0 Td (. )Tj 0.223 g 0.0209 Tc 0.437 0 Td (catarrhalis )Tj /T1_1 1 Tf 0.0077 Tc 9 0 0 9 101.67 543.12 Tm (ampicillin )Tj -0.0154 Tc 12.586 0 Td (78 )Tj 0.165 0.165 0.161 rg 0.0286 Tc 6.033 0 Td (46 )Tj 0.05 Tc 9.2781 0 0 9 323 543.12 Tm (49 )Tj 0.223 g 0.0475 Tc 9 0 0 9 377.64 543.12 Tm (59 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.05 Tc 9.0021 0 0 9 432.38 543.61 Tm (30 )Tj EMC ET BT /T1_1 1 Tf -0.0031 Tc 9 0 0 9 487.58 543.61 Tm (37 )Tj 0.01 Tc -42.932 -1.28 Td (cotrimoxazole )Tj -0.0151 Tc 12.639 0 Td (93 )Tj 0.0379 Tc 6.027 0 Td (76 )Tj -0.0151 Tc 6.027 0 Td (97 )Tj 0.0382 Tc 6.027 0 Td [(98 )-4715(99 )]TJ -0.0151 Tc 12.213 0 Td (99 )Tj 0.0086 Tc -42.931 -1.227 Td (doxycycline )Tj -0.0151 Tc 12.638 0 Td [(98 )-4822(97 )]TJ 0.0382 Tc 12.053 0 Td (99 )Tj -0.0151 Tc 6.027 0.053 Td (97 )Tj 0.0382 Tc 6.08 0 Td (96 )Tj -0.0049 Tc 6.127 0 Td (85 )Tj 0.007 Tc -42.927 -1.227 Td (erythromycin )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.021 Tc 9 0 0 9 210.902 509.995 Tm (100 )Tj EMC /Suspect <>BDC 0.0057 Tc 6.027 0 Td (100 )Tj EMC ET BT /T1_1 1 Tf -0.0151 Tc 9 0 0 9 323.438 509.995 Tm (99 )Tj 6.027 0.054 Td (98 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0324 Tc 9 0 0 9 427.874 510.481 Tm (100 )Tj EMC /Suspect <>BDC 0.0057 Tc 6.187 0 Td (100 )Tj EMC ET BT /T1_1 1 Tf 0.0109 Tc 9 0 0 9 101.219 499.429 Tm (ofloxacin )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0324 Tc 9 0 0 9 373.163 499.915 Tm (100 )Tj EMC /Suspect <>BDC 6.08 0 Td (100 )Tj EMC /Suspect <>BDC 0.0057 Tc 6.187 0 Td (100 )Tj EMC /Suspect <>BDC /T1_2 1 Tf 0.0024 Tc 8.8 0 0 8.8 64.39 488.89 Tm (P. )Tj EMC ET BT /T1_2 1 Tf 0.0164 Tc 8.8 0 0 8.8 74.818 488.89 Tm (aeruginosa )Tj /T1_1 1 Tf 0.0077 Tc 9 0 0 9 101.19 477.84 Tm (ampicillin )Tj 0 Tc 13.117 0 Td (5 )Tj 6.034 0 Td (2 )Tj 6.02 0 Td (6 )Tj 6.034 0 Td (4 )Tj 6.073 0.054 Td (7 )Tj 6.132 -0.054 Td (6 )Tj 0.01 Tc -43.464 -1.226 Td (cotrimoxazole )Tj 0 Tc 13.119 0 Td (3 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0219 Tc 9 0 0 9 269.445 466.806 Tm (10 )Tj EMC ET BT /T1_1 1 Tf 0.0314 Tc 9 0 0 9 323.202 466.806 Tm (12 )Tj -0.035 Tc 8.5945 0 0 9 377.94 466.81 Tm (15 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0 Tc 9 0 0 9 436.71 467.28 Tm (0 )Tj EMC ET BT /T1_1 1 Tf 9 0 0 9 491.889 466.812 Tm (6 )Tj 0.0086 Tc -43.463 -1.228 Td (doxycycline )Tj /T1_2 1 Tf 0 Tc 10 0 0 10 218.78 455.76 Tm (5 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 9 0 0 9 273.51 455.76 Tm (0 )Tj EMC ET BT /T1_1 1 Tf 9 0 0 9 327.312 455.76 Tm (2 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 9 0 0 9 381.996 456.246 Tm (0 )Tj EMC ET BT /T1_1 1 Tf 9 0 0 9 436.23 456.246 Tm (7 )Tj 6.186 -0.054 Td (6 )Tj 0.007 Tc -43.466 -1.172 Td (erythromycin )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0 Tc 9 0 0 9 218.799 444.726 Tm (0 )Tj EMC /Suspect <>BDC 6.027 0 Td (0 )Tj EMC /Suspect <>BDC 6.027 0 Td (0 )Tj EMC /Suspect <>BDC 6.08 0.054 Td (0 )Tj EMC /Suspect <>BDC 6.027 0 Td (0 )Tj EMC /Suspect <>BDC 6.133 0 Td (0 )Tj EMC ET BT /T1_1 1 Tf 0.0043 Tc 9 0 0 9 100.728 434.16 Tm (ofloxacin )Tj -0.035 Tc 8.7752 0 0 9 377.61 434.16 Tm (83 )Tj 0.0484 Tc 9 0 0 9 431.84 434.65 Tm (86 )Tj -0.0154 Tc 6.14 0 Td (79 )Tj -0.035 Tc 8.922 0 0 9 64.14 412.56 Tm (*: )Tj -0.0124 Tc 9 0 0 9 73.82 412.56 Tm (figures )Tj 0.0298 Tc 2.997 0 Td (not )Tj 0.0066 Tc 1.591 0 Td (accurate )Tj 0.0297 Tc 3.574 0 Td (due )Tj -0.035 Tc 8.4365 0 0 9 163.18 412.56 Tm (to )Tj 0.0049 Tc 9 0 0 9 172.23 412.56 Tm (antagonists )Tj 0.0391 Tc 4.802 0 Td (in )Tj 0.0312 Tc 1.019 0 Td (the )Tj 0.0188 Tc 1.493 0 Td (test )Tj -0.0044 Tc 1.653 0 Td (medium; )Tj 0.165 0.165 0.161 rg 0.0495 Tc 3.821 0 Td (**:new )Tj 0.223 g 0.0106 Tc 3.424 0 Td (criteria )Tj 0.0038 Tc 3.146 0 Td (employed )Tj 0.0207 Tc 4.213 0 Td (for )Tj 0.007 Tc 1.44 0 Td (erythromycin )Tj -0.0141 Tc 5.76 0 Td (from )Tj 0.165 0.165 0.161 rg 0.0078 Tc 2.192 0 Td (January )Tj 0.223 g 0.0149 Tc 3.438 0 Td (1986 )Tj 0.165 0.165 0.161 rg /T1_0 1 Tf 0.0128 Tc 8.7 0 0 8.7 63.78 385.69 Tm (Table )Tj 0.223 g 0.05 Tc 10.4403 0 0 8.7 88.2 385.69 Tm (5.-)Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 4.3665 0 0 8.7 104.98 385.69 Tm (13)Tj 0 g 0 Tc 8.7 0 0 8.7 109.84 385.69 Tm (-)Tj 0.165 0.165 0.161 rg 0.0217 Tc 0.322 0 Td (lactamase )Tj EMC ET BT 0.223 g /T1_0 1 Tf 0.0182 Tc 8.7 0 0 8.7 156.3154 385.69 Tm (production )Tj -0.0205 Tc 5.186 0 Td (in )Tj 0.0093 Tc 1.105 0 Td (respiratory )Tj 0.165 0.165 0.161 rg 0.0204 Tc 5.13 0 Td (pathogens )Tj 0.0273 Tc 8.6 0 0 8.6 300.68 385.69 Tm (1980-1986 )Tj 0.223 g 0.0157 Tc 8.7 0 0 8.7 345.99 385.69 Tm (as )Tj 0.0213 Tc 1.37 0 Td (percentages )Tj 0.165 0.165 0.161 rg 0.0156 Tc 6.024 0 Td (of )Tj 0.0264 Tc 1.108 0 Td (total )Tj 0.223 g 0.026 Tc 2.302 0 Td (isolates )Tj 0.05 Tc 8.91 0 0 8.7 473.2 385.69 Tm (of )Tj 0.0025 Tc 8.7 0 0 8.7 483.75 385.69 Tm (each )Tj 0.0178 Tc 2.484 0 Td (species )Tj /T1_1 1 Tf -0.006 Tc 9 0 0 9 63.34 363.61 Tm (Year: )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0149 Tc 9 0 0 9 190.726 363.61 Tm (1980 )Tj EMC ET BT 0.165 0.165 0.161 rg /T1_1 1 Tf -0.0206 Tc 9 0 0 9 245.446 363.61 Tm (1981 )Tj 0.223 g /T1_2 1 Tf -0.0243 Tc 8.8 0 0 8.8 62.95 342 Tm (H. )Tj 0.0123 Tc 1.289 0 Td (influenzae )Tj /T1_1 1 Tf 0 Tc 9 0 0 9 194.84 342 Tm (4 )Tj 9.6 0 0 9.6 249.47 341.53 Tm (5 )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf -0.0243 Tc 8.8 0 0 8.8 62.95 330.97 Tm (H. )Tj 0.223 g 0.0236 Tc 1.226 0 Td (parainfluenzae )Tj /T1_1 1 Tf -0.035 Tc 9.1317 0 0 9.8 190.72 330.49 Tm (13 )Tj 0 Tc 9 0 0 9 249.44 330.97 Tm (8 )Tj /T1_2 1 Tf 0.0031 Tc 8.8 0 0 8.8 62.87 319.93 Tm (S. )Tj 0.0302 Tc 0.962 0 Td (pneumoniae )Tj 0.0121 Tc -0.953 -1.2 Td (B. )Tj 0.165 0.165 0.161 rg 0.0209 Tc 1.13 0 Td (catarrhalis )Tj 0.223 g /T1_1 1 Tf 0 Tc 9 0 0 9 194.78 309.37 Tm (7 )Tj 0.05 Tc 9.0021 0 0 9 244.7 308.89 Tm (38 )Tj 0.165 0.165 0.161 rg -0.035 Tc 8.922 0 0 9 63.18 287.76 Tm (*: )Tj 0.223 g 0.0027 Tc 9 0 0 9 72.46 287.76 Tm (too )Tj -0.0119 Tc 1.538 0 Td (few )Tj 0.014 Tc 1.757 0 Td (strains )Tj -0.0045 Tc 2.938 0 Td (cultured. )Tj 0.0058 Tc 10.3 0 0 10.3 58.05 259.44 Tm (typical )Tj 0.0062 Tc 3.017 0 Td (seasonal )Tj 0.0287 Tc 3.745 0 Td (pattern )Tj 0.0153 Tc 3.213 0 Td (with )Tj 0.0112 Tc 2.088 0 Td (deep )Tj 0.0069 Tc 2.19 0 Td (dips )Tj 0.0314 Tc 1.958 0 Td (in )Tj 0.0203 Tc 1.078 0 Td (the )Tj 0.023 Tc 1.526 0 Td (summer )Tj 0.0297 Tc -18.823 -1.071 Td (and )Tj -0.0007 Tc 1.874 0 Td (high )Tj 0.016 Tc 2.147 0 Td (peaks )Tj 0.165 0.165 0.161 rg 0.0314 Tc 2.692 0 Td (in )Tj 0.223 g 0.0203 Tc 1.124 0 Td (the )Tj 0.0124 Tc 1.586 0 Td (winter )Tj 0.02 Tc 2.935 0 Td (months. )Tj 0.03 Tc -11.424 -1.072 Td (Table )Tj 0 Tc 2.606 0 Td (6 )Tj -0.0226 Tc 0.703 0 Td (gives )Tj 0.0467 Tc 2.282 0 Td (an )Tj -0.009 Tc 1.259 0 Td (overview )Tj 0.05 Tc 10.5727 0 0 10.3 178.46 237.37 Tm (of )Tj 0.0203 Tc 10.3 0 0 10.3 189.57 237.37 Tm (the )Tj 0.165 0.165 0.161 rg 0.0123 Tc 1.538 0 Td (theoretical )Tj 0.223 g 0.0124 Tc 4.56 0 Td (chances )Tj 0.05 Tc 10.5727 0 0 10.3 57.98 226.33 Tm (of )Tj -0.0026 Tc 10.3 0 0 10.3 75.25 226.33 Tm (failure )Tj -0.0002 Tc 3.458 0 Td (with )Tj -0.003 Tc 2.654 0 Td (the )Tj 0.0132 Tc 2.054 0 Td (blind )Tj -0.0133 Tc 2.935 0 Td (use )Tj 0.05 Tc 11.1292 0 0 10.3 211.57 226.33 Tm (of )Tj 0.0154 Tc 10.3 0 0 10.3 228.94 226.33 Tm (various )Tj 0.0328 Tc 3.86 0 Td (oral )Tj 0.0194 Tc -20.506 -1.072 Td (antimicrobial )Tj 0.0138 Tc 5.825 0 Td (agents )Tj 0.0099 Tc 2.899 0 Td (when )Tj -0.0038 Tc 2.462 0 Td (given )Tj 0.0314 Tc 2.47 0 Td (in )Tj 0.0338 Tc 1.07 0 Td (adequate )Tj 0.0062 Tc 4.055 0 Td (doses )Tj 0.0176 Tc 2.57 0 Td (to )Tj 0.0427 Tc -21.304 -1.072 Td (our )Tj 0.0302 Tc 1.876 0 Td (patient )Tj 0.0192 Tc 3.355 0 Td (population. )Tj 0.024 Tc 5.209 0 Td (The )Tj 0.0174 Tc 2.05 0 Td (calculations )Tj 0.0134 Tc 5.404 0 Td (\(based )Tj 0.0456 Tc 3.171 0 Td (on )Tj -0.003 Tc -21.057 -1.025 Td (the )Tj 0.0124 Tc 1.496 0 Td (percentage )Tj -0.0008 Tc 4.694 0 Td (frequency )Tj 0.05 Tc 11.1292 0 0 10.3 166.45 193.69 Tm (of )Tj 0.0126 Tc 10.3 0 0 10.3 177.5 193.69 Tm (occurrence )Tj 0.05 Tc 11.6856 0 0 10.3 226.45 193.69 Tm (of )Tj 0.0203 Tc 10.3 0 0 10.3 238.53 193.69 Tm (the )Tj 0.0154 Tc 1.539 0 Td (various )Tj 0.012 Tc -19.057 -1.072 Td (bacteria, )Tj 0.0212 Tc 3.903 0 Td (alone )Tj 0.05 Tc 10.5727 0 0 10.3 125.18 182.65 Tm (or )Tj -0.0152 Tc 10.3 0 0 10.3 138.15 182.65 Tm (in )Tj 0.0208 Tc 1.164 0 Td (combination, )Tj 0.0104 Tc 5.88 0 Td (multiplied )Tj -0.0118 Tc 4.616 0 Td (by )Tj 0.165 0.165 0.161 rg 0.0203 Tc 1.394 0 Td (the )Tj 0.0072 Tc -20.873 -1.072 Td (percentage )Tj 0.223 g 0.005 Tc 4.974 0 Td (frequency )Tj 0.05 Tc 11.1292 0 0 10.3 156.85 171.61 Tm (of )Tj 0.0444 Tc 10.3 0 0 10.3 171.26 171.61 Tm (drug )Tj 0.165 0.165 0.161 rg 0.0027 Tc 2.572 0 Td (resistance )Tj 0.05 Tc 10.3398 0 0 10.3 244.69 171.61 Tm (and )Tj 0.223 g 0.0022 Tc 10.3 0 0 10.3 267.33 171.61 Tm (then )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0009 Tc 10.3 0 0 10.3 57.4984 160.5684 Tm (divided )Tj EMC ET BT /T1_1 1 Tf -0.035 Tc 10.0482 0 0 10.3 94.09 160.57 Tm (by )Tj ET BT /Suspect <>BDC 0.165 0.165 0.161 rg /T1_1 1 Tf -0.0204 Tc 10.3 0 0 10.3 110.04 160.57 Tm (10,000\) )Tj EMC ET BT 0.223 g /T1_1 1 Tf 0.0038 Tc 10.3 0 0 10.3 145.2866 160.57 Tm (show )Tj 0 Tc 2.614 0 Td (a )Tj 0.165 0.165 0.161 rg 0.0072 Tc 0.981 0 Td (likelihood )Tj 0.223 g 0.05 Tc 11.1292 0 0 10.3 230.29 160.57 Tm (of )Tj 0.0052 Tc 10.3 0 0 10.3 244.21 160.57 Tm (failure )Tj 0.05 Tc 11.1292 0 0 10.3 276.85 160.57 Tm (of )Tj 0 Tc 10.3 0 0 10.3 57.42 150.01 Tm (8)Tj 0.392 0.392 0.384 rg 0.472 0 Td (-)Tj 0.223 g 0.025 Tc 0.565 0 Td (29% )Tj 0.0153 Tc 2.475 0 Td (with )Tj 0.0125 Tc 2.321 0 Td (cotrimoxazole, )Tj 0.165 0.165 0.161 rg -0.035 Tc 9.6688 0 0 10.3 186.87 150.01 Tm (14)Tj 0.392 0.392 0.384 rg 0 Tc 10.3 0 0 10.3 196.2 150.01 Tm (-)Tj 0.223 g 0.0107 Tc 0.606 0 Td (35% )Tj -0.0002 Tc 2.434 0 Td (with )Tj -0.0008 Tc 2.321 0 Td (doxycy\255)Tj -0.0053 Tc -18.874 -1.072 Td (cline, )Tj 0.05 Tc 10.3147 0 0 10.3 83.46 138.97 Tm (24-45% )Tj -0.0002 Tc 10.3 0 0 10.3 123.35 138.97 Tm (with )Tj 0.0123 Tc 2.181 0 Td (erythromycin )Tj 0.05 Tc 10.3398 0 0 10.3 206.77 138.97 Tm (and )Tj 10.3147 0 0 10.3 226.98 138.97 Tm (25-45% )Tj -0.0002 Tc 10.3 0 0 10.3 266.87 138.97 Tm (with )Tj -0.003 Tc -20.32 -1.072 Td (the )Tj 0.003 Tc 2.043 0 Td (aminopenicillins. )Tj 0.0473 Tc 7.784 0 Td (The )Tj -0.0027 Tc 2.476 0 Td (two )Tj 0.165 0.165 0.161 rg -0.0152 Tc 2.369 0 Td (figures )Tj 0.223 g -0.0101 Tc 3.588 0 Td (for )Tj 0.0027 Tc 2.004 0 Td (each )Tj 0.0155 Tc -20.318 -1.072 Td (antimicrobial )Tj 0.0212 Tc 5.779 0 Td (agent )Tj 0.0143 Tc 2.526 0 Td (represent )Tj 0.0203 Tc 4.052 0 Td (the )Tj 0.011 Tc 1.483 0 Td (extreme )Tj -0.0008 Tc 3.554 0 Td (possibilities )Tj 0.0132 Tc -17.395 -1.026 Td (for )Tj -0.003 Tc 1.872 0 Td (the )Tj 0.0302 Tc 1.855 0 Td ('various )Tj 0.0394 Tc 3.963 0 Td (other )Tj 0.0207 Tc 2.807 0 Td (bacteria' )Tj -0.0036 Tc 4.192 0 Td (which )Tj 0.0493 Tc 3.02 0 Td (cannot )Tj 0.165 0.165 0.161 rg -0.0014 Tc 3.552 0 Td (be )Tj 0.223 g 0.0083 Tc -21.262 -1.072 Td (analysed )Tj -0.035 Tc 9.9195 0 0 10.3 97.84 95.28 Tm (in )Tj 0.165 0.165 0.161 rg 0.0151 Tc 10.3 0 0 10.3 109.34 95.28 Tm (detail )Tj 0.223 g -0.0136 Tc 2.712 0 Td (here. )Tj 0.024 Tc 2.322 0 Td (The )Tj 0.165 0.165 0.161 rg 0.0091 Tc 1.957 0 Td (last )Tj 0.223 g 0.0198 Tc 1.77 0 Td (column )Tj -0.0152 Tc 3.496 0 Td (in )Tj 0.0203 Tc 1.171 0 Td (the )Tj 0.0049 Tc 1.678 0 Td (table )Tj -0.0012 Tc -20.19 -1.071 Td (shows )Tj -0.003 Tc 2.808 0 Td (the )Tj 0.0184 Tc 1.531 0 Td (corresponding )Tj 0.0047 Tc 6.198 0 Td (chances )Tj 0.05 Tc 11.6856 0 0 10.3 201.49 84.25 Tm (of )Tj 0.03 Tc 10.3 0 0 10.3 213.57 84.25 Tm (treatment )Tj -0.0026 Tc 4.326 0 Td (failure )Tj -0.0002 Tc -19.563 -1.073 Td (with )Tj -0.003 Tc 2.188 0 Td (the )Tj 0.0334 Tc 1.585 0 Td (modern )Tj 0.165 0.165 0.161 rg 0.0201 Tc 3.534 0 Td (quinolone )Tj 0.223 g 0.0212 Tc 4.473 0 Td (agent )Tj 0.0006 Tc 2.611 0 Td (ofloxacin. )Tj 0.0149 Tc 9 0 0 9 299.69 364.09 Tm (1982 )Tj -0.0029 Tc 6.027 0 Td (1983 )Tj 0.165 0.165 0.161 rg 6.08 0 Td (1984 )Tj 0.223 g 6.08 0 Td [(1985 )-3098(1986 )]TJ 0 Tc 10 0 0 10 303.78 342 Tm (2 )Tj 9 0 0 9 303.74 330.97 Tm (7 )Tj -0.035 Tc 9.6396 0 0 10 298.98 309.37 Tm (22 )Tj 0 Tc 9 0 0 9 358.04 342 Tm (4 )Tj 6.072 0 Td (6 )Tj 6.088 0.054 Td (4 )Tj 5.326 -0.054 Td (6 )Tj -17.502 -1.226 Td (* )Tj 6.08 0.052 Td (* )Tj 6.133 0 Td (* )Tj 5.28 -0.052 Td (* )Tj 0.0476 Tc 9.3 0 0 9.3 353.24 309.37 Tm (44 )Tj -0.0058 Tc 9 0 0 9 407.88 309.37 Tm (51 )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.05 Tc 9.3623 0 0 9 462.62 309.84 Tm (70 )Tj EMC ET BT /T1_1 1 Tf -0.035 Tc 8.6772 0 0 9 513.01 309.37 Tm (63 )Tj 0.165 0.165 0.161 rg /T1_3 1 Tf 0.024 Tc 9.4 0 0 9.4 402.21 259.44 Tm (Discussion )Tj /T1_1 1 Tf 0.05 Tc 10.5034 0 0 10.3 320.09 237.37 Tm (In )Tj 0.223 g 0.0203 Tc 10.3 0 0 10.3 333.09 237.37 Tm (the )Tj 0.0155 Tc 1.683 0 Td (previous )Tj 0.165 0.165 0.161 rg -0.003 Tc 3.91 0 Td (ten )Tj 0.223 g -0.0019 Tc 1.68 0 Td (years )Tj 0.0203 Tc 2.515 0 Td (the )Tj 0.0214 Tc 1.683 0 Td (pathogenic )Tj 0.165 0.165 0.161 rg 0.0086 Tc 4.939 0 Td (bacterial )Tj 0.223 g 0.0014 Tc -18.652 -1.072 Td (flora )Tj 0.0294 Tc 2.237 0 Td (from )Tj 0.0052 Tc 2.423 0 Td (airways-infections )Tj 0.165 0.165 0.161 rg 0.0314 Tc 7.831 0 Td (in )Tj 0.223 g 0.0203 Tc 1.171 0 Td (the )Tj 0.0245 Tc 1.619 0 Td (southern )Tj 0.0446 Tc 4.024 0 Td (part )Tj 0.05 Tc 11.1292 0 0 10.3 529.81 226.33 Tm (of )Tj 0.165 0.165 0.161 rg 0.0473 Tc 10.3 0 0 10.3 309.51 215.29 Tm (The )Tj 0.223 g 0.0253 Tc 1.924 0 Td (Netherlands )Tj 0.0117 Tc 5.4 0 Td (has )Tj 0.0176 Tc 1.664 0 Td (shown )Tj 0.165 0.165 0.161 rg 0.0159 Tc 2.987 0 Td (quite )Tj 0.223 g 0.0132 Tc 2.377 0 Td (considerable )Tj 0.165 0.165 0.161 rg 0.0021 Tc 5.499 0 Td (quali\255)Tj 0.223 g 0.0138 Tc -19.799 -1.072 Td (tative )Tj 0.05 Tc 10.3398 0 0 10.3 336.37 204.25 Tm (and )Tj 0.0257 Tc 10.3 0 0 10.3 355.58 204.25 Tm (quantitative )Tj 0.0067 Tc 5.313 0 Td (changes. )Tj 0.05 Tc 10.5589 0 0 10.3 449.67 204.25 Tm (The )Tj 0.0218 Tc 10.3 0 0 10.3 470.38 204.25 Tm (most )Tj -0.0027 Tc 2.323 0 Td (impressive )Tj 0.0161 Tc -17.943 -1.072 Td (change )Tj 0.0117 Tc 3.271 0 Td (has )Tj 0.0114 Tc 1.726 0 Td (been )Tj 0.0203 Tc 2.28 0 Td (the )Tj 0.0077 Tc 1.579 0 Td (increase )Tj 0.165 0.165 0.161 rg 0.0314 Tc 3.682 0 Td (in )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0276 Tc 10.3 0 0 10.3 450.8409 193.2084 Tm (13-lactamase )Tj EMC ET BT 0.223 g /T1_1 1 Tf 0.0193 Tc 10.3 0 0 10.3 504.9777 193.2084 Tm (produc\255)Tj -0.0013 Tc -18.931 -1.025 Td (ing )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf 0.0331 Tc 9.6 0 0 9.6 326.47 182.65 Tm (Branhamella )Tj 0.223 g 0.0157 Tc 5.885 0 Td (catarrha/is. )Tj 0.165 0.165 0.161 rg /T1_1 1 Tf 0.05 Tc 10.5034 0 0 10.3 433.85 182.65 Tm (In )Tj 0.223 g 0.0059 Tc 10.3 0 0 10.3 446.79 182.65 Tm (general, )Tj 0.165 0.165 0.161 rg /T1_2 1 Tf 0.0286 Tc 9.6 0 0 9.6 484.4 182.65 Tm (Haemophi/us )Tj 0.223 g -0.0039 Tc -18.171 -1.15 Td (in.fiuenzae )Tj 0.165 0.165 0.161 rg /T1_1 1 Tf 0.035 Tc 10.3 0 0 10.3 353.27 171.61 Tm (has )Tj 0.223 g 0.0226 Tc 1.622 0 Td (continued )Tj 0.0176 Tc 4.387 0 Td (to )Tj 0.0044 Tc 1.077 0 Td (play )Tj 0 Tc 1.945 0 Td (a )Tj 0.0318 Tc 0.758 0 Td (predominant )Tj 0.165 0.165 0.161 rg 0.0106 Tc 5.589 0 Td (role )Tj 0.223 g -0.0152 Tc 1.81 0 Td (in )Tj 0.0013 Tc -21.384 -1.072 Td (this )Tj 0.0135 Tc 1.764 0 Td (district, )Tj 0.0346 Tc 3.448 0 Td (although )Tj 0.0203 Tc (the )Tj 0.0084 Tc 5.635 0 Td (slight )Tj 0.0077 Tc 2.569 0 Td (increase )Tj 0.165 0.165 0.161 rg -0.0152 Tc 3.682 0 Td (in )Tj 0.223 g 0.0027 Tc 1.08 0 Td (resistance )Tj 0.0176 Tc -18.177 -1.073 Td (to )Tj 0.0074 Tc 1.623 0 Td (aminopenicillins )Tj 0.165 0.165 0.161 rg 0.0117 Tc 7.606 0 Td (has )Tj 0.223 g -0.0199 Tc 2.183 0 Td (led )Tj 0.05 Tc 10.4772 0 0 10.3 448.77 149.52 Tm (to )Tj 0.0044 Tc 10.3 0 0 10.3 465.93 149.52 Tm (some )Tj 0.0118 Tc 2.952 0 Td (problems, )Tj -0.0064 Tc -18.141 -1.071 Td (especially )Tj 0.0314 Tc 4.755 0 Td (in )Tj 0.0097 Tc 1.678 0 Td (general )Tj 0.0061 Tc 3.832 0 Td (practice. )Tj 0.0473 Tc 4.323 0 Td (The )Tj 0.0176 Tc 2.469 0 Td (drugs )Tj 0.165 0.165 0.161 rg 0.0218 Tc 3.13 0 Td (most )Tj 0.223 g 0.0128 Tc -20.187 -1.025 Td (frequently )Tj -0.0046 Tc 5.044 0 Td (used )Tj 0.0195 Tc 2.647 0 Td (outside )Tj 0.0147 Tc 3.784 0 Td (hospital )Tj -0.0086 Tc 4.101 0 Td (were )Tj 0.0057 Tc 2.694 0 Td (originally )Tj 0.0071 Tc -18.269 -1.072 Td (ampicillin )Tj 0.0203 Tc 4.519 0 Td (\(now )Tj 0.0029 Tc 2.574 0 Td (replaced )Tj 0.0348 Tc 3.87 0 Td (by )Tj 0.0073 Tc 1.433 0 Td (amoxycillin\) )Tj 0.05 Tc 10.3398 0 0 10.3 494.77 116.89 Tm (and )Tj 0.0188 Tc 10.3 0 0 10.3 514.94 116.89 Tm (cotri\255)Tj 0.0082 Tc -19.938 -1.073 Td (moxazole, )Tj 0.165 0.165 0.161 rg -0.0027 Tc 4.652 0 Td (doxycycline )Tj 0.223 g 0.05 Tc 10.5727 0 0 10.3 412.22 105.84 Tm (or )Tj 0.0215 Tc 10.3 0 0 10.3 425.65 105.84 Tm (erythromycin, )Tj 0.0213 Tc 6.338 0 Td (although )Tj 0 Tc 4.101 0 Td (a )Tj 0.025 Tc -21.712 -1.025 Td (25% )Tj 0.0103 Tc 2.418 0 Td (failure-rate )Tj 0.035 Tc 5.043 0 Td (has )Tj 0.0161 Tc 1.855 0 Td (often )Tj -0.0041 Tc 2.62 0 Td (been )Tj 0.0193 Tc 2.375 0 Td (noted. )Tj 0.024 Tc 3.066 0 Td (Cotrimoxa\255)Tj -0.0071 Tc -17.378 -1.071 Td (zole )Tj 0.0293 Tc 2.139 0 Td (appears )Tj 0.05 Tc 10.7518 0 0 10.3 370.45 84.25 Tm (at )Tj 0.0203 Tc 10.3 0 0 10.3 384.45 84.25 Tm (the )Tj 0.165 0.165 0.161 rg 0.0178 Tc 1.776 0 Td (present )Tj 0.223 g 0.0153 Tc 3.49 0 Td (time )Tj 0.05 Tc 10.4772 0 0 10.3 463.17 84.25 Tm (to )Tj -0.0208 Tc 10.3 0 0 10.3 477.11 84.25 Tm (yield )Tj 0.0203 Tc 2.515 0 Td (the )Tj 0.0106 Tc 1.775 0 Td (best )Tj 0.0227 Tc -20.555 -1.073 Td (therapeutic )Tj 0.165 0.165 0.161 rg 0.0003 Tc 5.035 0 Td (results )Tj 0.223 g 0.0365 Tc 2.973 0 Td (for )Tj 0.0132 Tc 1.596 0 Td (blind )Tj 0.0214 Tc 2.513 0 Td (therapy )Tj 0.165 0.165 0.161 rg 0.0187 Tc 3.546 0 Td (but )Tj -0.0027 Tc 1.667 0 Td (doxycycline )Tj ET endstream endobj 23 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ .-jp2hihdrcolrՏjp2cOQ)R \#B@HHPHHPHHPHHP((( ߆JT#.2 S0j%, c`HKz p}z7^IqRд\(ߋrHCQRH D!ىmQU341('/%Ũi1̺aFdz[R~9nѥTU/{||HgziJ2v<\ol[dh{ z: 3C-9Br b ]׷UKӳG`ۅ2'{ݓ =-l!{\4f>iYM2@ #hR%Y&c]N:Ms숼 z[c|rU&pΟe)K\! "Fmvkt!o]X(6Ai}h*L ٭i:EUr쇥>?CB59 V'XYP mr Q!+9(f`ӫTu+&Z?+%NP 8ZJ To~,1N$E!oτA ||O:fX2u%GԬD,+f^ixdd,/DϨ-\Nq޻˨H+FT*A!=1n>_ w]N$A݅WFkDRa~?T4<|K0TF@2tt=ۯ$A?VtAuܙ|4;CNX-Wbtsz}[/3Z' j^,UŘwuF -,ݤz^72nyJAf804Q4 `P|I|~trN NZ;*YY3d JCPsJB2sBe:7Mw^@Oh):s5CBKa$ m>-ɱ`C C"(x|sm*_@Y 's|~Y'B|m];ri_h;t%gI9|KL}Z]^I|t \7<2ҀN& ,̀IRWZE7ڠw d;K?[sQ=?~ts j+-AzEl=J+㡕u%_zԡhaXvj&),HuCv}830#v-V૱hd1-YZQä́p~s5qa{잤i, !ܫIⲣ۾Kza! !`_up<,@8^F_<448(d x9$ X@r0npڿLHxHFoP6B2eVbZ(W1bTDzKПq l.%hnȘ6S_>ƙ@rVV iRy~302b<5r w٪ C8&ݟHgB;9 mdB`ˈr Ѵ j`@2yL#$SLBUdgh[gJvԋ]@z iV^GMA? Zo3ʇBS ^,}o@IU:5)Fan]rU A o_4?տj૿wO;hg[&]c|ɜ^z5 u7c&yno¯Y2 R!jYj`*0_\OCtHaӏ2r ΩZ g 2yq'Jg(ZX8](sENMdxٯq09JeD6PCВZ_WQl]J-WfΕZ@WTd[*xd0"ӹ]d8~>YIM+,/fum 9S dJ%_ƮG>{HV)cx}j隴'$@_#@@񩈧w"mUi%+Jr)R_x<͹T xn7=eyZCXv=0dd|! 0X#TZTy(HNϔ(eŝsy(rel;ic[pʎJRu].HNc)yڄFKO8rA퉰a#'Qfd+|x}Nss;Hј/LyN=v˔gHX2LPίC>ug5˜et j̕W(EF-4Qn WZ6Er{66z֊^U!On*"Cİ~/斷^-M 8Jh htdI WC6w{^׉msnxf贯:G] !AΆDO8İQ'w98/{ N nGTrBZpln elNs&1$uXbN98TxH I܅} XY2, 7*3#Mt6j%Iw9 :eCuT 5 vWIҒ*^0|5%PL3A[w#דJ$3+z %Xi3v⤋N}XO^) E=V9ӲvޑO;PkuGUݭ%PA\r9>$f ^$%Dz6y#wx#)޺^9SXtf0~!L.,燙华ka {4M2IT uѮ5il&`ՓvDcˬϤx6 :lw\P4Xnw?kžf^>?э_aM#?;7\`_tH i)%ܒTFy-ہx6l#beӏvdsd8' 5={[ do_8?[SvCl0IK?-EkHfߕhKTH"jg=Ȣm5?{4qߔW6P*֧,ڑ9luq%3r&x#x&`Sl=|}QC{uA`zWk#5\y/2H2TғX4[>"_otfi٨Z8OhX>GF)1T1Dxm&~ @TBp* mzB<"%AIצz;,0=0֛fr+YQh`2wpcQ ݻ0.<[EgL0-7%ƒmmpf%sOr(6*I=Bw;r' w'!!o @|Y,$lZ4U=E< Ѿe {96Cb]>g.Dfѻ{ w.n1._$ ;4@`JDb.-"ʿ8+sLˇ)M9Hm0aauD ;IZ\ֺ5RvO2G &a%Z'g~w]EsA/"WT렎w:hL/*=|5$bʌoޫ%F/v7nKC(&NP.BPcySbԆA+7FӺ`*Rk쉁6A&\d ^yj&_K\n>z͡Eg$ŏl\Rmgֺ#̒ fgJ"%^+#7sЂ3[5bvd j;We"beE),j>!f (њvfK' ud8b |:')"xx!jN,=q, 3Q 8m!MԢNu/t)o-nǪk^ ^3c0nKE nQh)3yvDkP@V ]zFs2@m65&ҾI#PG@sfE9.٫g8-~^ky}ПLًZ1l-JègY;ވ89D1(V6igBT3eTwG%ԕ"N[gΈE#4tKUK>I_%&,`q_3 Dxflʇ ,8*`\Xa/:_!< /jrsPNU{ђ?Z-eaxHPPz, sr2;j~ggszd M z 1;qz‘e2m~l/EkQqL}1dX5';ݶo#xh^2T},M1F])s0 dͥ45ǝa,b袭ER =!E3-K08##h5LDsT 5s NO?U>:WA{4';KiOYmlBb;@"-w q\zsA_@S;~Z}ȉ =N#SB@`<zd^uhEm)w7gl5mV}Ġ/Ѓ$nm~q9{O3gAxzǩtFuU낔DjE܊"X)#[,dmqfLofg&RlsM4O.VD6 @ϸr/-y}( X2&^D~$ ]6kbrP V~6EHɰ,'&_1hz5 ^ %Qc tVWUKt]w!6j !xR6-~@4_DŽsu qh LLj/~dDߧ/G}r^mEV=ui3 Ocop1Us}< 湚R| .; z8i:L^ >na%JLt>SjW\/W%͇1"+S2Lq81nυF3zsLyE&J<Հ1c\X!=T+m#|i6NvnVޖan yۡ< õG-0]JV ݐHs] ub)&G想y: &'ܷ%P:5k&F97{żk$T[$*ȝbdzQ7OWޑ"8zo_Qф~,I=aL)&'Ydz ]P6t6:Œ,~јN]!Fm/$ZF(m^@ '-ݭ16aD\Q)! Mݺ]~p:Kޔ) ^OнsS<dfq$ke;!G|Џ7 fqҲ mgXϐYd:e+N #g#l8Ʋ ]t.[G|U SyvSa' Qޠsz`@:s,HW˪=v{zo@òCfK9sX8h/z;[r߈Dd1=[&\4I X^@/-f+ HuƂ g ql$q\Wr'FZځܔNwj[`ʍj&Hfi7 ́a=; u:äkRd؁4[F :ݫ[y"~=6b{}pvW8+븄q k7زݣx2wQ&Fcr? ̋/bcЖ.ct4S#[o"LBq=VSVY. _iP9p1Ja$ Nj(`xg/?=0v[;u4d lBTo<")}oG6]h>(zJcN%Ti]ϯb4cYV yYr܏(҂8J:pv /@Kj&N)D~ 1+Ի~"|jJ C;T}&| =Z"JF\:g5@Nቘza5yv.Ӫ1#bdm2_ `'<)e(bs}&AABh>dj ž?Lܣ_+Gd@uͷn}AB񬆀:-& ČB=*ޤ{mc(4~#}lihu)5/7nS!P5!AfmMy̶fV=0#*c9ܣn"[B2b{M6|b,~j`cW?{Kt,u$;OULJ6sj4=L{ : طd j>rQ⍅G֏0H=r\LYKDA˽&w9"/;}PIW]Wr9|#z+5~ Yޣؠf9exՉٟ tbp?W `W* 7)2u+Ӣr߬a Mj /RI*t@?B9-i!x%V۟w評SK:i`)шnmMb%%~bc$OD -\f\/=_Fd<PhЮ!\Qs$rA \ yY-wm5K)Ȕjݿl"zΆ_ǃOݵ@~WeXco^*92yt@5" c8&+#`4gvWRRo+)z>`ͥZE:rm"Ā_]^/JBBrԐC6@TN@.>:#H{&H#1V*#8Gg7֛<A\ǔڛacÔQ\Ȑc!UhWbI08*1s+E[,L_Z6ALSZsB1dniCTK$;A8Vͷ3r z Nrڗ)nnΞy0 JrSMAV`Wcp'Υ-'4\.;2<1?m>+ˇ\sEzIt&oZl6鷊@4{uT3 *Gԁ 'Ǣ&wcDW6̲=FYV]&ڋd 94Ѝ/Jm_ sB@3I=ܫp)`χ1y@C˃(XҮ]rəWV1ZnJ\H.~(nbgjȸVsZCP_e-q DzATM?DJyvn/5 %ۛW&[q 6Lڌ#85>v3cf 7s),\7T5kR(Ej]f-~ցt.ZD'&vcs cx1 UCNH ѡr/2$s/ oTCcsTD1͞1QݠAMavC3%w2u1__Pbv" Wr?!Ga9*TccɌy<\c`?ɸh?ϐPљGS፪P/< a^_ڜmܚ׼ZT' rI(^3Javw"-YZj8ZDC.C = (A(i JgIXKǴc(X!j=4oVvZDD`;>;$f}E,bPA܍%P/s-Ƀ BJqe"L*}oĤQ<!rVh'@Xܸ,F1p3>[ ʍRfes˔1x E6G'bS[]J4F%O1r}</6͆=ŝ0ݞ =x͊yIQ57硊 9F4'R/=~L1mS^5bޫ1 t)%Z#)_qY䘿6Xԥ6y=p,b0Z\L ~ N\H^Uq7b &z`R ͢q Q<8ExGsyC[V>Q|D5澚{L28 S^'"6:yyN |  MT({g7y\@l)Mk =6pԦ\/r 76"  tU`a˺5AUE.*;Hn%|<>Dh랠aڱ;OFރBm&R7* t`7iV2 6f|u6!5[?>_ 3 JRHr sqa)uBT>\jo"Eۖvմ7kQV] $q&rkDCėgn%8o< "k.* M/üCSvocp9ҷv >,&k6OZs&"οE %SԦVa|Ȩ7Qɡ/W'\nN뀧ye>V"RQp\vx_uf"CIzxb(z[v3]^p.ק=p:xB %(r,S9cJwk0VMӳjðC'M39fw -hlzƍX{jb%ᡞِOhXۦO`uZK| ԣ~@{Gp_ŧc*6VFT;u뻟1,ݖqӣ0^X=5,1ˠ55s#gǰ>y! ?54‘|mwY ્?ߔΔ<5UmIb>\*߭V8|[Y㈴hr4UOWCCUS7$6 kO¤]0"؟'FTz!9qkh'"d3L4@肕asx~9l߫ͨIhbDd(@.B H&=CSio~>gBk4/]{=#uKsO R~ wc~Oeo>1+̧_Rn==]]rgSgz{ ۽w@GݧQxQ[Ia)KQ@) j%#_ly6!/Æ!m?vY.medҏ^I*93tHJ}GkH+ R_h1\e [h|F<B<@XgLՇUmXgbC9Ԟ(`8%OUFwϿ.h="8gEߟ#R grHS@,9_&*qJ=!D*Z4 7]+irႁ w$j 6O OA6rn٪>ALSV؎vU$#9buxN_d-2D= l OT}Jn<k1ox0AHB)k &E{]c4Nf7EX'nٸUf͔GƱ$LROH?av늑P𙺲 jʽ.o,w]JE:NHQq6:=\P*MWd9C!y,#CB(U:3eUcا{p|4Jgu0K!T?kB>QdٖĵKvY69-YyThसS1W/P4Œ^`֝ `kc'VQpYjTl JEQsZ["b- P)$ADy|fۍFf(cA>4ՇO=QyyE1L'S~PZ<%K ʛk-2;.} d> #K>_!ݡ >Ap93~93ђwo+v*<Sw,ؖ'|vׁΘ+4!5ig\uew]?4"Aq x]s^#я)H ˔/,>!e&6mAy̰(=^f/O>Xႛ4yCREןݲ8Tγ NP/pyKu-R "߽1b3)-B5"L8W8ŻmS8>/w']-s2 aI!hS>wP]&OA[nnKhiu<̺"\vu|{GC} ˑ4LާAfѸro O@^..~~Ĺ^|aZk/u F;{ӆ w] >ƺ;CJc/nWb'.Y!bYby-.97qE6~ǟWQղ'飭o@ |ºG)cv*n48p,$vXtژܓg|߹EHVUna1X,ʟ"_O&o偭}ɚ虂ůd^}t .,.W'DEg]1\JQQ T[#Ӫϣ%Yh,̚ej9f2V\4bg<)5WSZ6{F9 nɨ*11Wϔ ; drlKep$n$bݶoM9E ֙UF= c$ ɶ1.PC쾵9}k-z!=+0#q!Q{{^a0 xEY(hvi {Uޖj7/B`}NdwU?r.j'Ek86ܨ4_Lmm)ȦX/3>s @nb˚d+92LMTK$- v mI |F'G^.+̧tÂU: ႆ 'xk\S]sya*UI-3KG:i[QhN/S3mk`h8T, %yp{.^h>ΥшR{ሮd<3ሮG˯!,2rሮs)@¸AZǣK,Q spݹN[`Nyb7D.n~a&C55{9@*Kzjh@U %hU0D줲M5a1rq{spfA 6i^vkIqhb$nt q |\8Th's+/$˥snb"v>1u-:|ɁR)<:fN ҡz9v=_T̗|iҊ,|B&dofV^4Kc%~#m6B+."I 5$%ЋǺ$gem&+yu.Wsٍ]T˘iMY 8eޠc4+wO퇨ĩ܂"M%Hw ~ [ả'c Ҏ,\+  Vnb{81%oVǢR:68EHAӻ|JC$fyVžu.r&KPk̶XY1-|\Ŗ|VЭjd!rvF M4l_!"`×g A2M1`=ؿ[^Jt-n8tèN=z ""w7>[~;߇IR=e O|=z?F?x:4jCtwG֫?+{Wn.곕+wNö߇JSwwK߇ti{ra?o;^nkﻷAzAu떮wø}{MO9l(Bi+M|so.`,R76DZ /X L̃qܽC)J(ėΓ, F> ^w:FUG05TuU:|@iPi:hDlcˆR {o4WM~C{+0tSPWs,"0}k*kYkUZ&]S/,@S8]\s"i*ߛnģM=13 xrD"^2YhpW ^`{kX $.=x-<~}AYqvi+/.7 i#RE2HZDq?bTZ +@!8 ׄCmcz$w3"?J':GP ā.Li< i1.L\",dcq (**v1) *Bn>gK6Oo G{<|$@8|T`"@y i"+#M@{*ش_|3KVj\!'m,s/,ʹ <Hk96ݮ GS oqt[mX&^)v ^@|׭7-)!=mKx@1E T!ԌjM3:]‚FJ?MrNY:5A@z,=/)à n< Vw=#j GmD1_i>j)]d4){! ";C^ʼnPg#dV$ @[S=1O |Kc0M;(y\FwұqL'E) tdn?ɊVn2]"h\ q_EOͧibjrOK<˷p"Ʋɋw=ьE;29H-׆M:k$eN Cyӟ䨟&s-W!g,5)$O)#TJ1^9+⦣4%snMl{lp,}sg{:NOzL4 kMTض[ 9p$3˳.k_w?~e-4,k* [o03fXhQchdN695vQ,$uu.v.m(Bm((6`"0M# b{57*=7+%c%ZN7W6c/[("f#@kA[)L2+!k9+4Lc% oie3,aNOm\aUY/hCJtGqFOD_<"No=Vҁ*ԲG}!7҈Z{!Vs-`ؔIC3=)b*IbRO/ϑΣC:CWԹA, 5L76lW_\/<TliMHpA& :p dd W "y]b 1.T 1@ݷ;3T[6)~G| Ɉ&ze ǰ kNc|VGbR8AxzZlIݾ[hr U/IN0nS]Z^Mq9@3le dXjv t1Lm\:X[8N:?V v"Nڥ96 0E|ր\$a/N*㠨mLS0Hmv. xbWCG]hDW Ml9㒜 .Gr]D+֭, 8LFH9+Sf?O9/ڡ0;QlZ%[k1@M$RVˏ8gr[4iJ)r'[4: 脱UA|`Zy,}zXG7an4Ýi|̞oGU:-)6M➐*-D=OcaiZzqXþPQIe CagEڼ8ݭ9c[MN}/Uy|:}͖~v@xwCB MCTi`o]D뫈b|b Ftـ_r2($;#"I-˃X*%hXB7Fp@M^*6ϧx uWR0$kxrgEps14O\ZTVhf׏,8̫vSpM"*p{8Љrwiʁsck?U*'jX^.vQ%n܃Vk4rStSxaӴҩ u]f5B_HOf bZ|N UABh;R+*{K=JG~B;R1KO"fŽlCp!.UO٠3!dD-&Xn4̰&)vݑ/m,A݁1&TYoyE2s%bPI$Wm.H٩<&:1o*x{Yoo'RBC/e;g^+vzT#WJISϺlg]e̷)-nwGQ  {ޮ &Џ9KXG!5`)ոvJH~>64~S'm,l U;7#Cj='ҁq[i QƓx;`}p,[}Z ȾORhTCR\z&B KqD{j@IXlܼtjdϷ]=2x9j]漎HnqVNܔՌVGzXҖkCFn#lEe1*}0U)"Λ2-Mfwm,r߱y^f&U A%͂s!~ڛ 6;3V+;G#EJ|}5yq`5&I8(j.6;i? tdL_ 'Ey;~NN9|R%\ޜKPy#r^9ȥSͨ:EXi867#B?3 0AMhi}i觭Z>Lof0K+%8=d *7cvM`{EЙ,ҳ;HNٻ4 'Y q \Xf|؇bFt=9_$Gv.v,퍷qVsq7iʲtW~QUéؼt#ZKPwI9 "?-~ۑ$uk]vs1b]IK2{dv ^L6"ښvDGGK&+^سiCW~ߎ8t=?ƇWs5\cZe& l6\ޤ PX eX4C,^tp1¡c#JzNE>0̟$Z_&1opH%a?T~ub[Xιc2W@>ޔNwsR&b'1~ ShhR, L[Z[w/@]?AK/)їjr)Kʏ{XJh y;+LM[ Zmf{~_"cV3@ã=^(,; lu SsЯ.?pt;7鬥X\1% j(?Yg_wLBz~SbN-IdL>xKãzJ6V)>$N29XN x9c+{Rgks)hLdmRuFH#'xg']Abj:CèCc;v鐟Ȗ{`NGSmRtzsdzhHP(IJMf1Kug $hU! |fC1IV-h˼Š>8]Ǝ,Hȉ@5w67yX擭[Nh'SSt{٬#E|\f!nlˈ|Ә<8aqjznޝ`{H->p%zw c!T07k>)Zy ^:ɻY.H/tlb 1U~ҵrvFnȉ+B8թڒW H8C:)ϞnZ*`Ó(fJ;RRIlCGJ\K !/0'53Z"eʗ{faTS?d:Cg0Ȯ~}S = T=9I;_$ j\x`Itzn1I06xvq7e|{U㼨PX ôl a?\~hRHsR GYUbB5G.',Lzm|AQ$zu(>iڊP٫0Vq Z|-GZY@st|kH&Up7bxR?z6rR,=yGY &,8s$3s?ٷ`y`%3RSڣ+i8=Kt*'*kX8\P,C8ﷱ$-PBH,.Ti~l#PXܕoyZŽ$zxH_2k7dQaaQE;'9ĢmyW#N7 3jCBȯhVq$ ih<~scjᑝMͬpJ>/" o\ i_66/5{ ۳ MfEQ[G̵G#2/{i2]uyUfJe'*U O>\˭[*Y`ZU1$z͂`XDɽ# ?,jl;"߬Oo47o2>gr OI%n'"= tzFfK$ ? yH3/F5?c6c*Л8ؚ$01!SVdaJkZm3{tU!d509jex4qvV/k _)wtʑO[PF? 8ID4ǽ&TIބe%?)1YihYpUm 2(PN9ԅ-1de$8Z3xy9l\IzHâUS|sW(v=V Nޔ #$PI~%~($BÏ1-e~)%(In`O(u ER-4z*4<4pn%J8[Zo7nH=2EsΏ'j4),ŝcKVT bǟ.o +tQXi~ '}@PbuRqZ$z,e|P,~v;-8ͱV).A:ʽҧ3rR=#JB1ח45)3q{t](_KGˌ@* S Ipaa>PJɪ*XQ=;fnm;V{[oC 3N/U Tn=9'yuRr?\?rYh]":oSkzh?_\k_su^sU)aue%_'U=+v 6_O4@*|ES*wʏo+-J拴gkzǖ_OGsOr,-gyOǴ5^ONi]Sy[o4Y̊nU)LeWu^:ͬO:{U\kW=O~YLIzko7Tmk:/vuV^Yz_;]eܰh[SVIU{s56Za%7XWYuɓ7\m_uh뽢OXݬv~כC;T+Vj^wcսo.C>_Տ)5 忴׾7jݵ?*րjW7loVZVjh::忮{꾻 έuז }톊˿k ,xcQXdXP x|!5?'|bʯo,S$tr17cj keaaB 0%CcO Zqw1tݚ^Q7-Wnu۷դhͅi$1eI`$7ǷIۓ6; M+1DΡˠ (Yvna"p#;pʏ̽ _̪U/(\)x&"#fV|.Ky_tÊ"_.+Fx2uPM|oT RVKT'b&٬*ff@~4ɏ)DB*}g_x+B <7ʅ~iݪԀA T(Q?>4 <)1%Z6f56ҳ[xPB&%Kg[X3fD,=S]u鈓ڟTPI"+w wRTm0OPdJ(J2}HP##bzz_I%3ҟ$թBTBR^ŶV{AcYM;6.o=%ˣZAs˧ &f ]=b$/<Я#G'pI'ur#՞qe#$ziV-k5*Őc~cxyJ_s:3M"6q5PvMkzj`}' AȞjQ[)īwgW f.J$ÈUHF B`I[~G:43piy`=ɓh7~.--ӵu"SA ^Ϸ[8w3֣NLsUsu*pcO,}}%wpJ̿gte-F50T5Jpx{._ !eTôh4ǽ_ߍΥ' s\ I-j IjMXR42kÌܯ(Q_QU,sߗv[wS+Q #M[% (+wf6G_ʬߋ.}q֧  ̳S m^ ]apu۸bD*9nJ)nžD-}]-2c?w]Ksg~-$cR԰^7LSȔH:1Zd|* ^@n@'SЌ)_eDgVV}|7zЗ.`O3eg #,q.˴|]p$L%NS&sL82)F!im-G7NdD0?AeS9H'pfi36ht(w/z]բ@V^^t-$D9IPu5SFDW)1@@Rkޝl~g3??4l^c-DP?W5]$J" ̢q$jfyww1RAE+;F`;L|mLS~Ϋ4 jDeE.ǡ2.J3 1BBC3UQ`{yGa=ejԓQFsCrM~gcb^rȨf'b&Nbm~zk{'t^2*k,@h(7@C!(s?fvUrA-$d2f{\*7XqL.i &:p"DHó2퀆$eK1^'ÁUn_51٧,0Mc\hZ0S<}A7CthgwAe-٥ RWD[&|L!NhTk-p|IgoR49C'm_7I1f2֢*öT^؝& m֋:H@+mIDJ `0oF aF,]@k :./T Kq ~m5_ a~-Te%)%0ue'\ؾJy#XMy ^GsGt~$NBe-&V]/]9{I:(4 n (,ˢLFMr|yoT|7fd៶}E&V[~m}=<ޘ;H8utYAM_AX$.+F ALŹ7ZDr Qa k@xIo~$(̆8舔~QOQJoH:fIF3q<BSXbsE˜cRi^Pkm; t [~Jh1X0Q n.z VLIKǬ TstWcdʪ1Y2`-$(_Յ6:4¤3Ʃ(m|u0/XײOIH͓ VH}uie`Ht 6d쵗=!<>!@z|sbٔ?t V3ʶ3 06'2E_:77!RVn C֢[#!P8!A&9LE>)߉7pr4{U>V-@L [_2SpL dSM>[u4!g&h̓hֳP z /oV] tmŋ4vkߙBYD&+Nā!~;+LpYNvaRA3ae%aozvY PRéfm]HҰH,0"yaX{6Q\{􅿻m>5o7QNpV*ص֓om!WуaK4naJF68هk>}3j/8O OAw@s6cJr'v:P~COރ%T!uTRM(lJшhƯvhdѐ<$7Lz/#bӬ̀ۜqR P[RB:C)zS]+`ڍqљ安 g}{/A D Wf8#Ab̭:wO@:ASuND.wE{lSw&Z -8\YGV>~ɷ 15imR^~($K+5e ~Z@H%kwY2$oË-123_!i C&YL$JHWJQ-h*Ae`[CLW:Z7g=7^&mn&3QMwX}8q`xWƲەYB)7i߬P?Ma[C΄̥kW@ߛ n(=@"[vޢlDr.S>_n4Y\a'~.el_h4_~[ ICSY)p}{_l+-vlr?ၰ: %nD/iũ.Z`ɄjnVwT'ˎeaq^ ̂@K0`׬S!;rCC.R>;t[7hmD֛s bMM2>yHhR^2K 68V*jz1+ J1oj7[Z Yu_֡bNw7T^$r &zqNi3"2W_IS\z6˴8֔`ʼn241'< KdnsjFO͆bq{@`|$Fl O?7ބIm`2Я ං 3~wC0{Ց?rV6 h4[۪l nVTm2q\=EnaV563rs>: /Zd[Ρ#p5xZ)qp-$~c;jCvfc#8d.{yMݿp}_M\ݠݿp_ɮնi)F}%h ݬചo,f;$B>OJݿpC]%6܀k=wpu,(,Pۗ+5 [iH.ѫjI"g6KeI#iDf Лsom?_'߭JF%frzS(9<]l|!=GmQ9`c-,\H9BILˠT-G+iK\DNMnr%(|$Ũ@8}SJIhĂ Br%Uv~"]%@o+wDS9DGjWLM&H_I<Ϡ?ƔI%Lۑ1)R$߰::/,3}DvԨѤVWauDB~VyoL!TC g\i¥ս-*B*wUI.Bhp_oC#?BMŽv=3uM0]$"` *nxn@R̎Qbl7m3Ywg[G(aol@Sart_x ܳ:O28`]Y\ņ D Ep(2WKW/zBIE.1JܝA"lj 櫨No#QLq[i̙1CIi0P}}9䎹/[Ç -n4RWޯRM=Q1i^cb&jIhz9;MyNbJ# w龤 3&e#$~oAp OIAT x'Ձ0'uk8 3$1Ek, H' m{-j1m"`Rd5`ywlBV(sHQ_k(zQȓdNvGwL~Bh~o2ӜĊ=GSB  >?>-.m5)V?uz.`{=tnW1cl+KH1#[^h;ustg3h*%"p?^!z)%Z?̫γջ(avzQX}!܃wsԗ`jE`kO+!6ְ=uovVk7MQMTgwo\ծeD57)mKKѲNVDưRmxAA|"e͋m5m1)TZ)w I$.գ_vqW>+I> k:Eyģ1Xez}VR⏄ uժ*o"3`Hsa`]] թ-7ϭ%owR=43$Yv# i͝Ԑ9zұvƮJ&>*vөR6_XTy] ilv鴆:Z (2[Q X=7^Ohke${f'+[d>Xd1 ?Q}H}yKsݦ>ecSܥr5黏CSXzMW'/30Μ0Iuk=(X :2 ULJl=C K%I'L}^mՅ;{9BA%&gXwEӎ}`F׬ׯ:Zt<,M]i٭Ec>6SnblM 0Md۷A}v&.;hVpnXIc!kK`鷌_h\ ̤y>7=)6DxTRbr;ω[HazcuLI=7 ݻx3ё]:IqF5Џ^i;(cMHP՟?5 '*S J8lF#}\ g"}hӲ+%h-(I C;+@Mimqè̐{A8Ik Cwo|ly{-yee˽iG\/ֿ.Mn6O~n_yѮtO:_gx7Gvr6BA\M]s`?A[\+7OMQۥu/6g/ksz m]LQݗϝK va+:~w/: v\ֿMl|wopj*=\@;=hzNLg~"_T~Ϳ ;h>K_mj #jڽU?m {jnAnSStݣ֭/ۥ[۟h~;}Kn[}f_k?h:}6m6]UVwvݵw7S.;Cj}mr7EOwQN}~={X}_|q:޷տP>>Ү_DO_ǝާ[Sm>tSO{owu>};O-6{[h{Gkiڎvi=^t[WKu6>x5S/u0x5 CTN-T; IdAL-NZQ* I|R l nDJUR1JX(qs@S w|1 eڪMAML$b:}`s\i=a]pO X 4lAGh_T:rLiQ){U|ŒzV ق6u?GHN$De:+0^:-4TLޛ6ŲMt׎od|K~/ϩ7bEx;]n ^߂ȬRXe!L4?! )jiTgy}>ps; W`CP-KRjFI-Z2)Bi IZ'y0~kn46;dcFhXG."yyKp_:86d]6rn g ޛ3ȒEֳ: O]s5ް~YUޛ#On򃯋\B_dQ]9&£BDpjμj+cR^<Uf7퐜OwK 68XW)9B^@TmCdZ]zgЋaW@/2VhB-B_ަg>Ji0{w'qEv6].#r;q?YLyRGE1]ʟZ:ճҊ7Pl}dwi$o Y#8Ӿ[:0x!3#(Cی1_k1ߏd)[j@f2ucR;!8';:r͆1Zx> )'꫏a%M("TP@'x1&L4F+G8(c AY bG'sL@qO)ӫ(Tm[]8R(鹔H2>ƋFswkU %T\*ٞb_TmO"ֻSeh_ 8t[d椈^k⾺k*n@>pTs̬V/dOԪ|֍[ţB4. { 5(wu;t?48OSuM_G1~Ɯf\$ }߲&> }q:׵|>)|_ӑvmrA[ir8`wclZ"fd 86hp#N1 05'D>2)=2 !Cn8'/C#?XLD .Z'"T3ytyj,Ѐjd92xoQꓽQ;FyHJ?]!&R>ߟS a yS.8q5X?-HSpheeCd}OBbTB ŖZbVp11 -Q jҍ!4`.h7ۉX_0َ'V~V0#a蒤yJЈ&|Chۏ16&k.y5ʛ1q\efShu?y5}J"?4ZUBe3,9L,=)`O w&N3RY=v=R]StZݾ`=o+qwKE\M6f _06Tt I-HCм0d=>KTCڦg̗z5(%!hK"И+uIijY=GG5L\W}>R b(xr ;͆)@ yL*!jSƅ0@gn1b۬7iH‹XT_WVazgaI&j^ hX? 2J5(X*6:3ѶyCVޭZ9J3u/!{mtcsQKztV].ͳS)b9w!t5R J Z,ϝ,5XdE 6YjVXoqrq!a hRo6bmP|vyM~2 WʫesXȂCmp^XgϺjIlz+D-֞ ZOex=3 OʹfO'v`u/uP\7q,0$ ٓ=Sfkې!/`ѹ.d`did!RX;{fa`Ҳ+r ӕDIc˦_scG?N`$ -r17I'SZ&\lDMvXXse(W{'5Z!Wۃ!xI;ѡ4p*OzQ!5^_In+O'~Hk$d]3"o .BAm6wzh\;9|љ`BCr{f}hvv %>2oe !`u)On>0{G>%~8>8xTwi?՛Q$>9I 4 (NHXnN`s+)W^gʒf5ZMp~*?Y/By?ǂ=Bx0 ޲,x$sRS.$ŷW?0a>շ5 ?CؓZXFZ\eިT|/eF_,H؃X@Z;!3(F~&}}ajiIsT`hkBAd8ق{YQRh!kZp 5@Ʌ6пkF9c;Mhʖ h|`!'i MNwȠG%{QlX*r %7dgEǻ#oQeuDXP ,ЀX>yn؄oRY2T!B Dվr|"i+%{<֡dI̍b+x၂<11j|.&(|,Y{qX[I ߣ:ur^X&;1Ysg}߈l׮(\UpcwU6Qm`:9ݢ0pNsA8c%>)tŮK. ]A:d}u/`IGܻƆM2<}W)z۴SMcz:iZ8?_(evs.\9 L*KzPq[_߀  t ׶m6)(q!'#o WL~<8E7UpE U@g35<:ǸU;/]D_h/ej{ڶ^'J+ZZZPDE(&V-(LjMj;a_s2@vLTNMEH< Zvu#PM^sJ^@W0@CGCلH$'r5+Wl+_ϛ!@00KWs n36: &5-27'1${>t=AUtT 0hiB̍|HO΢K:,E1ܹo]@X\jpɔI=;g1G= Rxa[1o|P9TGv%<@DG ?F#Bb#lquŋnÔy@wy9VlpS[`Q@ $$z\LC st͚hkS>amir2.a 0*".z&_&d n~Uʿ^1Fv˝A֎e SX|BWf(x`H>+1ݷJ'5bR~\SDp7& =dk~1%7ۙ|B C^;/g'E=[.# W]Q$@F\%L)Fa @26˨(a<2x]TFRjB^hi92í)0\u}bzvGӋ%׶Z|B"$һډ]?-%џ 2If\/?Vބ-6ӷay{C5jZR'?9i)˩aSC_ %<炽hX!%ZS'cQK8В6~AhK>*>Ƅ+.Ry}$4o׋NXҳe=FZ}`\O]'NB3,m/ IGQrbH3mM9`ob,jAVW}؍:y67FN`[Oݰ (g[.c鷽?_d]yZCMTMQ^.Gqdۻш5$2~ʳvp2&cj N!)h*{N{BNc]u,bBټYm,NJҫ+a|%po=8Mg Yu'ӛnvoqWNj $[ze!~uaS \'[uM 郬ouϕ/𵛒f5|Az1~Px_Z] =O{hk(>l ʑ^";HN4&#~}6<˭愾 ] k\:x\JTv$(aHtOl&(Cz5fΩS ˅ƟY)m%qDpQ].DV?kCpz)Q*|;RIҏ.ڐOveH.v1j%<;)NMc9vX8q0x2khUhMz1ӌz?;dНtޮfVaMJnrߋ 6r:|UU3oD"Ҕ%GRe%auDkCSdv'7".|]"Ci1IX^4~TAy"%4y/Pd6b ʏޭ>q|4z,|8;Y 1 >:7Xl 5qPTǑI:iizl#*i|D%j,כn8P@[{$_3) Řⷰ%Ȗ:US*7 `Xi58_*=hmS!8R?AZٸ6y5/ΨݖI }n;ڄ%c;5}%' -'/(k 1vC`eEס!S79K6w4QBdXL:P9=w$GL/>7yN7tQDbj2p FTl͠Dc~fnƲ 6背<cFkm}[4@k%Ŷܤ_1V+ _!rj0fxx ?TP h|vI^:f8"DDO(62բ8ckX_O>x:#[h| L#GgXum˩5íJ/A#}턒v=n""oDK#*=TǕ pq8aFPk's#\Ivw5k=PMx1ǰzS)*TVX>@"; ~R >18ݿsUb_+P1y*Y:2Pr 6Hxfj% !1jm:PV1&LY!.9*1FO[CfbF^xe8ߌ#k]aMW>ULDuNFC>J<49j?"_Ξ jHkPf̊@)%aCAL`7+i4~*pcGd +X8M;*+߳uQdw a1 &ȧ7$ LGWd o}2b SMV:?\f15[l_,!Rga6˜,$"ؔJ`|?ޔ!&\ɟ|[ I>@"Dvͤ!˯9{HXҗ| 0̓!umD+ 珵o.?1A+20I?ͥ_ʡfX̓!c:̓!՜ßm̓!]Efre̓!3_@̓! hOx|-y/q5%#7v̓Ul!0C4 ̓ʵLvdd.8f̶4sWS (^zͰA9 @̯K5S~&H]gVqb!.W>,\56{kHh8REfu݁xN!J/覞MȤ!6VI6diI) "W +255( +|p_ ,EM|#9-Յ˓7cii'z u@8Fq!xgվG%&8q5"2 >Xq֬SMGt.ݱLF܏ (ZI"+\c``S=4VBQF@';FL.>̮vYp hðOVvEQBf9bw 2jҠ5t SvPu2q0} )U!OuDfv#Q >sGS:@ '5?\-$t_;5jzf/oKɋ={Y]d`W~5 fPDoR{RQuS sy.̒q+U_؝?r3zȁ皷I"zcX%Ĕbw\ԝP\FUFyi3޿R~1FK&Zdc GJ kJG4aC<iPJ:=퇍B"(,nPrnUF6RFAmkQ D,8yWB\KI?1&|޼IOa;% )|@3@ck2+dOk'(Ts\'/xQI^%*˸d\^*h:8з$0]%+ júJnL?Ba__!PEw|Chb]eXDQ0[ycQx裯룱4_*P` .qTن0R$Lk : XR==apSS )?d @=^ z{Œ~XptXb1ig<}HATq\o(ʒ4Uu}LJm{Z(yJ裂8ei>|'ٵR$J57ox=_|;_v40(#ʹ娼F/Eſ G} g@X%rrUgtbxI˝$͢ўx>cԓnq9ׂj[6`f9?%EJvʿfo1xSsU%>fHPz%n߹]mw" TJ*F8*t)&:{G(O).Iq'Ii`k}{:"bOH AfRt(nO0ۧq/bh.v'?Nݜ^,;e"o$"O :H箶z^HQd]"֏1@;S/ A9_.Ùp`&6f2|ݝ<کH5` {(sIJi=Ϛg=c8"L{WuÊnOB8%?D/ 蓓\nsYfhטw]VSH2!^uHdA͸9НtԔ@a&q ũ"Iɫ\G;BaOE p(mrȺ6г>asɪYch$M:V{j%`7$pG77誌~vWޜ޲38ATZ Z'-ZC:_Y[`d9{Ō4B v|*xĀ8Oe dIVe9c Enn$CU=?WK,as :~Ӯ1 EwSPXoC ,06 k9|Phgo<=[er&qK.s@QU(aeXLP;=$K?q|o8OBr? K^kkU4+JwBZ~4@kz%C)(kQ?JxN;_ĜUq7v\@mvJ0~𓫒$p*JDZ]#Lс) ʯp\V ?cś7f)'G4N"g I=[bM88gMf{zmzםw4f/0g8D6>ُ}-`Hu/lC9kUsE]/6.!kgvlEGE%W/@/N)Y .ya `F-ک7  ;~906|V5:+F ;&}]o'l]AČi@NtNzRӼY@ZY(g($"o0 0%lm}4U>F7!ST08?L5\l1{͋?~ ? yݜʛ2~bl' YSbU@{tvq8&ScLbMc0R /3 c۞ilH<76"cw+bf՞sM9Ic;Vr7!>Kvtn{-]ۮT#~aBC(!lSsS"?hyL sHz?́7'C̗=ѫBɇ=Kz"o(l}JP5pG \}$n1o8M>Rbʰ&=5]Jdǡ9{̩M-`q\{ ꊔ@ޑo؈2z䵈a9M>oL4=Н#F#Ц "UX|Hlwq'oQ֗.+ \i1zTq_k>S`zONiL~'!.tXE?#q@-IUgoT}? X2_dإ(sKiAXv:]պb0~C{I_-Q0GC\<8~{ ~yH vTo(ioSPik#B'̐ڧ 3Τon|"^P&t!hحپ"3ܟaPMh΃>Bɟ>ʄt12m,ȹ @p{̪sX,P D3O:MvY̩^fÏ7e~*D{4YK#pK̪heLړႹh:#+7ӣ#|&!wj_Ao Naf|7X!_eLj| QA,ߙ>[ϙdș+3ֈ׫Wns{5ơ]\(-`1/|Ljw^0Lf+IZ8Gb2%;1ٞf0p faCiIdVSsIE̼6@%ѷ YZIA3\cK BM7Gy0 \,09ΐő!ƕ$k5,9Z@dˆqQA Yqr7<V!T"$s=~-ؕXLq ҷB;4(UI㣩 ו+ Oψc^WDWDXM0Al7q + ( >q7zap"j&>$?.#56쿧k,v}bZ$\N^DŽÁOUy&5{1Oσ.~?YI"nW '\i(.6Md 6KIxj!OZ>0.nhvZe]M@̫^)AȸOQ%,x>msreZ͑k 5Z0tLP&W`YyAu'Xf>{"カcɄ"߳600+rMIɴ㠂ua4"7rdW`š+Rg$Qk?5;Sy4`=\I)p{zLTҩ;ZS (m(X 5f EgD\|W"Q`9@x`xo@8'y:A=t]ؽ@"s!?!!OR}+\v`, si3J?O=,\&mՍ80B{/ EډMEDb;ESZYHdZ2?-@è+H9C{;գtF|v[s-=s#E?ϓv,, ];'eKŽ/{ 5*WW b {]W@۩K`)>PӸʁ#z?<Y rA@՜ҚQA^_7[l]E3:;EIq%B04VtVg]\˯>M%S5"Hç9,2 dkm s.B盞*,_EK Bue1@WԖޝ}JZߙQ{,]J, OYK&pu:⏗q<6we%͚=ѱ5/knx,"kyҍ Oˬ3J{BF A`-/ 3Ph?AMX/" >x 5kƽ1{'kV8lov: b9xǚn' ґ " @/ZI3u.J| ֥y ]Zn;{*0Ioف ]F!5OӡyAM"ZzӟR+P^( (x?`a{ q|B((5 @n'ԿayW"#IXSW F^x"z-+}])}r/L6(*4-erNAu{nTtĠ$ґOcNϋ~CԍH\&0G-q" ZfQyKf%+)Ҍ۲AF4P=y*  B@ GSW?_/,N':ؚlY-k+{ 3˅VO}ٛcrjcL'Ʀ`a(*#AoRg24ZB%5=t[/I)o5(v-w#٩, ['I^=ִR2eDLX1+p'^[_>x ,Q4쟃D\ΣD\7_ @o'}sUysG">6{Ai} ix衾eШ;ݍGL:* DD ۇ @-g D G+NE烙GvbUl4Hh:ixrwiƨm_ [fC$3Ar[H̯p& KQY;q5ۏբGXKgebwÉ_VlrAȺ]6BlAo"Šjc J8Cvz7.𹞢- Tc߶Soq&M3hh03HNѵs_bŝ_nu90r63c{ +G5گK)gMZD3bԊ)EϤv ԅCN "&r5& ^e8Q7VE89]o8o-p]>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 14681/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream "Dɐf+}8LSF`\nY!XJs^[cHQf uzaFMH.q+$Kzž|[tx,X#T* "2]P/:~@LZ5g삊2Q 0ąVenc,av>2=jh"d){B2r~ `luku4[J<6G K:dĶP!VƘ Dؔ4 Eg=:_\F$eY +ukw5uC\ADQڤ(E='T`td?Z@劆{iIVTɔHF/rix0G|aȃ?OS^u**͞ @ܳX{gRD16mGYs-a߀?y#eYP=zh>EϮ=)Xk,f! =aK۽ڝ WZv qx_bBƟQ3.%T-,K|>8`A:mJ#FVՖ~RZ.yA:䂙LnR#pc (:i9WE,zv)ԇ#+=gUWy$e(Ŕ591Ί{5p«bIht.R]H*PH17sNfZN_-{{!=O5˽OD9ֿ/f5#I!g Uֈdg{:Q^ėwcYp|%X9|.]RZ^K:*kWh4ZʀR8'`X5:&M>#_ !} P7|Jsyf7 uXG$'UVUQJ -{>Y?Vɯv((W Ը@ѠI%5Q5 8` .B~޼zjвqYJG%<.Rn k7n 旌ēR҄xnlٚ`,ouXݶ3ý12AJƄmW?ܞ\?|`)0`2[@kg^3\Q wiʆLa'ƣlU `iQ^`Ls$%ua+,~M؋//Ts_c^>c6}/N,H4g̝|};gcHW'<ѽmg|&>OviW+ ӽIܤӷKGf@ge8 janC|R=. `W13uaݍKCyo{-Miwn0;HH !͊#Aum ;B-@R^iZ=b'&Wi9z dhb=D# L_:4Zt^ɐ@'_[A6)e:OHZm{MëdpB8 ){=a^Kc#mG~"ZФŵmУwv8e`Fea~þ^e ]Rܳ3K'XO1/֎O ͘W !,.2Q$1~vtW3Z;n11Co_w]rO-Md}戂C;`lqv8Hb=0XQV[rCd*w0kR/-Jhbzdg '=l 6[.t}%ˑ$5nXD=h:孱pU?1̸RCBX`b*]Bv+w+1 l?]OH h2SXbP@A+]~ZU@>ȑ,-Bb0M&;2Đ]pmox]:0yp-`GwgE)ɛк:co 89RМ:%(gڣ.ILgew .I~gO+FYC<WYKC,Rn9sRu9? lOĚ<+no S/:Xoj nJLwe{t #Pq"(f )Ò~*wML(aB_ |S(F=.j'+~9ђ'QZ/Q z97FQ[4G+t}vzVKqÁ_O>FXFMZ>3ΖCOʍAA/i% 6EJfMZO,x's1Iԇ0`'D?pUA'`^_ʹqiО'd>$!q>l@/mu|zc-%1)Ө\qږf[;YWjngԮ!( u,S!gݿxJg״F+Xݮ $B􋣯J6p-co;:NYI~G:ʃkt>sJ z5:7yyCoeT%m9HKwG|Hs|w :H$ms&$cTǿN7@*!~j+'t-\a B 걞Yf5~n^رǺ|C7F10IҖwi~w!qBQ,JP1.*yHcnA[<,a@-Wg1 Q0 GA?VŢtW<#mfθ%;T~u|7(_3+so/ӓY]ndʤ{99?w2zmEf֓mmo1 Xngpy܂ľ+;"^-J!Z 6ro?n*YBEWtFSPe@A )' (HxY%yålª!.t;5p axIBBj` JT}q}~s_ʋ%\>+@}Vg44aZym1O wʔ;|uySM^, QDV(v@Q# W5z!5u0蕘$=ܪhMrKq! omr&]mKDda%Ydk`~%&7U8d Pt$G -nN)]V;|'*9> c_^9?PiIغf;aJז1i9U3,Bv# vF S1ׇhgBp)F%"Q'1J "g24M9|JaeGIcVL?HGA/$ӧk*7>W4A_~ [%@yw@5 j6i6+Tgk/7$D)#R't%|ڹѼʖ$֍YeK CheƗHS$+rOe uҡ#[hXsS4]]Vq-E \,ӎՇ0MS~تcOa*S{lW00>03xV[ c͇I0Z4屰>ᬜi-h2hl^;F׺۵vU*.W%bkt/-; b@dJ[ |absӊHk65%qΆ _L/폅h{j .f)1>ƧIEcBHH<5r:4zs+Rg;23ZV<;g%:$$=애9y"-p9Վ{)-AnwB%*wIfvgAiHU3Ҟak82$#B哼82liEsie"1zn.㤨vK>vLjRхXpH!áD[Z+;0dZ7ո뻸t&73'/Y ̈MfTlGD9%5R[hJ!:+޲%T/Y[ iĿ.BͿ ve!dvfEᑌRpJ 7ZsO.Ƌwf%vF;ȹuDZ WM^ysXvO?\U_ܡy8E m +~`5>'PʼnSgؑxM:0yP&W"d_-co{FX0f@!*ѤD1a}cKvܟTXxN%Fv 0MYl;7Jc$fiEc:=.6C;r4#;x3<@V<uajC%ەtɪ2/Q#Zmd-f;$du `.uWO7 ݂/T!a&Y;mwlV:@yqSX~'wpW)QJҴ%%)=A|sG#b;J tiS$h FFu⋉rJ'rQ p7_Gwj/.09c'*`y`yA48T>G768{߶T0]T%dMzj5ve#^}I6Z9;Y7qclޥ%b@xk1me!}J{Kg/ 0ҝo"iHݎ]ԖʫOf\R,}Nu82`ЏmZF1]_рWnsdɍ EEJaI&bV:6:[h(# B,J٤9ʬ 󃶵Ioԗ{㾯 aqP+2ICs !PQwu}Ih[6;hٝ,4eeAU_ I/ӝ:FIջypYWΗmS6x[`oa"m1+Jh":͡BL.$u!1nnAaqCbuviU}NJXH1?qVqj MA+v\6VM{ؠgNE&IM7u˶nd 6D<"EݻӰJ̧MaWDGnd?:8Hnyn{*]-F-[q^p瓜xKx8omIyL&aÂeyrQytLkn_j2v)X3 3s87ޠ@j+H4uē؀qpr b0;+ЅKujAbsD Z`M͎@9 )?Fi%{S duFSwO%(7K麨.+*GnwF~Do톦0x巚 [. "Z2Ӳ'? (Tj׽vYmўdGaO@$dPN 2j"NPZF J?t?}Z]Q/sRYz>9yVVvܲ*>{8d]r Lpwq^Aio0QOc2#S-?󃲰ykʏCD[tCXȈQόBۈBV[_TU1"*V̾Y%ط%\#bSېƫDv+P&O;{'cT kE2uؾOjҖiS@+PvQŋA (ps݋C=3d cu-t/i k+Ol23_NouG0@  +]TRw[/g˶?sÔ4_9bQNUQX*ԫga`%o}mFEzmBWAEձiq5JZC-O1[ ]HBPɸ=6[i?jqv7=Eh^zs3KRs7DPHw)%X[z>t[$jCA 4҇emv1 8ywV֒ltUۘd.Tp)_βñEZ c't67t}eʋ[^rO $-"C;O o$V9kfH<^bٞ"Ë[hb >%Æ3"P[HBeU 4#T;.^ӵq'E[QǨbUJT"}"ьj.]z,c`v2j߮U5=.!iZ[8G}f%Uv@7w|g61 |>.x4`Hkza]ک22䠤0M0|[o. SXtzVIx ۜK-KKs ORr&. ie r*pB^6dI)k}B9U+rRBߎCx`l.I6"7U[&h@?@E {>ͥxm_m+j<11<6dTR,Զp1SxH,)Zr|m]({Osͨ;o&g}ꈼ/~ܜM[:^\rz\Ouߙ A9q`QPs*B4wHiܘ"cvb2cB@sdop?x=jBnnm!^txXgXUtmI?)! h8c)/7(oI@7(^98GM'@I/a^AC('g p/h+b Iu@?"AUUA;P~`0TqRWeq2ity}Vwv :GX=ED}“ًh.U~ږz>UXGn*kԪk'3O1cqq\!Y,ATҋY) nvV<~Jlfd p U8=xb|:RV Z@[x: ޗI#bIiAşF1RQɭdWxKQ/<2/fwXS-#9̬ džĎ{w7qݸ+>.wy!SgGhGdPMS+fE~y<5|_h %= *)g.MzxJM fGw1GXN@TѼմ)d_pF rZKPÇp h=9*\ 9nMul㎘kOHoS 5IыǙ:V~rP}3+-Kv(>|J1~rQr⧿L.(f Fc7p5dJᑁƺJ RFDLJV\'煃2gaZ_a/['l_gӷsQC61Mpɤ\ȉ$^@T)k(s"s??7\WL)VUXxIlGU{Q~L3w0]`,0iIeM`MBmoe-ŕUDpHM,q6U^۾:OaoSye]BvCaHw}^"UR$X!>|Jb&&T!8p{?Ō%i"Υ/COvЉ~u(_ǻy3ȐӅzaEe6|Ԣw=yYD2b3J.PYV]UL7_dIebĠDa)$#qRͪB@‘4J owzqa<sxz<]=WW$ 6MX?#;ef OgJ-m|4ptpieepL ONc~Ҝ# BIB+qK{5F>` u6 P-LnWCm>V'7`cܞ.a%SmUI QbbIxH'YĠz%Mq^+碶i.2(Rr}ӱx%ee9{dFOWᄽ_ka]} nMEle-̕95J|zx`qT3xJԕh;L9Tp4w̽gDvXȩ@4P9| LQ,׋o LEN꓍D;$9}:\Pīyvb k/vټj}te.:βO`\R=1c9q5WyLSqyG)IBN8Uu79pDQk5Q׳>f1LEgP)Y(_!|S}`}_s|r[GW^.]}r7BK!Upح~tv}رNn8 {&O۰V-ٲktxxRWO~`$_;ѕX~hi-SVF #T*TA_D;[^#Vr.U Ԇ9!JryJARhÉSy,gEDxVX?@{+!3gy3TeqcA.@s dqDSVAC/nP3"@Mǰ1/Z4v_W@S[ 2#ɣM ſKf[H<"!jlK~qQS67%]\L+U #%֐v#-]&Hk{_`]ab@1"+">5D"YÁ&gF-Nf ??>Л&uM|<}HdNqyVY^X l5fO 21_,->jD0~d@L'z@PH9*HuF/ T)!k sڹA/jb4Iơi ;./Z)n6:'~ Q{lX**-qH_ UkW m*;ʛKdhAVD':zkbkE'^}`Bb(icE3iUMLVQy=0ٯy&d%@^S endstream endobj 25 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ .-jp2hihdrllcolr zjp2cOQ)llllR \#B@HHPHHPHHPHHP((( aϷSPTEǍ]}P7I#N,(h >u4K::pQ' ='90.{fws їuhJ}}۹A?ڀO- #i{ʭNQƝTrU›WٴIItYG4ez]Id,-cev<,o?pZfLp'j R@=l2*{&y(wCzxIH|13übyK0|Ho=ktJ+^/>e"Lޅaʈ{xETG(-dŔj <%QtG xaCHM 1/cM fHt$'\k x 1m D*XOt\< mh3IT߳JpB9dV7M`Pmq{[%X">sC59^>iF1U9@47&Pw c2~zMhmo7;w(;hemO :C+gC'J$Jݓ<-7;kxjyfLggߥ yJgZ}12u \O 1:pˈEQjx䤁Lz>!Ozd(@\_̺u#h?Yҳ?ɱm:C,OGKObC}vk/mY헽J*YtOJE z*2;Z//T sYV7G)ndm!M!ۋO+f5w c&Zve=B8~Żk9#QPm `0Den̹gOt]k2k YG9-N;̌vm2= RNmae OaKJ$ǂa٭'5W$ĉ8DZݸaaRfiio eF@E]\Ey=YWZd!* KŁ-)S0Z68FT w}B=J_S*j^{J~$Z_u=]Njtu^%eo꾚#$Z!U|K# ?2/&yBܕ߾@ L@G+!1:I=FMoAX;V'LȔ򓟯ϛK`Քup{stc1mQ?#b8R )BD@*OMg^=dA[_gC'T^hh\rbYIL}V.[_U.S'KbUt;*mveMU A\)90^(6*+\aKW:"x!b@rſ^fqE`2EcAa$  YkP:B;T_M/~o?-uyR0[6`u ꚝ !U>Er;K& 2*,ahv4! P ∌K2 nHh#4/m0+i{Z/#UW"($wr,MXt_P=l5K"^[i)zzi#Dw*ff9'E1Qkéބ£"bDOq.IkhخgE01xlQU`Dt7\SBI-X4߁9,3Nk[`/ܟ4ma(0h"qC Ŗ Éd0^oLB}c`D\1sUvu3 o@" S_T/TB@hN!JHN NJHN!HMo]_o7 prmP>f RN:mlK.aZIR~ FFmahq-7ffmk*ʛx!a!a! IZ ٯ+c5Ao/=!O]oVt<!ghVl\!x!~ɖ|I[̾J1̾.}Tϭ I/E1KU;i"I!i&Hk:[̾JCD+8[̾G(`x"\_@d̓! endstream endobj 26 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴhLt v" 1:4: x T$tP=t  u͗`|&@:D | Dg@5`A~aX`:0*B $1@Nκ3*so݅X% h:  endstream endobj 27 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr"colrpjp2cOQ/""R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ 0t ! :  |"I N :    endstream endobj 28 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrgjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ 0t !  : |"|    endstream endobj 29 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr"colrsjp2cOQ/""R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ 0t ! : @ |"@I: :   endstream endobj 30 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr"colrjjp2cOQ/""R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ 0t !  : |"I N    endstream endobj 31 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrmjp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t !  @ >茠    endstream endobj 32 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr;colrjp2cOQ/;;R \#B@HHPHHPHHPHHP880 )ϴ$;5NE0쬐t@ E lh:":$ UT:$z r E@ ]j%:| t=Z#B_ sv >hD:,p]>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr<colrwjp2cOQ/<<R \#B@HHPHHPHHPHHP880 :ϴ@:[;dD[OK\}Ut$+/ VL tr7 eTH2#<)ŤڑǮ:\|@ # %ᘥ\w T jHݷq"9D87o@:L \Ki.n˵\@9- :zHIDtxw4bEp嫲櫞敕s~T⼽Br|,@|5p\u$l }o+j3[j3w,h1)ݱ ; uA9\/GR*JbP+=7 V8/DK8hWםʃ)9K,%ښPk\&)=gyEb ).G-`Q?Nj.J=sj2@;455-)~^΍ @ZD-BAZj4w8Nv_VPyCW `pg8}C巇AuR9:Q%ra-ؠ )Y0N\D¥)haz 3:5A YCekQuKuLYpp{maD mfu} Zz~42|)_3OMOyp*i`s n ˑP9A$8 ` AϽGĢyx *x *Ķ< X G = endstream endobj 34 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolr5jp2cOQ/R \#B@HHPHHPHHPHHP880 ߂p$_='B'Z OE5cBs\ T"Ҿǭjy[-rRsI$ŕOw;n_ یy7nW<[%_1ef2 N+ț*o "*@#xo p]n=7MU0Y1x!( /b hEeFs'#Qm61Ap%ܛL4~CwCe]&t3~୦iA8v1apP {!)- C6eEˏqG׏<r˄E#!iǻTE cR}8ɳII/(ېK{7xPL:fKXH9}3[+v$XBh)YQBB#-*)q[Pp H؏v7 - e&P"}kl ûW$eu_v^ ]DЯWP68_|L /ҿ#t6?ROɮ5:6}BoI045Ȝu(em=avdV %wxSɒQAV7dosžj r9]dSP-Fבj>֔YVE{hd`jzҋv}˱RI|Ru^Uq%96g Ͷ{Ǫ~/48|oFM^!z]Wro'zc{dJZ.g^زH͙XYK(YZ?Yo^KPg7T; ®I/Ȍ6@.r:Y>IøӊYpv~ zwu䨏-6o4OQĥZ{bet z+be+/.D\M0caJ.?h>}Y2uA"nLguD_ŴdptfU|\yQu]c(K5 BO c 3(UꀃecXA;p'HglKyrco`]:{7hޟ5L!ޫL_3;R6# ȟuk!XMVTj8D12# ~5 kMc؈3⣖_˿xjI_cy%=ON`{ۊY"oكi]X;3Mє^ɉm)^/lB!@SnmʬՀg^ Щ 2#Eؾ?#_)M Yl4~bWȄƐm`\zȾ.t<QkXV,f9qq,8;OLSBm[F\M^PJSt\Mr&Ծq$*wӾF/R\ytoSTr[N0o3|Bv1PXnQ-vrHho"_Njr;tEs\lx}ypŽeRŨ%Wli3oM~j3~܅@fE.8L7Ӭ\H-LxSOE;r<ـ+?h,%}L\LJ7|| sPG_^eԝb01BB!`pwX7֯U]I }}w˛{yM+pmPڡhJNk DދtC7_A;'H4GOI?FvvG?t "m"? ciC{X=LĄ K0껃p"T.?͘6.)\HFA@&,ۅ0 (6-\0 VX f+w/w]']8/Tl̎v|uh˽B2na˶T@/-܇%Ѕ<`c؇%rse贐e'\^dnFJ2lD`?hh9v`eWmr[17&Lěܯ"x u{)Oo8(CuNOӭdL4"FPh)U}h$1oC&ˁfpHPGKyUjg⹞'1Y("WE]ݛ|`MeJ|VCdPj\꯺~5"<ጨ=:dAL;ޑ |!Wx6LG04kRtU~fY,'$BI 1#L~*|In6.}K i0U+fF6 En?cKѧFNMFa cXGn 7cgz&ϼ< O+ ʹQ,i$@ڲ2jnƑaf93kK3RRǔ\83qK5 ۴ w}W_4rI\ $o"-'p0gsR5՞ ӤЅ3kS:t.>+%atO *o͑{RrY xRa-ҰyR|o|sQW|=`~l;}U-$_1R\ h%_&PAe>I^uz"7 F`Z`QlӪKzuA.:Ͽ.:ق! ^I"TOQy?sg` WLO~uҳ􄁏(wGjNF #Q¢wW=qtRkJ.3GS.SoR(zKЮ*g@G144  4(jvOYB]9.dU'F7_euqE3DvF$qPN>Fh ;äzR!$5<dB+kPXLeh0 %RlMP|B26\qrWSMSW8BsKgL9ң_9O I!Ykx !"k愉ǍӕGs% endstream endobj 35 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr.colrjp2cOQ/..R \#B@HHPHHPHHPHHP880 *ϴ$-*btFZt@< 9@ (:4, l "x&- U S@:8%+,(vI:L„ҀKܓ+*gt9G?L!T69բ 3kn 4>Hſ* yȑ ۥ&Œ  h#'7h= Pʀ endstream endobj 36 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrD+colrjp2cOQ/+D+DR \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ1GD X". '@z|!: ! ':4$@ ?w;7 #|'qƬ ɋh tX%'Y  endstream endobj 37 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrBcolrzjp2cOQ/BBR \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ"xt "  :  |"x`qD |$rf of   endstream endobj 38 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr"colrnjp2cOQ/""R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t ! : @ |"}) N b   endstream endobj 39 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr"colrrjp2cOQ/""R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t ! @:  d|"1( :   endstream endobj 40 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr"+colrpjp2cOQ/+"+"R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ{C" $:@  pO_    endstream endobj 41 0 obj <>stream h޲0W0PP0UT0W0475R0Q04210? endstream endobj 42 0 obj <>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 43 0 obj <>stream q 0.188 0.188 0.188 rg 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q q 489.1199951 0 0 48.9600067 0 751.1999969 cm /Im1 Do Q q 64.3200073 0 0 79.6799927 516.9600067 716.6399994 cm /Im2 Do Q q 14.3999939 0 0 12.4799957 566.8800049 636 cm /Im3 Do Q q 22.0800018 0 0 20.1600037 559.1999969 505.4400024 cm /Im4 Do Q q 14.3999939 0 0 12.4799957 566.8800049 482.3999939 cm /Im5 Do Q q 26.8800049 0 0 64.3200073 555.3600006 351.8399963 cm /Im6 Do Q q 21.1199951 0 0 25.9199982 560.1600037 321.1199951 cm /Im7 Do Q q 14.3999939 0 0 16.3200073 564.9600067 223.1999969 cm /Im8 Do Q q 18.2400055 0 0 14.3999939 563.0399933 63.8399963 cm /Im9 Do Q q 33.6000061 0 0 33.6000061 547.6799927 25.4400024 cm /Im10 Do Q q 18.2400055 0 0 12.4799957 10.0800018 4.3200073 cm /Im11 Do Q q 18.2400055 0 0 16.8000031 563.0399933 0 cm /Im12 Do Q q 25.9199982 0 0 11.0399933 524.6399994 0 cm /Im13 Do Q BT 0.243 0.243 0.239 rg /T1_0 1 Tf 0.05 Tc 3 Tr 8.8707 0 0 8 202.04 753.85 Tm (DUTCH )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 8.5184 0 0 8 238.52 753.85 Tm (RESP)Tj 0.023 0.023 0.02 rg 0 Tc 8 0 0 8 261.55 753.85 Tm (I)Tj 0.169 g 0.05 Tc 8.4855 0 0 8 265.4 753.85 Tm (RATORY )Tj EMC /Suspect <>BDC 0.243 0.243 0.239 rg 8.8768 0 0 8 306.68 753.85 Tm (PATHOGENS )Tj EMC /Suspect <>BDC 0.169 g /T1_1 1 Tf 0.0398 Tc 6.2 0 0 6.2 69.56 552.24 Tm (JAN )Tj EMC ET BT 0.243 0.243 0.239 rg /T1_1 1 Tf -0.0228 Tc 6.2 0 0 6.2 86.2504 552.24 Tm (FEB )Tj 0.169 g -0.035 Tc 6.1539 0 0 6.2 102.11 552.24 Tm (MAR )Tj 0.243 0.243 0.239 rg -0.0211 Tc 6.2 0 0 6.2 119.53 552.24 Tm (APR )Tj ET BT /Suspect <>BDC 0.169 g /T1_1 1 Tf -0.035 Tc 5.8537 0 0 6.2 137.15 552.24 Tm (MAY )Tj EMC ET BT 0.243 0.243 0.239 rg /T1_1 1 Tf 0.0118 Tc 6.2 0 0 6.2 154.04 552.24 Tm (JUN )Tj ET BT /Suspect <>BDC 0.11 0.11 0.106 rg /T1_1 1 Tf 0.0174 Tc 6.2 0 0 6.2 171.3194 552.24 Tm (JUL )Tj EMC ET BT 0.243 0.243 0.239 rg /T1_1 1 Tf -0.035 Tc 6.1832 0 0 6.2 186.73 552.24 Tm (AUG )Tj ET BT /Suspect <>BDC 0.169 g /T1_1 1 Tf 6.0677 0 0 6.2 204.4 552.24 Tm (SEP )Tj EMC /Suspect <>BDC 0.0046 Tc 6.2 0 0 6.2 220.24 552.24 Tm (OCT )Tj EMC /Suspect <>BDC -0.035 Tc 6.0951 0 0 6.2 237.47 552.24 Tm (NOV )Tj EMC ET BT /T1_1 1 Tf 5.7573 0 0 6.2 254.27 552.24 Tm (DEC )Tj 0.243 0.243 0.239 rg /T1_0 1 Tf 0.0049 Tc 8.2 0 0 8.2 43.17 534 Tm (Fig. )Tj -0.0287 Tc 1.871 0 Td (2. )Tj 0.0257 Tc 1.757 0 Td (Mean )Tj 0.0212 Tc 2.637 0 Td (monthly )Tj 0.0245 Tc 3.746 0 Td (totals )Tj 0.05 Tc 8.9033 0 0 8.2 145.84 534 Tm (of )Tj 0.0009 Tc 8.2 0 0 8.2 155.45 534 Tm (isolates )Tj 0.05 Tc 8.9033 0 0 8.2 182.32 534 Tm (of )Tj /T1_2 1 Tf 0.0174 Tc 7.8001 0 0 7.8001 191.59 534 Tm (Haemophi/us )Tj 0.0106 Tc 5.824 0 Td (injluenzae )Tj 0.376 0.376 0.372 rg /T1_0 1 Tf 0 Tc 8.2 0 0 8.2 42.62 525.36 Tm (\()Tj 0.243 0.243 0.239 rg 0.0311 Tc 0.363 0 Td (upper )Tj -0.0009 Tc 2.694 0 Td (blocks\) )Tj 0.045 Tc 3.209 0 Td (and )Tj /T1_2 1 Tf -0.035 Tc 8.676 0 0 8.7 109.5 525.36 Tm (Branhame/la )Tj ET BT /Suspect <>BDC /T1_2 1 Tf -0.029 Tc 8.7 0 0 8.7 153.53 525.36 Tm (catarrha/is )Tj EMC ET BT /T1_0 1 Tf 0.009 Tc 8.2 0 0 8.2 191.42 525.36 Tm (\(lower )Tj -0.0009 Tc 2.94 0 Td (blocks\) )Tj -0.0067 Tc 3.278 0 Td (between )Tj -0.035 Tc 8.1597 0 0 8.5 43.4 516.24 Tm (1982 )Tj 0.045 Tc 8.2 0 0 8.2 60.4 516.24 Tm (and )Tj -0.035 Tc 8.1597 0 0 8.5 75.56 516.24 Tm (1986)Tj 0.376 0.376 0.372 rg 0 Tc 8.5 0 0 8.5 91.02 516.24 Tm (. )Tj 0.243 0.243 0.239 rg 0.0016 Tc 8.2 0 0 8.2 95.02 516.24 Tm (Vertical )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 3.84 0 0 6.24 123.36 516.24 Tm <006200610072007E0020>Tj EMC ET BT /T1_0 1 Tf 0.018 Tc 8.2 0 0 8.2 139.67 516.24 Tm (represent )Tj 0.0385 Tc 3.967 0 Td (standard )Tj 0.0131 Tc 3.927 0 Td (deviations )Tj 0.0093 Tc 4.448 0 Td (from )Tj 0.0058 Tc 2.291 0 Td (the )Tj 0.0125 Tc -26.459 -1.112 Td (mean. )Tj 0.0128 Tc 10.2 0 0 10.2 42.7 479.76 Tm (may )Tj -0.015 Tc 2.106 0 Td (still )Tj -0.035 Tc 10.1515 0 0 10.2 83.05 479.76 Tm (be )Tj -0.0094 Tc 10.2 0 0 10.2 96 479.76 Tm (useful, )Tj 0.0261 Tc 3.002 0 Td (as )Tj 0.169 g -0.035 Tc 9.8086 0 0 10.2 139.19 479.76 Tm (we )Tj 0.0158 Tc 10.2 0 0 10.2 154.07 479.76 Tm (have )Tj 0.243 0.243 0.239 rg 0.0124 Tc 2.246 0 Td (shown )Tj -0.0079 Tc 3.018 0 Td (in )Tj 0 Tc 1.127 0 Td (a )Tj 0.169 g 0.0112 Tc 0.856 0 Td (retrospec\255)Tj 0.243 0.243 0.239 rg -0.0119 Tc -18.166 -1.082 Td (tive )Tj 0.0213 Tc 2.063 0 Td (comparative )Tj 0.0178 Tc 5.737 0 Td (study )Tj 0.0391 Tc 2.829 0 Td (in )Tj -0.0094 Tc 1.419 0 Td (which )Tj 0.0265 Tc 3.058 0 Td (the )Tj 0.0124 Tc 1.836 0 Td (results )Tj 0.169 g 0.0048 Tc 3.284 0 Td (from )Tj 0.243 0.243 0.239 rg 0.0111 Tc -20.225 -1.081 Td (recent )Tj -0.0108 Tc 2.87 0 Td (times )Tj -0.0181 Tc 2.495 0 Td (were )Tj 0.0199 Tc 2.203 0 Td (analysed )Tj 0.05 Tc 10.3398 0 0 10.2 160.21 457.69 Tm (and )Tj 0.0317 Tc 10.2 0 0 10.2 179.42 457.69 Tm (compared )Tj 0.0056 Tc 4.479 0 Td (with )Tj 0.0145 Tc 2.211 0 Td (those )Tj 0.0223 Tc -20.093 -1.082 Td (noted )Tj 0 Tc 2.743 0 Td [(1 )303(7 )]TJ -0.0211 Tc 1.257 0 Td (yrs )Tj 0.0028 Tc 1.556 0 Td (previously )Tj -0.035 Tc 9.7837 0 0 10.2 146.16 446.65 Tm ([8]. )Tj 0.11 0.11 0.106 rg 0 Tc 10.2 0 0 10.2 52.73 436.09 Tm (I)Tj 0.243 0.243 0.239 rg 0.373 0 Td (f )Tj 0.05 Tc 10.2679 0 0 10.2 62.78 436.09 Tm (ant)Tj 0.11 0.11 0.106 rg 0 Tc 10.2 0 0 10.2 76.72 436.09 Tm (i)Tj 0.243 0.243 0.239 rg -0.0169 Tc 0.288 0 Td (mic)Tj 0.11 0.11 0.106 rg 0 Tc 1.46 0 Td (r)Tj 0.243 0.243 0.239 rg 0.0353 Tc 0.415 0 Td (obial )Tj 0.0307 Tc 2.353 0 Td (chemotherapy )Tj 0.0192 Tc 6.352 0 Td (for )Tj 0.037 Tc 1.554 0 Td (any )Tj 0.0112 Tc 1.884 0 Td (infection )Tj -0.035 Tc 10.1489 0 0 10.2 263.44 436.09 Tm (is )Tj 0.0253 Tc 10.2 0 0 10.2 42.7 425.05 Tm (to )Tj 0.169 g -0.035 Tc 10.1515 0 0 10.2 57.13 425.05 Tm (be )Tj 0.243 0.243 0.239 rg -0.0048 Tc 10.2 0 0 10.2 71.86 425.05 Tm (successful, )Tj 0.0235 Tc 4.906 0 Td (then )Tj 0.0192 Tc 2.4 0 Td (there )Tj 0.0313 Tc 2.627 0 Td (are )Tj 0.0105 Tc 1.882 0 Td (only )Tj 0.0046 Tc 2.361 0 Td (two )Tj 0.0305 Tc 2.11 0 Td (options )Tj 0.0157 Tc -19.2 -1.083 Td (available )Tj -0.0217 Tc 4.149 0 Td (to )Tj 0.0265 Tc 1.176 0 Td (the )Tj -0.035 Tc 10.1061 0 0 10.2 113.18 414 Tm (cl)Tj 0.11 0.11 0.106 rg -0.0248 Tc 10.2 0 0 10.2 120.4 414 Tm (ini)Tj 0.243 0.243 0.239 rg 0.0091 Tc 1.033 0 Td (cian. )Tj 0.0322 Tc 2.357 0 Td (Either )Tj 0 Tc 3.008 0 Td (a )Tj 0.0267 Tc 0.843 0 Td (suitab)Tj 0.11 0.11 0.106 rg 0 Tc 2.546 0 Td (l)Tj 0.243 0.243 0.239 rg 0.233 0 Td (e )Tj -0.0029 Tc 0.797 0 Td (spec)Tj 0.11 0.11 0.106 rg 0 Tc 1.794 0 Td (i)Tj 0.243 0.243 0.239 rg 0.0128 Tc 0.241 0 Td (men )Tj 0.0047 Tc -20.527 -1.081 Td (\(such )Tj 0.0261 Tc 2.543 0 Td (as )Tj 0.0229 Tc 1.22 0 Td (sputum\) )Tj 0.0283 Tc 3.776 0 Td (must )Tj -0.035 Tc 10.1515 0 0 10.2 143.53 402.97 Tm (be )Tj 0.0182 Tc 10.2 0 0 10.2 156.38 402.97 Tm (cu)Tj 0.11 0.11 0.106 rg 0.026 Tc 0.942 0 Td (lt)Tj 0.243 0.243 0.239 rg 0.0043 Tc 0.668 0 Td (ured )Tj 0.037 Tc 2.155 0 Td (and )Tj 0.0149 Tc 1.878 0 Td (susceptib)Tj 0.11 0.11 0.106 rg 0 Tc 3.865 0 Td (i)Tj 0.243 0.243 0.239 rg -0.0151 Tc 0.281 0 Td (lity )Tj 0.0039 Tc -20.934 -1.035 Td (tests )Tj 0.0198 Tc 2.063 0 Td (carried )Tj 0.05 Tc 10.261 0 0 10.2 96.86 392.41 Tm (out )Tj 10.7226 0 0 10.2 113.66 392.41 Tm (on )Tj 0.037 Tc 10.2 0 0 10.2 128.06 392.41 Tm (any )Tj 0 Tc 1.784 0 Td (s)Tj 0.11 0.11 0.106 rg 0.429 0 Td (i)Tj 0.243 0.243 0.239 rg 0.0051 Tc 0.234 0 Td (gnifican)Tj 0.11 0.11 0.106 rg 0 Tc 3.348 0 Td (t )Tj 0.243 0.243 0.239 rg 0.024 Tc 0.616 0 Td (pathogens )Tj 0 Tc 4.554 0 Td (g)Tj 0.11 0.11 0.106 rg 0.525 0 Td (r)Tj 0.243 0.243 0.239 rg 0.0083 Tc 0.368 0 Td (own, )Tj 0.0304 Tc -20.286 -1.082 Td (so )Tj 0.0131 Tc 1.18 0 Td (allowing )Tj 0.0022 Tc 3.871 0 Td (precision )Tj 0.05 Tc 10.5727 0 0 10.2 134.78 381.37 Tm (of )Tj 0.02 Tc 10.2 0 0 10.2 146.3 381.37 Tm (antimicrobial )Tj 0.0207 Tc 5.89 0 Td (therapy, )Tj 0.05 Tc 10.5727 0 0 10.2 244.22 381.37 Tm (or )Tj 0.0029 Tc 10.2 0 0 10.2 256.78 381.37 Tm (the )Tj 0.0232 Tc -20.988 -1.082 Td (treatment )Tj 0.0283 Tc 4.329 0 Td (must )Tj 0.0078 Tc 2.356 0 Td (be )Tj 0.0228 Tc 1.26 0 Td (commenced )Tj 0 Tc 5.375 0 Td (b)Tj 0.11 0.11 0.106 rg 0.508 0 Td (l)Tj 0.243 0.243 0.239 rg 0.0082 Tc 0.283 0 Td (indly)Tj 0.11 0.11 0.106 rg 0 Tc 2.105 0 Td (. )Tj 0.169 g 0.0328 Tc 0.583 0 Td (Although )Tj 0.243 0.243 0.239 rg -0.035 Tc 9.8086 0 0 10.2 258.23 370.33 Tm (we )Tj 0.0443 Tc 10.2 0 0 10.2 42.14 359.28 Tm (do )Tj 0.0455 Tc 1.421 0 Td (not )Tj -0.0161 Tc 1.694 0 Td (wish )Tj 0.0253 Tc 2.211 0 Td (to )Tj 0.0246 Tc 1.121 0 Td (encourage )Tj 0.0029 Tc 4.668 0 Td (the )Tj -0.0304 Tc 1.602 0 Td (use )Tj 0.05 Tc 11.1292 0 0 10.2 188.53 359.28 Tm (of )Tj 0.0065 Tc 10.2 0 0 10.2 200.65 359.28 Tm (blind )Tj 0.169 g 0.0294 Tc 2.444 0 Td (treatment, )Tj 0.243 0.243 0.239 rg -0.035 Tc 9.8086 0 0 10.2 42.23 348.72 Tm (we )Tj 0.169 g 0.0039 Tc 10.2 0 0 10.2 59.51 348.72 Tm (recognise )Tj 0.243 0.243 0.239 rg 0.05 Tc 10.215 0 0 10.2 104.62 348.72 Tm (that )Tj 0.0144 Tc 10.2 0 0 10.2 127.66 348.72 Tm (many )Tj 0.169 g 0.02 Tc 2.922 0 Td (practitioners )Tj 0.0177 Tc 5.822 0 Td (\(particularly )Tj 0.243 0.243 0.239 rg 0.0145 Tc -17.12 -1.081 Td (those )Tj 0.0165 Tc 2.533 0 Td (outside )Tj 0.0029 Tc 3.396 0 Td (the )Tj 0.0295 Tc 1.601 0 Td (hospita)Tj 0.11 0.11 0.106 rg 0 Tc 3.098 0 Td (l)Tj 0.243 0.243 0.239 rg 0.0091 Tc 0.23 0 Td (s\) )Tj 0.0291 Tc 1.094 0 Td (manage )Tj 0 Tc 3.624 0 Td (t)Tj 0.11 0.11 0.106 rg 0.33 0 Td (h)Tj 0.243 0.243 0.239 rg 0.001 Tc 0.508 0 Td (eir )Tj 0.0282 Tc 1.425 0 Td (patients )Tj -0.035 Tc 9.9195 0 0 10.2 261.52 337.69 Tm (in )Tj 0.0061 Tc 10.2 0 0 10.2 42.22 326.65 Tm (this )Tj -0.0251 Tc 1.836 0 Td (way. )Tj 0.169 g 0.05 Tc 10.4358 0 0 10.2 84.43 326.65 Tm (For )Tj 0.243 0.243 0.239 rg 0.0061 Tc 10.2 0 0 10.2 103.66 326.65 Tm (this )Tj 0.169 g 0.0149 Tc 1.836 0 Td (reason)Tj 0.376 0.376 0.372 rg 0 Tc 2.715 0 Td (, )Tj 0.243 0.243 0.239 rg -0.0311 Tc 0.626 0 Td (we )Tj -0.0162 Tc 1.508 0 Td (believe )Tj 0.0269 Tc 3.144 0 Td (it )Tj 0.008 Tc 0.891 0 Td (essential )Tj 0.05 Tc 10.215 0 0 10.2 252.46 326.65 Tm (that )Tj 10.7542 0 0 10.2 41.65 315.61 Tm (an )Tj 0.0057 Tc 10.2 0 0 10.2 58.46 315.61 Tm (analysis )Tj 0.0177 Tc 3.902 0 Td (should )Tj 0.0078 Tc 3.403 0 Td (be )Tj 0.0334 Tc 1.55 0 Td (made )Tj 0.05 Tc 11.1292 0 0 10.2 178.45 315.61 Tm (of )Tj 0.0265 Tc 10.2 0 0 10.2 193.42 315.61 Tm (the )Tj 0.01 Tc 1.874 0 Td (frequency )Tj 0.05 Tc 10.5727 0 0 10.2 261.02 315.61 Tm (of )Tj 0.0122 Tc 10.2 0 0 10.2 42.14 304.56 Tm (occurrence )Tj 0.05 Tc 11.1292 0 0 10.2 90.61 304.56 Tm (of )Tj 0.0029 Tc 10.2 0 0 10.2 102.7 304.56 Tm (the )Tj 0.0204 Tc 1.553 0 Td (various )Tj 0.11 0.11 0.106 rg -0.0079 Tc 3.382 0 Td (in)Tj 0.243 0.243 0.239 rg 0.0052 Tc 0.797 0 Td (fecting )Tj 0.0243 Tc 3.06 0 Td (organisms )Tj 0.0391 Tc 4.567 0 Td (in )Tj 0.0087 Tc 1.079 0 Td (each )Tj 0.0115 Tc -20.423 -1.035 Td (district, )Tj 0.037 Tc 3.624 0 Td (and )Tj 0.05 Tc 10.215 0 0 10.2 99.82 294 Tm (that )Tj 0.0061 Tc 10.2 0 0 10.2 121.42 294 Tm (this )Tj 0.0192 Tc 1.922 0 Td (analysis )Tj 0.0177 Tc 3.808 0 Td (should )Tj -0.035 Tc 10.1515 0 0 10.2 213.61 294 Tm (be )Tj 0.0182 Tc 10.2 0 0 10.2 227.42 294 Tm (combined )Tj 0.0056 Tc -18.203 -1.081 Td (with )Tj 0.0092 Tc 2.579 0 Td (an )Tj 0.01 Tc 1.741 0 Td (assessment )Tj 0.05 Tc 11.1292 0 0 10.2 139.57 282.97 Tm (of )Tj 0.0029 Tc 10.2 0 0 10.2 156.46 282.97 Tm (the )Tj 0.016 Tc 1.965 0 Td (suscept)Tj 0.11 0.11 0.106 rg 0 Tc 3.065 0 Td (i)Tj 0.243 0.243 0.239 rg 0.291 0 Td (b)Tj 0.11 0.11 0.106 rg 0.509 0 Td (i)Tj 0.243 0.243 0.239 rg -0.0151 Tc 0.281 0 Td (lity )Tj 0.05 Tc 11.1292 0 0 10.2 239.89 282.97 Tm (of )Tj 0.0265 Tc 10.2 0 0 10.2 256.3 282.97 Tm (the )Tj 0.024 Tc -21.031 -1.082 Td (pathogens )Tj 0.0253 Tc 4.514 0 Td (to )Tj 0 Tc 1.075 0 Td (a )Tj -0.035 Tc 9.9515 0 0 10.2 106.42 271.93 Tm (se)Tj 0.11 0.11 0.106 rg 0 Tc 10.2 0 0 10.2 114.71 271.93 Tm (r)Tj 0.243 0.243 0.239 rg -0.0052 Tc 0.323 0 Td (ies )Tj 0.05 Tc 11.1292 0 0 10.2 131.89 271.93 Tm (of )Tj -0.0159 Tc 10.2 0 0 10.2 142.94 271.93 Tm (common.ly )Tj -0.0144 Tc 4.716 0 Td (used )Tj 0.02 Tc 2.061 0 Td (antimicrobial )Tj 0.0054 Tc -16.706 -1.082 Td (agents. )Tj 0.169 g -0.0146 Tc 3.3 0 Td (We )Tj 0.243 0.243 0.239 rg 0.0158 Tc 1.744 0 Td (have )Tj 0.012 Tc 2.296 0 Td (found )Tj 0.05 Tc 10.215 0 0 10.2 145.9 260.89 Tm (that )Tj 0.0095 Tc 10.2 0 0 10.2 166.42 260.89 Tm (such )Tj 0.0132 Tc 2.263 0 Td (calculations )Tj 0.05 Tc 11.1292 0 0 10.2 243.73 260.89 Tm (of )Tj 0.0265 Tc 10.2 0 0 10.2 256.3 260.89 Tm (the )Tj 0.0098 Tc -21.043 -1.035 Td (chances )Tj 0.05 Tc 11.1292 0 0 10.2 77.65 250.33 Tm (of )Tj -0.0167 Tc 10.2 0 0 10.2 90.1 250.33 Tm (success )Tj 0.05 Tc 10.3922 0 0 10.2 123.24 250.33 Tm (\(or )Tj 0.0077 Tc 10.2 0 0 10.2 139.09 250.33 Tm (failure\) )Tj 0.05 Tc 10.6052 0 0 10.2 173.66 250.33 Tm (do)Tj 0.376 0.376 0.372 rg 0 Tc 10.2 0 0 10.2 185.12 250.33 Tm (, )Tj 0.243 0.243 0.239 rg -0.0079 Tc 0.573 0 Td (in )Tj -0.0031 Tc 1.174 0 Td (fact)Tj 0.376 0.376 0.372 rg 0 Tc 1.548 0 Td (, )Tj 0.243 0.243 0.239 rg 0.0152 Tc 0.571 0 Td (agree )Tj 0.0056 Tc 2.55 0 Td (with )Tj 0.0101 Tc -20.471 -1.082 Td (reality, )Tj 0.0211 Tc 3.19 0 Td (even )Tj -0.0143 Tc 2.269 0 Td (when )Tj 0.0282 Tc 2.497 0 Td (patients )Tj 0.169 g 0.0001 Tc 3.668 0 Td (have )Tj 0.243 0.243 0.239 rg 0.002 Tc 2.308 0 Td (been )Tj 0.0262 Tc 2.209 0 Td (treated )Tj 0.0082 Tc 3.297 0 Td (blindly )Tj 0.0165 Tc -19.446 -1.082 Td (outside )Tj 0.0092 Tc 3.35 0 Td (hospital. )Tj 0.05 Tc 10.303 0 0 10.2 51.34 217.21 Tm (Apart )Tj 0 Tc 10.2 0 0 10.2 83.41 217.21 Tm (f)Tj 0.11 0.11 0.106 rg 0.339 0 Td (r)Tj 0.243 0.243 0.239 rg 0.014 Tc 0.368 0 Td (om )Tj 0.0265 Tc 1.984 0 Td (the )Tj 0.0481 Tc 1.922 0 Td (apparent )Tj 0.0235 Tc 4.424 0 Td (disappearance )Tj 0.05 Tc 11.1292 0 0 10.2 242.77 217.21 Tm (of )Tj /T1_3 1 Tf 0.0018 Tc 10.1 0 0 10.1 258.6 217.21 Tm (H. )Tj /T1_2 1 Tf 0.0165 Tc 9.7 0 0 9.7 41.13 206.65 Tm (parainjluenzae )Tj /T1_0 1 Tf 0.0024 Tc 10.2 0 0 10.2 104.63 206.65 Tm (which )Tj 0.0128 Tc 2.775 0 Td (may )Tj 0.169 g 0.0158 Tc 2.119 0 Td (have )Tj 0.243 0.243 0.239 rg -0.0137 Tc 2.308 0 Td (been )Tj 0.0359 Tc 2.154 0 Td (due )Tj 0.05 Tc 10.4772 0 0 10.2 218.85 206.65 Tm (to )Tj 0.0101 Tc 10.2 0 0 10.2 230.8 206.65 Tm (improve\255)Tj 0.0164 Tc -18.582 -1.082 Td (ments )Tj -0.0079 Tc 3.053 0 Td (in )Tj 0.0029 Tc 1.418 0 Td (the )Tj 0.0224 Tc 1.829 0 Td (ident)Tj 0.11 0.11 0.106 rg 0 Tc 2.118 0 Td (i)Tj 0.243 0.243 0.239 rg -0.0015 Tc 0.279 0 Td (fication )Tj 0.05 Tc 11.1292 0 0 10.2 167.89 195.61 Tm (of )Tj 0 Tc 10.2 0 0 10.2 182.86 195.61 Tm (t)Tj 0.11 0.11 0.106 rg 0.33 0 Td (h)Tj 0.243 0.243 0.239 rg 0.003 Tc 0.509 0 Td (ose )Tj /T1_2 1 Tf 0.0331 Tc 9.7 0 0 9.7 211.28 195.61 Tm (H. )Tj 0.0185 Tc 1.711 0 Td (injluenzae )Tj /T1_0 1 Tf 0.0244 Tc 10.2 0 0 10.2 41.14 184.57 Tm (strains )Tj 0.0141 Tc 3.345 0 Td (able )Tj 0.0253 Tc 2.314 0 Td (to )Tj 0.0414 Tc 1.4 0 Td (sto)Tj 0.11 0.11 0.106 rg 0 Tc 1.283 0 Td (r)Tj 0.243 0.243 0.239 rg 0.32 0 Td [(e )-350(X )]TJ 0.0138 Tc 2.4 0 Td (facto)Tj 0.11 0.11 0.106 rg 0 Tc 2.127 0 Td (r )Tj 0.243 0.243 0.239 rg 0.0147 Tc 0.931 0 Td (endogenously )Tj 0.0279 Tc 6.307 0 Td (after )Tj 0.0201 Tc -20.423 -1.083 Td (growth )Tj 0.05 Tc 10.2564 0 0 10.2 75.26 173.52 Tm (on )Tj 0.0029 Tc 10.2 0 0 10.2 90.7 173.52 Tm (the )Tj 0.0234 Tc 1.651 0 Td (primary )Tj 0.169 g 0.0143 Tc 3.714 0 Td (medium )Tj 0.243 0.243 0.239 rg -0.035 Tc 9.5041 0 0 10.2 183.61 173.52 Tm ([5])Tj 0.376 0.376 0.372 rg 0 Tc 10.2 0 0 10.2 194.72 173.52 Tm (, )Tj 0.169 g -0.035 Tc 9.8086 0 0 10.2 201.11 173.52 Tm (we )Tj 0.243 0.243 0.239 rg 0.05 Tc 10.6052 0 0 10.2 215.9 173.52 Tm (do )Tj 0.0455 Tc 10.2 0 0 10.2 231.35 173.52 Tm (not )Tj 0.11 0.11 0.106 rg 0 Tc 1.788 0 Td (h)Tj 0.243 0.243 0.239 rg -0.0051 Tc 0.556 0 Td (ave )Tj 0.037 Tc -20.988 -1.034 Td (any )Tj 0.0207 Tc 2.117 0 Td (explanation )Tj 0.0192 Tc 5.506 0 Td (for )Tj 0.0029 Tc 1.891 0 Td (the )Tj 0.0112 Tc 1.826 0 Td (extens)Tj 0.11 0.11 0.106 rg 0 Tc 2.638 0 Td (i)Tj 0.243 0.243 0.239 rg -0.035 Tc 9.5735 0 0 10.2 186.7 162.97 Tm (ve )Tj 0.0082 Tc 10.2 0 0 10.2 201.98 162.97 Tm (changes )Tj -0.0079 Tc 3.908 0 Td (in )Tj 0.0265 Tc 1.418 0 Td (the )Tj 0.0129 Tc -21.079 -1.082 Td (bacterial )Tj -0.0169 Tc 4.035 0 Td (flora. )Tj 0.11 0.11 0.106 rg 0 Tc 2.639 0 Td (I)Tj 0.243 0.243 0.239 rg 0.382 0 Td (n )Tj 0.037 Tc 0.932 0 Td (any )Tj 0.0144 Tc 1.929 0 Td (case)Tj 0.376 0.376 0.372 rg 0 Tc 1.782 0 Td (, )Tj 0.243 0.243 0.239 rg 0.0007 Tc 0.661 0 Td (selection )Tj 0.0163 Tc 4.063 0 Td (pressure )Tj 0.0204 Tc 3.846 0 Td (from )Tj 0.0029 Tc -20.226 -1.082 Td (the )Tj -0.0069 Tc 1.743 0 Td (use )Tj 0.05 Tc 11.1292 0 0 10.2 77.65 140.89 Tm (of )Tj 0.0261 Tc 10.2 0 0 10.2 91.1 140.89 Tm (certa)Tj 0.11 0.11 0.106 rg 0 Tc 2.073 0 Td (i)Tj 0.243 0.243 0.239 rg 0.289 0 Td (n )Tj 0.0239 Tc 0.979 0 Td (antimicrobial )Tj 0.0189 Tc 6.118 0 Td (agents )Tj 0.0252 Tc 3.102 0 Td (such )Tj 0.0261 Tc 2.404 0 Td (as )Tj 0 Tc 1.363 0 Td (\()Tj 0.11 0.11 0.106 rg -0.0079 Tc (in )Tj ET BT /Suspect <>BDC 0.243 0.243 0.239 rg /T1_0 1 Tf 0.0217 Tc 10.2 0 0 10.2 41.1812 130.333 Tm (order\267 )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 11.1292 0 0 10.2 69.01 130.33 Tm (of )Tj 0.0225 Tc 10.2 0 0 10.2 82.48 130.33 Tm (importance\) )Tj 0.0163 Tc 5.551 0 Td (ampic)Tj 0.11 0.11 0.106 rg -0.0097 Tc 2.543 0 Td (illin)Tj 0.376 0.376 0.372 rg 0 Tc 1.592 0 Td (, )Tj 0.243 0.243 0.239 rg 0.0023 Tc 0.759 0 Td (amoxycillin, )Tj 0.0232 Tc 5.553 0 Td (cotri\255)Tj 0.0039 Tc -20.039 -1.083 Td (moxazole )Tj 0.0354 Tc 4.463 0 Td (and, )Tj -0.0217 Tc 2.408 0 Td (to )Tj 0 Tc 1.31 0 Td [(a )-342(lesser )]TJ 0.0177 Tc 3.811 0 Td (extent, )Tj 0.0024 Tc 3.342 0 Td (doxycycl)Tj 0.11 0.11 0.106 rg 0 Tc 3.673 0 Td (i)Tj 0.243 0.243 0.239 rg 0.0015 Tc 0.289 0 Td (ne )Tj 0.037 Tc 1.497 0 Td (and )Tj 0.0215 Tc -20.848 -1.081 Td (erythromycin )Tj 0.0361 Tc 6.307 0 Td (cannot )Tj 0.0078 Tc 3.587 0 Td (be )Tj 0.0029 Tc 1.691 0 Td (the )Tj 0.0301 Tc 1.921 0 Td (explanation )Tj 0.0192 Tc 5.647 0 Td (for )Tj 0.0029 Tc 1.985 0 Td (the )Tj 0.0167 Tc -21.137 -1.083 Td (development )Tj 0.05 Tc 11.1292 0 0 10.2 99.25 97.2 Tm (of )Tj 0.0123 Tc 10.2 0 0 10.2 112.31 97.2 Tm (resistance)Tj 0.376 0.376 0.372 rg 0 Tc 4.075 0 Td (. )Tj 0.169 g 0.05 Tc 10.2667 0 0 10.2 160.73 97.2 Tm (If )Tj 0.243 0.243 0.239 rg 0.0061 Tc 10.2 0 0 10.2 171.82 97.2 Tm (this )Tj -0.0024 Tc 1.883 0 Td (were )Tj 0.0078 Tc 2.34 0 Td (so, )Tj 0.0235 Tc 1.565 0 Td (then )Tj 0.169 g 0.0181 Tc 2.251 0 Td (one )Tj -0.0001 Tc -20.838 -1.082 Td (would )Tj 0.243 0.243 0.239 rg 0.0098 Tc 3.096 0 Td (expect )Tj 0.05 Tc 10.215 0 0 10.2 105.58 86.16 Tm (that )Tj 0.169 g 0.0025 Tc 10.2 0 0 10.2 128.62 86.16 Tm (typical )Tj 0.243 0.243 0.239 rg 0.0323 Tc 3.329 0 Td (strains )Tj 0.05 Tc 11.1292 0 0 10.2 196.69 86.16 Tm (of )Tj /T1_2 1 Tf 0.027 Tc 9.7 0 0 9.7 211.19 86.16 Tm (Streptococcus )Tj 0.0208 Tc -17.581 -1.089 Td (pneumoniae )Tj /T1_0 1 Tf -0.0053 Tc 10.2 0 0 10.2 94.44 75.6 Tm (\(which )Tj 0.11 0.11 0.106 rg 0 Tc 3.305 0 Td (r)Tj 0.243 0.243 0.239 rg 0.0185 Tc 0.32 0 Td (emain )Tj -0.0018 Tc 3.069 0 Td (highly )Tj 0.0112 Tc 2.999 0 Td (sensit)Tj 0.11 0.11 0.106 rg 0 Tc 2.359 0 Td (i)Tj 0.243 0.243 0.239 rg 0.0037 Tc 0.241 0 Td (ve )Tj 0.0253 Tc 1.412 0 Td (to )Tj 0.0052 Tc 1.318 0 Td (these )Tj 0.169 g 0 Tc 9.7 0 0 9.7 358.47 672.73 Tm (o )Tj 0.243 0.243 0.239 rg -0.035 Tc 6.2957 0 0 9.7 368.99 672.73 Tm (..... )Tj 0 Tc 9.7 0 0 9.7 378.63 672.73 Tm (o )Tj 0.169 g -0.035 Tc 6.2957 0 0 9.7 388.67 672.73 Tm (..... )Tj 0 Tc 9.7 0 0 9.7 398.79 672.73 Tm (o )Tj 0.243 0.243 0.239 rg -0.035 Tc 7.6177 0 0 9.7 409.28 672.73 Tm (.......... )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 9.12 0 0 5.28 429.13 672.73 Tm <007E006F00380020>Tj EMC ET BT /T1_1 1 Tf -0.035 Tc 4.0104 0 0 6.5001 449.66 665.05 Tm (....... )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 7.5324 0 0 6.72 358.57 564.24 Tm <003000300030007E00300030007E007E007E0036005C003000380020>Tj EMC ET BT 0.11 0.11 0.106 rg /T1_1 1 Tf 28.4 0 0 28.4 449.01 552.24 Tm (-)Tj ET BT /Suspect <>BDC 0.169 g /C0_0 1 Tf 6.96 0 0 7.2 358.57 354.49 Tm <007E007400270022006C007E007E007E007E007E0064005C003000380020>Tj EMC /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 7.8837 0 0 14.3 449.6 349.69 Tm (.... )Tj EMC /Suspect <>BDC 0.243 0.243 0.239 rg /C0_0 1 Tf 0 Tc 4.9201 0 0 5.76 358.57 251.76 Tm <005C003100220029007E002D005C0031002200290031002800220029007E007E0036005C003000380020>Tj EMC /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 5.2402 0 0 9.2 450.13 243.13 Tm (...... )Tj EMC /Suspect <>BDC 0.11 0.11 0.106 rg 0.05 Tc 8.7055 0 0 5.6 469.44 720.73 Tm (\\0 )Tj EMC ET BT 0.169 g /T1_1 1 Tf -0.035 Tc 4.0104 0 0 6.6 469.82 716.89 Tm (....... )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 6.1 0 0 6.1 469.38 712.09 Tm (0 )Tj EMC /Suspect <>BDC 8.5 0 0 8.5 469.35 705.36 Tm (0 )Tj EMC /Suspect <>BDC 0.243 0.243 0.239 rg /C0_0 1 Tf 7.2 0 0 4.32 469.45 306.49 Tm <007E0020>Tj EMC /Suspect <>BDC /T1_2 1 Tf 0.05 Tc 6.989 0 0 5.1 469.32 302.16 Tm (00 )Tj EMC /Suspect <>BDC 0.169 g /T1_0 1 Tf 0 Tc 6.1 0 0 6.1 469.38 297.37 Tm (0 )Tj EMC /Suspect <>BDC 8.5 0 0 8.5 469.35 291.12 Tm (0 )Tj EMC /Suspect <>BDC 6.4001 0 0 6.4001 469.86 208.57 Tm (0 )Tj EMC /Suspect <>BDC 14.8 0 0 14.8 469.79 200.89 Tm (g )Tj EMC ET BT 0.11 0.11 0.106 rg /T1_1 1 Tf -0.035 Tc 4.0104 0 0 6.6 470.3 193.69 Tm (....... )Tj /T1_0 1 Tf 9.6031 0 0 9.7 507.8 754.33 Tm (41)Tj 0.243 0.243 0.239 rg 0 Tc 9.7 0 0 9.7 517.81 754.33 Tm (9 )Tj ET endstream endobj 44 0 obj <>stream Hd͊zy8 >sRhF^#y QG#Oç==o/ϧ;c_mӷKv|~_oo~y>}~W=|z>{O݇q~?>Ï?o+~ߒ~;%zΏx߽w;>lp?(O?{wٸ^ PZUuTGu^5P5FjFDMԤU PjVjUmFmک]uPuNNE]E5|| _#_k55|| _#_k55|| _#_k55|| _#_k5Z||-_+_kZ||-_+_kZ||-_+_kZ||-_+_ku:||_'_uu:||_'_uu:||_'_uu:||_'_uz||=_/_z||=_/_z||=_/_z||=_/_ || ߀o77 || ߀o77 || ߀o77 || ߀o77 KG#(~? ?G#(~? ?G#(~? ?G#(~? ?z $߄o77MM&|| $߄o77MM&|| $߄o77MM&|| $߄o77MM&||3,ߌo77f||3,ߌo77f||3,ߌo77f||3,ߌo77f|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|ۯ\t;]~~߅ww;]~~߅ww;]~~߅ww;]~~߅w߁w;;|C߁w;;|C߁w;;|C߁w;;|C߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S ߅w]..|K ߅w]..|K ߅w]..|K ߅w]..|?|x>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 18306/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream ,h+m⼭˥ [Ikr ׶Ioc,YJK ,G^|_Mˉ|y&yҙ;Վ0fqdID rd5̞ @2xg"\RCvWU;~qJ~`!gtbp1l[of!5 +AEOHȭ4tbU7f3Ae*d,f2R+k>,)ٱ#*%T鰋1]؃!/Wu!9`ek:R! Fsd>揳Y䒩3܄ހ!ݒ9ާ3+s[xQlJ>7Ik~y<#96)YdG̒M I 93- wB`a4Nm=I^u1 ]u8qB@۔?LĄ,D]7H81~*%?0IUX[aۃ&ޞ.s{lW9a]]"lp:<#R*#ٵݽPcbcilLlTΙuImRp{p2o7G @X߀QlH`vxCZGy0uuZ2j L GbVLfGi&(r5 ~,XB #Ni~U8ױRN [33zShEOÅSP D!'4w>qRiv0 -N\Ve k2 $'B"KKm;[zO&|G:õl"\F{]~LT!H]Ji1yéDqSx>/{I˔axžO"j-,Հ:yڗE[E3,ґVܦ0 =$|}H+ha9>]U%Pq6H` @0wֶrw?%!˦z &Kzt '#}]6YzT{ʹDaASNH p`{ͦQq5FZ69]E>[}Bq^ ]:DU; ,^oPk,syYߑo@ޮ`_@O;7,p^Q4+=s1H k~/1L]fa!7|^Q<DN2*mm ͸=;n?;+ƽ eWzy)S :i|衫0ܱTh}}|3gD*-hg?X,Μb2[Zсq8@:&٪R\$Zd|O?dFEh.FOxyM9[w"wՎkoζe?q{UǷUQ'xwă U,X`$(^0py2Śzy.7[7-G~mme`ɣHCbu$p ܐ/ua2|"si 3ϔMWPe >㥕jDlc~KHތwXRnެĶ4Mk|w[1_=m2Z :Ɇ [}vˆ1BVs:drumh 8vQ5 eƧ7In pΘmLb3hYtӷJ DyJXly/gw7~, |;\+w<*N{nscB?pTu&[iCDrhH%xV|08DG©Dֿk53%TF"xp-)kSTG!QN_,O)F/$k}jh(i'f^h?1PxwU5ah{=bl@\q=vN)YgnRvs…r#0GDJ=-Mَa~&p|L/A]!6*,͊X.Uzr^GJƘUU>ovzɀT`XjUm(T-T|b#$d)GJPU: ީ$cbvZp̘:H+w15 ¤EA#}RRP4E~?",>P]Qv|C*(l X5A"k౏m[luoRu$~%w)Scrhj@-QAnxdio까f7.λW$^3Ig9t=8QvL |NTPco}>٢oZ2@ v"Mȩb1{EҡY<`0 +/SD䣒7S/[6+'bĻ[ dz#NVԌߐ!{Cjq,Z$[(q@6Ih80gB~nʲT=B̛8O툮ϓJ}g'c_LnWreMTVIb't:lrf9$uK W¾@b)/i3V ɮ+iԕ.(͗ڈ`ʇ 磟*~7k*^t>Hg]sۥ%pBFb$ҚeBn_о7'd6eB?PF!Plȇq1;a! 3ɑs;7}sO9O?Gewpz$6i4ί] ũb_;Q"FGc^C%AckS!E3Ĝ7@ےߢ!Qc3BX'r=>)OpSl@SjnEj?݃r{,JTAHT)Ϸux7h:9;4z2vNx ecqdo)TU!lڶAw>.^=G-3*M[qT,hd$G$lm)3B#+B{39?iO~E<Ӊu(T噯bh߽RzF=n5TpOّ_ NIqW(i #@z$+bB@b 2dS̥+yJbܾƼYwXh"~->l&iqPچ!>˫6.P@y4Ez~"͝$Ajc<ZrP1 c#='\VV\ORHE}>R&/-\u];Sq-nmS^T츧`M5ix 83B!_Loئ"r]+{jmU%@UGȐi1㩡Q,~ϲms&G2 ~X1yY)k}Sl 4Kc5 |mMKuXmvX5cX5jY=@G)F"k\ȁ ]?PFQGoZ+"4 iWb?KKt$Mس*0R_8ab7Ɨ"tvQ8*EŒ>Nę;U2 #•qbG -A^&9 ǔl%k3p ?yZZnʎ1BE[X,-8]l+XJxAA)?e/3N͋sOUɄ@;6? YxߤoEĄ M N.' 4wPR/ ~hXX̞X$WBfc(CUpt`77e),ϯs.AdzR/V ,0&k:CjBf6 1_:BGFBg&Z\ 0g5"I|nAu:9x N']A$ۊWO(Arr,Yu@ǃp)M%\J\ gf-YyxʳN46 -5Zj`wIA.(T"aXvi?~O8PA>\QntW/mquI$ R7E ؐr˥EFMEF ؂S3"}W5X%˃9y`)L" W0. 4zor`[qvKϡ H$}̭ {w!_bFfi]AEpiDwrO58Z6}`"1_`á֓g0~>O&A)32qqVÐud:2Nؙ?S!wˀ~*D\J G%cjFGq&lpǨKf$[r:yP *Zj@ȱѼmC6S*C E;X6A!O'mH,vhhaO:}wDtW t)]V<,ۀdI%J-BtSԼM1DWRo& ; {/)o?um*E7E5 JpO'M;ŪN6,7>a<3u~v3'E?OwLqG*ꟶMeW5"o1J$:c-NqvPT(aIs ~~999_ᏻTMQWn@W$FeYgf@\s$ J?dZc9 ﮐ~T Ŧ3o2٭rQ ltYULrM dO8*VV#aw%m5K}6w(Ĩ}!I<:*,dǹ Q=m4rkXe.L<2 <Ր}rZvԄxfPէ2df( ѱ 7p?Fhruf Jcq3:~ v%xGyuqŵ*OLg7Oנrx^sܴ2j;ĵܻTtczCGlp߷)񂰘;>˝iTNmsUkNG])_R>Zaъ{YoZpl9p!PLC+1?Ù^hsd:/بfW̛ޣtY83J7)p6…Jk";F~@d(d°Mx4%# `ɣ BLU8uvڲVi0Akɏ G?ZeYCJdէ0B[#=Kro@.{lA׫[C48MxO7us{ˆ_4++4޳;۸<(q= =,(ۯ9FOf#e_ݶp_ zi+ڔ^{k}wk+Ȍ{ZJ\@H#@CG]&" z6iDT# Cg m^.| _]mmRXwŰT[Hz|o2 ]yLjqwHma `XTcC[mzzK̇y4*-q9.v_oZ&'k inZR]t".|}Mz^=џFn#3 S`5!l:jVt ΂Sjbin xt-Oy?*֐BqI&JN+^7ȑ~ްMv9~aٛiˁ-.7r }wjay hpp~ns}2 6տ@*ICඃ- `s&WqPBFq8z͑9uJي|!T(#hr%6>R&lDXELsk@2ukgS PYrٝlLh8,'lֳ~qh::lr/T44lfšAquwl# 8`1&~G;`nbJ\[-eR,N"o&y=vM]52+@LLp0~ĺ54bQ鍷Mɲdv!2 !A"rEHT|:=Wj{)vIQnѪkj}A֒"ZIg6@+[C힏G*o_R4 `Zy58JwA\rF"jEHߴ@ s'"2yhx UXJG:x%2>K`B;7gp cs\ MN hJ\KghD=H{2雴Ɍ-t7>2αr|n+xQh:ְJB؞hkF(mԇ=JuP,,&Sr|Vt*U 3ajK>Fg"xO!RƌϬr fw;Щg$&rO^ {SҨ `\.A&F_fN?FS>k) g[ yF %cfD,?$0Xw\ }߇ Y4uu(Z" R{ pMEE\(/>C@cSD0p? * <$yf@ddѺRSCq0!çzF/VyJ@ZYhIR#)|f>TM K[ͷ/ c\" [$5նy$ 2е﯉28d`.uwDƤik qs.QOOWeY)AxUMyx(dW:Q(,XA-3Bوxۖ6Gw"TYҴs7T6{jLIϑڏ͎{'r4M?9ҋT7eCKLqν c*jp +J ~Ah:HH? Y s eLS7>ULc~"u >ogD@d=@ 4и Jf8XmjJ5W 1܎xGuEi--XKTIWӐ:xܟBIҠ|x%}o<֨_o 芴dU;&焖(V* ګ~*F5>y^&0Y$`tOA @X! ϋ  gIS%TQ7a3[Iy* 9l%_:#MCsH݊E5nݒe&PUԤ#6gb8.ujrsʥTl˨q=Aa?}~{;$ç^2M^,絻W}C'L_\t,7s*:ruP">)瘍'!M)tυ|-bU[kΨvH$/PtaQl b7Qj%CC'Nut#m+ej> K4@&K\MCDfrV]7V }JuGx'% ,%ehKz5>" LdCuN5KИ 2\Ӧ4(`!ƽC2cCIV"C0?ձvcck Tjkw?ɪ%c~U$q` :AF(sT`]=7xu4koy~0@ ^ 5.$@>>*3=KLక1 {diA.YRO#a7aVt Dv:ߤ?-&9)Y5\e[+Yǣa%:%s'\`=sA5hDaarA1XrB0ZM?3AAa 8 &@10axV<$jx6 wo;y?I1FϺ~24oۜxn2>4;C}so&nFUmV8 Lefɢkkj &h/63a%y:aV*_@󨶋u]Fq-jJ`[F?ojS9EG(2ىT}0Z>_~@g7EΑ? FM[$uQOr- L)ig`>#ьÂ-7`S}9Pgi#L2Uo|AjF`!CpME>?sO z]Y Q]#(Xʵq~=OYs V>N48Fy~jihtKjf2eL9S'XcW,oۨdH@_:ryv4{N\'7`eIoi)O9tڛs+6&q|J5j"HvZ*'eVbgsH$sRnO=*Vg}W"`".$|qRh;;Mh#vꅺ0d)ɐd5,l?;lݼPPsA덖xtWRv3l}ƞ-^K5d9*q fՈHFGxsKk*t ’*L]ZhA}NQ8ށe9ў'|_neG'sP,dn'Pޗ2 xj.P'@׹ԿՓRʤ+-hd4 z3yz5MsHAn 8 uwT _/:w P7MN f*zҧLې`GXJ,w9JK.(F/ʄEeaHE p먴&tC&bʠjC5产{{j*;C=pL8 i9h?䮳L<=Fp-hޠO%u٤8F@>THK:=#r V_+PR5TE-σVw%=Gwx&V]b04xkP𵱍&X%Z4? $0Q?pnvĻX F7뇋 eVAbnh(Z ?:[Q(f}+ ‘b72aSIY-eVyin; ۩b_3*Jell wĶ1a̰P$z1|ŲLGSlM%,ǡ+yC&]HI'ִq_Z[4HQCq=-֓U,jrwwyz.Wt:o#XvG:O)3Zn10K*ޅRd'''~p!Տ "94![Z],Uh,e' !@Z7A:۴'L=^iA$ZkacHJ.x&i`)T &|ϻ|8hYv{ Ill-ICa!-=E:O2Tq0(o#)NqJ' <`H;(W֫W)&q jTLI@n 34-!,Bv3 ] [Mז]8nPWya*dH:[{[+4EaU2JK4&.>8mU[{y̿btH/`][3_*0b0dg]5tyP_v9<.\,=uc?!&6)} f>.6TaNM5 f6,  LEBq^J$@I]]/ D=ŐͫMQQ2٩J!ugȞ6Έ EMK)*bWuޖ+puVNq.g/Mty$W垛N%18tdcۊ5% P=꼔^cd5[I]מr=->poY85(pU?QJnjOET X%k28֥Pdu]_4es!7>v{ Tf.˦MZ3p9U$)W*xf߀̑??Wr^_46ׇymCt>< -NHg+g wviJV']_+˫V!eC[8Q^MAzŕ(URjH[T@@H*8'(/ Osj7pLԲ}H>Ss6Zz ߖ#cm= KK \BFΐ#9sP  Ї;}@j8f,?$YT'ձ:[#z 5Jޒ^HOA~ѩ$r+W8)S#V?Bg >4f6Le2r7)itREgRCzyBtOg7_'`yaG[~&גۉg%S3YC:9a'С*ex0d8W*TC7u_Qpe- L*3ͥ :skumcsGr$23s)IRd3"Zd]:F+uo|9-u-=3d>yT ,CPC VM.ӻ=_#t2^y+'60&mꊪˋ:q.Kh-)YG=[|?ӍDinJlEz ʥ,ʛ }TMTJ-)X}#{=`2_ bTi3)2 eZ+(CGaU] k;F/q.l;Ѣ܄KA qw:(\ 8.]a/`7bjb^Q$]2v:/[V.-x܉"RA@{,/Sy~OS4[Reb6Oz5םۓoUI{7>VcPD"Ċ7mIe6Z;3]\<7;Z8 fAS]1]i'Q(L]*=2kEdŃwp/H(/U_>~4y6wcAq㼢/@éC/ /k웽)m$q~^bߵƏ 2T{ 7% =ռ@!tnw-_j5[ Maڠׄ_A c]٤a=ThtP{ƫǤ =; 듂 T:e`9?C-CS3OgbF)+i2O}vu÷%Ъz_͵ntJv[RF+ Kb{VEdNOm.gOG~̕yj3#tu&fft{Hawh \? 4՟:%7MV3&s!DK?0lOb?xFa\ܱV)jϜiDp?6_ړR_h j5JʾY2M:w>VRK Vcƴ cw!uĘ$.(iu&P(c%MfWFu[ᫌR)Mcr|q˄ ۗ)QgAEAtJoُ9!qaWM\5lTS)G&LW;xn()6EC Fg<;chRqH.sK,e{R'ZQEkAquzAͨy7Zh)sl:kbU U`NbGrdEZB Mo[-ށKxxL;C h`|x{j)"NƐx V[''=%N fD?Jh|aF<6Ȳ3,잻72'8p8z/_oZLw }AH^J(P(롦#6v>2K Ao 0}=U_ &`@BDhCK*)ؾ9ᲁCr44_Kഺx?`ZGdȏ7uV6ǴiEcfhgXS-`ܶZ_Q;DGz 7"?M)=_MdD m6'ݑ7 L@:qŏvc$kΩ8DeÉ-Wɀ3,.<$ w>Ar>H$4! ~%}`,sHjr;Da1%!A%|PSCF^i@ٝoze~P 39,<:)2^+Zr Utךl{;#x;/'_O2Kqk͛5/vgny!ٻ7xUt0$jJ7e!JGA4e 5 endstream endobj 46 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrfcolr 8jp2cOQ/ffR \#B@HHPHHPHHPHHP880 ߂(fB+{!G3=U8m}D-.;{X:Pg4N;uKoo({{@ҩORi V7.j`Zm3O"Bd&W(pu@Y Lw1V/5y4B d_e A4X q/MIȖmf,;U`M$Uhf7h$T_/%ѣ w%_ ̏\ꖨ^;ڭ}٥xt4E4%w}q s8Q_ 'o |<z3{0F]dKtDp]R&|X@i"5r3V.~#乤J_|+@&6رj&f3jXPyʽv XDiKhSr e kjLlB{! G5togPCMW8@ﳋm~.W !&ְovNm-(_ߐ,Th ֳ]ͼ4'0'-pޟ3]stJєV7kSbHW]4JĉQ9ʉE .ۑ}gD׃/#< W##)|&ZHѤ`&Jf}=H%Z$/=Λfl܁*Ђ Xb|W,o$ b]#Fz֏ K[Mҿ-E E/8ũOy)re4^g3X\(@& ا[FՑ IY E`? !k3hЏm$8NAY,Hͫ{BXZ u1µn\tH݂SC&Z`MP/C7t/jont`(;-(q_aͼ/%YY#PmT~y?R!'@n-44JƖJ{mz Ц(2L8(X%x,CRڙIёc|;ϲ)6Պl,^Ko^sEW$~qoj)M6Y0:h$ oydM]R!{m=:/Ó܉7!.r K0,."KY˶^Acbb+~&^t1.G5Q<y}k˶Hq z^kVHJ[/c㊋{iN>h/ԇ7/)?Ϡүe*BOvsb*9Eۛ<_v)T`^qo;ENCmhU.YMER<S8(tݧ"z8]%LԀ r'kZGeu~J֧"ȿ:oS}**@Nk/ٯ dObۃRRY02\+H^Yj+p Y}  ֜/5N?b&2r'[-9n!ⶢ,NZ_DEr&,ņmA3԰fkJh oHr_d VLʧr'wSor4Wy,gnЎmdGW!gtΪ@&X{Że< %E`w<^.@UV*hE0 .V ޅ47'U&3x!=4vYHAͦw.HI;GyY<w;qh\9K Y&T}ruAVE4{O ]' #K14zfXWh>ZL0`tWGJVO1ْ4mŌ6xZhl(G3KBxe=+^+|߼9  t$- AݘL["BHA/ף뢳2Θ=u$ܫh&j^ҮBU\2`Q(גy?S$anl> 1ژ$麭n# &[A9-,:'IqD+9Yƣ&o@.l;V,6|NðWdVCW%87#d::ʻ[fٸvsR(7=8{ r6t)ťK(b j><ŇPb6M2C_(hu+5( "~A.MaNr|.n\ cSvXƳfEcۜMYV.R$ _8&v*oE T5\5sj%_W<I8IHt&='NBk^>EbTG#eypQyvͤCٱۻ3U1' Hop=c-G0,wU&tԢKi endstream endobj 47 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrFFcolrFjp2cOQ/FFFFR \#B@HHPHHPHHPHHP880 &ϴ4wAED~t0 &)|"@:Ѐ5Ȁ 3:, Zq$z?:<I x{)n I4Hr fa6u-zY€ gNRu endstream endobj 48 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colrljp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t  "@:@ @ ɠ>    endstream endobj 49 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr#&colrjp2cOQ/&#&#R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴEt0" % :@>@ |"I4 p"O `3G*  endstream endobj 50 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr6colrhjp2cOQ/66R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ  t ! : m ڀ   }   endstream endobj 51 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrRjp2cOQ/R \#B@HHPHHPHHPHHP880 >߀;`t/!>'&GLL p ZaytpfG @G,7XmiuȃL ?7th$ۼYUU: 8&(>!@9zY>A ՛|W<'4|x E:>AG`9Kӟ',iy=N_ AD. i K?)'5tBF)՛G,/X}"3NEEHl 0^rDa4  * !}n󌓽WCrn ~?%1N~ЈKdEquC>n"D܃j sО^{] s9%c$9(`eu_u Ǖ2GLP endstream endobj 52 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrqjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt  -@ :> U 4::    endstream endobj 53 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr*.colrkjp2cOQ/.*.*R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴPC $" :  pL"    endstream endobj 54 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolr{jp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴt @ *:> U 4 B H  J*['x  endstream endobj 55 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr8colrjp2cOQ/88R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴDEd " 6:$ȏ3|":@/U00:  (|%@:@v#RI@t &RONAUrrFaP~U  $y@Kc?8w1 2>ƭnj;#uC`{ɇHQSr endstream endobj 56 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr6,colrjp2cOQ/,6,6R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ4CPA" , :Ѐ c B : ~|# b%0Y @>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr"colrpjp2cOQ/""R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t  ": |" b#RYʀ   endstream endobj 58 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr&colr}jp2cOQ/&&R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t ! # : @@ ": >l: -   endstream endobj 59 0 obj <>stream h޲4P0P4T0U4R0W0475R0Q04210>@ endstream endobj 60 0 obj <>/ProcSet[/PDF/Text/ImageB/ImageC]/XObject<>>>/Rotate 0/Type/Page>> endobj 61 0 obj <>stream q 0.196 0.196 0.196 rg 595.1999969 0 0 840.9600067 0 0 cm /Im0 Do Q q 82.0800018 0 0 168 0 632.1600037 cm /Im1 Do Q q 264 0 0 22.0800018 86.8800049 778.0800018 cm /Im2 Do Q q 12.9600067 0 0 68.1600037 0 348 cm /Im3 Do Q q 20.6399994 0 0 28.8000031 0 317.2799988 cm /Im4 Do Q q 12.9600067 0 0 37.4400024 0 271.1999969 cm /Im5 Do Q q 12.9600067 0 0 16.3200073 0 225.1199951 cm /Im6 Do Q q 28.3200073 0 0 95.5200043 0 0 cm /Im7 Do Q q 17.7599945 0 0 11.0399933 33.6000061 0 cm /Im8 Do Q q 219.8399963 0 0 37.4400024 363.3600006 764.6399994 cm /Im9 Do Q BT /Suspect <>BDC 0.243 0.243 0.239 rg /T1_0 1 Tf -0.035 Tc 3 Tr 10.8575 0 0 11.2 58.99 752.41 Tm (420 )Tj EMC ET BT 0.169 g /T1_0 1 Tf 0.05 Tc 10.0802 0 0 7.6 233.23 752.89 Tm (B.l. )Tj ET BT /Suspect <>BDC 0.243 0.243 0.239 rg /T1_0 1 Tf 8.689 0 0 8.2 253.88 752.89 Tm (DAVIES, )Tj EMC ET BT /T1_0 1 Tf 9.713 0 0 8.2 295.16 752.89 Tm (F.P.V. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0467 Tc 8.2 0 0 8.2 327.8 752.89 Tm (MAESEN )Tj EMC ET BT 0.169 g /T1_0 1 Tf 0.0103 Tc 10.3 0 0 10.3 59.41 728.89 Tm (agents\) )Tj 0.243 0.243 0.239 rg 0.0055 Tc 3.272 0 Td (would )Tj 0.0095 Tc 2.889 0 Td (have )Tj 0.0146 Tc 2.228 0 Td (disappeared. )Tj 0.05 Tc 10.5116 0 0 10.3 202.95 728.89 Tm (That )Tj 0.0013 Tc 10.3 0 0 10.3 227.01 728.89 Tm (this )Tj -0.035 Tc 10.1489 0 0 10.3 245.68 728.89 Tm (is )Tj 0.0389 Tc 10.3 0 0 10.3 255.83 728.89 Tm (not )Tj 0.0203 Tc 1.722 0 Td (the )Tj 0.0088 Tc -20.838 -1.072 Td (case )Tj 0.0277 Tc 1.965 0 Td (may )Tj -0.0007 Tc 2.038 0 Td (sometimes )Tj -0.035 Tc 10.1515 0 0 10.3 147.37 717.85 Tm (be )Tj 0.0203 Tc 10.3 0 0 10.3 159.33 717.85 Tm (the )Tj 0.013 Tc 1.493 0 Td (result )Tj 0.05 Tc 10.5727 0 0 10.3 201.02 717.85 Tm (of )Tj 0.0203 Tc 10.3 0 0 10.3 212.13 717.85 Tm (the )Tj 0.0014 Tc 1.496 0 Td (presence )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 4.9201 0 0 7.68 266.4 717.85 Tm <006F0066007E00AD>Tj EMC ET BT /T1_0 1 Tf 0.0039 Tc 10.3 0 0 10.3 59.45 706.8 Tm (Iactamase )Tj 0.0188 Tc 4.483 0 Td (producing )Tj /T1_1 1 Tf -0.035 Tc 9.8837 0 0 9.9 153.67 706.8 Tm (B. )Tj 0.0082 Tc 9.9 0 0 9.9 166.96 706.8 Tm (catarrhalis )Tj /T1_0 1 Tf 0.05 Tc 10.5727 0 0 10.3 215.9 706.8 Tm (or )Tj 0.169 g /T1_2 1 Tf 9.6096 0 0 9.4 229.8 706.8 Tm (H. )Tj 0.243 0.243 0.239 rg /T1_1 1 Tf 0.009 Tc 9.9 0 0 9.9 245.16 706.8 Tm (injfuenzae )Tj /T1_0 1 Tf 0.02 Tc 10.3 0 0 10.3 58.89 696.24 Tm (strains )Tj 0.0138 Tc 3.081 0 Td (destroying )Tj -0.0097 Tc 4.718 0 Td (penicillins )Tj 0.05 Tc 10.6532 0 0 10.3 184.69 696.24 Tm (and )Tj 0.0047 Tc 10.3 0 0 10.3 204.93 696.24 Tm (thus )Tj 0.169 g 0.0222 Tc 2.055 0 Td (protecting )Tj 0.243 0.243 0.239 rg 0.0203 Tc 4.609 0 Td (the )Tj 0.0065 Tc -20.826 -1.071 Td (pneumococci. )Tj 0.05 Tc 10.583 0 0 10.3 120.94 685.21 Tm (At )Tj 0.0203 Tc 10.3 0 0 10.3 135.33 685.21 Tm (the )Tj 0.0079 Tc 1.619 0 Td (same )Tj -0.0161 Tc 2.435 0 Td (time, )Tj 0.0203 Tc 2.377 0 Td (the )Tj 0.0069 Tc 1.532 0 Td (inexplicable )Tj 0.001 Tc 5.274 0 Td (rise )Tj -0.0152 Tc -20.652 -1.025 Td (in )Tj /T1_1 1 Tf 0.0115 Tc 9.9 0 0 9.9 73.03 674.65 Tm (Branhame/la )Tj 0.0033 Tc 5.9 0 Td (catarrha/is )Tj /T1_0 1 Tf -0.0152 Tc 10.3 0 0 10.3 181.35 674.65 Tm (in )Tj 0 Tc 1.35 0 Td (a )Tj 0.0006 Tc 0.988 0 Td (relatively )Tj 0.0333 Tc 4.279 0 Td (constant )Tj 0.0224 Tc -18.502 -1.072 Td (antibiotic )Tj 0.0032 Tc 4.382 0 Td (climate )Tj 0.04 Tc 3.402 0 Td (cannot )Tj -0.035 Tc 10.1515 0 0 10.3 173.29 663.61 Tm (be )Tj 0.0006 Tc 10.3 0 0 10.3 187.09 663.61 Tm (explained )Tj 0.169 g -0.0118 Tc 4.392 0 Td (by )Tj 0.243 0.243 0.239 rg 0.0297 Tc 1.433 0 Td (any )Tj 0.0191 Tc 1.907 0 Td (such )Tj 0.0022 Tc -20.179 -1.073 Td (selection )Tj 0.0069 Tc 4.164 0 Td (process )Tj 0.0297 Tc 3.622 0 Td (and )Tj -0.035 Tc 10.1489 0 0 10.3 161.2 652.56 Tm (is )Tj 0.05 Tc 10.4827 0 0 10.3 173.75 652.56 Tm (not )Tj -0.0038 Tc 10.3 0 0 10.3 193.9 652.56 Tm (merely )Tj -0.003 Tc 3.401 0 Td (the )Tj 0.0036 Tc 1.866 0 Td (result )Tj 0.05 Tc 11.1292 0 0 10.3 277.33 652.56 Tm (of )Tj 0.169 g 0.0083 Tc 10.3 0 0 10.3 58.95 642 Tm (increased )Tj 0.243 0.243 0.239 rg 0.0067 Tc 4.425 0 Td (awareness )Tj 0.169 g -0.0152 Tc 4.802 0 Td (in )Tj 0.243 0.243 0.239 rg -0.003 Tc 1.45 0 Td (the )Tj 0.018 Tc 1.858 0 Td (laboratory. )Tj /T1_3 1 Tf 0.05 Tc 13.1112 0 0 10 241.56 642 Tm (It )Tj 0.169 g /T1_0 1 Tf -0.035 Tc 10.1489 0 0 10.3 255.28 642 Tm (is )Tj 0.243 0.243 0.239 rg 0.0001 Tc 10.3 0 0 10.3 267.82 642 Tm (very )Tj 0.0256 Tc -20.326 -1.071 Td (curious )Tj 0.0455 Tc 3.409 0 Td (that )Tj 0.0203 Tc 1.957 0 Td (the )Tj 0.0115 Tc 1.531 0 Td (development )Tj 0.05 Tc 11.1292 0 0 10.3 187.09 630.97 Tm (of )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 4.5382 0 0 7.68 199.68 630.97 Tm <007E002D006C0061006300740061006D0061007300650020>Tj EMC ET BT /T1_0 1 Tf 0.027 Tc 10.3 0 0 10.3 252.5 630.97 Tm (produc\255)Tj -0.0013 Tc -18.791 -1.073 Td (ing )Tj 0.169 g /T1_1 1 Tf 0.0115 Tc 9.9 0 0 9.9 77.83 619.92 Tm (Branhamel/a )Tj 0.243 0.243 0.239 rg 0.0082 Tc 5.9 0 Td (catarrha/is )Tj /T1_0 1 Tf 0.035 Tc 10.3 0 0 10.3 186.71 619.92 Tm (has )Tj -0.0041 Tc 1.959 0 Td (been )Tj 0.0003 Tc 2.459 0 Td (described )Tj -0.0152 Tc 4.475 0 Td (in )Tj 0.169 g 0.0057 Tc -21.292 -1.025 Td (Western )Tj 0.243 0.243 0.239 rg 0.0219 Tc 3.959 0 Td (Europe)Tj 0.365 0.365 0.357 rg 0 Tc (, )Tj 0.243 0.243 0.239 rg 0.0434 Tc 3.771 0 Td (Great )Tj 0.0152 Tc 2.941 0 Td (Britain )Tj 0.0297 Tc 3.35 0 Td (and )Tj 0.169 g -0.0152 Tc 2.052 0 Td (in )Tj 0.243 0.243 0.239 rg 0.0203 Tc 1.311 0 Td (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0258 Tc 10.3 0 0 10.3 256.7912 609.3625 Tm (United )Tj EMC /Suspect <>BDC 0.0146 Tc -19.217 -1.071 Td (States )Tj EMC ET BT /T1_0 1 Tf 0.0195 Tc 10.3 0 0 10.3 89.6531 598.3312 Tm (almost )Tj 0.0043 Tc 3.309 0 Td (exactly )Tj 0.05 Tc 10.7518 0 0 10.3 159.25 598.33 Tm (at )Tj -0.003 Tc 10.3 0 0 10.3 173.73 598.33 Tm (the )Tj 0.0079 Tc 1.759 0 Td (same )Tj -0.0003 Tc 2.668 0 Td (time )Tj 0.0297 Tc 2.322 0 Td (and )Tj 0.0159 Tc 2.098 0 Td (quite )Tj 0.169 g 0.0055 Tc -19.991 -1.026 Td (independently. )Tj 0.243 0.243 0.239 rg 0.0192 Tc 6.482 0 Td (Moreover, )Tj 0.05 Tc 10.615 0 0 10.3 174.63 587.76 Tm (it )Tj -0.035 Tc 10.1489 0 0 10.3 185.2 587.76 Tm (is )Tj 0.0028 Tc 10.3 0 0 10.3 196.31 587.76 Tm (now )Tj 0.0212 Tc 2.135 0 Td (clear )Tj 0.0455 Tc 2.43 0 Td (that )Tj 0.0002 Tc 2.097 0 Td (these )Tj 0.0133 Tc -19.999 -1.071 Td (organisms )Tj 0.0252 Tc 4.426 0 Td (are )Tj 0.0317 Tc 1.5 0 Td (more )Tj 0.0077 Tc 2.368 0 Td (frequently )Tj 0.0061 Tc 4.474 0 Td (found )Tj -0.0152 Tc 2.658 0 Td (in )Tj 0.0097 Tc 1.025 0 Td (industrialized )Tj 0.0136 Tc -16.498 -1.073 Td (districts )Tj 0.0036 Tc 3.63 0 Td (such )Tj -0.0287 Tc 2.241 0 Td (as )Tj 0.0181 Tc 1.204 0 Td (Scotland )Tj -0.035 Tc 9.4074 0 0 10.3 172.57 565.68 Tm ([9], )Tj 0.0297 Tc 10.3 0 0 10.3 189.49 565.68 Tm (and )Tj 0.0203 Tc 1.918 0 Td (the )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0278 Tc 10.3 0 0 10.3 226.0653 565.68 Tm (USA )Tj EMC /Suspect <>BDC -0.035 Tc 9.7536 0 0 10.3 250.8 565.68 Tm ([10] )Tj EMC ET BT /T1_0 1 Tf 0.0297 Tc 10.3 0 0 10.3 270.13 565.68 Tm (and )Tj 0.0455 Tc -20.497 -1.071 Td (that )Tj 0.0022 Tc 1.911 0 Td (they )Tj 0.011 Tc 1.996 0 Td (also )Tj 0.0384 Tc 1.911 0 Td (appear )Tj 0.0176 Tc 3.13 0 Td (to )Tj -0.0014 Tc 1.122 0 Td (be )Tj -0.005 Tc 1.2 0 Td (affected )Tj -0.0118 Tc 3.507 0 Td (by )Tj 0.0203 Tc 1.254 0 Td (the )Tj -0.0003 Tc 1.538 0 Td (time )Tj 0.05 Tc 10.5727 0 0 10.3 261.5 554.65 Tm (of )Tj 0.0203 Tc 10.3 0 0 10.3 273.09 554.65 Tm (the )Tj 0.0095 Tc -20.829 -1.025 Td (year. )Tj 0.0479 Tc 2.555 0 Td (That )Tj 0.0013 Tc 2.569 0 Td (this )Tj 0.0228 Tc 2.009 0 Td (phenomenon )Tj 0.0209 Tc 5.907 0 Td (could )Tj -0.0014 Tc 2.853 0 Td (be )Tj 0.0286 Tc 1.481 0 Td (due )Tj 0.0176 Tc 2.057 0 Td (to )Tj 0.0203 Tc 1.398 0 Td (the )Tj 0.0122 Tc -20.838 -1.072 Td (changing )Tj -0.0021 Tc 4.334 0 Td (degrees )Tj 0.05 Tc 11.1292 0 0 10.3 141.01 533.05 Tm (of )Tj 0.0383 Tc 10.3 0 0 10.3 155.89 533.05 Tm (air )Tj 0.0161 Tc 1.737 0 Td (pollution )Tj 0.0153 Tc 4.378 0 Td (with )Tj 0.0042 Tc 2.415 0 Td (oxides )Tj 0.05 Tc 11.1292 0 0 10.3 277.33 533.05 Tm (of )Tj 0.0325 Tc 10.3 0 0 10.3 58.41 522.48 Tm (sulphur )Tj 0.0297 Tc 3.452 0 Td (and )Tj 0.0174 Tc 1.827 0 Td (nitrogen )Tj 0.169 g -0.035 Tc 10.1489 0 0 10.3 151.12 522.48 Tm (is )Tj 0.243 0.243 0.239 rg 0 Tc 10.3 0 0 10.3 160.21 522.48 Tm (a )Tj -0.0006 Tc 0.805 0 Td (possible )Tj 0.169 g 0.0046 Tc 3.585 0 Td (hypothesis, )Tj 0.243 0.243 0.239 rg 0.042 Tc 4.895 0 Td (but )Tj 0.0203 Tc 1.674 0 Td (the )Tj 0.017 Tc -20.838 -1.072 Td (question )Tj 0.0218 Tc 3.783 0 Td (must )Tj -0.0068 Tc 2.271 0 Td (still )Tj 0.0233 Tc 1.691 0 Td (remain )Tj 0.0063 Tc 3.114 0 Td (completely )Tj 0.0044 Tc 4.753 0 Td (open. )Tj 0.169 g 0.0206 Tc 2.524 0 Td (Although )Tj 0.243 0.243 0.239 rg 0.0203 Tc -18.129 -1.071 Td (the )Tj 0.0185 Tc 1.671 0 Td (Gram-negative )Tj 0.0146 Tc 6.626 0 Td (respiratory )Tj 0.0131 Tc 4.943 0 Td (pathogens )Tj 0.169 g 0.0252 Tc 4.601 0 Td (are )Tj 0.243 0.243 0.239 rg -0.0067 Tc 1.687 0 Td (highly )Tj -0.0027 Tc -19.54 -1.026 Td (sensitive )Tj 0.05 Tc 10.4772 0 0 10.3 100.77 489.84 Tm (to )Tj -0.003 Tc 10.3 0 0 10.3 116.61 489.84 Tm (the )Tj 0.169 g -0.0036 Tc 1.913 0 Td (newer )Tj 0.0201 Tc 3.067 0 Td (quinolone )Tj 0.243 0.243 0.239 rg 0.0138 Tc 4.799 0 Td (agents )Tj 0.0036 Tc 3.258 0 Td (such )Tj 0.05 Tc 10.4714 0 0 10.3 276.85 489.84 Tm (as )Tj 0.169 g 0.0006 Tc 10.3 0 0 10.3 58.46 478.81 Tm (oftoxacin, )Tj 0.243 0.243 0.239 rg 0.0048 Tc 4.614 0 Td (only )Tj 0.0153 Tc 2.383 0 Td (time )Tj -0.0346 Tc 2.425 0 Td (will )Tj -0.02 Tc 2.049 0 Td (tell )Tj 0.0081 Tc 1.866 0 Td (whether )Tj 0.0203 Tc 3.866 0 Td (the )Tj 0.0052 Tc 1.866 0 Td (relative )Tj 0.169 g -0.0017 Tc -19.068 -1.073 Td (insensitivity )Tj 0.243 0.243 0.239 rg 0.05 Tc 11.1292 0 0 10.3 114.13 467.76 Tm (of )Tj -0.0258 Tc 10.3 0 0 10.3 128.45 467.76 Tm (S. )Tj 0.169 g /T1_1 1 Tf 0.0147 Tc 9.9 0 0 9.9 141.93 467.76 Tm (pneumoniae )Tj 0.243 0.243 0.239 rg /T1_0 1 Tf 0.05 Tc 10.4772 0 0 10.3 197.25 467.76 Tm (to )Tj 0.0002 Tc 10.3 0 0 10.3 211.65 467.76 Tm (these )Tj 0.0138 Tc 2.555 0 Td (agents )Tj 0.0494 Tc 3.155 0 Td ([II] )Tj 0.0046 Tc -20.63 -1.072 Td (causes )Tj 0.0159 Tc 2.994 0 Td (problems )Tj -0.0152 Tc 4.137 0 Td (in )Tj 0.0196 Tc 1.117 0 Td (actual )Tj 0.0002 Tc 2.855 0 Td (practice. )Tj 0.169 g /T1_4 1 Tf -0.0303 Tc 9.2 0 0 9.2 151.63 426 Tm (References )Tj 0.243 0.243 0.239 rg /T1_3 1 Tf 0.05 Tc 8.7408 0 0 7.5001 58.8 410.65 Tm (I. )Tj /T1_0 1 Tf 0.0225 Tc 8.2 0 0 8.2 72.44 410.65 Tm (Mulder )Tj 0.169 g 0 Tc 3.394 0 Td (J)Tj 0.365 0.365 0.357 rg 0.459 0 Td (, )Tj 0.243 0.243 0.239 rg 0.0213 Tc 0.533 0 Td (Goslings )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0394 Tc 8.2 0 0 8.2 141.5742 410.65 Tm (WRO, )Tj EMC /Suspect <>BDC 0.05 Tc 8.7427 0 0 8.2 166.54 410.65 Tm (Vander )Tj EMC /Suspect <>BDC 0.169 g -0.0035 Tc 8.2 0 0 8.2 197.24 410.65 Tm (Plas )Tj EMC /Suspect <>BDC 0.243 0.243 0.239 rg 0.0394 Tc 2.049 0 Td (MC, )Tj EMC ET BT /T1_0 1 Tf 0.0083 Tc 8.2 0 0 8.2 232.7624 410.65 Tm (Lopez )Tj 0.0346 Tc 2.863 0 Td (Cardozo )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0297 Tc 8.2 0 0 8.2 58.0368 401.5316 Tm (P. )Tj EMC /Suspect <>BDC 0.365 0.365 0.357 rg 0 Tc 1.106 0 Td (-)Tj 0.243 0.243 0.239 rg 0.0227 Tc 0.812 0 Td (Studies )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.3916 0 0 8.2 100.72 401.53 Tm (on )Tj 0.0058 Tc 8.2 0 0 8.2 112.3 401.53 Tm (the )Tj 0.0266 Tc 1.522 0 Td (treatment )Tj 0.0144 Tc 4.274 0 Td (with )Tj 0.0315 Tc 2.099 0 Td (anti )Tj 0.0184 Tc 1.65 0 Td (bacteria)Tj 0 g 0 Tc 3.256 0 Td (.)Tj 0.169 g 0.046 0 Td (! )Tj 0.243 0.243 0.239 rg 0.0175 Tc 0.55 0 Td (drugs )Tj 0.05 Tc 8.9033 0 0 8.2 243.28 401.53 Tm (of )Tj 0.0324 Tc 8.2 0 0 8.2 252.4 401.53 Tm (acute )Tj 0.169 g 0.045 Tc 2.459 0 Td (and )Tj 0.243 0.243 0.239 rg 0.0308 Tc -26.224 -1.054 Td (chronic )Tj 0.0189 Tc 3.64 0 Td (bronchitis )Tj 0.0224 Tc 4.555 0 Td (caused )Tj 0.0047 Tc 3.348 0 Td (by )Tj 0.169 g /T1_1 1 Tf 0.0096 Tc 8 0 0 8 164.23 392.89 Tm (Haemophi/us )Tj 0.243 0.243 0.239 rg -0.0019 Tc 5.919 0 Td (influenzae. )Tj 0.05 Tc 8.0193 0 0 8 250.68 392.89 Tm (Acta )Tj 8.0208 0 0 8 270.8 392.89 Tm (Med )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0113 Tc 8 0 0 8 58.07 383.76 Tm (Scand, )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 8.1597 0 0 8.2 83.72 383.76 Tm (1952)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 99.23 383.76 Tm (, )Tj 0.243 0.243 0.239 rg -0.0327 Tc 0.626 0 Td (143, )Tj 0.0293 Tc 2.013 0 Td (32-49. )Tj 0 Tc -7.663 -1.111 Td (2)Tj 0.365 0.365 0.357 rg 0.512 0 Td (. )Tj 0.243 0.243 0.239 rg 0.0105 Tc 1.187 0 Td (Davies )Tj -0.035 Tc 8.2945 0 0 8.8 99.32 374.65 Tm (BI, )Tj 0.0129 Tc 8.2 0 0 8.2 113.24 374.65 Tm (Macsen )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0135 Tc 8.2 0 0 8.2 143.4898 374.65 Tm (FPV. )Tj EMC ET BT 0.365 0.365 0.357 rg /T1_0 1 Tf 0 Tc 8.2 0 0 8.2 165.0312 374.65 Tm (-)Tj 0.243 0.243 0.239 rg 0.05 Tc 8.2125 0 0 8.2 172.73 374.65 Tm (The )Tj 0.0122 Tc 8.2 0 0 8.2 190 374.65 Tm (diagnosis )Tj 0.045 Tc 4.332 0 Td (and )Tj 0.0266 Tc 1.998 0 Td (treatment )Tj 0.05 Tc 9.4598 0 0 8.2 278.31 374.65 Tm (of )Tj 0.018 Tc 8.2 0 0 8.2 58.07 366 Tm (respiratory )Tj 0.169 g -0.0017 Tc 5.202 0 Td (infections. )Tj 0.243 0.243 0.239 rg /T1_1 1 Tf -0.035 Tc 7.5224 0 0 8.7 141.2 366 Tm (In)Tj 0.365 0.365 0.357 rg 0 Tc 8.7 0 0 8.7 148.17 366 Tm (: )Tj 0.243 0.243 0.239 rg /T1_0 1 Tf 8.2 0 0 8.2 155.03 366 Tm (A )Tj 0.0014 Tc 1.338 0 Td (clinical )Tj 0.0304 Tc 3.629 0 Td (approach )Tj 0.0449 Tc 4.573 0 Td (to )Tj 0.0108 Tc 1.467 0 Td (progress )Tj 0.0001 Tc 4.088 0 Td (in )Tj 0.169 g 0.0064 Tc -26.927 -1.111 Td (infectious )Tj 0.243 0.243 0.239 rg 0.002 Tc 4.623 0 Td (diseases)Tj 0.365 0.365 0.357 rg 0 Tc 3.267 0 Td (. )Tj 0.243 0.243 0.239 rg -0.035 Tc 7.9213 0 0 8.2 130.53 356.89 Tm (W. )Tj 0.169 g 0.005 Tc 8.2 0 0 8.2 145.88 356.89 Tm (Brumfitt)Tj 0.365 0.365 0.357 rg 0 Tc 3.501 0 Td (, )Tj 0.243 0.243 0.239 rg 0.036 Tc 0.888 0 Td (J.M.T. )Tj 0.0184 Tc 3.513 0 Td (Hamilton-Miller )Tj 0.0061 Tc 7.487 0 Td (eds. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0239 Tc 8.2 0 0 8.2 57.5168 348.2472 Tm (Oxford )Tj EMC ET BT /T1_0 1 Tf 0.0067 Tc 8.2 0 0 8.2 85.4296 348.2472 Tm (University )Tj ET BT /Suspect <>BDC 0.169 g /T1_0 1 Tf -0.0006 Tc 8.2 0 0 8.2 123.3218 348.2472 Tm (Press, )Tj EMC ET BT 0.243 0.243 0.239 rg /T1_0 1 Tf -0.035 Tc 7.8965 0 0 8.2 146.61 348.25 Tm (1983)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 161.63 348.25 Tm (, )Tj 0.243 0.243 0.239 rg -0.035 Tc 8.1261 0 0 8.2 167.24 348.25 Tm (132)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 178.95 348.25 Tm (-)Tj 0.243 0.243 0.239 rg -0.035 Tc 7.9309 0 0 8.2 184.05 348.25 Tm (158. )Tj -0.0107 Tc 8.2 0 0 8.2 310.47 728.89 Tm (3. )Tj 0.0147 Tc 1.757 0 Td (Cowan )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0393 Tc 8.2 0 0 8.2 350.7238 728.89 Tm (ST)Tj 0.365 0.365 0.357 rg 0 Tc 1.173 0 Td (, )Tj EMC /Suspect <>BDC 0.243 0.243 0.239 rg -0.0074 Tc 0.466 0 Td (Steel )Tj EMC ET BT 0.169 g /T1_0 1 Tf -0.0063 Tc 8.2 0 0 8.2 382.9908 728.89 Tm (KJ.)Tj 0.565 0.569 0.557 rg 0 Tc 1.574 0 Td (-)Tj 0.243 0.243 0.239 rg 0.0356 Tc 0.884 0 Td (Manual )Tj -0.0072 Tc 3.506 0 Td (for )Tj 0.05 Tc 8.3786 0 0 8.2 443.5 728.89 Tm (the )Tj 0.015 Tc 8.2 0 0 8.2 456.41 728.89 Tm (identification )Tj 0.05 Tc 9.4598 0 0 8.2 503.91 728.89 Tm (of )Tj 0.0009 Tc 8.2 0 0 8.2 513.1 728.89 Tm (medical )Tj 0.0068 Tc -24.64 -1.055 Td (bacteria. )Tj 0.0186 Tc 3.852 0 Td (Cambridge )Tj 0.0002 Tc 4.984 0 Td (University )Tj ET BT /Suspect <>BDC 0.169 g /T1_0 1 Tf -0.0006 Tc 8.2 0 0 8.2 421.3994 720.239 Tm (Press, )Tj EMC ET BT 0.243 0.243 0.239 rg /T1_0 1 Tf 0.0372 Tc 8.2 0 0 8.2 443.9576 720.239 Tm (London, )Tj -0.0178 Tc 4.01 0 Td (1974. )Tj 0 Tc -20.34 -1.112 Td (4)Tj 0.365 0.365 0.357 rg 0.568 0 Td (. )Tj 0.243 0.243 0.239 rg 0.0046 Tc 1.245 0 Td (Kilian )Tj -0.0163 Tc 2.81 0 Td (M.)Tj 0.365 0.365 0.357 rg 0 Tc 1.399 0 Td (-)Tj 0.243 0.243 0.239 rg 0.0372 Tc 0.826 0 Td (Haemophilus./n: )Tj 0.0356 Tc 7.434 0 Td (Manual )Tj 0.05 Tc 9.4598 0 0 8.2 455.91 711.12 Tm (of )Tj 0.0098 Tc 8.2 0 0 8.2 464.56 711.12 Tm (clinical )Tj 0.0089 Tc 3.285 0 Td (microbiology. )Tj 0 Tc -22.013 -1.054 Td (E)Tj 0.365 0.365 0.357 rg 0.629 0 Td (.)Tj 0.243 0.243 0.239 rg 0.0343 Tc 0.191 0 Td (H. )Tj 0.0093 Tc 1.346 0 Td (Lennette. )Tj /T1_1 1 Tf 0.05 Tc 8.4405 0 0 8 362.33 702.48 Tm (eta/, )Tj /T1_0 1 Tf -0.0134 Tc 8.2 0 0 8.2 381.03 702.48 Tm (eds. )Tj /T1_1 1 Tf 0.0403 Tc 8 0 0 8 396.6 702.48 Tm (Amer )Tj 0.05 Tc 8.0335 0 0 8 416.63 702.48 Tm (Soc )Tj 8.3694 0 0 8 430.04 702.48 Tm (for )Tj 0.0172 Tc 8 0 0 8 443.12 702.48 Tm (Microbiol, )Tj /T1_0 1 Tf 0.0235 Tc 8.2 0 0 8.2 480.93 702.48 Tm (Washington )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.3651 0 0 8.2 524.6 702.48 Tm (DC, )Tj EMC ET BT /T1_0 1 Tf -0.0325 Tc 8.2 0 0 8.2 311.24 693.36 Tm (1985, )Tj -0.0291 Tc 2.423 0 Td (387)Tj 0.365 0.365 0.357 rg 0 Tc 1.463 0 Td (-)Tj 0.243 0.243 0.239 rg -0.0291 Tc 0.585 0 Td (393)Tj 0.365 0.365 0.357 rg 0 Tc 1.454 0 Td (. )Tj 0.243 0.243 0.239 rg /T1_1 1 Tf -0.035 Tc 7.5657 0 0 8.1 310.48 684.73 Tm (5. )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0359 Tc 8.2 0 0 8.2 324.33 684.73 Tm (Santanam )Tj EMC /Suspect <>BDC 0.169 g 0 Tc 4.813 0 Td (P)Tj 0.365 0.365 0.357 rg 0.628 0 Td (. )Tj EMC ET BT 0.243 0.243 0.239 rg /T1_0 1 Tf 8.2 0 0 8.2 375.744 684.73 Tm [(-)-847(A )]TJ -0.0045 Tc 2.526 0 Td (modified )Tj 0.022 Tc 4.273 0 Td (method )Tj 8.2 0 0 8.2 324.33 684.73 Tm 16.865 0 Td (for )Tj 0.0149 Tc 1.875 0 Td (differentiation )Tj 0.05 Tc 8.9033 0 0 8.2 532.24 684.73 Tm (of )Tj /T1_1 1 Tf 0.0096 Tc 8 0 0 8 310.63 675.61 Tm (Haemophilus )Tj -0.0095 Tc 5.919 0 Td (injluen)Tj 0.365 0.365 0.357 rg 0 Tc 2.721 0 Td (z)Tj 0.243 0.243 0.239 rg 0.0258 Tc 0.405 0 Td (ae )Tj /T1_0 1 Tf 0.0093 Tc 8.2 0 0 8.2 394.95 675.61 Tm (from )Tj /T1_1 1 Tf 0.0139 Tc 8 0 0 8 415.75 675.61 Tm (Haemophi/u)Tj 0.365 0.365 0.357 rg 0 Tc 5.035 0 Td (s )Tj 0.243 0.243 0.239 rg 0.0169 Tc 0.87 0 Td (parainjluenzae)Tj 0.365 0.365 0.357 rg 0 Tc 6.196 0 Td (. )Tj 0.243 0.243 0.239 rg 0.024 Tc 0.797 0 Td (Eur )Tj 0 Tc 8.2 0 0 8.2 535.29 675.61 Tm (J )Tj 0.0098 Tc 8 0 0 8 310.4 666.97 Tm (Clin )Tj -0.0021 Tc 2.13 0 Td (Microbio{)Tj 0.365 0.365 0.357 rg 0 Tc 4.074 0 Td (, )Tj 0.243 0.243 0.239 rg /T1_0 1 Tf 0.029 Tc 8.2 0 0 8.2 365.48 666.97 Tm (1984,3, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 7.7728 0 0 8.2 395.25 666.97 Tm (150)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 406.47 666.97 Tm (-)Tj 0.243 0.243 0.239 rg -0.035 Tc 7.0662 0 0 8.2 411.6 666.97 Tm (151)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 423.19 666.97 Tm (. )Tj EMC ET BT 0.243 0.243 0.239 rg /T1_0 1 Tf 9.2 0 0 9.2 310.45 657.85 Tm (6)Tj 0.365 0.365 0.357 rg 0.461 0 Td (. )Tj 0.243 0.243 0.239 rg 0.0281 Tc 8.2 0 0 8.2 324.4 657.85 Tm (O'Callaghan )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.4722 0 0 8.2 369.51 657.85 Tm (CH)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 382.43 657.85 Tm (, )Tj EMC ET BT 0.243 0.243 0.239 rg /T1_0 1 Tf 0.0199 Tc 8.2 0 0 8.2 386.8416 657.85 Tm (Morris )Tj 0 Tc 3.165 0 Td (A)Tj 0.365 0.365 0.357 rg 0.688 0 Td (, )Tj 0.243 0.243 0.239 rg 0.0322 Tc 0.596 0 Td (Kirby )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0478 Tc 8.2 0 0 8.2 445.775 657.85 Tm (SM. )Tj EMC /Suspect <>BDC 0.0146 Tc 2.107 0 Td (Shingler )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.3861 0 0 8.2 493.91 657.85 Tm (AH)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 507.19 657.85 Tm [(. )-37(-)]TJ 0.243 0.243 0.239 rg -0.0105 Tc 1.43 0 Td (Novel )Tj 0.022 Tc -25.412 -1.054 Td (method )Tj 0.169 g 3.562 0 Td (for )Tj 0.243 0.243 0.239 rg 0.0192 Tc 1.64 0 Td (detection )Tj 0.05 Tc 8.9033 0 0 8.2 388.24 649.21 Tm (of )Tj 0.0173 Tc 8.2 0 0 8.2 398.89 649.21 Tm (beta-lactamase )Tj 0.0047 Tc 6.615 0 Td (by )Tj 0.0147 Tc 1.521 0 Td (using )Tj 0 Tc 2.624 0 Td (a )Tj 0.0248 Tc 0.878 0 Td (chromogenic )Tj 0.0175 Tc -22.478 -1.112 Td (cephalosporin )Tj 0.0162 Tc 6.493 0 Td (substrate. )Tj /T1_1 1 Tf 0.0243 Tc 8 0 0 8 401.88 640.09 Tm (Antimicr )Tj 0.05 Tc 8.7255 0 0 8 436.45 640.09 Tm (Ag)Tj 0.365 0.365 0.357 rg 0 Tc 8 0 0 8 445.85 640.09 Tm (e)Tj 0.243 0.243 0.239 rg 0.05 Tc 8.0658 0 0 8 449.24 640.09 Tm (nts )Tj ET BT /Suspect <>BDC /T1_1 1 Tf 0.0237 Tc 8 0 0 8 464.96 640.09 Tm (Chemother)Tj 0.365 0.365 0.357 rg 0 Tc 4.644 0 Td (, )Tj EMC ET BT 0.243 0.243 0.239 rg /T1_0 1 Tf -0.0325 Tc 8.2 0 0 8.2 510.44 640.09 Tm (1972, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0171 Tc 8.2 0 0 8.2 533.7034 640.09 Tm (I, )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 8.1639 0 0 8.2 310.51 631.44 Tm (283)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 322.47 631.44 Tm (-)Tj 0.243 0.243 0.239 rg -0.0307 Tc 0.532 0 Td (288. )Tj -0.035 Tc 7.6478 0 0 8.2 310.48 622.33 Tm (7. )Tj 0.0382 Tc 8.2 0 0 8.2 324.44 622.33 Tm (Doern )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0345 Tc 8.2 0 0 8.2 349.8436 622.33 Tm (GV)Tj 0.365 0.365 0.357 rg 0 Tc 1.516 0 Td (, )Tj EMC ET BT 0.243 0.243 0.239 rg /T1_0 1 Tf 0.0326 Tc 8.2 0 0 8.2 368.0968 622.33 Tm (Tubert )Tj 0.0367 Tc 3.278 0 Td (TA. )Tj 0.365 0.365 0.357 rg 0 Tc 2.105 0 Td (-)Tj 0.243 0.243 0.239 rg 0.0217 Tc 1.06 0 Td (Detection )Tj 0.05 Tc 9.4598 0 0 8.2 457.83 622.33 Tm (of )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 3.7091 0 0 6.24 469.45 622.33 Tm <007E002D006C0061006300740061006D0061007300650020>Tj EMC ET BT /T1_0 1 Tf 0.0087 Tc 8.2 0 0 8.2 513.52 622.33 Tm (activity )Tj 0.0398 Tc -24.82 -1.112 Td (among )Tj 0.0014 Tc 3.102 0 Td (clinical )Tj 0.0093 Tc 3.221 0 Td (isolates )Tj 0.05 Tc 8.9033 0 0 8.2 389.2 613.21 Tm (of )Tj /T1_1 1 Tf 0.0061 Tc 8 0 0 8 398.46 613.21 Tm (Branhamel/a )Tj 0.365 0.365 0.357 rg 0 Tc 5.565 0 Td (c)Tj 0.243 0.243 0.239 rg 0.05 Tc 8.2134 0 0 8 446.35 613.21 Tm (at )Tj 0.0125 Tc 8 0 0 8 453.07 613.21 Tm (arrha/is )Tj /T1_0 1 Tf 0.0144 Tc 8.2 0 0 8.2 481.43 613.21 Tm (with )Tj -0.0143 Tc 2.094 0 Td (six )Tj 0.003 Tc 1.41 0 Td (different )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 3.6655 0 0 6.24 310.57 604.56 Tm <007E002D006C0061006300740061006D0061007300650020>Tj EMC ET BT /T1_0 1 Tf 0.003 Tc 8.2 0 0 8.2 353.2 604.56 Tm (assays. )Tj /T1_5 1 Tf 0 Tc 8 0 0 8 379.13 604.56 Tm (J )Tj ET BT /Suspect <>BDC /T1_1 1 Tf -0.0102 Tc 8 0 0 8 386.242 604.56 Tm (Clin )Tj EMC ET BT /T1_1 1 Tf 0.0015 Tc 8 0 0 8 403.282 604.56 Tm (Microb, )Tj /T1_0 1 Tf -0.0185 Tc 8.2 0 0 8.2 432.68 604.56 Tm (1987)Tj 0.365 0.365 0.357 rg 0 Tc 1.891 0 Td (, )Tj ET BT /Suspect <>BDC 0.243 0.243 0.239 rg /T1_0 1 Tf -0.0009 Tc 8.2 0 0 8.2 453.0652 604.56 Tm (25, )Tj EMC ET BT /T1_0 1 Tf -0.0185 Tc 8.2 0 0 8.2 466.7592 604.56 Tm (1380)Tj 0.365 0.365 0.357 rg 0 Tc 1.955 0 Td (-)Tj 0.243 0.243 0.239 rg -0.0325 Tc 0.621 0 Td (1383. )Tj -0.035 Tc 7.7659 0 0 8.2 310.42 595.92 Tm (8. )Tj 0.0129 Tc 8.2 0 0 8.2 324.44 595.92 Tm (Maesen )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0135 Tc 8.2 0 0 8.2 354.6898 595.92 Tm (FPV, )Tj EMC ET BT /T1_0 1 Tf 0.0105 Tc 8.2 0 0 8.2 376.2804 595.92 Tm (Davies )Tj -0.0283 Tc 3.266 0 Td (81)Tj 0.365 0.365 0.357 rg 0 Tc 0.996 0 Td (, )Tj ET BT /Suspect <>BDC 0.243 0.243 0.239 rg /T1_0 1 Tf 0.0196 Tc 8.2 0 0 8.2 417.1 595.92 Tm (Van )Tj EMC ET BT /T1_0 1 Tf 0.049 Tc 8.2 0 0 8.2 435.4024 595.92 Tm (Noord )Tj 0.026 Tc 3.209 0 Td (JA. )Tj 0.365 0.365 0.357 rg 0 Tc 1.927 0 Td (-)Tj 0.169 g 0.0063 Tc 1.06 0 Td (Doxycycline )Tj 0.243 0.243 0.239 rg -0.035 Tc 7.9356 0 0 8.2 532.74 595.92 Tm (in )Tj 0.169 g 0.0238 Tc 8.2 0 0 8.2 310.07 586.8 Tm (respiratory )Tj 0.243 0.243 0.239 rg 0.0015 Tc 5.027 0 Td (infections: )Tj 0 Tc 4.682 0 Td (a )Tj 0.169 g 0.0011 Tc 0.945 0 Td (re-assessment )Tj 0.243 0.243 0.239 rg 0.0431 Tc 6.021 0 Td (after )Tj 0.169 g -0.035 Tc 6.9831 0 0 8.2 467.76 586.8 Tm (17 )Tj 0.243 0.243 0.239 rg 0.0091 Tc 8.2 0 0 8.2 478.07 586.8 Tm (years. )Tj /T1_5 1 Tf 0 Tc 8 0 0 8 501.53 586.8 Tm (J )Tj /T1_1 1 Tf 0.0328 Tc 0.984 0 Td (Antimicr )Tj 0.0162 Tc -24.875 -1.14 Td (Chemother)Tj 0.365 0.365 0.357 rg 0 Tc 4.63 0 Td (. )Tj 0.243 0.243 0.239 rg /T1_0 1 Tf -0.0185 Tc 8.2 0 0 8.2 352.04 577.68 Tm (1986)Tj 0.365 0.365 0.357 rg 0 Tc 1.891 0 Td (, )Tj ET BT /Suspect <>BDC 0.243 0.243 0.239 rg /T1_0 1 Tf -0.035 Tc 7.7937 0 0 8.2 373.17 577.68 Tm (18, )Tj EMC ET BT /T1_0 1 Tf 7.5656 0 0 8.2 385.34 577.68 Tm (531)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 397.35 577.68 Tm (-)Tj 0.243 0.243 0.239 rg -0.035 Tc 8.0457 0 0 8.2 402.13 577.68 Tm (536. )Tj -0.0227 Tc 8.2 0 0 8.2 309.99 569.05 Tm (9. )Tj 0.0158 Tc 1.762 0 Td (McLeod )Tj 0.05 Tc 8.4368 0 0 8.2 359.48 569.05 Tm (DT)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 370.91 569.05 Tm (, )Tj 0.169 g 0.0416 Tc 0.951 0 Td (Ahmad )Tj ET BT /Suspect <>BDC 0.243 0.243 0.239 rg /T1_0 1 Tf 0.05 Tc 8.5832 0 0 8.2 409.88 569.05 Tm (F, )Tj EMC ET BT /T1_0 1 Tf 0.0337 Tc 8.2 0 0 8.2 423.28 569.05 Tm (Croughan )Tj 0.05 Tc 8.3094 0 0 8.2 463.64 569.05 Tm (MJ, )Tj 0.0456 Tc 8.2 0 0 8.2 483.28 569.05 Tm (Calder )Tj 0.0114 Tc 3.576 0 Td (MA. )Tj 0.365 0.365 0.357 rg 0 Tc 2.687 0 Td (-)Tj 0.169 g 0.0218 Tc -27.33 -1.113 Td (Bronchopulmonary )Tj 0.243 0.243 0.239 rg 0.0119 Tc 8.367 0 Td (infection )Tj 0.044 Tc 3.921 0 Td (due )Tj -0.0137 Tc 1.822 0 Td (to )Tj /T1_1 1 Tf -0.0206 Tc 8 0 0 8 435.42 559.92 Tm (B. )Tj 0.0173 Tc 1.185 0 Td (catarrhal )Tj -0.035 Tc 7.8945 0 0 8 475.58 559.92 Tm (is: )Tj /T1_0 1 Tf 0.0014 Tc 8.2 0 0 8.2 485.2 559.92 Tm (clinical )Tj 0.0056 Tc 3.277 0 Td (features )Tj 0.169 g 0.045 Tc -24.643 -1.052 Td (and )Tj 0.243 0.243 0.239 rg 0.0191 Tc 1.939 0 Td (therapeutic )Tj 0.0106 Tc 4.977 0 Td (response)Tj 0.365 0.365 0.357 rg 0 Tc 3.61 0 Td (. )Tj 0.243 0.243 0.239 rg /T1_1 1 Tf 0.0013 Tc 8 0 0 8 400.88 551.29 Tm (Drugs. )Tj /T1_0 1 Tf 0.0166 Tc 8.2 0 0 8.2 426.92 551.29 Tm (1986,31 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0245 Tc 8.2 0 0 8.2 457.342 551.29 Tm (\(Suppl. )Tj EMC /Suspect <>BDC -0.0255 Tc 3.455 0 Td (3\), )Tj EMC ET BT /T1_0 1 Tf -0.0119 Tc 8.2 0 0 8.2 497.481 551.29 Tm (109)Tj 0.365 0.365 0.357 rg 0 Tc 1.428 0 Td (-)Tj 0.243 0.243 0.239 rg -0.035 Tc 7.9309 0 0 8.2 514.77 551.29 Tm (112. )Tj 8.0574 0 0 8.2 310.76 542.17 Tm (10)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 318.55 542.17 Tm (. )Tj ET BT /Suspect <>BDC 0.169 g /T1_0 1 Tf 0.0191 Tc 8.2 0 0 8.2 328.759 542.17 Tm (Pollard )Tj EMC /Suspect <>BDC 0.243 0.243 0.239 rg 0.026 Tc 3.218 0 Td (JA, )Tj EMC ET BT /T1_0 1 Tf 0.0124 Tc 8.2 0 0 8.2 369.0866 542.17 Tm (Wallace )Tj 0.169 g 0.05 Tc 8.2706 0 0 8.2 398.84 542.17 Tm (RJ )Tj ET BT /Suspect <>BDC 0.243 0.243 0.239 rg /T1_0 1 Tf 0.0449 Tc 8.2 0 0 8.2 409.87 542.17 Tm (Jr, )Tj EMC ET BT /T1_0 1 Tf 0.0373 Tc 8.2 0 0 8.2 420.9974 542.17 Tm (Nash )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.05 Tc 8.6439 0 0 8.2 441.08 542.17 Tm (DR, )Tj EMC ET BT /T1_0 1 Tf 0.0419 Tc 8.2 0 0 8.2 458.36 542.17 Tm (Luman )Tj 0.05 Tc 8.8155 0 0 7.9001 485.23 542.17 Tm (Jl)Tj 0.365 0.365 0.357 rg 0 Tc 7.9001 0 0 7.9001 491.88 542.17 Tm (, )Tj 0.243 0.243 0.239 rg 0.0095 Tc 8.2 0 0 8.2 496.29 542.17 Tm (Wilson )Tj 0.0082 Tc 3.218 0 Td (RW. )Tj ET BT /Suspect <>BDC 0.365 0.365 0.357 rg /T1_0 1 Tf 0 Tc 8.2 0 0 8.2 309.986 533.5272 Tm (-)Tj EMC ET BT 0.243 0.243 0.239 rg /T1_0 1 Tf 0.0141 Tc 8.2 0 0 8.2 316.7346 533.5272 Tm (Incidence )Tj 0.05 Tc 8.9033 0 0 8.2 351.27 533.53 Tm (of )Tj /T1_1 1 Tf 0.0121 Tc 8 0 0 8 360.54 533.53 Tm (Branhamelfa )Tj 0.0072 Tc 5.565 0 Td (catarrhalis )Tj /T1_0 1 Tf 0.0001 Tc 8.2 0 0 8.2 442.97 533.53 Tm (in )Tj 0.0351 Tc 1.06 0 Td (the )Tj 0.0498 Tc 1.51 0 Td (sputa )Tj 0.05 Tc 9.4598 0 0 8.2 485.19 533.53 Tm (of )Tj 0.0259 Tc 8.2 0 0 8.2 494.89 533.53 Tm (patients )Tj -0.0247 Tc 3.568 0 Td (with )Tj 0.0211 Tc -26.116 -1.112 Td (chronic )Tj 0.0176 Tc 3.455 0 Td (lung )Tj -0.0032 Tc 2.106 0 Td (disease. )Tj /T1_1 1 Tf 0.0013 Tc 8 0 0 8 384.56 524.41 Tm (Drugs. )Tj 0.169 g /T1_0 1 Tf -0.035 Tc 8.0056 0 0 8.2 410.6 524.41 Tm (1986, )Tj 0.243 0.243 0.239 rg 7.2407 0 0 8.2 430.48 524.41 Tm (31 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0147 Tc 8.2 0 0 8.2 441.02 524.41 Tm (\(Suppl. )Tj EMC /Suspect <>BDC 0.0308 Tc 7.8001 0 0 7.8001 468.87 524.41 Tm (3\), )Tj EMC /Suspect <>BDC 0.0084 Tc 8.2 0 0 8.2 481.16 524.41 Tm (103-108. )Tj EMC ET BT /T1_0 1 Tf 0.0403 Tc 8.8 0 0 8.8 310.98 515.29 Tm (II. )Tj 0.0105 Tc 8.2 0 0 8.2 328.28 515.29 Tm (Davies )Tj -0.0137 Tc 8.8 0 0 8.8 354.2 515.29 Tm (BI, )Tj 0.0129 Tc 8.2 0 0 8.2 367.64 515.29 Tm (Maesen )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0135 Tc 8.2 0 0 8.2 396.9304 515.29 Tm (FPV. )Tj EMC ET BT 0.565 0.569 0.557 rg /T1_0 1 Tf 0 Tc 8.2 0 0 8.2 417.5124 515.29 Tm (-)Tj 0.243 0.243 0.239 rg 0.0238 Tc 0.879 0 Td (Quinolones )Tj 0.0001 Tc 5.152 0 Td (in )Tj 0.0335 Tc 1.111 0 Td (chest )Tj 0.0042 Tc 2.518 0 Td (infections. )Tj /T1_5 1 Tf 0 Tc 7.8001 0 0 7.8001 534.65 515.29 Tm (J )Tj /T1_1 1 Tf 0.0328 Tc 8 0 0 8 310.2 506.65 Tm (Antimicr )Tj 0.0066 Tc (Chemother. )Tj /T1_0 1 Tf -0.0325 Tc 8.2 0 0 8.2 384.2 506.65 Tm (1986, )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.035 Tc 7.7937 0 0 8.2 405.33 506.65 Tm (18, )Tj EMC ET BT /T1_0 1 Tf -0.0088 Tc 8.2 0 0 8.2 417.07 506.65 Tm (296)Tj 0.365 0.365 0.357 rg 0 Tc 1.517 0 Td (-)Tj 0.243 0.243 0.239 rg -0.035 Tc 8.1639 0 0 8.2 433.87 506.65 Tm (299)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 446.23 506.65 Tm (. )Tj ET BT /Suspect <>BDC 0.243 0.243 0.239 rg /T1_0 1 Tf 0.0397 Tc 8.2 0 0 8.2 310.0362 491.2832 Tm (RESUME: )Tj EMC ET BT /T1_0 1 Tf -0.0124 Tc 8.2 0 0 8.2 352.2744 491.2832 Tm (Les )Tj 0.0157 Tc 1.935 0 Td (resultats )Tj -0.0176 Tc 3.972 0 Td (des )Tj 0.0194 Tc 1.815 0 Td (cultures )Tj 0.05 Tc 8.2927 0 0 8.2 446.32 491.28 Tm (de )Tj 0.0401 Tc 8.2 0 0 8.2 458.32 491.28 Tm (crachat )Tj 0.05 Tc 8.3173 0 0 8.2 488.07 491.28 Tm (et )Tj -0.02 Tc 8.2 0 0 8.2 499.13 491.28 Tm (les )Tj 0.0105 Tc 1.528 0 Td (tests )Tj 0.0026 Tc 2.334 0 Td (de )Tj 0.0071 Tc -26.932 -1.112 Td (susceptibilitie )Tj 0.05 Tc 8.4919 0 0 8.2 357.52 482.16 Tm (ont )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0278 Tc 8.2 0 0 8.2 370.47 482.16 Tm (eti: )Tj EMC ET BT /T1_0 1 Tf 0.0003 Tc 8.2 0 0 8.2 382.073 482.16 Tm (revus )Tj 0.05 Tc 8.2675 0 0 8.2 401.77 482.16 Tm (pour )Tj -0.02 Tc 8.2 0 0 8.2 419.45 482.16 Tm (les )Tj 0.0206 Tc 1.287 0 Td (annees )Tj -0.035 Tc 8.1597 0 0 8.2 455.24 482.16 Tm (1977 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 12.4 0 0 12.4 472.19 482.16 Tm (a )Tj EMC ET BT /T1_0 1 Tf -0.0185 Tc 8.2 0 0 8.2 478.76 482.16 Tm (1986 )Tj 0.0184 Tc 2.073 0 Td (avec )Tj 0.0115 Tc 2.048 0 Td (environ )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0178 Tc 8.2 0 0 8.2 310.7584 473.5336 Tm (1,700 )Tj EMC ET BT /T1_0 1 Tf 0.0194 Tc 8.2 0 0 8.2 330.6352 473.5336 Tm (cultures )Tj 0.0035 Tc 3.64 0 Td (positives )Tj 0.05 Tc 8.4273 0 0 8.2 392.65 473.53 Tm (par )Tj 0.0237 Tc 8.2 0 0 8.2 406.96 473.53 Tm (an. )Tj /T1_1 1 Tf 0.0096 Tc 8 0 0 8 420.55 473.53 Tm (Haemophifus )Tj 0.0123 Tc 5.799 0 Td (injluenzae )Tj /T1_0 1 Tf 0 Tc 8.2 0 0 8.2 502.96 473.53 Tm (a )Tj 0.0257 Tc 0.885 0 Td (toujours )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0236 Tc 8.2 0 0 8.2 309.9976 464.4116 Tm (occupe )Tj EMC ET BT /T1_0 1 Tf -0.035 Tc 7.9307 0 0 8.2 336.91 464.41 Tm (Ia )Tj 0.0128 Tc 8.2 0 0 8.2 346.09 464.41 Tm (premiere )Tj 0.0026 Tc 4.039 0 Td (place)Tj 0.365 0.365 0.357 rg 0 Tc 2.149 0 Td (, )Tj 0.243 0.243 0.239 rg 0.0327 Tc 0.591 0 Td (ayant )Tj 0.05 Tc 8.2761 0 0 8.2 423.76 464.41 Tm (apparu )Tj 8.2717 0 0 8.2 451.12 464.41 Tm (dans )Tj 0.0324 Tc 8.2 0 0 8.2 470.78 464.41 Tm (65% )Tj 0.0117 Tc 2.344 0 Td (des )Tj -0.0048 Tc 1.751 0 Td (specimens )Tj 0.0075 Tc -23.691 -1.055 Td (positifs )Tj 0.0133 Tc 3.149 0 Td (en )Tj -0.035 Tc 8.1597 0 0 8.2 346.28 455.76 Tm (1977 )Tj 0.05 Tc 8.3173 0 0 8.2 363.27 455.76 Tm (et )Tj 0.0362 Tc 8.2 0 0 8.2 371.44 455.76 Tm (dans )Tj 0.0385 Tc 2.165 0 Td (37% )Tj 0.0117 Tc 2.109 0 Td (des )Tj 0.0154 Tc 1.579 0 Td (echantillons )Tj 0.0133 Tc 5.21 0 Td (en )Tj -0.035 Tc 8.1597 0 0 8.2 473 455.76 Tm (1986)Tj 0.365 0.365 0.357 rg 0 Tc 8.2 0 0 8.2 488.47 455.76 Tm (. )Tj 0.243 0.243 0.239 rg /T1_1 1 Tf 0.0171 Tc 8 0 0 8 491.99 455.76 Tm (Streptococcus )Tj 0.0144 Tc -22.825 -1.139 Td (pneumoniae )Tj /T1_0 1 Tf 0.0119 Tc 8.2 0 0 8.2 351.28 446.65 Tm (occupe )Tj -0.035 Tc 7.9307 0 0 8.2 376.75 446.65 Tm (Ia )Tj 0.0069 Tc 8.2 0 0 8.2 384.4 446.65 Tm (deuxieme )Tj 0.0172 Tc 4.167 0 Td (place)Tj 0.365 0.365 0.357 rg 0 Tc 2.149 0 Td (, )Tj 0.243 0.243 0.239 rg -0.0011 Tc 0.474 0 Td (avec )Tj 0.0398 Tc 2.059 0 Td (une )Tj 0.0336 Tc 1.746 0 Td (augmentation )Tj 0.05 Tc 8.2927 0 0 8.2 520.72 446.65 Tm (de )Tj -0.035 Tc 6.9831 0 0 8.2 531.6 446.65 Tm (17 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 12.4 0 0 12.4 309.95 438 Tm (a )Tj EMC ET BT /T1_0 1 Tf 0.0295 Tc 8.2 0 0 8.2 316.75 438 Tm (27% )Tj 0.05 Tc 8.3101 0 0 8.2 335.92 438 Tm (au )Tj 0.0199 Tc 8.2 0 0 8.2 346.96 438 Tm (cours )Tj 0.0026 Tc 2.634 0 Td (de )Tj -0.035 Tc 7.9307 0 0 8.2 379.63 438 Tm (Ia )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0272 Tc 8.2 0 0 8.2 388.3 438 Tm (meme )Tj EMC /Suspect <>BDC 0.0192 Tc 2.872 0 Td (periode )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.2463 0 0 8.2 440.08 438 Tm (durant )Tj 0.0107 Tc 8.2 0 0 8.2 466.49 438 Tm (laquelle )Tj /T1_1 1 Tf 0.0061 Tc 8 0 0 8 496.38 438 Tm (Branhamelfa )Tj 0.0012 Tc -23.295 -1.139 Td (catarrhalis )Tj /T1_0 1 Tf -0.0178 Tc 8.2 0 0 8.2 349.35 428.89 Tm (est )Tj ET BT /Suspect <>BDC 0.169 g /T1_0 1 Tf 0.0189 Tc 8.2 0 0 8.2 361.9288 428.89 Tm (passee )Tj EMC ET BT 0.243 0.243 0.239 rg /T1_0 1 Tf 0.05 Tc 8.2927 0 0 8.2 387.28 428.89 Tm (de )Tj /T1_1 1 Tf 0 Tc 8 0 0 8 399.28 428.89 Tm (5 )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 12.4 0 0 12.4 406.91 428.89 Tm (a )Tj EMC ET BT /T1_0 1 Tf 0.0144 Tc 8.2 0 0 8.2 414.67 428.89 Tm (26%. )Tj -0.0124 Tc 2.694 0 Td (Les )Tj 0.0326 Tc 1.81 0 Td (chances )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0191 Tc 8.2 0 0 8.2 482.8612 428.89 Tm (theoriques )Tj EMC ET BT /T1_0 1 Tf 0.0359 Tc 8.2 0 0 8.2 522.7296 428.89 Tm (pour )Tj 0.0394 Tc -25.943 -1.113 Td (qu'une )Tj 0.0176 Tc 3.461 0 Td (therapie )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0 Tc 12.4 0 0 12.4 370.43 419.76 Tm (a )Tj EMC ET BT /T1_0 1 Tf 0.0102 Tc 8.2 0 0 8.2 380.09 419.76 Tm (l'aveugle )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0118 Tc 8.2 0 0 8.2 414.6284 419.76 Tm (echoue )Tj EMC ET BT /T1_0 1 Tf 0.05 Tc 8.4919 0 0 8.2 443.44 419.76 Tm (ont )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.043 Tc 8.2 0 0 8.2 459.75 419.76 Tm (ete )Tj EMC ET BT /T1_0 1 Tf 0.0135 Tc 8.2 0 0 8.2 474.1574 419.76 Tm (calculees )Tj 0.0059 Tc 4.327 0 Td (selon )Tj -0.035 Tc 5.2499 0 0 8.2 532.77 419.76 Tm (La )Tj 0.0029 Tc 8.2 0 0 8.2 309.99 411.12 Tm (frequence )Tj 0 Tc 4.333 0 Td (d)Tj 0.365 0.365 0.357 rg 0.584 0 Td (')Tj 0.243 0.243 0.239 rg 0.0325 Tc 0.235 0 Td (apparition )Tj -0.0176 Tc 4.683 0 Td (des )Tj ET BT /Suspect <>BDC /T1_0 1 Tf -0.0075 Tc 8.2 0 0 8.2 404.0686 411.12 Tm (especes )Tj EMC ET BT /T1_0 1 Tf 0.0208 Tc 8.2 0 0 8.2 431.5304 411.12 Tm (bacteriennes )Tj 0.0055 Tc 5.551 0 Td (individuelles )Tj 0.0167 Tc 5.56 0 Td (dans )Tj 0.169 g -0.035 Tc 7.6601 0 0 8.2 309.34 401.53 Tm (1es )Tj 0.243 0.243 0.239 rg 0.0278 Tc 8.2 0 0 8.2 320.08 401.53 Tm (cultures )Tj 0.05 Tc 8.2927 0 0 8.2 348.88 401.53 Tm (de )Tj 0.0401 Tc 8.2 0 0 8.2 358.48 401.53 Tm (crachat )Tj 0.05 Tc 8.3173 0 0 8.2 385.35 401.53 Tm (et )Tj 0.0205 Tc 8.2 0 0 8.2 393.48 401.53 Tm (selon )Tj -0.0023 Tc 2.406 0 Td (le )Tj 0.022 Tc 0.946 0 Td (pourcentage )Tj 0.05 Tc 8.2927 0 0 8.2 464.56 401.53 Tm (de )Tj 0.0135 Tc 8.2 0 0 8.2 474.6 401.53 Tm (souches )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0113 Tc 8.2 0 0 8.2 503.0294 401.53 Tm (resistantes )Tj EMC /Suspect <>BDC 0 Tc 11.8 0 0 11.8 309.48 392.89 Tm (a )Tj EMC ET BT 0.169 g /T1_0 1 Tf 0.0066 Tc 8.2 0 0 8.2 315.77 392.89 Tm (l'ampicilline, )Tj 0.243 0.243 0.239 rg -0.035 Tc 7.9307 0 0 8.2 360.91 392.89 Tm (Ia )Tj 0.0156 Tc 8.2 0 0 8.2 368.56 392.89 Tm (cotrimoxazole, )Tj -0.035 Tc 7.9307 0 0 8.2 421.39 392.89 Tm (Ia )Tj 0.0044 Tc 8.2 0 0 8.2 428.56 392.89 Tm (deoxycycline, )Tj 0.169 g 0.0248 Tc 5.855 0 Td (l'erythromycine )Tj 0.243 0.243 0.239 rg 0.0022 Tc 6.788 0 Td (et )Tj 0.0103 Tc -27.1 -1.113 Td (l'otloxacine, )Tj 0.0184 Tc 5.267 0 Td (avec )Tj 0.0305 Tc 2.107 0 Td (cependant )Tj 0.05 Tc 8.2333 0 0 8.2 408 383.76 Tm (un )Tj 0.0135 Tc 8.2 0 0 8.2 419.05 383.76 Tm (plus )Tj 0.0493 Tc 1.98 0 Td (grand )Tj 0.0298 Tc 2.75 0 Td (avantage )Tj 0.05 Tc 8.2675 0 0 8.2 491.53 383.76 Tm (pour )Tj 0.0084 Tc 8.2 0 0 8.2 510.17 383.76 Tm (l'ofioxa\255)Tj -0.0013 Tc -24.47 -1.054 Td (cine )Tj 0.0022 Tc 1.872 0 Td (et )Tj 0.169 g -0.035 Tc 7.9307 0 0 8.2 333.07 375.12 Tm (Ia )Tj 0.243 0.243 0.239 rg 0.0156 Tc 8.2 0 0 8.2 340.72 375.12 Tm (cotrimoxazole. )Tj 0.169 g 0.0235 Tc 6.448 0 Td (Aucune )Tj 0.243 0.243 0.239 rg 0.0149 Tc 3.385 0 Td (explication )Tj -0.0031 Tc 4.868 0 Td (ne )Tj 0.0386 Tc 1.173 0 Td (pouvait )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0347 Tc 8.2 0 0 8.2 498.6274 375.12 Tm (etre )Tj EMC ET BT /T1_0 1 Tf 0.0036 Tc 8.2 0 0 8.2 513.986 375.12 Tm (fournie )Tj 0.05 Tc 8.2675 0 0 8.2 309.61 366 Tm (pour )Tj 0.0248 Tc 8.2 0 0 8.2 328.53 366 Tm (!'augmentation )Tj 0.0026 Tc (de )Tj -0.035 Tc 7.9307 0 0 8.2 393.07 366 Tm (Ia )Tj ET BT /Suspect <>BDC /C0_0 1 Tf 0 Tc 3.6655 0 0 6.24 401.77 366 Tm <007E002D006C0061006300740061006D0061007300650020>Tj EMC ET BT /T1_0 1 Tf 0.0357 Tc 8.2 0 0 8.2 444.49 366 Tm (produite )Tj 0.05 Tc 8.4273 0 0 8.2 476.17 366 Tm (par )Tj /T1_1 1 Tf -0.0206 Tc 8 0 0 8 490.62 366 Tm (B. )Tj 0.0057 Tc 1.185 0 Td (catarrhalis, )Tj /T1_0 1 Tf 0.0061 Tc 8.2 0 0 8.2 309.59 357.37 Tm (rna )Tj -0.035 Tc 7.8068 0 0 8.2 320.58 357.37 Tm (is )Tj 7.9307 0 0 8.2 327.31 357.37 Tm (Ia )Tj 0.0243 Tc 8.2 0 0 8.2 334.96 357.37 Tm (disparition )Tj 0.05 Tc 8.2927 0 0 8.2 373.84 357.37 Tm (de )Tj /T1_1 1 Tf 0.0096 Tc 8 0 0 8 384.07 357.37 Tm (Haemophi/us )Tj 0.0123 Tc 5.605 0 Td (parainjluenzae )Tj /T1_0 1 Tf 0.0276 Tc 8.2 0 0 8.2 479.92 357.37 Tm (aurait )Tj 0.05 Tc 8.2998 0 0 8.2 502.09 357.37 Tm (pu )Tj 0.007 Tc 8.2 0 0 8.2 513.11 357.37 Tm (resulter )Tj 0.0117 Tc -24.828 -1.112 Td (des )Tj 0.0211 Tc 1.698 0 Td (ameliorations )Tj 0.05 Tc 8.2998 0 0 8.2 372.4 348.25 Tm (du )Tj ET BT /Suspect <>BDC /T1_0 1 Tf 0.0111 Tc 8.2 0 0 8.2 384.49 348.25 Tm (procede )Tj EMC ET BT /T1_0 1 Tf 0.0158 Tc 8.2 0 0 8.2 413.682 348.25 Tm (d'identification. )Tj ET endstream endobj 62 0 obj <>stream Hd͊zy8 >sRhF^#y QG#Oç==o/ϧ;c_mӷKv|~_oo~y>}~W=|z>{O݇q~?>Ï?o+~ߒ~;%zΏx߽w;>lp?(O?{wٸ^ PZUuTGu^5P5FjFDMԤU PjVjUmFmک]uPuNNE]E5|| _#_k55|| _#_k55|| _#_k55|| _#_k5Z||-_+_kZ||-_+_kZ||-_+_kZ||-_+_ku:||_'_uu:||_'_uu:||_'_uu:||_'_uz||=_/_z||=_/_z||=_/_z||=_/_ || ߀o77 || ߀o77 || ߀o77 || ߀o77 KG#(~? ?G#(~? ?G#(~? ?G#(~? ?z $߄o77MM&|| $߄o77MM&|| $߄o77MM&|| $߄o77MM&||3,ߌo77f||3,ߌo77f||3,ߌo77f||3,ߌo77f|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--|| "߂oȷ[--||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V||+*ߊoŷʷ[V|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|| &߆o÷ɷmm6|ۯ\t;]~~߅ww;]~~߅ww;]~~߅ww;]~~߅w߁w;;|C߁w;;|C߁w;;|C߁w;;|C߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S߉w;;NN|'S ߅w]..|K ߅w]..|K ߅w]..|K ߅w]..|?|x>/Filter/JBIG2Decode/Height 1752/ImageMask true/Length 20372/Name/X/Subtype/Image/Type/XObject/Width 1240>>stream -j%.vNjnëGՠm⑳UGYjFdF4>S}3u :Ւ`5eDyXOʽ±Rͭ]x$?%^\we#!u݃雮uifEnXŪL 9^-iql#*Cܭr(dsF0bLR޿~5>'Uaԍi4$!0W=lDE ύ^nsdIk1{`c+0ЛXBƛRC*uJZJ F#[av#~#K]MyV@g_Q %}<&Ǹis`;2wρೣԛcaU>ڥu? i1g m у[gʔ[CjqVk{v_m> #uG ׉xt2Tt3X/L%&cO4dO$F=<ݰ=#u[gwO& 3NibOkhgT"%z&j0jN( Gѭ""Uku8V=SIVu#Mh p}˚eStSQx'X_)tVءd!Z2m'}mJjV&Gẅ$'mM@x^cTA+z7O^|ȆHS\ 0*edO0=hZN! PV~6(>#J-wPNkuN݇{PyړFE{//DNKݎLtsbbG;7L?ƑaZsCfͰu3PmZb޿[!6jR7 -}^3B3sCZJ"~ xYp.ǫc3vQ:({:lƲ,'?!w+dLܺ8cbd4o0nEPm*S1FgPgb9o/'g83l&**}VpP%xkŤǛ9>A'{j& RL&oVsJ#[qQ>=%g,ꇈL VSDqC`mf6~IS]_ؙmI6kHy0m_`Eޭ<]7v>!^Jl&"-蒂ER?nXV p!b_3ߡÞ/ejX`(tliCo ҃[\yCI9]5\NDNrVbqz?X̮>C}9?i0aEz $F1g%Nma +@M.e5VmqB#9k@\dF]x%o')>Hr@g9H]g\# _cIHL!H7Dg޳# z,ݫBoynyH~tįx3~Dq[#""w9t&ݗɥpŊ|0kGpd^+]ȒZ$M3]/!y0쨳4_Xk2BNܝ#%P|lvz+3ȍ`OkTgs*ymx1# F). 7kP)Eemn0{jq)tj3~QF(筲Mr_<֮gtM`b8Ny Wy2J K9ItU%YԎє7o. ܙ,̰',&I;ZB!U*g&{t?{b]Pyl],t$ WDѨKlf g}l펣)u*v_! sӀuy2a?c#hz9_6MAEp|}Dh 9ϘW= b+  <Xgq{x1|U펕Cf8 PO:P5LsN̖ab+xH.{.6@Of2߾h,5#`cx y$1+-yĔn ho)+댩}cy/EB5.k4dA̙#I ޓ[T ^~ (TF\"*nq&Pش8o#mAlcGc5;COU9'EVx~kBo nD~i:^ 1(@Y{C;1\mnK{$͆O= 5_h7ZаU͜m'*9%ne~U# ҌMٌ-٤ $&G3beyى-*J qGhڗ0򀚷;bE³crHJ#f~7o*fWA -e厲_1e=7[kHPh0I'Ve2>%T;y_ Ӂrz~5.fˇn'8؁2ef(ܿA%Yk;-GAjj ASelfj/sˡdŪ1DnoBnTPq)Ҭ::`.RBjĬJ ܓ4;3# A&YoE,Ѻa/H>K+=4lPO cݱt~ Dц=JG qlsGi+fW{: !RhӍaA7 Kb󚊾2D k*ݗvSԴ63Nf[g.8"hYg/T_II)dxh3C&dRe˩^Зr <ՓIP\N8}Tͤ7Ov^! TದX&0*nۺzr;sHvzR r(7`F"^oj59vگnRE2Et*f}n V L* 4T'JJėhcsI>?yu9r!L/`4"h퓻v n/ndڞlS{n9!sOaܸ@.bXo28{mgcZޑjNv/a\,]޶I4- {D?g@C\rk͉*YY1,+QH R֖ /3mB2;q lVJk:˯=Kvc %25@:a>*#K}7}W 3! /qj*Mz[J[:(0cd\8mVDFSoXSV`-T..55r] ODdY]TSЩrWdx_ b jDG֘&=7frBvX95b+Xq{@A(G׬̥CUQmIytIVgV_Eg Y\9XbQ)ƲgPX6m e䲼/ˠs0ؙH©vGGDG> MDmK0Q!v]\0Ek%ܴ bt09B# g%9V.Lo8SWS6NKM!!B{-> FسB~u0S։VV?#?%5**"ϫ&s}9/^2ւhB&&߿wn=Ԑdw5 Z?nuB:5]Z$'Í.+rUd']hkqQ.n]V"LvUjg@HrǩxIFZ2?& թ2b^-ەJ N6 ļ. $,U :Z0\sS_Gķ21OYUDǸx́T`X蝙I;pMa0} IZ^: &İ+1%H]rNgۈ>;87!DJ.[_Uyc]\C \̱&[ٔ-LUoqA)9Z0151 䃾_/& -GHkRasohFt$&oNpPD)}Vz4Cb^ Gr_z+ urdy=:"G7 zrw06L*XDjJ"CGu6*^nT,!WtˇmdžcGiTJk =*Qåd!{ÄYEA7).>K:23Į73TeN)aJ'֠DmWF!OJL+uǔ]IQ3gK8CYjFHN:̽Ga-[K"L$~KdQ뗈 &7#P!Sd?׳[o+po?9o^r$4y0(0kr;gF.z  oŴ xNaH3gi:*i/k0?6~¢dB1 n2NUCh/CHQ+Q #q ?4EN%+mF> f {Ѓa*y(*cJul] gw"J}#/mJCml#?؅J ֺ ?D`jfwGB窗 h@~Y|*bw8@\Y -f@fm|ĆPPwy~ޅil˻o~1*̀ߋk!?"jM|w\~ \Թ a3rH:FnpY}G'f/pi&%R _.jw}1h״ 7_>3풺}d.K vTXL"N%uU_,#Q`H)mYfmL|A_bZ9ݙ>ǣ}i.{W^I P2{؜fL\s_>0KԝS@Zv?%F\- B1S~<n+)NKIJ[al%к8i1)n\qW>, \GBMF_Xdqo-59{j-y`JRg1M;y  81k&hUAi KCHu⫠9a]l~~1=<YsGsHI5WHoEabr/X1tߌe W"=LDO1qB]hY!.F8'))[X[c.ل}b^x~Y :T:4* A|H[Td>ZݖG#t//ŸpI< ^4)5H8l3wƶ|+(qsJa9]p7nKsfV,vhߓ=28myMؓaAH:,!uq?ƅ;rFcavBg c"h{Fk߆Ѷio7^(kk>ns*$rUFZ/;&S2",X\h X(L~ƟPG,M\JgC3C:@*IxBl?)g6C6O8³[vpuH cJnt!|+BmиGT$!}C)d~푬ESϮ"m@WD3*I/LP@̝O9v%A?\9T_詾fMy`jh{pՐ'޽EHNAqk\ M~E֌I5nb}+3q2|$ca*r/2gni&ZyW[r*pU1_j@-gЀ.DnHI2qQ_V9MuBCyb/)) ; gϹVBSrϩpH"o׵>PU!eSI" ޛʩ^mژjjnT'xa0%KyF?Mdddw&ꆃ`7jiy2J{7 !-vM)N2;FбmMN[/cL`T y7=AWfqTTX$ei": 48=` td^NI7#36@ 18j%1SnNX2c<*}XWK}u&ּN6tȮBR(i# :̙p0 vHz63?ߢЛsJ魐HJ 6^UיrJ7A 1)KNrgVIeGE?9Oz9 ⬿MI"Y]P %FB]o jpgVVY^s2HDO2 dJtHU:iZBN{ BVwxۿzjZ eezOUҩ_ogУ,[ku\wZuyN --. l 3?8pA iBtxXA<-%f(%9N4ųKeD9SZ@xI#&B/qjomnY(aYfPJu+T&Ư\(ORGOԢMESӸ-Cc1k1/;U(WH'C7镵Q@rkg<&g5쒉U]%>\<aƲ==p/WFH=.-HwQk[@ 'y-ؚxءRJt`f%Tw;Nr (&Z蓆o'Q 4mϛ'Ly>&3p_'B~K}ƭt6Q=A94p" zU0ֹ͵$'~&.yꃜĘՠP #v{)tT=bz)n!&GZ_v A70G\1 =Ġae]X[}%MX& PJ!}kli645"v6vTw/DtT +{!A P]&&6jX!7h%27,BbQ7|dy_T z yt"#|("w,>V="HW^lLJUI([ZAukDoC¿Šl'w+M6>.E8$vTؕϾbΒ'jzx߇NXJ6hX|g%z*pNP1[sB&̅g;T?/=cTa'c=oK7?^`)$"'|I& WErarlǵ\]v򘝻O ЂEoNQD4]|HH&љ$L$6f[ ;snaYwVU{Co\R||&br<9yd[ArWve&[C[I0CFj|p7z(O;dԾ2+xB|*eQ{h-jsTQ &pZLT6%'XfAH_Sg'>|ի"/'~&Ydz#{3nb'asJlqhzh+[?bN f囲LJcGO2[.%:9>? R1z0,5 XΖO!AlFqnC{Η'wro>syߤFJy"@m+QD@Cb%k?bٽl2)VK]s^@Ra*ҝ@[Cp&=ẻLj(y tkXq:WZرnc,q*u?/*x p?tDgq(&L'BG!DRy~\}*|P($ KwM0p;Ә~ 97@0wwirѪt%cJ ͸Dl{6BfQfTA~j 7>W{˵vu*% 5 |?X%]l 9l>򆾴HvX$9M7M ?8:rqҿkbaj"5 T--Idgs[|8sڈE5fc.{$2,jHs,=:Ѱ56+7[`GuҡNEw*ۢȵ"N2[T>h*q(ONlr&CYϺd F@=uen/}jS7}֔LE<~`?o `R$9iE{ewFP?FJ֞[W|ĝ5o칯KZ7e*.6'mfV֋;l.A8M"(5{8-6$6-e4"LtX =e]@WXޡz WaJAfLEٍX{2-ЃmyKkź w J؞CdWpOTL\_4sa߾͟4 |^R+W\kUвg|bM_} *u.^c>. ӕoq&֬Yp&EC#*Y=Y%?lQg)gjB Z3R;"P XK" w_3Se&{FL%5`,5ޥQ@YT=sHu0э|-FEw^E) f06Pj1"}V]f ->`NURq/9Fe86{2\℣1M %we2Vbۇ6uݕ݂*Gl:7hS; i6bËGS @0ͱ@!WKwX 'vr4D{[4?%^ DCUK}1'd8dB>Ԙg~P10zC答07 ʯ'RY1e0ѥr=w" bm$aZ#~pj7&9sI^ώL @33Izn="4o;U9dpƝ ?Q $}C8"H `-a腡l5'r[|8NV<|0$j:D8.w[{ (Ia'f'`NCk(Ƶ`֤7_l$p QxtdU2k`]%Fs'C$F-$PEb%=s}0ڛXpƪj0s:WUA*C++,!;I޺{䫯хj#_E|GFwn Jc|I~"|$," dP@ڽ.^+v^x@Pg7 1Ն_F]y8vD`$@&ke R6~r%HX p"oJD},!odaƵWlᴥ?AN1h򹳊8mĖՀÆo@\ p|8*F^堸Of> LDT4=o h(?}ۍ0eТza,!hƀ`ܢ|nn6Y'b"n3t=]0s&2!^pđH%ZyBrމ Phf }?Q6xpőøWGtM/2aHUѤ9O3&Fm3ys}d]&<4胕Cc%1j=^)m[ srf=kGW~rC[d\N`k33 {E)Y-[R%TEz,Q)nޝrŻ+@D LkI$/93 {#a^ZPy1oBͩ=4Q$?^[R-V~۲N$f"Ukn1iX Uƫ>s~zGGߧ0=L ;[kYʾ4ym҃% dcs FPNVآ(Xoi)ٽ*36lāE?mi64lsy]i?hxИĉ?ĮN-2#'iuLg@BqHy0P4`$Y^K6:#}B>t?a  WdzTU0R_e3-t;mMd'%,;fG5F܋[Γ1{LB`/s,s%+Í)p`7G ,kx7^\s*(.GG(Qzlh X>@b8\95( g\ ]җV_.ciwEڍQ!I-=Ivplu>SXje_4{{>ˇ@Wѕ7S4Z/Jߴd_OHKł eё3exw-ͧN~ȈKJc=WuB?[Ժ$VcBAզ]` ixvn<M3]d0 h)k_J9.p/C72Ƅ!BrܞL Ōp*ĽiC~_B'LhUlQ\?)ɂ8G%ګj,j!3`W f]CNM%ܹEٌ# |jQЪ 7zn:Xl~,+.{ #/ GEҟѫήue+?OխVz/w(1 NzDY҇(Xޭ*ezT>d鶚aģXW#E0ֱ1SbwLY_ f<2[%sUsyMQ|XgeP`ANDz\蘟HR  vX577N_H 9ͬ7,`:<t>9yDġKX9 mJ~wEX1dvcxbleڐoZVq)p&}>@;/>ՍͥVfO{ ȯvܤ-~Uy_ZMa` iKC#\x5g {j:òx3ȱme\b(;?T13=hs`6RDv3=6143>[xt8uDǴl6uV܋2\OP$, ,\7-6~ ɀ)*ͣjgmص>ٍ༢9gˬXS O$ŇR uJnow5,K OW(#+?Qͽn%~vJ^~n>mYJ !H'qm쾡&?FC8fLVőgX:Qɩ9ݎ9iY3f3}FT>`/@S>y96D=Eb =ZQ!hx&-y3(;lG1!$]ٶbȄ0GycxX`IyF?se- Ol'w8i%U 2IfJ7)U6TY==f%+orbuіhb)Xi@iUR`Swb,$˹O[gǨl=o%PXLŒaHJ=\e=̥Ge*;2Z9;Ӽ)5ü=KWMɴԍڏKt}EPtn8f O;ܧ U*}38{z 0* p#5@z9ttMqXn 11[}$tA ;?q,:n|Sŕ$pRG5 MbKj>v4&n!)- _G}=tC S0ͮoX :O,okk4.~g]A{-ԁUS=!*pz$;RCdNSڢ`>IY.%QK.^ ؿڍ;%MEX8La[M(2Hb)SM< A9 EӲs:& O-cxNM04x ŘHJ$:2u$焨kؔWmք=> $`%Y~ƭ'$nptTc,6it 6-I xb<:6&х7$/$-#Vˌc6?g`Ajqug# }o~ 0is$o @-Okm%Y 'iÆ峭횂!N@m8lT›r*=;fV`*"pJMz)eзh1vq^rԁiᩬܬ0i1',\ ,I6n 5]*@L4#FgA.GDi25ڎ(!h }c|lS4[;a0]3C=\tM;ö͸E0HfYGeS.3߉DF1T o$o~sICJy!VOJRĮ:J_u&W-śL,c0@C ҙ`2\pڹu:*+1!zeɨw2Fsp*q/}F;l9Gde;UyQh!%t2]O7yp3V3<lђkCWQ-z>ߔ;@ؗ,1̖\)dD-?S/I2t ŇNB*F5Uo@x0vDgc`كL锖0πIhJ x,֗G?e/C @Ii~kݲr ڡ3ڐ_ "\*>xTR|\ igUOI3D ٓnn{=j$T0ѷg,HQ?-JXTzY+ʸ?+ IF)AGMڴfOqaC^trgp+xEg GB I >stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr^colr jp2cOQ/^^R \#B@HHPHHPHHPHHP880 n߁$_x'*? Xf@L7栰*mQA O4'Q2b2U !&0>O גK{'tC" 3 e-I>==iOJsjZ˚.EXJDJqYbU3';K:_;|vEt rW2}ԉ ̾>U0ր5h¢IoX.q<~tQymS/U!T$%.#OH) J&ݹlWPV3_t(nwxhn$C{1h=C{]`0˲ l??ȬRPCˊu"*Tx'GRM=,@g8~WBx m~kʌ_gԝWRCm0WEFSXЮv쟙Vfc$lȻ_^`:UJd֜Y* Nl6.B毣:9@GZ 9,8؀PpI7/LgrnlbU>z>[[va邯Έk%2vPai-f2˔3Sb" :! xWr֪KJy`Y$UeY>?Z)"z8X8oS,iA@ީxBrqE  c_?g|=ϛbWV[]:݄dM5ڑ؎/C.5]qE+ù uiř(U:mA^uzյGLmQ9 [(7[@F'WB~E5ԫW'3L&=#v Yw{[@:QUlofwВHQ`Ϸl'2v9"_ Ki:( B+R/("s!H&+j%nmOzVDfmF^6+Z^+  Tdβ@xpoP<(?&}|~%>/EgeźI.t!#ܰ<Ƨqu;n>#I"""OROqY>Ӟv$sݗȥ /4/^$xUҾfËIEޕhmUepKEkԜ)ϜQ"]`EfB' +N,:׼,a3p 3; >xֿ1KeY%D-HsTW_S?kT?n#7z ?$,;ad:\\ DpACFV)$mׂY Qg:f~HGM3XAQm.$6 M?U -~lˏ:&hG +~_;I}Uoӿm*DhC:$ϊgCH2ekYI̩H%쯊e:Lǭ>9,PP{w؉Xֽ[uaa1ƉƝ^j+'jU?]"r ekrSL|D/p͐v75ر|0^(fU']h8fVpc VvSlgtҼOӻ lW`n'3E} Q,sֿ#aC:鄌!M%K%x%1 c/x8XwEB<8LH!qۚT׈GxQau 1KAg)%W""e@zR^]9 , cJw$d@!>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr.&colr2jp2cOQ/&.&.R \#B@HHPHHPHHPHHP880 =ϴD f;< FhL\H&/ t _]g[ G7:<LрCF(VKl;2o@@꿤pm:  SxS&BQs9ퟺ v xzЭRml l}Ren)RJF U@{L  >dTvZSEGG pڏj?H'AcFu<1)]e+ϳ[\Sz@le(XA<;hrMN(tu0+8 ץ58s$  (.89? Cr)݀ +Znb endstream endobj 66 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrcolrjp2cOQ/R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ#t0c" @@L <:4  <'|#:$}v&,-t :PsNi $ETl 8L  endstream endobj 67 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr<+colrjp2cOQ/+<+<R \#B@HHPHHPHHPHHP880 !ϴ;>C $t0 ` 5: r m|!@|!  k %|#@: sUNM@]    endstream endobj 68 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrNcolrojp2cOQ/NNR \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ #t " @ h $ |": }'m[    endstream endobj 69 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr"colrgjp2cOQ/""R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t ! @: |"1 N    endstream endobj 70 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr;colrjp2cOQ/;;R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ(< ZAtSG^##1 >@ UOLT:,@ ~z7Az< V:dP}σ62@\dni: |">stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdr%colrkjp2cOQ/%%R \#B@HHPHHPHHPHHP880 ]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHP880]$B@HHPHHPHHPHHPHHPϴ t      |!Ԁ   endstream endobj 72 0 obj <>stream jP ftypjp2 jp2 jpxbjpx rreq@ --jp2hihdrNcolrjp2cOQ/NNR \#B@HHPHHPHHPHHP880 AϴH4r2/_ %qO%}m3lt1'T? j:D5^/PzMpR:T\Ҁ_eʅ|}u=3*j?ܤ?@:42 * Rq_F~zn =PߘDix2{)D,O^cg@1Ԑ̖Cn9v^=RF篸^ۀ (Ԁ$>stream h޲4V0P4Q0U4U0W0475R0Q04210> endstream endobj 74 0 obj <>stream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endstr endstream endobj 75 0 obj <>stream hVn09&v 0ु}h I] AX,R['!9Dm}!B)IRPQeMJJ d]Q@$5EA=$H {DiXH,8 hi HbT CxQ@[ec, ISvzǨd=[+lZ'%tu%3uՊ57mҮŇj]ڈqwF`Q~l?i:Vh:e;qۼzoD(L5\޵f;P5iu1Rkum\nW-$}1^rJilܺn|Jc#n`e&n~e=Cop8I~k[LH3S5/}hA) I:;/m>. cO_{rNy(R#;~''79GNBPG̊aϳ:*]-Hk3C?f?w'_ C endstream endobj 76 0 obj <>stream h242Q0P042U07Rf  66`! ĢԼT4_jEwj~HeA~pIQi2X"(?hPP XWK~ri.P'H u" endstream endobj 77 0 obj <>stream 2012-10-24T10:37:53+01:00 2012-09-17T11:44:52+01:00 2012-10-24T10:37:53+01:00 Canon iR-ADV C2020L PDF application/pdf uuid:99d6bcdc-b8e3-4d94-9487-d909a2ec0b02 uuid:75b587dd-fc04-41f4-9834-b33ecae14d9a Adobe Acrobat 10.14 Paper Capture Plug-in endstream endobj 78 0 obj <>stream h242W0Pw/+Q0L)646)@Hs0i)3RYZlg`G endstream endobj 79 0 obj <>stream hLA 0n*a7'V  FӍbOwG>ϱL=֝: EU,zO0 V͝_A4awpa_S9´>48E㷼K_q0.M endstream endobj 80 0 obj <>/Filter/FlateDecode/ID[<2B793C921F46A241A42488A6F1E90108>]/Info 128 0 R/Length 291/Root 130 0 R/Size 129/Type/XRef/W[1 3 1]>>stream h̑/Q}Gc7"Do*I&JVN!d׷B!NT$4*T[t D@Sh6&1+њ3g{;F3NsWbR3u'*}Jwɽ(v]1nчhЗ$r'1/pSK謫q k$+lY1iFآt=ijVu2΢7kI? wRA!K,a'*xCeul<+ۋGTҳߊ%69VӷOi}*8{n_ x;T endstream endobj startxref 116 %%EOF